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 Abstract 
 
 
Parkinson’s disease (PD) is a progressive, degenerative, neurological disease. The 
progressive disability associated with PD results in substantial burdens for those with the 
condition, their families and society in terms of increased health resource use, earnings 
loss of affected individuals and family caregivers, poorer quality of life, caregiver 
burden, disrupted family relationships, decreased social and leisure activities, and 
deteriorating emotional well-being. Currently, no cure is available and the efficacy of 
available treatments, such as medication and surgical interventions, decreases with 
longer duration of the disease. Whilst the cause of PD is unknown, genetic and 
environmental factors are believed to contribute to its aetiology. Descriptive and 
analytical epidemiological studies have been conducted in a number of countries in an 
effort to elucidate the cause, or causes, of PD. Rural residency, farming, well water 
consumption, pesticide exposure, metals and solvents have been implicated as potential 
risk factors for PD in some previous epidemiological studies. However, there is 
substantial disagreement between the results of existing studies. Therefore, the role of 
environmental exposures in the aetiology of PD remains unclear. 
 
The main component of this thesis consists of a case-control study that assessed the 
contribution of environmental exposures to the risk of developing PD. An existing, 
previously unanalysed, dataset from a local case-control study was analysed to inform 
the design of the new case-control study. The analysis results suggested that regular 
exposure to pesticides and head injury were important risk factors for PD. However, due 
to the substantial limitations of this existing study, further confirmation of these results 
was desirable with a more robustly designed epidemiological study. A new exposure 
measurement instrument (a structured interviewer-delivered questionnaire) was 
developed for the new case-control study to obtain data on demographic, lifestyle, 
environmental and medical factors. Prior to its use in the case-control study, the 
questionnaire was assessed for test-retest repeatability in a series of 32 PD cases and 29 
healthy sex-, age- and residential suburb-matched electoral roll controls. High 
repeatability was demonstrated for lifestyle exposures, such as smoking and coffee/tea 
 consumption (kappas 0.70-1.00). The majority of environmental exposures, including 
use of pesticides, solvents and exposure to metal dusts and fumes, also showed high 
repeatability (kappas >0.78). 
 
A consecutive series of 163 PD case participants was recruited from a neurology clinic 
in Brisbane. One hundred and fifty-one (151) control participants were randomly 
selected from the Australian Commonwealth Electoral Roll and individually matched to 
the PD cases on age (± 2 years), sex and current residential suburb. Participants ranged 
in age from 40-89 years (mean age 67 years). Exposure data were collected in face-to-
face interviews. Odds ratios and 95% confidence intervals were calculated using 
conditional logistic regression for matched sets in SAS version 9.1. Consistent with 
previous studies, ever having been a regular smoker or coffee drinker was inversely 
associated with PD with dose-response relationships evident for packyears smoked and 
number of cups of coffee drunk per day. Passive smoking from ever having lived with a 
smoker or worked in a smoky workplace was also inversely related to PD. Ever having 
been a regular tea drinker was associated with decreased odds of PD. Hobby gardening 
was inversely associated with PD. However, use of fungicides in the home garden or 
occupationally was associated with increased odds of PD. Exposure to welding fumes, 
cleaning solvents, or thinners occupationally was associated with increased odds of PD. 
Ever having resided in a rural or remote area was inversely associated with PD. Ever 
having resided on a farm was only associated with moderately increased odds of PD. 
Whilst the current study’s results suggest that environmental exposures on their own are 
only modest contributors to overall PD risk, the possibility that interaction with genetic 
factors may additively or synergistically increase risk should be considered.  
 
The results of this research support the theory that PD has a multifactorial aetiology and 
that environmental exposures are some of a number of factors to contribute to PD risk. 
There was also evidence of interaction between some factors (eg smoking and welding) 
to moderate PD risk.  
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 1 
1.0 Introduction 
 
Parkinson’s disease (PD) is a progressive, degenerative, neurological disease 
characterised clinically by four major symptoms: rigidity, bradykinesia, tremor and 
postural instability. PD is classed primarily as a movement disorder, although 
cognitive functioning is also often affected (Adams et al. 1997). PD is generally a 
disease with an onset late in life, although a small percentage of cases have an onset 
prior to age 40. The progressive disability associated with PD results in substantial 
burdens for those with the condition, their families and society in terms of increased 
health resource use (hospitalisation, medication, surgical intervention, medical 
practitioner and allied health professional visits, nursing care), earnings loss of 
affected individuals and family caregivers, poorer quality of life, caregiver burden, 
disrupted family relationships, decreased social and leisure activities, and 
deteriorating emotional well-being (Whetten-Goldstein et al. 1997; Scheife et al. 
2000; Guttman et al. 2003). After Alzheimer’s disease, PD is the most common 
neurodegenerative disease, and an increase in the number of people with PD is 
expected over coming years due to the ageing of the ‘baby boomer’ generation 
(Hermanowicz 2001). Currently, no cure is available and the efficacy of available 
treatments, such as medication and surgical interventions, decreases with longer 
duration of the disease due to the higher doses (which are associated with side-effects 
such as drug-induced dyskinesias) that are required to counteract the disease’s 
progression (Tan 2001). Recent developments involving implantation of stem cells 
into the affected parts of brains of people with PD has shown promise as a more 
effective treatment or possible cure, however this research is still early in 
development and consistent results are yet to be obtained (Lovell-Badge 2001; 
Snyder and Olanow 2005). Therefore, PD is likely to remain a significant public 
health issue for some time due to its substantial health economic burden, and impact 
upon the quality of life of affected individuals and their families. 
 
PD has a substantial impact upon the quality of life of both affected individuals and 
their families. Motor symptoms can impair social functioning due to mobility 
difficulties and social embarrassment and as the disease progresses, the ability to 
perform activities of daily living. Psychological symptoms, particularly depression, 
and communication difficulty due to hypophonia (soft voice) can greatly affect 
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relationships. Studies measuring quality of life in people with PD report substantial 
impairment of physical, mental, emotional and social well-being of affected 
individuals (Jenkinson et al. 1995; Kuopio et al. 2000; Schrag et al. 2000; Behari et 
al. 2005; Chapuis et al. 2005). A longitudinal study in Norway showed that despite 
modern treatment and care, people with PD experienced increased distress in the 
dimensions of physical mobility, pain, social isolation, and emotional reactions after 
a 4 year follow up period compared to their baseline states (Karlsen et al. 2000). 
Caregivers of people with PD, who are typically family members, also experience 
decreased quality of life as do adolescent and adult children of people with PD .   
 
The complete economic impact of PD is difficult to quantify and estimates of the 
economic costs associated with PD vary between studies depending on which direct 
and indirect factors are included. Many costs, such as loss of income for family 
caregivers, home adaptations such as hand-rails, transportation costs and mobility 
and self-care aids are excluded from the majority of studies. A Finnish study of 
hospital outpatients with PD estimated the mean total annual cost-of-illness of PD to 
be $13,100 USD per patient with PD in 1998. Of the annual total cost burden, direct 
costs accounted for 41%, early retirement due to PD 43%, and informal home care 
16%. Of the direct costs, hospitalization was the main cost driver accounting for 
41%. PD medication accounted for 20%, formal home care 14%, rehabilitation 
outside hospitalization periods 9%, inpatient care other than hospitalization 7%, and 
hospital outpatient visits and visits to GPs and specialists 9% (Keränen et al. 2003). 
Similar results were reported in a Swedish study which estimated total mean annual 
costs at $12,400 USD per patient for the year 2000 (Hagell et al. 2002). Estimates of 
annual economic burden of PD per patient in the United States have been estimated 
at $22,914 USD for the year 1999 (Rubenstein et al. 1997; Muir and Zegarac 2001). 
Costs associated with treatment of PD increase dramatically with disease severity, 
such as the costs of assisted living or nursing home care which can exceed $100,000 
USD per patient per year (Muir and Zegarac 2001).  
 
In addition to the medical costs associated with PD-related symptoms, people with 
PD also experience more co-morbidities such as pneumonia, psychosis, 
gastrointestinal disorders, urinary tract disorders including infections, disorders of 
fluids and electrolytes and fractures, particularly hip-fractures related to their higher 
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risk of falls compared to other community-dwelling older people (Johnell et al. 1992; 
Wood et al. 2002; Guttman et al. 2004; Leibson et al. 2005; Wielinski et al. 2005). 
The rehabilitation process following injuries, such as hip-fractures, is also 
significantly slower, less successful and more resource-intensive for people with PD 
than those without (Jonsson et al. 1995).  
 
While the causes of sporadic PD have not been established, genetic and 
environmental factors are believed to contribute to its aetiology. A greater 
understanding of the causes of PD is important as this information may provide new 
strategies for prevention and treatment of the disease. Identification of environmental 
exposures that are involved in PD aetiology is important as this may lead to 
preventive measures. For example, if a particular chemical compound is strongly 
associated with increased risk of PD, stricter controls on its use could be 
implemented. Alternatively, such findings may lead to identification of metabolic 
pathways involved in PD pathogenesis. A greater understanding of the PD 
pathological process could assist development of treatments to protect the remaining 
neurons from further degeneration. Descriptive and analytical epidemiological 
studies have been conducted in a number of countries in an effort to elucidate the 
cause, or causes, of PD. However, there is substantial disagreement between the 
results of existing studies. Therefore, the role of many factors in the aetiology of PD 
remains unclear. This is particularly true for environmental factors that have been 
implicated as potential risk factors for PD in some studies. A number of issues are 
likely to contribute to the disagreement between previous studies of PD aetiology, 
including the complexity of the disease’s pathogenesis and symptom trajectory, 
geographical variation in risk factors and methodological issues. Many of the 
existing studies have potentially serious methodological flaws that may invalidate 
their results. Therefore, there is a need for well-designed epidemiological studies 
using sound methods to re-examine this issue.  
 
Few epidemiological studies of environmental exposures and PD risk have been 
conducted in the Australian setting. As environmental exposures vary between 
geographical areas it is desirable to examine potential relationships between 
environmental exposures and PD risk in multiple countries as this may lead to 
identification of unique risk factors or confirm risk factors previously identified in 
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other populations. The primary aim of this thesis is to add to the existing Australian 
studies with a well-designed epidemiological case-control study of environmental 
exposures. This thesis is divided into seven chapters. In Chapter 2, the literature 
concerning PD aetiology is reviewed, with a particular emphasis on the possible role 
of environmental exposures. Key environmental exposures are identified from this 
review, for further later examination in the main study. 
 
In Chapter 3, an existing, previously unanalysed, dataset from a local case-control 
study was analysed. The results of this analysis informed the design of the main 
study, a case-control study. The aims, research questions, hypotheses and methods 
for this original research component are outlined in Chapter 4. In preparation for the 
main study, a new exposure measurement instrument was developed. Chapter 5 
reports a test-retest repeatability study and a comparison of this new exposure 
measurement instrument and the exposure measurement instrument used in the 
dataset analysed in Chapter 3. The results of a new case-control study are presented 
in Chapter 6. Chapter 7 presents an integrated discussion and conclusions which 
cover the thesis as a whole and put the results into a public health context. Avenues 
for further research in this area are also discussed. 
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2.0 Literature Review 
 
2.1 Definition and Symptoms of PD 
The disease was named “Parkinson’s Disease” after James Parkinson, who wrote the 
first published, detailed description of the disease in his “An Essay on the Shaking 
Palsy” (Parkinson 1817). The disease is often referred to as ‘idiopathic 
parkinsonism’ to differentiate the disease from other similar conditions and 
syndromes, such as drug-induced parkinsonism. The clinical picture of PD can be 
complex and quite variable between affected individuals in terms of age of onset, 
symptoms experienced, and rate of disease progression (Agid 1991; Schiess et al. 
2000). 
The cardinal features of PD include resting tremor, akinesia (defective movement 
initiation), bradykinesia (slow movement), muscular rigidity and postural instability. 
These symptoms are usually asymmetric. Diagnosis is made by clinical assessment 
based on the presence of the cardinal features. Pathological confirmation is only 
available on autopsy, and is based on the presence of Lewy bodies1 in particular 
regions of the brain and reduced numbers of dopaminergic neurons in the substantia 
nigra pars compacta region of the brain (Gibb and Lees 1989). Standard diagnostic 
criteria, such as the UK Brain Bank Diagnostic Criteria for PD (Appendix A) or 
those of Calne et al. (1992) (Appendix A) are often used, although practitioners may 
modify these or employ their own criteria. Studies of diagnostic accuracy suggest 
many affected individuals are misdiagnosed. A clinico-pathological study of 
neurologist-diagnosed PD cases found that according to autopsy results, 24% had 
been misdiagnosed (Hughes et al. 1992). A lower rate of diagnostic accuracy can be 
expected in community-based samples where many people with PD may not have 
been examined by a neurologist. A community-based study of patients recruited from 
general medical practices found that only 53% of those diagnosed with PD had 
clinically probable PD according to standard diagnostic criteria applied by a 
neurologist (Meara et al. 1999). The highest accuracy of clinical diagnosis is 
achieved by specialist clinicians employing standard diagnostic criteria 
supplemented by long-term clinical observation (Hughes et al. 2001).  
                                                 
1 Lewy bodies are eosinophilic cytoplasmic inclusions containing the proteins ubiquitin and alpha-
synuclein. Lewy bodies are found in the brains of sufferers of neurodegenerative diseases including 
PD, Alzheimer’s disease and diffuse Lewy Body disease. 
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In addition to the cardinal features, other ‘motor’ symptoms include micrographia 
(small handwriting), a mask-like facial expression and a small shuffling walk. 
Cognitive symptoms, such as memory disturbances, and particularly depression, are 
experienced by many people with PD (Appollonio et al. 1994; Mandir and Vaughan 
2000). Dementia is also reported to be higher amongst people with PD than in the 
general population of the same age (Brown and Marsden 1984).  
 
Sensory disturbances, such as pain, tingling, numbness and burning have also been 
reported in many people with PD. Up to 90% of people with PD report a decreased 
sense of smell (Pahwa and Koller 1995). Other symptoms experienced by people 
with PD can include orthostatic hypotension (low blood pressure induced by standing 
upright), chronic gastrointestinal problems such as nausea, abdominal pain, and 
bloating (Soykan et al. 1999; Hardoff 2001), sexual dysfunction, dermatitis, 
excessive sweating, and urinary problems (Pahwa and Koller 1995). There is 
significant variability in the symptoms exhibited by people with PD and new 
symptoms may develop as the disease progresses (Schiess et al. 2000).  
 
2.2 Other Parkinsonian Syndromes 
In addition to PD there are a number of very similar conditions (outlined in Table 
2.2.1, below). Included in these syndromes are some hereditary diseases of the 
central nervous system, multiple system atrophies, infectious and post-infectious 
diseases, toxic causes, pharmacological causes and metabolic causes.  
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Table 2.2.1 Classification of Parkinsonian Syndromes 
A. Hereditary diseases of CNS associated with parkinsonism 
 Wilson’s disease, Huntington’s disease, Hallervorden-Spatz disease 
B. Multiple system atrophies with parkinsonian features 
 Progressive supranuclear palsy, Olivopontocerebellar atrophy, Striatonigral 
degeneration, Shy-Drager syndrome 
C. Other diseases of the CNS with parkinsonian features 
 Primary pallidal atrophy, Idiopathic dystonia-parkinsonism, 
Corticodentatonigral degeneration, Hemiatrophy-hemiparkinsonism, 
Parkinsonism-ALS-dementia complex of Guam, Atherosclerotic, 
Alzheimer’s disease, Pick’s diseases, Creutzfeldt-Jakob disease 
D. Other CNS disorders 
 Normal pressure hydrocephalus, Stroke, Tumour, Trauma, Subdural 
haematoma, Syringomesencephalia 
E. Infectious and postinfectious 
 Encephalitis lethargica, Encephalitides, Syphilis 
F. Toxic 
 Manganese, Carbon monoxide, Carbon disulfide, Cyanide, Methanol, 1-
methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) 
G. Pharmacological 
 Neuroleptics, Reserpine, tetrabenazine, α-Methyldopa, Lithium, 
Fluphenazine 
H. Metabolic causes 
 Hypoparathyroidism and basal ganglia calcification, Chronic hepatocerebral 
degeneration 
Source: Pahwa, R. and W. Koller (1995). Defining PD and Parkinsonism. Etiology 
of PD. J. Ellenberg, W. Koller and J. W. Langston. New York, Marcel Dekker Inc: 
pg 12. 
 
The range and complexity of symptoms experienced by people with PD, a substantial 
potential for misdiagnosis and the involvement of cognitive dysfunction have 
important implications for research into PD aetiology. Accurate diagnosis of 
participants is crucial to the validity of studies of PD. Inclusion of alternative 
parkinsonian syndromes in these analyses may distort the results. The potential 
impact of cognitive dysfunction on the repeatability and validity of exposure data 
collected from affected individuals needs to be considered and is discussed later in 
this review. 
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2.3 Pathophysiology 
The most prominent pathological lesion observed in PD occurs in the basal ganglia 
of the brain’s extra-pyramidal system. The disease is characterised by a gradual loss 
of pigmented cells, mainly in the compact zone of the substantia nigra. These 
pigmented cells produce and store the neurotransmitter dopamine (Hornykiewicz 
2001). While a loss of dopaminergic cells is also seen in the normal ageing process, 
the loss of cells in people with PD is highly selective (Bonnet and Houeto 1999), 
following a characteristic pattern (Agid 1991; Hornykiewicz 2001), and far more 
dramatic. Why this selective neuronal loss occurs in PD is still unclear, although 
oxidative stress mechanisms are possibly involved (Mandir and Vaughan 2000). This 
loss of dopaminergic neurons results in a deficit of dopamine in all the components 
of the basal ganglia (Adams et al. 1997; Hornykiewicz 2001). Reductions of 
dopamine by more than 95% in the putamen and 80% in the caudate nucleus2 are 
typically seen in people with PD and represent a defining biochemical feature of the 
disease (Agid 1991; Hornykiewicz 2001). 
 
It is interesting to note that before the disease becomes clinically evident as a motor 
disorder, the striatal dopamine loss must reach a critical value between 70-80% 
(Agid 1991; Hornykiewicz 2001). This lag in disease expression is explained by the 
existence of a compensatory mechanism whereby the remaining dopaminergic 
neurones increase their dopamine turnover (synthesis and release) and postsynaptic 
dopamine receptors become hypersensitive (Blum et al. 2001; Hornykiewicz 2001). 
This finding is also consistent with the generally accepted theory that the underlying 
disease process is present for some time before diagnosis. During this 
‘presymptomatic’ phase, people with PD may experience non-motor symptoms, such 
as depression or loss of olfaction, which have been reported to occur in people with 
PD up to 10-20 years before their ‘onset’ of PD (Pahwa and Koller 1995). A long 
pre-symptomatic period has important implications for the design of studies of PD 
aetiology. It may be difficult to distinguish which exposures occurred after the 
commencement of the disease process. Consideration must be given to exposures 
from many years prior to commencement of symptoms, which may be more relevant 
than recent exposures.  
                                                 
2 The putamen and the caudate nucleus are anatomical structures located in the basal ganglia of the 
brain. 
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Other neuronal systems are also affected and deteriorate to different degrees as the 
disease progresses (Agid 1991). As such, people with PD vary in their clinical 
presentation. The classic triad of motor symptoms (resting tremor, bradykinesia and 
rigidity), is mainly due to degeneration of ventral mesencephalic dopaminergic 
systems, whereas early cognitive deficits (frontal syndrome and depression) may 
arise from subcortical lesions. Between 15-30% of people with PD develop a 
dementia syndrome which may be due to damage to the cerebral cortex (Aarsland et 
al. 1996; Hornykiewicz 2001).  
 
The rate of dopaminergic neuronal degeneration differs between people with PD, 
although cell loss continues throughout the course of the disease. Cell loss has been 
estimated to range from being extremely severe (90%) over short periods of time to 
relatively mild (60%) after many years of illness, in different affected individuals 
(Agid 1991). Studies of disease progression in PD by Hoehn and Yahr (1967) and 
Marttila and Rinne (1977) have reported a marked variability in the rate of 
progression between people with PD. Some were confined to a bed or wheelchair 
within 3 years of onset, while others only experienced minimal or no functional 
impairment after 10 years with the illness (Pahwa and Koller 1995). 
 
2.3.1 Oxidative Stress 
Oxidative stress results when reduced oxygen species are formed in excessive 
amounts, producing cytotoxicity. Oxidative stress from either exogenous or 
endogenous neurotoxins has been suggested as one mechanism for the accelerated 
neuronal degeneration seen in PD. A number of studies support the role of oxidative 
stress in the degeneration of dopaminergic neurons, which have been consistently 
shown to be particularly vulnerable to reactive oxygen species (Blum et al. 2001). 
Mitochondrial dysfunction has been reported in a large percentage of people with PD 
(Mandir and Vaughan 2000), which gives support to the oxidative stress theory since 
reduced oxygen species are produced as intermediates in the production of cellular 
energy (Irwin and Langston 1995). A number of markers of oxidative stress, such as 
decreased glutathione levels3 and increased levels of malondialdehyde4 and lipid 
                                                 
3 Maintenance of high levels of glutathione is important for protection against damage induced by 
reactive oxygen intermediates by decomposing hydrogen peroxide, reacting directly with oxygen 
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hydroperoxidation, have also been reported in brains of people with PD (Dexter et al. 
1994; Irwin and Langston 1995; Mandir and Vaughan 2000; Butterfield and Kanski 
2001). 
 
The discovery that the chemical MPTP (1-methyl-4-phenyl-1, 2, 3, 6-
tetrahydropyridine) can cause parkinsonism also supports an oxidative cause of PD 
(Mandir and Vaughan 2000). MPTP binds with high affinity to the extra-neural 
enzyme, monoamine oxidase (MAO) type B, after traversing the blood brain barrier. 
This oxidation process transforms MPTP to the toxic pyridinium metabolite, MPP+ 
(1-methyl-4-phenylpyridinium). MPP+ then binds melanin in the dopaminergic 
neurons in sufficient concentration to destroy the cells (Adams et al. 1997). The 
resulting syndrome is clinically indistinguishable from idiopathic PD and produces 
an akinetic-rigid state.  
 
Environmental exposures may be involved in the aetiology of PD through oxidative 
stress mechanisms, as environmental pollutants including nitrogen dioxide (from 
vehicle exhaust fumes), halogenated hydrocarbons and pesticides may cause free 
radical reactions, either spontaneously or by active intermediates produced through 
their metabolism by the cytochrome P-450 enzyme system (Papas 1999). 
 
2.3.2 Apoptosis 
Apoptosis is a mode of cell death by which cells are programmed to 'suicide' by 
forming fragments that are phagocytised by other cells. While apoptosis is a normal 
functional process by which certain cells are removed, it may also be involved in 
various disease pathologies. Dysfunction in the regulation of apoptotic cell death can 
cause cells to die inappropriately, too much, or not at all (Stoian et al. 1996). 
Apoptosis has been suggested by some as the mode of death of cells in PD (Irwin 
and Langston 1995; Blum et al. 2001). It has been suggested that apoptosis may be 
chemically induced by the accumulation of free radicals generated either outside or 
inside the cell (Stoian et al. 1996), which is consistent with the oxidative stress 
theory. 
                                                                                                                                          
radicals and other oxidising species, and also through the repair of oxidised proteins (Irwin and 
Langston 1995) 
4Nigral polyunsaturated fatty acids are a target for peroxidation by oxygen radicals, and 
malondialdehyde is an intermediate in the lipid peroxidation process (Irwin and Langston 1995) 
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2.3.3 Inflammation 
A growing body of literature recognises the role of inflammation of the brain  
(neuroinflammation) in the pathogenesis of PD. Post-mortem examination of the 
brains of people with PD have revealed the presence of pro-inflammatory factors, 
including complement proteins5 and cytokines6 (Liu et al. 2003). Neuroinflammation 
can be induced by exposure to infectious agents, such as viruses, or to toxic 
substances. For example, the toxicity of rotenone to dopaminergic neurons is greatly 
increased by interactions with microglia7, the resident immune cells in the brain 
involved with inflammation. Rotenone appears to activate microglia to produce free 
radicals (Gao et al. 2002; Gao et al. 2003a) and has been shown to interact 
synergistically with an inflammogen (lipopolysaccharide) to induce dopaminergic 
neurodegeneration. The involvement of activated microglia releasing free radicals 
and inflammatory cytokines in the neuroinflammation process is also consistent with 
the oxidative stress theory (Koutsilieri et al. 2002).  
 
2.4 Prevalence and Incidence of PD 
PD is found worldwide and in all races (Zhang and Roman 1993). The crude 
prevalence of PD ranges markedly between studies (Marttila and Rinne 1981; 
Sutcliffe and Meara 1995; Tandberg et al. 1995; Fall et al. 1996; Kuopio et al. 1999a; 
Taba and Asser 2002). The average adjusted prevalence ratio reported by a review of 
prevalence studies was 103 per 100,000 (Zhang and Roman 1993). Differences in 
estimated prevalence may be due to true geographical variations, variance amongst 
studies in case definition and ascertainment, differences in population age structure, 
or a combination of these factors. Previous studies have suggested that Oriental races 
appear to have the lowest prevalence and Caucasians the highest (Roman et al. 
1995). However, these conclusions are based on studies from the 1980s in Chinese 
populations (Li et al. 1985; Wang et al. 1991). Since then other studies in China have 
reported prevalence rates equivalent to those reported in Western populations (Zhang 
et al. 2003a). This could be due to a true increase in prevalence since these earlier 
                                                 
5 Proteins that bind to antibody-antigen complexes and help degrade the complexes by proteolysis. 
6 Proteins produced by white blood cells that act as chemical messengers between cells and promote 
an inflammatory response. 
7 Microglia act as the immune cells of the Central nervous system. Microglia are normally inactive but 
become activated in response to antigenic stimulation. Once activated, they proliferate and migrate to 
the site of injury where they bind to antigens by using the molecules on their surface. They produce 
the toxic cytokins IL-1 and TNFalphan when activated. Microglia also act as scavengers by 
phagocytosing dead cells and other debris. 
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studies, such as through improvement in life-expectancy of people with PD or an 
increase in incidence, or may be an artifact due to methodological differences 
between studies. Studies examining different racial groups within one geographical 
area have reported conflicting results. Schoenberg et al. (1985) reported no 
difference in age- and sex-adjusted prevalence between races, while Mayeux et al. 
(1996) reported a lower age-adjusted prevalence of PD in African-American men 
compared to Caucasian or Hispanic men. Geographical variation in PD prevalence or 
mortality within homogeneous populations has also been reported (Aquilonius and 
Hartvig 1986; Kurtzke and Goldberg 1988; Svenson 1990; Bonifati et al. 1993; 
Imaizumi 1995; Lanska 1997), with some studies noting higher prevalence in rural 
compared to urban areas (Svenson et al. 1993; Tandberg et al. 1995; Kuopio et al. 
1999a). 
 
Many different study designs have been used to assess PD prevalence and incidence. 
These include cross-sectional studies, longitudinal cross-sectional studies, drug 
consumption studies8, medical record audits, and door-to-door surveys. In general, 
the door-to-door survey is accepted as the gold-standard design for estimation of the 
prevalence of PD, however even these surveys vary greatly in their methods, which 
limits their comparability. Door-to-door surveys can detect previously undiagnosed 
cases and have generally reported a greater prevalence of PD compared to studies 
using other methods, such as surveys of general practitioners (de Rijk et al. 1997b). 
However, door-to-door surveys are costly and time-consuming and so usually cover 
smaller areas than other methods (Marras and Tanner 2004). If there are differences 
in the geographic distribution of PD cases, then the prevalence may be over- or 
under-estimated if results are extrapolated to the entire population. Drug 
consumption studies can also be influenced by multiple confounders, such as 
treatment practices and the introduction of new drugs. These studies also miss those 
not treated with conventional pharmaceutical treatments for PD.  
 
 
 
                                                 
8The prevalence for chronic diseases treated with drugs that are specific to the disease and must be 
taken continuously can be estimated from the total amount of drugs sold in a given region and the 
mean intake of these drugs, which can be based on the defined daily doses, the prescribed daily doses, 
or the consumed daily doses (as estimated in a sample of patients with the disease of interest) (Sartor 
and Walckiers 1995) 
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2.4.1 Prevalence of PD in Australia 
The crude prevalence for PD in Queensland has been estimated at 146-248 per 
100,000 in 1998 based on a state-wide postal survey of general practitioners (Peters 
et al. 2006). Higher prevalence was observed in rural and remote regions compared 
to metropolitan areas. Another Queensland prevalence study conducted in Nambour 
was based on 1,207 people randomly selected, age-stratified from the state electoral 
roll and yielded a crude prevalence of 414 per 100,000 (McCann et al. 1998). The 
study included physical examination of all participants for signs of PD by a medical 
practitioner. However, the estimate was based on only 5 observed cases and the 95% 
confidence interval was wide (53-775). Being limited to the rural town of Nambour 
on the Sunshine Coast hinterland, a popular rural retirement destination, the study 
results cannot be applied to the remainder of the state or country. Another Australian 
prevalence study conducted in the Randwick area of Sydney from 1998-1999, using 
a door-to-door method, produced a crude prevalence ratio of 775 per 100,000 (95% 
CI 434-2031 per 100,000) with the assumption that there were no cases of PD below 
age 55 in the study population (Chan et al. 2001). This estimate is much higher than 
the Australian prevalence studies conducted by Peters et al. (2006), and Jenkins 
(1966) and reflects the upper limit of the estimate reported by McCann et al. (1998). 
The authors suggest the higher prevalence may be due to the inclusion of new, 
undiagnosed cases of PD identified during the study which would go undetected in 
surveys of general practitioners, such as conducted by Peters et al. (2006) and 
Jenkins (1966).  
 
2.5 Age-Related Factors 
PD is generally considered a disease of the elderly and occurrence in younger age 
groups (less than 40 years) is rare. Most PD prevalence studies show a steadily 
increasing prevalence with age (Morgante et al. 1992; Tison et al. 1994). Some also 
show a peak prevalence followed by a decrease in the oldest age groups such as 80 
years and over; however, this may be due to lower numbers of participants in the 
oldest age groups resulting in unstable prevalence estimates, or a survivor effect 
(Rosati et al. 1980; D'Alessandro et al. 1987; Casetta et al. 1990; Kis et al. 2002). 
Generally, door-to-door surveys, which are the most accurate in estimating 
prevalence, do not report a drop in prevalence in the oldest age range (Schrag 2002). 
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Similarly, most incidence studies also show steadily increasing incidence with 
increasing age (Baldereschi et al. 2000). Some studies also show a reduced incidence 
in the oldest age groups (Marttila and Rinne 1976; Rajput et al. 1984; Granieri et al. 
1991; Wang et al. 1991; Bower et al. 1999; Kuopio et al. 1999a; MacDonald et al. 
2000; Chen et al. 2001b). This may be due to a real decrease in incidence or 
decreased case-finding in the very elderly who may be less likely to participate in 
surveys or are afflicted by other conditions that make diagnosis of PD more difficult, 
less of a priority, or result in mortality prior to PD diagnosis.  
 
2.6 Gender-Related Factors 
A number of studies have reported that more males than females are affected by PD. 
However, given that initial reports of a male preponderance were derived from non-
population based studies which are subjected to biases that may distort sex 
distributions, the result has received criticism (Ellenberg 1985). The differences 
among the study designs used makes it difficult to compare results, however most 
prevalence studies have reported a higher prevalence in males than females by up to 
1.7:1.0 (Rosati et al. 1980; Bharucha et al. 1988; Svenson 1990; Granieri et al. 1991; 
Morgante et al. 1992; Tandberg et al. 1995; Fall et al. 1996; Kuopio et al. 1999a). 
Other studies report no difference in prevalence between males and females (Taba 
and Asser 2002; Bergareche et al. 2004) or higher prevalence in females (Kimura et 
al. 2002). Interestingly, some studies have reported the difference in prevalence of 
PD between males and females decreases at older age groups (Bharucha et al. 1988). 
This could be due to longer life-expectancy of women with PD or less sex-related 
differences (due to post-menopausal decrease in female hormones) in incidence at 
older ages. 
 
Gender-related differences in incidence may be more informative than prevalence for 
generating aetiological clues, given that prevalence may be reflective of increased 
mortality in one gender rather that higher incidence. Indeed, higher mortality in 
women with PD compared to men has been reported by some studies, which could 
explain the higher male prevalence of the disease (Diamond et al. 1990; Elbaz et al. 
2003).  
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Higher incidence of PD in men has been reported by many studies (Rajput et al. 
1984; Elbaz et al. 1992; Bower et al. 1999; Kuopio et al. 1999a; Van Den Eeden et 
al. 2003; Foltynie et al. 2004). Other studies have reported no difference in incidence 
between the sexes (Marttila and Rinne 1976; Granieri et al. 1991; Wang et al. 1991; 
Mayeux et al. 1995; Chen et al. 2001b) and some have reported a higher incidence 
for women (Harada et al. 1983; Hofman et al. 1989a). There may be a real difference 
in sex-specific incidence between geographical locations. However, study design 
issues, such as lower case-finding amongst one gender, may have distorted the 
findings. Mortality studies have generally shown higher mortality rates from PD in 
men than women (Kurtzke and Goldberg 1988; Lilienfeld et al. 1990). One of the 
major limitations of mortality studies of PD is the dependence upon accurate 
recording of PD on death certificates. A study linking multiple databases and death 
certificates found only half of those with PD reported during life had PD reported on 
their death certificate (Pressley et al. 2005). While there was a bias in reporting 
between those with high and low incomes, the rate of discordant reporting of PD 
during life and on death certificates was similar for males and females. Survival 
analysis studies generally show no difference in age of onset, progression and 
duration of disease or age at death between men and women with PD (Diamond et al. 
1990; Fall et al. 1996; Elbaz et al. 2003; Marras et al. 2005), therefore different 
mortality between men and women with PD doesn’t offer an explanation for a male 
preponderance in prevalence.  
 
A meta-analysis of incidence studies reported a significantly higher age- and sex-
adjusted incidence rate of Parkinson's disease among men with the relative risk being 
1.5 times greater in men than women (Wooten et al. 2004). As the meta-analysis 
excluded studies that did not adjust for differences in the sex distributions of the 
populations, this source of potential confounding was avoided.  
 
2.6.1 Oestrogen 
There is some evidence that oestrogen is responsible for gender-related differences in 
risk of PD and symptom profiles in people with PD. Oestrogen has been shown to 
modulate nigrostriatal dopaminergic activity and to exert a neuroprotective effect in 
animal models of PD (Dluzen et al. 1996; Dluzen 1997; Miller et al. 1998; Sawada et 
al. 2002; Shughrue 2004). Some studies report more hysterectomies, surgically-
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induced menopause, and early menopause in women who subsequently develop PD 
compared to those who do not (Benedetti et al. 2001) while other studies report no 
difference in the time or type of menopause (natural or induced) between PD cases 
and controls (Martignoni et al. 2002; Martignoni et al. 2003) and other studies have 
reported reduced risk with early menopause (Popat et al. 2005). The differences in 
results may be due to a difference in the study populations, such as whether hormone 
replacement therapy was routinely used by women undergoing early menopause in 
one group or not.  
 
Exacerbation of symptoms such as a levodopa-induced "On-Off" phenomenon 
following withdrawal or reduction of conjugated oestrogen therapy has been reported 
by some women with PD (Sandyk 1989). Some studies have also reported lower 
symptom severity in women with PD with a history of having received oestrogen 
therapy (Saunders-Pullman et al. 1999) and a reduced risk of dementia has been 
reported in women with PD undergoing such therapy (Marder et al. 1998; Fernandez 
and Lapane 2000). Some case-control studies have observed that women who take 
postmenopausal oestrogen were less likely to develop PD than those who had not 
(Benedetti et al. 2001; Martignoni et al. 2002; Currie et al. 2004). However, other 
studies have reported an increased risk of PD with oestrogen therapy following 
hysterectomy. These have also reported increasing risk of PD with increasing 
duration of oestrogen use and no association between PD risk and hormone use 
among women with natural menopause (Popat et al. 2005). Controlled trials of 
oestrogen therapy in women with PD have produced inconsistent results. Some have 
not demonstrated any improvement in PD symptoms (Blanchet et al. 1999; Strijks et 
al. 1999), while others report improvements in motor scores and “on” and “off” times 
(Tsang et al. 2000; Tsang et al. 2001). The inconsistency in study results concerning 
PD risk and oestrogen therapy and the uncertainty surrounding how oestrogen may 
exert its neuroprotective action mean further studies are needed to understand its 
possible role in PD aetiology and clinical usefulness in therapy (Shulman 2002; 
Amantea et al. 2005). 
 
2.7 Genetic Factors 
Although generally considered a sporadic disease (>80% of people with PD do not 
claim a family history (McCann et al. 1998)), there is evidence to suggest that 
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genetic factors play a role, at least in part, in the development of PD. Family history 
of PD is consistently associated with increased risk of PD in epidemiological studies 
(Butterfield et al. 1993; Hubble et al. 1993a; Semchuk et al. 1993; Wang et al. 1993; 
Morano et al. 1994; Vieregge et al. 1994; De Michele et al. 1996; Chan et al. 1998; 
McCann et al. 1998; Menegon et al. 1998; Elbaz et al. 1999; Taylor et al. 1999; 
Werneck and Alvarenga 1999; Behari et al. 2001; Pals et al. 2003). A number of 
studies have described familial clustering of PD cases as evidence of a genetic cause 
(Golbe 1995). While common exposure to environmental factors has also been cited 
as another possible explanation (Payami and Zareparsi 1998), shared environment is 
not sufficient to explain the increased prevalence of PD in relatives with different 
residential histories. The findings of Uitti et al. (1997) suggest that family history 
may play a greater role than previously thought. The study found the prevalence of 
familial cases of PD is likely to be significantly higher than previously reported due 
to inaccuracy of family histories obtained from people with PD and that the 
prevalence rate in relatives of affected individuals was up to five times higher than in 
the general population.  
 
2.7.1 Twin Studies 
Twin studies can provide information concerning the relative contribution of genetic 
and environmental factors to the aetiology of a disease, such as PD. Monozygotic 
twins share 100% of their nuclear DNA, whereas the proportion of shared DNA in 
dizygotic twins (50%) is the same as in non-twin siblings. If concordance rates of PD 
in both types of twins are the same, then PD is more likely to have an environmental 
cause, whereas a genetic cause would result in a higher concordance of PD in 
monozygotic twins than in dizygotic twins.  
 
The most typical bias present in twin studies is a generally greater response rate of 
monozygotic than dizygotic twins. It should also be noted that some non-genetic 
exposures which have been linked to PD risk, such as cigarette smoking and coffee-
drinking, can be very similar between twins (Tanner 2003). Therefore, a higher 
disease concordance in monozygotic twins compared to dizygotic twins may be due 
to an increased likelihood to share an environmental exposure, rather than a genetic 
cause. 
 
 18 
Studies of PD in monozygotic twins have not resulted in the high concordance rates 
that would be expected for a disease with a strong hereditary link (Duvoisin et al. 
1981). These have historically been cited as evidence against a strong genetic basis 
to the disease. However, re-evaluation of twin studies using the technique of positron 
emission tomography (PET) has weakened this evidence. PET can detect reduction 
in dopamine uptake prior to symptomatic disease. This technique has revealed a 
higher concordance rate among monozygotic twins than previously reported, 
suggesting that previous findings may have been due to variability in age of onset 
and a long latent period of preclinical disease in the non-PD twins (Payami and 
Zareparsi 1998).  
 
2.7.2 Genetic Mutations 
A number of specific genetic abnormalities and several chromosomal loci have been 
linked to rare forms of familial parkinsonism. Implicated genes that have been 
identified include Alpha-synuclein, Parkin, Ubiquitin carboxy-terminal hydrolase L1 
(UCHLI), PTEN-induced putative kinase 1 (PINK1), DJ-1 and Leucine-rich repeat 
kinase 2 (LRRK2). 
 
These genetic loci, the features, including the typical resulting phenotype, the 
chromosomal location of the mutation and the inheritance pattern, are outlined in 
Table 2.8.1. In addition to these, a number of other loci believed to confer higher 
susceptibility to PD are being characterised via family studies (Scott et al. 2001; 
Pankratz 2003). 
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Table 2.8.1 Genetic Loci Implicated in Parkinsonism and PD  
Gene loci Features 
PARK1 
(Polymeropoulos et al. 
1997) 
• Familial PD 
• Mutation in alpha-synuclein gene on chromosome 4q21 
• Inheritance: Autosomal dominant 
PARK2  
(Kitada et al. 1998) 
• Early-Onset Parkinsonism 
• Mutation in the parkin gene on chromosome 6q25.2-q27 
• Inheritance: Autosomal recessive 
PARK3  
(Gasser et al. 1998) 
• Familial PD 
• Linkage to chromosome 2p13 
• Inheritance: Autosomal Dominant  
PARK4  
(Singleton et al. 2003) 
• Familial Lewy Body Parkinsonism 
• Triplication of alpha-synuclein gene 
• Inheritance: Autosomal dominant 
PARK5 
(Leroy et al. 1998) 
• Mutation in the UCHL1 gene on chromosome 4p14 
• Inheritance: Autosomal dominant 
PARK6  
(Valente et al. 2004) 
• Early-Onset PD 
• Mutation in the PINK1 gene on 1p35-36 
• Inheritance: Autosomal recessive  
PARK7  
(Bonifati et al. 2003) 
• Early onset PD 
• Mutation in the DJ1 gene on chromosome 1p36 
• Inheritance: Autosomal recessive  
PARK8 (Funayama et 
al. 2002) 
• Familial PD 
• Mutations in the LRRK2 gene on chromosome 12q12 
• Inheritance: Autosomal dominant 
PARK9 (Hampshire 
et al. 2001) 
 
• Kufor-Rakeb syndrome (nigro-striatal-pallidal-pyramidal 
neurodegeneration) 
• Gene in region of 9 cM between markers D1S436 and 
D1S2843on chromosome 1p36 
• Inheritance: Autosomal recessive 
PARK10  
(Hicks et al. 2002) 
• Higher susceptibility to late-onset PD 
• Gene on chromosome 1p32  
• Inheritance: Autosomal dominant 
 
2.7.3 Genetic Susceptibility  
Various studies have also investigated whether common genetic variants can confer 
differential risk for Parkinson’s disease in individuals with sporadic disease. 
Candidate genes examined have included the PARK loci (Table 2.8.1) and genes 
involved with xenobiotic metabolism. In addition to familial parkinsonism caused by 
parkin gene mutations, polymorphisms in the parkin gene have also been associated 
with increased susceptibility to sporadic PD . Similarly, polymorphisms in the UCH-
L1 gene alter susceptibility to sporadic PD, such as a polymorphic variant of UCH-
L1 (S18Y), which is associated with decreased risk for PD (Maraganore et al. 1999; 
Zhang et al. 2000). A large collaborative meta-analysis has confirmed this protective 
association (Maraganore et al. 2004). 
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2.7.3.1 Genes Associated with Toxin Metabolism 
An inherited susceptibility to toxins has also been suggested as a cause of PD. In this 
theory, it is assumed that the general population is exposed to chemicals that have the 
potential to damage nigrostriatal dopaminergic neurons should the chemicals or their 
toxic metabolites reach these neurons in sufficient quantity (Williams 1995). 
Whether an environmental exposure will result in PD depends on the individual’s 
innate ability to protect the neurons from the toxin. One such mechanism for 
protection may be the metabolism of toxins to more inert substances. Thus genetic 
variability in the genes that code for proteins involved with xenobiotic metabolism, 
uptake pathways and other defence mechanisms may influence disease risk 
(Williams 1995). Polymorphisms of genes involved in toxin metabolism which are 
candidates for increasing risk of PD include Cytochrome P450 (CYP2D6), 
Monoamine Oxidase B (MAOB), Glutathione-S-transferase (GST) and paraoxonase 
(PON1 and PON2). Two recent studies have reported an increased risk of PD in 
CYP2D6 poor metabolisers who were exposed to pesticides compared to unexposed 
subjects and pesticide-exposed CYP2D6 extensive metabolisers (Deng et al. 2004; 
Elbaz et al. 2004). 
 
2.7.4 Family History of Other Neurodegenerative Diseases 
Family studies have confirmed that genetic risk factors also play an important role in 
the aetiology of neurodegenerative diseases other than PD, such as Alzheimer’s 
disease (Heston et al. 1981). Some of these genetic risk factors might overlap with 
those for PD. For example, the apolipoprotein E4 genotype is a major genetic risk 
factor for AD (Saunders et al. 1993) and has also been linked to earlier age of onset 
and increased risk of dementia in people with PD (Pankratz et al. 2006). A number of 
studies have demonstrated an increased risk of PD associated with family history of 
Alzheimer’s disease and vice versa (Hofman et al. 1989b; van Duijn et al. 1991; 
Marder et al. 1999).  
 
An increased risk of Down’s syndrome (Trisomy 21) has been observed in relatives 
of people with Alzheimer’s disease and vice versa (Heston and Mastri 1977; Heston 
et al. 1981; Schupf et al. 1994). Additionally, dementia of the Alzheimer’s disease 
type, with accompanying pathology, is common in people with Down’s syndrome, 
particularly after the age of 40 (Hestnes et al. 1997). Extra-pyramidal signs, similar 
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to the parkinsonian features observed in advanced Alzheimer’s disease, have also 
been observed in people with Down’s syndrome with dementia (Vieregge et al. 
1991) and olfactory dysfunction is common to Down’s syndrome, Alzheimer’s 
disease and PD (Warner et al. 1986; Hemdal et al. 1993; Ponsen et al. 2004). Lewy 
body pathology in the substantia nigra in addition to cortical Alzheimer-type 
pathology in people with Down’s syndrome has been reported (Raghavan et al. 
1993). However, few studies have examined family history of Down’s syndrome in 
people with PD.  
 
2.8 Medical History  
2.8.1 Infections 
Encephalitis lethargica which often resulted in postencephalitic parkinsonism was 
believed to be caused by a virus, due to the widespread and epidemic nature of the 
disease that occurred between 1916 and 1925. As the disease occurred around the 
time of the 1918 influenza pandemic, many have linked the two aetiologically, 
although there is no evidence for this connection and some evidence to suggest a 
connection is unlikely (McCall et al. 2001; Reid et al. 2001). While postencephalitic 
parkinsonism and PD have distinct differences in symptoms and pathology, it is the 
similarities which raise the question of whether PD, in some cases, could also be the 
result of an infection. Most case-control studies of viral infection and PD have not 
observed a relationship between the two factors. A small study comparing antibodies 
to coronavirus in cerebrospinal fluid of PD cases and controls reported a greater 
antibody response in PD cases (Fazzini et al. 1992). However, the results of this 
study have not been confirmed in other populations.  
 
Some retrospective studies have focused on common childhood infectious diseases, 
such as measles, mumps and rubella. Martyn and Osmond (1995) reported an 
increased risk of PD with self-reported childhood sickness of croup, rheumatic fever 
or diphtheria, but not with chickenpox, whooping cough, scarlet fever or measles. 
Semchuk et al. (1993) did not observe any relationship between PD risk and self-
reported history of chicken pox, encephalitis, measles, mumps, rubella or Spanish 
flu. However, Sasco et al. (1985) reported a reduced risk of PD with most childhood 
viral infections, including measles. Wang et al. (1993) reported no difference 
between cases and controls for antibody levels of four virus (measles, rubella, HSV-
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1, CMV) in a Chinese case-control study. Kuopio (1999b) reported no relationship 
between PD risk and self-reported infections of rubella, whooping cough, diphtheria, 
measles, varicella, herpes zoster, scarlatina, mumps and genital herpes. The major 
limitation with all of these retrospective studies, except that of Wang et al. (1993) is 
the reliance on self-report. Childhood illness is likely to be difficult to remember 
accurately in old age due to the time lapse between exposure and reporting.  
 
Bacterial pathogens have also been investigated as potential risk factors for PD. A 
relationship between the ulcer-causing bacterium, Helicobacter pylori and PD has 
been proposed as a higher incidence of gastro-duodenal ulcers was reported in cases 
of PD from a case-control study of 200 PD cases and 200 age- and sex-matched 
controls (Strang 1965; Altschuler 1996). One theory suggests H. pylori may act by 
predisposing the infected individual to immuno-suppression and autoimmunity 
(Dobbs et al. 2000; Weller et al. 2005). Nocardia species, which are soil-dwelling 
pathogens, were implicated in a laboratory study in which mice injected with 
Nocardia asteroids developed a syndrome resembling PD in clinical and 
pathological aspects (Kohbata and Beaman 1991). However, an epidemiological 
case-control study failed to find any difference in seropositivity for Nocardia species 
between PD cases and controls. 
 
Several epidemiological studies examining rates of PD amongst different 
occupations have noted a higher rate amongst professions such as teachers and 
healthcare workers compared to other occupations (Schulte et al. 1996; Tsui et al. 
1999; Park et al. 2005b). These findings have generally led to speculation that 
workers in these professions would be at higher risk of exposure to infectious agents 
and therefore an elevated risk of PD amongst these workers may be due to a higher 
rate of infections. However, referral bias must be considered in studies, such as these, 
that have obtained their PD cases from specialist movement disorder clinics. Patients 
with medical training and higher educational backgrounds may be more likely to 
request referral to movement disorder specialists than those from other occupations. 
The higher incidence of PD amongst professional occupations may also be due to 
differences in lifestyle exposures between ‘white collar’ and ‘blue collar’ workers, 
such as a lower prevalence of smoking amongst professionals (Hill et al. 1998; 
Barbeau et al. 2004; Wen et al. 2005).  
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2.8.2 Head Injury 
Case reports of acute severe cranial trauma describe a progressive parkinsonian 
syndrome in some patients (Doder et al. 1999; Bhatt et al. 2000). Also, repeated head 
trauma, such as experienced in the sport of boxing, has been shown to cause 
parkinsonism (Stern 1991; Calne 2001). A number of epidemiological studies have 
also linked self-reported head injury to risk of PD (Stern et al. 1990; De Michele et 
al. 1996; Seidler et al. 1996; Smargiassi et al. 1998; Taylor et al. 1999). Conversely, 
many studies have not been able to establish this relationship (Hofman et al. 1989a; 
Morano et al. 1994; Martyn and Osmond 1995; McCann et al. 1998; Kuopio et al. 
1999b; Werneck and Alvarenga 1999).  
 
The main criticism of retrospective studies of head injury and PD has been the 
possibility of recall bias. Studies using medical records avoid this potential bias, but 
may introduce selection bias. The medical records linkage system in Olmsted 
County, Minnesota, which was developed as part of the Rochester Epidemiological 
project, largely avoids selection bias as it has included the lifelong medical records 
of virtually every resident in the county since the 1960s. This medical records 
linkage system was used in two epidemiological studies consisting of a longitudinal 
follow-up study and a case-control study, of head injury and PD. The follow-up 
study of head trauma patients did not find an increased standardised morbidity rate 
for PD in this group compared to the general population (Williams et al. 1991). 
However, the case-control study which assessed episodes of head trauma preceding 
PD onset, reported an elevated odds of PD with history of mild head trauma with loss 
of consciousness or a more severe trauma (OR of 11.0, 95% CI = 1.4 to 85.2). Head 
trauma resulting in hospitalization was also more frequent in cases than in control 
subjects (OR = 8.0; 95% CI = 1.0 to 64.0) (Bower et al. 2003). The different results 
in these studies may be due to study design. As head trauma is a relatively rare event 
(Bower et al. 2003), there may have been insufficient number of participants with 
serious head injury in the follow-up study to obtain a stable estimate of PD risk, as 
acknowledged by the authors. Also, the case-control study considered the severity of 
the head injury and found this factor determined the risk of PD. 
 
2.8.3 Anaesthesia 
Surgery with general anaesthesia has been suggested as a risk factor for PD. Case 
reports have described the emergence of parkinsonian symptoms, such as rigidity 
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following surgery involving general anaesthesia. In one such report, a 54 year old 
male developed a “dystonic, parkinsonian-type phenomenon” following emergence 
from general anaesthesia and was diagnosed with PD 18 months later (Muravchick 
and Smith 1995). While the patient did not have any motor symptoms prior to the 
surgery, he mentioned complaints of persistent anxiety, a lack of a general sense of 
well being, and recurrent constipation, which are non-motor symptoms often 
reported in people with PD prior to onset of disease, suggesting that he may have had 
undiagnosed PD prior to the operation (Abbott et al. 2001). It is likely that the trauma 
of surgery or the anaesthetic may act as a trigger for symptoms of underlying PD, 
rather than being a causative factor. 
 
A follow-up study comparing causes of death between male anaesthesiologists and 
internists reported an elevated risk of PD for anaesthesiologists compared to 
internists after more than 10 years follow-up. As both groups were matched on many 
factors such as smoking and coffee drinking, and the rates were age-standardised, the 
increased risk may be due to exposure to anaesthetic gases (Peretz et al. 2005). Most 
case-control studies have not observed a relationship between PD and treatment with 
general anaesthetics or surgery (Hofman et al. 1989a; De Michele et al. 1996; Pals et 
al. 2003). Others report only marginally elevated exposure to general anaesthesia 
amongst cases (Seidler et al. 1996; Gasparini et al. 2002). A case-control study 
comparing history of surgery in Alzheimer’s disease cases, PD cases and non-
degenerative neurological control patients reported only a small difference in the 
number of PD cases reporting surgery in the 5 years before disease onset compared 
to controls (82.6% versus 76.9%). In the year prior to disease onset, fewer PD cases 
underwent surgery compared to controls (56.5% versus 63.5%) (Gasparini et al. 
2002). As hospital records were used to assess surgical history the results would not 
be affected by recall bias and any exposure measurement error would be non-
differential. 
 
Chloral hydrate, which has been used for many years as a sedative and hypnotic is 
also a commonly found by-product of water chlorination. It is an intermediate in the 
synthesis of insecticides and as a metabolite of the hazardous industrial solvent 
trichloroethylene. Chloral hydrate can form 1-trichloromethyl-1,2,3,4-tetrahydro-b-
carboline (TaClo) in vivo, a molecule with structural similarities to MPTP, a toxin 
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known to cause parkinsonism (Akundi et al. 2004). TaClo has been detected in 
human subjects receiving treatment with chloral hydrate (Bringmann et al. 1999). 
While TaClo causes cell loss in neuronal and glial cell cultures and induces a slowly 
developing neurodegenerative process in rats (Riederer et al. 2002), a clear link 
between chloral hydrate exposure and PD risk is lacking. 
 
2.8.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 
A number of experimental studies indicate a possible therapeutic effect of NSAIDs 
against progressive dopaminergic neurodegeneration in animal models of PD (Ferger 
et al. 1999; Casper et al. 2000; Carrasco and Werner 2002; Sairam et al. 2003). Two 
epidemiological studies have examined the relationship between use of NSAIDs and 
risk of PD. The Health Professionals Follow-up Study, 1986-2000, and Nurses' 
Health Study, 1980-1998 prospectively collected data on aspirin and non-aspirin 
NSAID use. A reduced risk of PD was seen for regular users of aspirin (2 or more 
tablets per day: RR 0.56, 95% CI 0.26-1.21) and non-aspirin NSAIDs (RR 0.55; 95% 
CI 0.32-0.96) compared to non-users of NSAIDs, respectively (Chen et al. 2003a). 
 
2.9 Lifestyle Factors 
2.9.1 Tobacco Smoking 
Studies dating back to the 1960s have reported the negative relationship between 
smoking and PD (Nefzger et al. 1968; Haack et al. 1981). Since these early papers, 
many retrospective and a number of prospective studies have also confirmed the 
association (e.g. Grandinetti et al. 1994; Ascherio et al. 2001; Pals et al. 2003). 
 
Dose-Response 
Many studies have also reported dose-response relationships between PD and 
smoking (Butterfield et al. 1993; Grandinetti et al. 1994; Seidler et al. 1996; Fall et 
al. 1999; Gorell et al. 1999c; Taylor et al. 1999; Paganini-Hill 2001; Checkoway et 
al. 2002; Zorzon et al. 2002; Dong et al. 2003; Levecque et al. 2003; Tan et al. 2003; 
Gorell et al. 2004; Wirdefeldt et al. 2005)).  
 
Age of Onset 
Some studies have reported that age of onset of PD was significantly older in the 
ever-smoked group than the never-smoked group (Rajput et al. 1987a; Kuopio et al. 
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1999b). However, Alves et al. (2004) and Papapetropoulos et al. (2005) observed 
that age of onset was significantly younger amongst people with PD who smoked 
compared to people with PD who didn’t smoke. Haack et al. (1981) reported a 
younger onset age for smokers, although the effect was most evident for women. 
Other studies have reported onset age to be similar for people with PD who smoked 
as for those who didn’t smoke (Golbe et al. 1986; Mayeux et al. 1994).  
 
Rajput et al. (1987a) found a difference in risk of PD for smokers according to age at 
diagnosis, finding an increased risk amongst those with a diagnosis age <60 years, 
and a decreased risk for those with diagnosis after 70 years. Smoking status was 
determined by medical records which are likely to lack precision and contribute to 
exposure misclassification. In contrast, other studies have shown a decreased risk of 
PD with smoking in younger individuals (OR 0.4; 95% CI 0.1-0.9) and a significant 
trend of increasing risk with advancing age (Tzourio et al. 1997). Stern et al. (1991) 
reported a greater reduction in risk amongst people with old-onset PD (OR 0.5, 95% 
CI 0.2-1.0) compared to people with young-onset PD (OR 0.8, 95% CI 0.4-1.6), 
although the small number of participants in each group contributed to the lack of 
statistical significance for the results. Elbaz et al. (2000) report a reduction in risk for 
smoking only amongst those aged 75 years and under without a family history of PD. 
In the older age groups and the younger group with a family history, smoking was 
associated with an increased risk of PD, although the confidence intervals are wide 
and include unity due to the small numbers in each group. In a study of people with 
young-onset PD, Tsai et al. (2002) reported a reduced risk amongst current smokers 
(OR 0.30, 95% CI 0.03-3.11), but increased risk amongst ex-smokers (OR 2.40, 95% 
CI 0.29-19.7), however the confidence interval was wide for both results. 
 
Symptoms 
Alves et al. (2004) also reported no difference in symptoms (disease severity 
measured by Hoehn and Yahr staging, depressive symptoms measured by MADRS, 
cognitive impairment measured by MMSE, daily levodopa dose) between people 
with PD who smoked and those who didn’t smoke at baseline or in progression of 
these symptoms over 4 and 8 years.  
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Mortality 
Mortality over the follow-up period was also similar between people with PD who 
smoked and those who didn’t smoke. These studies suggest that tobacco smoking 
does not delay symptom onset or progression of symptoms. 
 
Meta-Analyses 
A number of meta-analyses examining the relationship between smoking and PD 
have been conducted. (Allam et al. 2004). These have reported pooled risk estimates 
between 0.51 to 0.59 for ‘ever smoking’ (95% CIs stretched from 0.41 to 0.63). 
 
Twins 
Studies of twins discordant for PD have observed less smoking in the PD affected 
twins compared to their unaffected co-twin (Ward 1983; Bharucha et al. 1986; 
Tanner et al. 2002; Wirdefeldt et al. 2005). The inverse relationship with smoking 
was observed in both dizygotic and monozygotic twins, which is suggestive of a 
biologic protective affect of cigarette smoking as monozygotic twins are matched for 
genetic factors. 
 
2.9.1.1 Explanatory Hypotheses 
A number of possible explanatory hypotheses have been suggested, such as: selective 
mortality; a biologically protective effect; and premorbid behaviour determined by 
either an undesirable effect produced by smoking due to altered metabolism in 
susceptible persons (Kessler and Diamond 1971) or a premorbid personality 
associated with PD susceptibility characterised by an aversion to smoking (i.e. an 
aversion to smoking is an early manifestation of the disease).  
 
Selective Mortality 
The “selective mortality” hypothesis suggests that smokers with PD (or prone to 
developing PD) have a higher mortality risk than smokers without PD and non-
smoking PD cases, therefore there are less smoking people with PD available for 
recruitment into case-control studies (Nefzger et al. 1968; Riggs 1992). However, 
this theory has largely been discounted by the observation of an inverse smoking 
relationship in case-control studies that have only recruited incident PD cases and 
with the availability of data from a large prospective study (Grandinetti et al. 1994). 
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In the latter, it was found that age-specific mortality rates in smokers and non-
smokers without PD were similar before age 60. As a reduced incidence of PD was 
observed in cigarette smokers at all ages, including those at younger ages when 
mortality from any cause was low, selective mortality does not offer an explanation 
for the phenomenon. The size of the difference in mortality between smokers and 
non-smokers was the same in those who developed PD and those who did not 
develop PD (Morens et al. 1996a). This result was confirmed by Alves, (2004) in a 
prospective study of mortality and symptom progression in smoking and non-
smoking people with PD. The study found no difference in progression of symptoms, 
cognitive impairment or mortality between people with PD who smoked (either light 
or heavy smoking) and those who did not smoke. 
 
Biological Explanation 
Tobacco smoke contains numerous chemicals that could be responsible for the 
apparent protective effect, although most research has focused on nicotine. Animal 
studies that have suggested that nicotine protects cells in the substantia nigra against 
induced neuronal loss (Payami and Zareparsi 1998; Quik and Di Monte 2001) are 
supportive of a biologically protective effect. These results also lend weight to the 
hypothesis that PD is induced by exposure to environmental toxins. Components of 
cigarette smoke reduce enzymatic activity of monoamine oxidase B (MAOB) in the 
brain (Fowler and Volkow 1996), thus possibly affording neuroprotection as MAOB 
may activate neurotoxicants similar to MPTP (Chiba et al. 1984). 
 
Nicotine modulates nigrostriatal dopamine release (Zhou et al. 2001) which could 
benefit PD by alleviating motor symptoms in the short-term and/or protecting against 
nigrostriatal damage in the long-term. An example of a possible mechanism for 
neuroprotection is by increasing the release of dopamine which may then actively 
compete with and displace the neuronal uptake of toxic substances, such as MPP+ 
(the toxic metabolite of MPTP), which is selectively transported into neurons via the 
same uptake system as dopamine (Snyder and D'Amato 1986).  
 
Nicotine may also work through other mechanisms to offer neuroprotection, such as 
by enhancing elimination. Experiments in animal models of PD, including the 
MPTP-treated mouse have shown nicotine administration to attenuate nigrostriatal 
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damage in part, by decreasing striatal MPP+ levels (Quik and Di Monte 2001). 
Alternatively, nicotine, possibly with other components of tobacco smoke may 
suppress the formation of toxins by acting as an antioxidant or by alternating 
monoamine oxidase activity (Obata et al. 2002). Cigarette smoking is associated with 
decreased (40%) brain monoamine oxidase B (MAOB) activity, suggesting it may 
protect against neurodegeneration by decreasing levels of hydrogen peroxide, a by-
product of dopamine metabolism, or by reducing enzymatic conversion of 
endogenous or exogenous compounds to toxic metabolites (Fowler and Volkow 
1996; Castagnoli and Murugesan 2004).  
 
Premorbid Behaviour 
Some have suggested that rather than a biologically protective effect, an aversion to 
smoking is a result of a personality common to most people with PD. PD may be 
present for many years before symptoms develop and some researchers have 
theorised that this subclinical disease produces subtle effects such as characteristic 
personality traits and typical behaviours. Such observations have been reported in 
early reports dating back to 1913 in which PD was reported to affect “mostly those 
persons whose lives had been devoted to hard work…The people who take their 
work to bed with them and who never come under the inhibiting influences of 
tobacco or alcohol…” (Menza 2002). People with PD have been described as 
industrious, rigidly moral, stoic, serious, and non-impulsive. There is a biological 
basis for this theory as some aspects of personality and behaviour are influenced by 
brain levels of dopamine, noradrenaline and serotonin, which can all be affected in 
PD (Smythies 1965; Shannak et al. 1994; Tomer 2004). For example, some studies 
have reported a relationship between polymorphisms in dopamine receptor genes and 
novelty-seeking behaviour, which is allegedly decreased in people with PD (Rogers 
et al. 2004). A polymorphism in the dopamine transporter gene (termed allele 9, 
SLC6A-9) was found to be associated with less initiation of smoking, later initiation 
of smoking, and greater cessation of smoking. The polymorphism was also 
associated with low scores for novelty-seeking, which was correlated with smoking 
cessation (Lerman et al. 1999; Sabol et al. 1999). 
 
A number of case-control studies have attempted to assess personality differences 
between PD cases and control subjects. These studies have described people with PD 
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as workaholics, pedantic, rigid in personality, loners, non-smokers, suffering from 
depression/introversion, more socially alert, apprehensive, self-reproaching, tense, 
driven, restless, sceptical, cautious, reflective, rigid, stoic, slow-tempered, frugal, 
orderly, persistent, less flexible and more conventional and stereotyped in thought, 
and with less novelty-seeking behaviour than control subjects (Eatough et al. 1990; 
Poewe et al. 1990; Menza et al. 1993). Not all studies have reported a difference in 
premorbid personality in people with PD. Smythies (1967) did not observe the 
differences in personality reported in anecdotes. The study compared the people with 
PD to two control groups of sufferers of chronic disease, which suggests that some of 
the ‘personality’ differences reported by others may just be a reaction to having a 
chronic disease. However, the questionnaire used seemed simplistic and subjective 
and no information about the validity of the instrument was provided. Other, more 
recent studies also using controls with a chronic motor disorder have failed to 
observe any difference in premorbid personality of people with PD compared to 
controls (Glosser et al. 1995).  
 
While most studies have reported differences in personality between cases and 
controls, many of these studies are limited by design flaws. Most are based on only a 
small sample of participants and do not report details of how the control participants 
were selected or the response rates (Eatough et al. 1990; Poewe et al. 1990; Hubble 
et al. 1993b; Menza et al. 1993; Heberlein et al. 1998; Fujii et al. 2000). These issues 
make it difficult to judge how representative the participants are of their respective 
populations. There is a strong possibility that controls who are more out-going and 
enjoy new experiences are more likely to volunteer for such studies, thus biasing the 
results. Heberlein et al. (1998) observed that the control volunteers in their study 
scored higher on “life satisfaction” and “extraversion” and less on “inhibitedness”, 
“strain”, “somatic complaints” and “emotional stability” than ‘normal’ values. Some 
studies have used standardised instruments to assess personality traits (Eatough et al. 
1990; Menza et al. 1993; Fujii et al. 2000), but some do not (Poewe et al. 1990).  
 
A larger study (n=244) which reported response rates for cases and controls had only 
50% response amongst people with PD and 24% response for controls randomly 
selected from a community registry (Jacobs et al. 2001). The only difference between 
the two groups was a higher level of “persistence”, which characterises individuals as 
 31 
being industrious, hard-working, persistent, and stable despite frustration and fatigue, 
amongst PD cases compared to controls. However, the low response rate reduces 
generalisability. It is also difficult to assess personality retrospectively when current 
personality is likely to influence self-perception.  
 
Interestingly, one study also reported more traumatic life events in the childhoods of 
PD cases compared to the two control groups in the study (Eatough et al. 1990). 
Whilst this study was small and did not present an estimate of the effect size, it raises 
the issue of whether emotional stress in childhood may affect the brain chemically 
and structurally resulting in a chronic decrease in dopamine and the development of 
typical personality traits and increased susceptibility to developing PD. 
 
Decreased dopamine, as experienced in PD, appears to influence personality traits 
and/or behaviours. However, this relationship does not negate the possibility of a 
biologically protective effect from smoking. People with these particular personality 
traits and associated behaviours may be at increased risk of PD due to their 
propensity not to smoke. Thus, they fail to benefit from smoking-related 
neuroprotective factors. As decreased novelty-seeking may be an indicator of an 
underlying susceptibility in the dopaminergic system or evidence of subclinical 
disease, abstaining from smoking may simply contribute to a process that is already 
underway.  
 
2.9.2 Coffee and Tea Consumption 
Consumption of coffee has also been found to have a strong negative relationship 
with PD in retrospective (Baumann et al. 1980; Jiménez-Jiménez et al. 1992; 
Hellenbrand et al. 1996; Fall et al. 1999; Benedetti et al. 2000; Preux et al. 2000; 
Paganini-Hill 2001; Ragonese et al. 2003; Tan et al. 2003) and prospective studies 
(Grandinetti et al. 1994; Ross et al. 2000; Schwarzschild and Ascherio 2004).  
 
The analysis of PD incidence and coffee consumption in the Honolulu Heart Study 
was the first prospective study to show a strong inverse relationship between coffee 
consumption and PD, including a statistically significant dose-response relationship 
(Ross et al. 2000). This study’s results, which were confined to men of Japanese 
ancestry, were similar to those obtained in another prospective study involving a 
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male-only cohort, the Health Professional’s Follow-Up Study (HPFS, n=47,351) 
(Ascherio et al. 2001). However, a clear dose-response pattern was not evident in a 
female-only cohort (Nurse’s Health Study, n=88,565) analysed by the same authors. 
In women, the relationship followed a ‘U’ shape rather than a continually decreasing 
reduction in risk with increasing dose. When women in this cohort were stratified 
according to whether they had used postmenopausal hormone therapy, a difference in 
risk with coffee consumption was noted. Use of hormone therapy was associated 
with reduced risk of PD (RR 0.39, 95% CI 0.13-1.17) in combination with low 
caffeine consumption and increased risk (RR 2.44, 95% CI 0.75-7.86; p for 
interaction = 0.01) with high caffeine consumption. These results were confirmed in 
another large prospective study, the Cancer Prevention Study II Cohort, which 
included both men (n=301,164) and women (n=238,058). A statistically significant 
reduced risk was found in men who drank coffee (albeit without a clear dose-
response relationship), whereas the relationship seen in women was weaker. When 
women were stratified according to whether they had taken oestrogen-replacement 
therapies, a significant reduction in risk of PD was seen in those who did not take 
oestrogens and drank coffee, similar to the result for men who drank coffee, although 
no relationship was seen for women who took oestrogens and drank coffee.  
 
Some case-control studies have also observed a strong inverse relationship in men, 
but no effect in women (Benedetti et al. 2000; Wirdefeldt et al. 2005). Although, 
other case-control studies have reported the same reduction in risk for men and 
women (Ragonese et al. 2003). A statistically significant dose-response relationship 
with number of cups of coffee per day in men was observed by Benedetti et al. 
(2000). Other studies do not present gender-specific data, but demonstrate a dose-
response relationship in the mixed-gender samples (Hellenbrand et al. 1996; Fall et 
al. 1999; Tan et al. 2003). In contrast, Checkoway et al. (2002) failed to find a 
relationship between coffee drinking and PD, including no suggestion of a dose 
response trend, although a relationship with tea was found. Likewise, Ayuso-Peralta 
et al. (1997) found an inverse relationship with tea, but not with coffee. However, 
this study used spouse controls and therefore the control group was mismatched to 
the case group on gender. If coffee and tea consumption is different between men 
and women in this population, these results may be biased. Zayed et al. (1990) 
showed only a small difference in the number of cases and controls who drank 
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coffee, although the proportion of subjects who drank coffee was much higher than 
in other studies (81% of cases and 93% of controls drank coffee). 
 
In addition to the studies by Checkoway et al. (2002) and Ayuso-Peralta et al. (1997), 
Fall et al. (1999) and Tan et al. (2003) also reported an inverse trend of decreasing 
risk with increased consumption of tea. While the prospective study by Ascherio et 
al. (2001) only found the relationship in men (p for trend = 0.02). Other studies have 
not found a clear relationship between tea consumption and PD (Ho et al. 1989; 
Hellenbrand et al. 1996; Ascherio et al. 2001; Paganini-Hill 2001); while Preux et al. 
(2000) even reported a nearly two-fold increase in odds of PD with tea drinking (OR 
1.9 95% CI 1.1-3.2).  
 
Studies that have analysed coffee and tea together, rather than separately have 
typically failed to find a relationship between consumption of either and PD (Haack 
et al. 1981; Nuti et al. 2004). 
 
No studies have shown a relationship between decaffeinated coffee consumption and 
PD, suggesting that caffeine may be the component of significance (Haack et al. 
1981; Ascherio et al. 2001; Paganini-Hill 2001; Checkoway et al. 2002; Ascherio et 
al. 2004). Caffeine is also a likely candidate for a biologically protective effect 
against PD due to its known actions upon the nervous system, most notably, 
blockade of A1 and A2A subtypes of adenosine receptors9, which appears to be 
responsible for the stimulant effects of coffee (Dunwiddie and Masino 2001; Daly 
and Fredholm 2004). Adenosine A2A receptors and dopamine D2 receptors are 
functionally antagonistic . Thus, blockade of A2A receptors would be expected to 
increase activity mediated by D2 receptors. As blockade of A2A receptors potentiates 
the effects of levodopa, A2A receptor antagonists, including theophylline, a 
metabolite of caffeine, have been investigated as potential candidates for new drug 
therapy in PD (Kulisevsky et al. 2002). In addition to enhancing activity of dopamine 
receptors, A2A receptor antagonists can prevent dopaminergic neurodegeneration in 
                                                 
9 Adenosine is involved in a diverse array of functions in the central nervous system, including 
regulation of sleep, arousal, neuroprotection, and epilepsy. Rather than acting as a neurotransmitter, 
adenosine is a neuromodulator of physiological responses. Many of its effects are inhibitory, 
depending on the brain system and the complement of adenosine receptors that are present 
(Dunwiddie and Masino 2001; Fredholm et al. 2005) 
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experimental ‘toxin-induced’ models of PD. Therefore, blockade of A2A receptors 
may exert both acutely anti-symptomatic and chronically neuroprotective activities 
(Ikeda et al. 1992). Toxicological research of caffeine in the MPTP animal model of 
PD has provided evidence supportive of a biologically protective effect. Caffeine, at 
doses in mice (5 to 30 mg/kg) comparable to those of typical human exposure, dose-
dependently reverses the loss of striatal dopamine triggered by MPTP (Chen et al. 
2001a). 
 
In addition to antagonism of adenosine receptors, caffeine is associated with other 
biological effects that may be relevant to PD aetiology, such as increasing plasma 
oestrogen, plasma estradiol, and sex hormone-binding globulin levels (Ferrini and 
Barrett-Connor 1996). As women appear to have decreased incidence of PD 
compared to men, and there is evidence that oestrogen may be protective against PD 
(see Section 2.7), elevation of plasma levels of oestrogen may reduce risk of PD. In 
addition to caffeine’s ability to raise endogenous oestrogen levels, coffee is also a 
source of phytoestrogens (Mazur 1998). A protective effect of estradiol and certain 
phytoestrogens (quercetin and resveratrol) has been reported in neuronal PC12 cell 
cultures (Gélinas and Martinoli 2002). Administration of MPP+ alone to neuronal 
PC12 cells decreased dopamine transporter expression, while treatments with MPP+ 
together with 17α-estradiol, 17 β-estradiol, quercetin, or resveratrol restored 
dopamine transporter protein expression to control levels.  
 
Coffee contains many other biologically active constituents including antioxidants, 
such as polyphenols, and other chemoprotective components (Manach et al. 2004). 
The chemoprotective effects of these coffee components and whole coffee is 
associated with modifications of the glutathione-S-transferase (GST) and N-
acetyltransferase (NAT) detoxification pathways. Kahweol and cafestol, two 
constituents of unfiltered coffee, cause various modifications of xenobiotic 
metabolism that are overwhelmingly beneficial, including induction of GST and 
inhibition of NAT. Other coffee components such as polyphenols and 
kahweol/cafestol-free coffee are also capable of increasing GST and partially of 
inhibiting NAT, although to a somewhat lesser extent (Huber and Parzefall 2005). 
Therefore coffee may also provide protection against PD through reduction of 
toxicity of environmental exposures.  
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2.9.3 Alcohol Consumption 
Studies that have assessed alcohol consumption and risk of PD have produced 
equivocal results (Baumann et al. 1980; Haack et al. 1981; Koller 1983; Ho et al. 
1989; Stern et al. 1991; Levine et al. 1992; Mayeux et al. 1994; Morano et al. 1994; 
Watanabe 1994; Morens et al. 1996b; Kuopio et al. 1999b; Benedetti et al. 2000; 
Behari et al. 2001; Paganini-Hill 2001; Pals et al. 2003; Ragonese et al. 2003; 
Galanaud et al. 2005). However, men with heavy alcohol consumption may be at 
reduced risk of PD (Benedetti et al. 2000) 
 
2.9.4 Diet and Vitamin Intake  
A decreased risk of PD with increased intake of vitamins has been proposed 
presumably from anti-oxidative action of some vitamins such as vitamin E or C, or 
similar protective mechanisms. An inverse relationship between PD and vitamin 
intake has been reported for vitamin E (de Rijk et al. 1997a; Zhang et al. 2002), beta 
carotene (Hellenbrand et al. 1996; de Rijk et al. 1997a), and ascorbic acid 
(Hellenbrand et al. 1996). Conversely, a number of the studies investigating dietary 
factors also reported no relationship with vitamin E (Hellenbrand et al. 1996; 
Logroscino et al. 1996; Morens et al. 1996b; Ayuso-Peralta et al. 1997; Scheider et 
al. 1997; Anderson et al. 1999), vitamin C (Logroscino et al. 1996; Ayuso-Peralta et 
al. 1997; Scheider et al. 1997; Anderson et al. 1999; Zhang et al. 2002), vitamin B 6 
or 12 (Chen et al. 2004), folate (Chen et al. 2004), carotenoids (Scheider et al. 1997; 
Zhang et al. 2002) and vitamin A (Anderson et al. 1999). 
 
A number of retrospective studies have suggested an increased risk of PD with high 
consumption of animal (saturated) fats (Logroscino et al. 1996; Logroscino et al. 
1998; Anderson et al. 1999; Johnson et al. 1999). However, this relationship was not 
confirmed in other retrospective studies (Hellenbrand et al. 1996; Powers et al. 2003) 
or in prospective studies (Chen et al. 2003b; de Lau 2005). 
 
Obtaining an accurate assessment of dietary intake is generally difficult, particularly 
when historical, rather than current intake is of interest (Schatzkin et al. 2003). The 
main limitation of many of the studies examining diet and PD aetiology is the 
measurement of current rather than historical diet information. Causation is difficult 
to establish in cross-sectional and case-control studies as changes in diet may have 
 36 
been due to developing PD. For example, people with PD may consume more refined 
food, lacking in nutrients, which is easier to prepare as a result of physical disability, 
compared to unaffected individuals. Any inferences drawn from the results of these 
studies must assume that current diet is representative of the participants’ diet before 
development of PD. 
 
2.10 Environmental Factors  
As previously discussed, there is a significant body of evidence to suggest that 
environmental factors play a role in PD aetiology. Exposure to toxic substances, such 
as pesticides or neurotoxic metals (e.g. example manganese or lead) could 
conceivably contribute to mechanisms such as oxidative stress leading to nigral 
neuronal cell death. If such exposures occur against a backdrop of genetically 
determined decreased ability to counteract these toxins, the likelihood of disease may 
be greatly increased.  
 
2.10.1 Case Studies of Parkinsonism Associated with Exposure to Toxins  
Symptoms of parkinsonism can occur in individuals subjected to acute exposures of 
toxic substances, including manganese, carbon disulfide, carbon monoxide, 
organophosphate pesticides and the synthetic chemical MPTP. These ‘toxin-induced’ 
forms of parkinsonism have been influential in leading researchers to investigate the 
possible role that environmental toxins may play in the development of PD and the 
alternative hypothesis that PD has an environmental cause.  
 
MPTP 
The occurrence of an irreversible parkinsonian syndrome identical to PD amongst 
intravenous drug users who injected drugs contaminated with the chemical MPTP (1-
methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine) has been influential in focusing 
research into an environmental cause of PD (Tetrud and Langston 1989; Le Couteur 
et al. 1999). The toxicological pathway for MPTP-induced parkinsonism (described 
previously) has been identified, providing clues for the search for other possible 
parkinsonism-inducing neurotoxins and giving support for an environmental cause of 
PD (Bonnet and Houeto 1999).  
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The MPTP model has been highly useful in developing a number of theories relating 
to the development of PD. MPTP-susceptibility has been shown in laboratory mice to 
be related to age. Older animals suffered neuronal degeneration with MPTP 
exposure, while younger animals did not suffer the same degeneration when 
administered with twice the dose. Extrapolation of the results to PD in humans 
suggests that exposure to environmental toxins throughout life may only result in PD 
once changes due to ageing of the nervous system (Tetrud and Langston 1989) 
and/or hepatic detoxification system have occurred (Le Couteur et al. 1999). 
 
The mode of exposure to MPTP also appears to be important to the pathophysiology 
of the resulting syndrome. Chronic delivery of MPTP results in parkinsonism more 
closely resembling PD than when acute high doses are administered. The 
subpopulations of dopaminergic neurons lost as a result of acute exposure are not 
identical to the pattern seen in people with PD (Mandir and Vaughan 2000). Again, 
consideration of the implications of this finding for PD suggests chronic exposure to 
environmental toxins, rather than a ‘once off’ exposure, may be influential in the 
development of the disease. 
 
Pesticides 
Pesticides include a large number of different chemical compounds that are generally 
grouped into the categories of insecticides, herbicides, fungicides, rodenticides and 
fumigants, according to their use. The predominant chemicals used in pesticides have 
changed substantially over time and greatly increased in diversity.  
 
The herbicide paraquat has been identified as a possible neurotoxic agent due to its 
molecular structure, which is similar to MPTP (Bonnet and Houeto 1999; Brooks et 
al. 1999). Furthermore, MPP+, a metabolite of MPTP shown to damage neurons in 
the substantia nigra, has been commercially marketed as a herbicide under the name 
‘cyperquat’ (Hertzman et al. 1990). An association between direct exposure to 
paraquat, cyperquat or diquat and parkinsonian symptoms has been reported in a few 
cases. Sechi et al. (1992) describes a case of a 72-year-old farmer who suffered 
parkinsonian symptoms including decreased blinking rate, facial masking, flexed 
posture of arms, trunk, and neck, a walk with short slow steps, postural instability, a 
slow monotonous voice and cogwheel rigidity after skin contact with 10% diquat 
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dibromide for approximately 10 minutes. The patient's symptoms developed within 
10-14 days of the exposure to diquat and did not subside, resulting in persistent 
parkinsonism.  
 
A case report by Meco et al. (1994), which describes a 37-year-old man who 
developed parkinsonism after 3 years of chronic exposure to the fungicide maneb, is 
also suggestive of a link between the man's fungicide exposure and development of 
parkinsonian symptoms. 
 
Carbon disulfide is used as a solvent in industrial processes and has also been used as 
a pesticide, usually in the form of a fumigant. Parkinsonism including the symptoms 
of resting tremor, finger tremor, cogwheel rigidity, slow speech, and micrographia, 
has been described in some reports of carbon disulfide exposure (Peters et al. 1988; 
Chapman et al. 1991; Spencer and Butterfield 1995).  
 
Cases of transient severe parkinsonism following acute organophosphate poisonings 
have been described (Bhatt et al. 1999). In these reports, the patients developed 
parkinsonian symptoms such as bradykinesia, facial masking, resting tremor, 
postural instability and hypophonic speech. Recovery from the parkinsonian 
symptoms without medication was seen in all patients. While these cases show a link 
between exposure to pesticides and development of parkinsonian symptoms, the 
cause of these symptoms is likely to be different to those of PD due to the 
reversibility of the observed parkinsonian conditions. In these transient cases, 
organophosphates may have caused a dysfunction in the dopamine receptors of the 
striatum, rather than damage to the dopamine-producing cells, the characteristic 
feature of PD. As such, these acute poisoning incidents are likely to be of limited 
relevance to the aetiology of PD.  
 
Neurotoxic Metals 
Exposure to the neurotoxic metal manganese has been identified as a cause of a 
parkinsonian syndrome very similar to PD (Huang et al. 1998; Discalzi et al. 2000). 
A feature of manganese intoxication, or manganism, which resembles PD, is the 
continuation of degeneration long after exposure has ceased (Huang et al. 1998). 
However, there are clinical dissimilarities between manganism and PD, such as less-
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frequent resting tremor, more frequent dystonia, a propensity to fall backward, and 
failure to achieve a sustained therapeutic response to levodopa (Calne et al. 1994). 
 
Welding involves joining metals by electric arc or flame with a filler material (or 
consumable). This process typically produces concentrated particulate fumes and 
gases containing elements such as manganese, silica, arsenic, nickel, chromium, 
beryllium, cadmium, copper, lead, cobalt, zinc, and selenium. Gases released include 
carbon monoxide, carbon dioxide, ozone, phosgene, and fluorine compounds. The 
presence of manganese in welding fumes is of particular interest to PD as the 
neurodegenerative syndrome associated with manganism that includes features of 
parkinsonism has also been noted to occur in welders (Ono et al. 2002; Sadek et al. 
2003), as have elevated blood serum levels for manganese (Ono et al. 2002; Li et al. 
2004). A connection between exposure to welding fumes and PD aetiology is 
particularly controversial due to legal action in progress by current and former 
welders seeking compensation from manufacturers of welding materials for 
parkinsonism, including PD, they allege was caused by their exposure to welding 
fumes. There are a number of large class actions underway, and the situation has 
been compared to that of asbestos-related compensation litigation (Wyckoff and 
McBride 2004).  
 
Solvents 
Organic solvents comprise a large group of compounds with a variety of chemical 
structures. These include alcohols, ketones, ethers, glycols, aldehydes, aliphatic and 
aromatic saturated and non-saturated hydrocarbons, halogenated hydrocarbons, and 
carbon disulfide, among others. They are commonly used in a wide variety of 
industrial processes due to their ability to dissolve and readily disperse fats, oils, 
waxes, paints, pigments, varnishes, rubber, and many other materials. Exposure to 
solvents has been linked to neurological symptoms including, irritability, memory 
impairment, depression, emotional instability, sleep disturbance, alcohol intolerance, 
impaired psychomotor function, impaired verbal abilities, disturbances of mood, 
psychiatric disorders and parkinsonism (Hageman et al. 1999; Fiedler et al. 2003; 
Kaukiainen et al. 2004). 
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A number of case reports of parkinsonism developing in patients following exposure 
to solvents have been described (Melamed and Lavy 1977; Sandyk and Gillman 
1984; Pezzoli et al. 1989; Tetrud et al. 1990; Vanacore et al. 2000; Kuriwaka 2002). 
Some cases have been described as a parkinsonian syndrome which is clinically 
indistinguishable from PD and responsive to levodopa treatment. Such a condition 
was described in a female patient following acute exposure to lacquer thinner 
through abuse. The parkinsonism persisted for more than 3 months, but PET studies 
showed normal fluorodopa uptake and reduced raclopride binding, indicating an 
unusual disturbance of striatal dopaminergic function, rather than degeneration of 
dopaminergic neurons (Uitti et al. 1994). Another report describes a female patient 
who was diagnosed with PD following seven years of professional exposure to 
trichloroethylene, causing suspicion of a link between the chronic solvent exposure 
and the development of PD (Guehl et al. 1999). 
 
2.10.2 Laboratory Studies of Environmental Toxins and PD  
A number of important and highly suggestive findings in relation to PD and 
environmental toxins have come from laboratory studies. Laboratory experiments 
have the advantage of studying the relationship between suspected environmental 
toxins and development of parkinsonian symptoms under controlled conditions, 
thereby reducing biases and confounding factors. These studies have also been used 
to demonstrate a biological plausibility behind theories of environmental exposures 
and PD. However, while providing suggestive evidence of an environmental cause of 
PD, laboratory results cannot be treated as definitive evidence of an effect due to the 
vast difference in the laboratory situation and real-life conditions. 
 
Investigation of organochlorine pesticides has featured in a number of laboratory 
studies of PD (Fleming et al. 1994; Seidler et al. 1996; Miller et al. 1999; Corrigan et 
al. 2000). Miller et al. (1999) found in studies involving injection of mice with the 
organochlorine pesticide heptachlor and in vitro studies with the oxidised metabolite 
heptachlor epoxide, that the pesticide disrupts nigrostriatal dopamine transport. The 
researchers postulated that this disruption of dopamine transport could increase 
susceptibility to endogenous and exogenous dopaminergic toxins, providing a 
plausible explanation of a link between organochlorine pesticide exposure and 
incidence of PD. 
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The herbicide paraquat has also received much attention as a possible aetiological 
agent for PD (Koller 1986; Rajput and Uitti 1987; Rajput et al. 1987c; Sanchez-
Ramos et al. 1987; Brooks et al. 1999; Thiruchelvam et al. 2000a; Thiruchelvam et 
al. 2000b). Experimental research provides evidence that paraquat, or a metabolite of 
the herbicide can cross the blood-brain barrier to reach the substantia nigra. Systemic 
injection of mice with paraquat elicited a dose-dependent decrease in substantia nigra 
dopaminergic neurons, a decline in the striatal dopamine nerve terminal density and a 
decrease in ambulatory activity, similar to that obtained with injection of MPTP 
(Brooks et al. 1999). These results give credibility to the theory that paraquat may be 
involved in the aetiology of PD, although are not conclusive due to the significant 
differences between the experimental and human modes of exposure (acute and 
injection versus chronic and transdermal absorption or inhalation). 
 
The insecticide rotenone (Derris dust) has been shown to cause highly selective 
degeneration of nigrostriatal dopaminergic neurons in rats treated by chronic 
systemic infusion with the pesticide (Betarbet et al. 2000). The clinical symptoms 
exhibited by the treated rats were similar to those of people with PD, such as 
bradykinesia and rigidity. Furthermore, fibrillar cytoplasmic inclusions containing 
ubiquitin and alpha-synuclein accumulated in the nigral neurons mimicking a 
neuropathological feature of PD. The researchers found that rotenone infusion 
inhibited complex I of the mitochondrial electron transport chain10. This finding is of 
particular interest as complex I is the site inhibited by MPP+, a metabolite of MPTP 
and has been shown to be reduced in the brain cells and platelets of people with PD 
(Mann et al. 1994; Mandir and Vaughan 2000). Overall, the study provided some 
toxicological evidence to link chronic exposure to a common pesticide (rotenone) to 
the anatomical, neurochemical, behavioural and neuropathological features of PD.  
 
The results of another study demonstrated in-vitro that common pesticides including 
rotenone, dieldrin and paraquat can induce changes in alpha-synuclein and 
significantly accelerate the rate of formation of alpha-synuclein fibrils (Uversky et al. 
2001).  
 
                                                 
10 Complex I is an enzyme in the mitochrondrial electron transport chain that provides energy for the 
cell to make adenosine triphosphate (ATP). 
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These studies by Betarbet et al. (2000) and Uversky et al. (2001) demonstrate a link 
between pesticides and the formation of Lewy body-like structures, a major 
pathological feature of PD, providing biological plausibility to the involvement of 
pesticide exposure in PD aetiology. 
 
Studies have also reported that primates exposed to carbon disulfide can develop 
motor disturbances including slowness of movement, un-coordination of movement, 
plastic and cogwheel rigidity, and resting tremor. However, other non-parkinsonian 
symptoms, such as action tremor, were also induced and the pathological 
characteristics were distinct from PD (Spencer and Butterfield 1995). 
 
Manganese ethylene-bis-dithiocarbamate (Mn-EDBC), a major component of the 
fungicide maneb, has been implicated in PD pathophysiology, both on its own and 
synergistically with paraquat, in animal studies (Thiruchelvam et al. 2000a; 
Thiruchelvam et al. 2000b; Zhang et al. 2003b). Rats treated with Mn-EDBC 
developed selective reduction of striatal dopamine and dopaminergic 
neurodegeneration (Zhang et al. 2003b). Rats treated with both paraquat and maneb 
together experience sustained decreases in motor activity and potentiated effects that 
appear to target the nigrostriatal dopamine system (Thiruchelvam et al. 2000a). 
 
2.11 Epidemiological Studies of Environmental Risk Factors for PD  
Potential environmental risk factors examined in epidemiological studies include 
living in a rural environment, pesticide exposure, exposure to metals, solvent 
exposure, occupation, and well-water consumption.  
 
2.11.1 Ecological Studies 
In ecological studies, the frequency of disease and exposure are compared among 
populations without individual enumeration of persons with disease or exposures. 
Ecological studies of PD have implicated heavy metals and pesticides as potential 
risk factors. A Swedish ecological study noted a high consumption of anti-
parkinsonian drugs in a county characterized by 3 large steel alloy working plants 
that include the use of iron, manganese, chromium, vanadium and other heavy metals 
in the manufacture of a special steel formulation. This result is suggestive of an 
increased prevalence of PD due to exposure to the heavy metals. However, as the 
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study is based on drug sales data, there are many confounding variables that may 
influence the result, such as regional differences in prescribing patterns and policies, 
the age structure of the population and differences in drug purchasing behaviour (e.g. 
whether prescriptions are filled at one pharmacy or multiple pharmacies) (Aquilonius 
and Hartvig 1986).  
 
An ecological study conducted in California by Ritz and Yu (2000) presented some 
basic evidence that pesticide and herbicide exposure may be risk factors for PD. This 
study used 'pesticide use' report data to classify Californian counties into several 
pesticide use categories and then compared cause of mortality data from death 
certificates over a 10-year period in each of these counties. Mortality from PD as the 
underlying cause of death was found to be higher in agricultural pesticide-use 
counties than in non-use counties. A similar study in the Canadian Province of 
Quebec, was also conducted by Barbeau et al. (1987). This study used four different 
methods to estimate PD prevalence, namely:- information on diagnosis obtained 
from a required reporting system to the state medical insurance department; 
calculations based on the geographical sales of Levodopa; examination of death 
certificates for cause of death; and patient residence information obtained from major 
movement disorder clinics and practicing neurologists. The obtained prevalences 
were then mapped according to the nine major hydrographic regions of Quebec. 
Similar results were found from all four methods. The authors noted the 
hydrographic region consistently identified as having the highest prevalence of PD 
was a region known as the "garden of Quebec" as it is the source of nearly 80% of 
the Provinces' commercial production of vegetables. This area is also the largest user 
of various forms of pesticides, including herbicides, fungicides, mineral oils and 
insecticides.  
 
These two studies provide suggestive evidence of a link between pesticide use and 
PD. However, ecologic studies are rarely accepted as proof of causality because a 
number of competing interpretations of results is possible. 
 
2.11.2 Cross-Sectional Studies 
Cross-sectional studies have the advantage of being relatively quick and inexpensive 
to perform and can often be conducted within existing cohort studies. Their main 
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limitation is that exposure and disease status are measured concurrently, therefore it 
is difficult to establish causation.  
 
A cross-sectional study by Ferraz et al. (1988) examined prevalence of parkinsonian 
symptoms amongst rural workers exposed to maneb and rural workers without the 
exposure. The study found a significantly higher prevalence of a number of 
symptoms (plastic rigidity with cogwheel phenomenon, headache, fatigue, 
nervousness, memory complaints, and sleepiness) amongst the maneb-exposed 
workers. Other signs, such as postural tremor and bradykinesia, were also noted. 
Another cross-sectional study, which was nested in a previous cohort study involving 
orchardists, examined symptoms of parkinsonism amongst exposed and unexposed 
workers. No associations were found for use of well water, farm employment or any 
specific pesticides. There did appear to be a dose effect for ‘any pesticides’ as 
elevated prevalence ratios were reported for the 2nd and 3rd tertile of years of 
exposure compared to the first tertile. One of the major limitations with this study 
was the low percentage of the original cohort that participated in the cross-sectional 
study. Only 310 of the original 1300 subjects (24%) participated in the cross-
sectional survey as a large proportion were deceased (34%), could not be contacted 
(19%), were lost to follow-up (9%) or refused to participate (12%). If PD cases 
amongst the original cohort group were more likely to be deceased or uncontactable, 
then prevalence of PD and/or parkinsonism in the original cohort could be 
underestimated.  
 
A large cross-sectional study (n=4496) nested within the Italian Longitudinal Study 
on Aging examined environmental and lifestyle related factors (Baldereschi et al. 
2003). In the results, possession of a pesticide-use license was significantly 
associated with PD (PR 3.68, 95% CI 1.57-8.64).  
 
Recently, a prevalence study by Racette et al. (2005) reported a higher prevalence of 
parkinsonism in welders compared with a general population. However there were a 
number of limitations in this study. The ‘affected’ welders were part of a litigation 
case in which the welders were alleging their parkinsonism was caused by exposure 
to welding and had been sourced from the legal firm representing them. Therefore, 
the welders may not have been representative of all welders in the community and 
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may have over-reported their welding exposures and/or symptoms. Welders were 
diagnosed with parkinsonism through videotaped footage rather than by physical 
examination by a neurologist and there was no mention of the validity of this method 
for measuring the outcome variable. Moreover, the study did not identify the 
prevalence of parkinsonism in the general community within the same geographic 
area but extrapolated data from an older study performed in a different and smaller 
geographic area (Schoenberg et al. 1985). Unfortunately, this comparison study only 
included those with the diagnosis of idiopathic PD and used a different method of 
diagnosing PD (physical examination by a neurologist); as such it is not an 
appropriate comparison for the cohort of welders, which included other forms of 
parkinsonism in addition to PD.  
 
2.11.3 Case-Control Studies  
Case-control studies of PD deserve special attention as this is the most efficient 
design to explore the aetiology of relatively rare conditions, such as PD. The 
majority of epidemiological studies of PD aetiology have been case-control studies. 
In a case-control study, cases of the condition of interest are identified and their 
exposure status is determined. Cases are often identified and recruited from medical 
care facilities. However, in order to determine if the exposure is associated with the 
condition of interest, the prevalence of the exposure in the population without the 
condition also needs to be established as a comparison. A control group is sampled 
from the entire source population that theoretically gives rise to the cases for this 
purpose. While case-control studies are an efficient study design to examine PD 
aetiology, there are many potential sources of error that can invalidate the results 
(Rothman and Greenland 1998a; Rothman and Greenland 1998c; Tanner and Ross 
2004). 
 
2.11.3.1 Systematic Review of Case-Control Studies of Environmental Risk 
Factors for PD 
A comprehensive and detailed review of all case-control studies of environmental 
exposures and PD was completed to: establish the existing knowledge with respect to 
environmental exposures and development of PD; identify ‘gaps’ in the existing 
knowledge; identify the environmental risk factors of most importance and the 
estimated size of the previously reported associations; generate hypotheses to explain 
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the variability in result findings amongst different studies; and to develop ways of 
addressing these possible explanations. The review was limited to case-control 
studies to improve comparability between studies.  
 
Methods 
The databases Medline, Pre-Medline, Biological Abstracts, Current Contents and 
Academic Search Elite were searched with the parameters “Parkinson* AND 
environment*” and “Parkinson* AND exposure” and “Parkinson* AND case AND 
control” in default fields (abstract, title, keywords). Articles reporting original 
research into PD aetiology and examining environmental exposures were identified. 
Key review articles were also located through this same process. The reference list of 
each of these journal articles was then reviewed for new case-control studies that had 
not been identified through the search of the databases. This process was repeated 
until no further articles were identified. Seventy-one (71) peer-reviewed journal 
articles were identified as at 4th of April 2002. Sixty-six articles were published in 
English, 1 in Chinese, 2 in French 1 in German and 1 in Japanese. The articles 
published in languages other than English were translated into English. Three PhD 
and two Masters theses examining environmental risk factors for PD by means of a 
case-control study were also located and reviewed. Results from unpublished studies 
were not included in the review.  
 
The results from many of the studies were not directly compatible with each other 
due to differences in exposure definitions and measurement. Therefore, a meta-
analysis was not performed. Rather, the studies are summarised in table format 
(Tables B1-B6 in Appendix B) and the odds ratios and 95% confidence intervals for 
each of the similar exposures from all the studies were plotted as a forest plot 
(Figures 2.11.1-2.11.8). This allowed a visual inspection of the results for trends 
between studies. Where studies have reported multiple results (e.g. different doses or 
sex-stratified), all results are presented. Due to limited space, individual studies have 
been identified with a number. Tables listing the bibliographic reference 
corresponding to each study number are listed in Appendix C. 
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Rural Residency 
Residence in a rural environment has been identified in a number of studies as a risk 
factor for PD (Rajput et al. 1986; Rajput et al. 1987c; Ho et al. 1989; Golbe et al. 
1990; Koller et al. 1990; Stern et al. 1991; Wong et al. 1991; Butterfield et al. 1993; 
Liou et al. 1997; De Palma et al. 1998; McCann et al. 1998; Smargiassi et al. 1998; 
Zorzon et al. 2002), however other studies have found no association (Semchuk et al. 
1991; Vieregge et al. 1994; Martyn and Osmond 1995; Seidler et al. 1996; Chan et 
al. 1998; Gorell et al. 1998; Kuopio et al. 1999b; Taylor et al. 1999; Werneck and 
Alvarenga 1999) or a negative association (Tanner et al. 1989; Zayed et al. 1990; 
Wang et al. 1993; Behari et al. 2001). A possible explanation for a positive 
association between residence in a rural environment and PD may be due to factors 
that are common to rural life so that ‘rural residency’ might simply be a proxy 
variable for one or more causative environmental agents common rural environments 
(Spencer and Butterfield 1995). These may include:- drinking well water 
contaminated with toxic substances, exposure to herbicides and pesticides associated 
with agriculture, and incidental agricultural exposure such as through pesticide spray 
drift. An alternative explanation may be that urban living is associated with a 
reduction in risk of PD. For example, detoxification pathways may be enhanced by 
low level exposure to contaminants common to urban environments. 
 
Butterfield et al. (1993), Seidler et al. (1996) and Gorell et al. (1998) attempted to 
identify which of these common components of rural life may be risk factors for PD. 
Significant positive associations were found with insecticide and herbicide exposure 
(Butterfield et al. 1993; Seidler et al. 1996; Gorell et al. 1998), depending upon the 
number of years of exposure in one study. No significant associations were found 
with PD and living close to agricultural spraying (Butterfield et al. 1993) or well-
water drinking (Butterfield et al. 1993; Seidler et al. 1996; Gorell et al. 1998). While 
these results suggest that the main contributor to risk of PD from rural living is 
exposure to insecticides and herbicides, other factors should not be excluded due to 
the limited number of studies specifically looking at rural living and exposures 
associated with rural life. The disagreement between studies on the issue of rural 
living is likely to be due to a number of issues, including:- differences in definition 
of 'rural residency', geographical differences in study location which includes 
differences in the exposures associated with rural life in different areas, and 
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differences in the quality of case and control selection, data collection and data 
analysis.  
 
Definitions of ‘rural residency’ used in these studies have included towns of set 
population size, or other descriptions such as ‘village’, ‘small city’, ‘isolated house’ 
or ‘non-metropolitan area’ while others have left the meaning to the participant to 
define. If the causative agent is associated with an aspect of rural life that is not 
necessarily connected to population size or another selected measure of ‘rural 
residency’, substantial misclassification may occur resulting in different results to 
other studies. Relying on participants to interpret what is meant by ‘residence in a 
rural area’ is also likely to result in misclassification, as there is likely to be 
substantial variability amongst participants’ concepts of rurality. 
 
The results for the 22 published case control studies that examined rural residency 
are presented in Table B1 (Appendix B) and are also displayed in Figure 2.11.2. A 
key to the figure (details of authors) are presented in Table C1 (Appendix C). 
Substantial variation in the estimates of risk associated with rural residency can be 
seen within each geographical region, suggesting that the variability between studies 
is not solely due to geographical differences, but also reflects differences between 
these individual studies.  
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Geographic location 
Study. Exposure Location Size
1 RR Australia 534
2 RR US 608
3 RR 1st 15 years Canada 390
3 RR 1st 45 years Canada 390
4 RR US 300
5 RR ≥1 year US 298
5 RR 1-10 years US 298
5 RR 10+ years US 298
6 RR US 287
7 Rural experience US 212
5 RR ≥1 year US 160
5 RR ≥1 year US 138
8 RR at diagnosis US 131
9 RR Canada 126
9 RR 1-10 years Canada 126
9 RR 11-20 years Canada 126
9 RR 21-30 years Canada 126
9 RR >30 years Canada 126
10 RR US 76 
11 Popn density Germany 759
11 Popn density Germany 756
12 Isolated house England 515
12 Small Town England 515
12 Village England 515
13 Rural birth Italy 408
13 RR Italy 408
14 RR Italy 300
15 RR Germany 138
16 % of life rural China 528
17 RR Taiwan 360
17 RR 1-19 years Taiwan 360
17 RR >19 years Taiwan 360
18 Village  China 300
19 Small Cities China 279
19 Rural China 279
20 RR 1-20 years Hong Kong 140
20 RR 21-40 years Hong Kong 140
20 RR >40 years Hong Kong 140
21 RR ≤10 years India 754
21 RR >10 years India 754
22 Rural life Rio de Janeiro 202
RR: Rural Residency 
 
OR and 95% CI
0.1 1 10
 
Figure 2.11.1 Plotted Odds Ratios and 95% Confidence Intervals for “Rural 
Residency” Arranged by Geographic Location 
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Well Water Consumption 
Some studies have identified drinking well-water as a risk factor for PD (Tanner et 
al. 1989; Koller et al. 1990; Zayed et al. 1990; Wechsler et al. 1991; Wong et al. 
1991; Butterfield et al. 1993; De Michele et al. 1996; Seidler et al. 1996; De Palma et 
al. 1998; Gorell et al. 1998; Smargiassi et al. 1998; Kuopio et al. 1999; Behari et al. 
2001), others have found no association (Tanner et al. 1989; Golbe et al. 1990; 
Semchuk et al. 1991; Hertzman et al. 1994; Vieregge et al. 1994; Seidler et al. 1996; 
Chan et al. 1998; Gorell et al. 1998; Taylor et al. 1999), while some reported an 
inverse association (Wang et al. 1993; Liou et al. 1997; McCann et al. 1998). Wong 
et al. (1991) found in a study of 19 sibling pairs with PD and matched controls, that 
people with PD had drunk well-water for more years than the control subjects, 
suggesting that length of exposure may increase risk in a dose-response relationship. 
However, the study did not find an overall statistically significant association 
between well-water drinking and PD. Further reasons to interpret the results of this 
study with caution include design limitations, such as a small sample size (38 cases 
and 76 controls consisting of two distinctly different control groups). The results of 
the 22 studies that examined well water as a potential risk factor are presented in 
Table B2 (Appendix B) and Figure 2.11.2. A key to the figure (details of authors) are 
presented in Table C2 (Appendix C). 
 
As previously mentioned, the association of drinking well water and PD may be due 
to contaminated groundwater from leaching of agricultural chemicals, including 
herbicides and pesticides. This may explain why well water has not been shown as a 
risk factor in all studies conducted in different geographical areas as not all 
groundwater would be uniformly contaminated. In a study conducted in China, 
Tanner et al. (1989) found no association with well-water drinking and PD. The 
authors identified China as a location where industrialisation has only occurred since 
1949 and particularly in the two decades prior to the study. Given this relatively new 
status as an industrialised country, the groundwater ingested by the study participants 
may not have been contaminated, or not contaminated for sufficient time, to become 
a risk factor for PD. 
 51 
 
 
OR and 95% CI
0.1 1 10
Study Exposure Location Size
1 Well or spring water Australia 534
2 Well water US 608
2 Before Age 20 US 608
2 Well Water Ever US 608
3 First 15 years of life Canada 390
3 First 45 years of life Canada 390
4 Well water US 300
5 Well water ≥ 1 year US 298
6 Well water (years of) US 287
7 Well water in men Canada 266
7 Well water in women Canada 266
7 Well water (Men) Canada 263
7 Well water (women) Canada 263
8 Well water US 212
5 Well water ≥1 year US 160
5 Well water ≥1 year US 138
9 Well water Canada 126
10 Well water US 114
11 Well water Germany 759
11 Well water Germany 756
12 Drill Water Age<20 Years Finland 369
12 Drill water between ages 20- Finland 369
12 Drill water after age 40 Finland 369
13 Well water Italy 348
14 Well water Italy 200
15 Well water Italy 172
16 Well water Germany 138
17 Well Water China 528
18 Well Water Taiwan 360
18 Spring Water Taiwan 360
19 Well water China 300
20 Well water China 279
21 Well water ≤10 yrs India 754
21 Well water >10 yrs India 754
22 Well water Rio de 
Janeiro
202
 
 
Figure 2.11.2: Plotted Odds Ratios and 95% Confidence Intervals for “Well 
Water Consumption” Arranged by Geographic Location 
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Farming and Other Agricultural Exposures 
Farming as an occupation has been suggested as a possible risk factor for PD, 
presumably due to exposures such as handling pesticides. Although other factors, 
such as zoonotic diseases, may also be involved. A positive association between 
farming and PD was observed in some studies (Hertzman et al. 1990; Semchuk et al. 
1991; Wechsler et al. 1991; Gorell et al. 1998; Kirkey et al. 2001). However, other 
studies did not report an association with PD (Tanner et al. 1989; Koller et al. 1990; 
Wong et al. 1991; Seidler et al. 1996; Smargiassi et al. 1998; Fall et al. 1999; Kuopio 
et al. 1999b; Tsui et al. 1999). Some studies have also found statistically significant 
negative associations with certain types of farming (Tanner et al. 1989). Differences 
in results may, in part, be explained by geographical variability in farming practices 
between study areas. For example, the study conducted by Tanner et al. (1989) was 
located in China, where agricultural chemicals have only recently been introduced. 
Whereas farming practices in western countries are likely to have included the use of 
pesticides for a longer duration. 
 
Another explanation for these conflicting results may be differential definitions of 
'farming'. For example, ‘farming’ can be defined as purely agricultural and 
horticultural or may include animal raising. Some definitions of ‘farming’ also 
include forestry and fishing, while others do not. Farming is a diverse occupational 
field involving a multitude of different crops, herds and practices. As each study 
examining the general exposure of ‘farming’ is likely to have a different mix of these 
crops, herds and farming practices, the diversity in results is not unexpected. The 
study by Gorell et al. (1998) examined the independent and joint effects of farming 
as an occupation and occupational pesticide exposure. After the effect due to 
occupational pesticide exposure was removed, farming still appeared to be a risk 
factor, independent of pesticide exposure. Possible dose-response relationships were 
seen in a Canadian study for the variables of agricultural work, field crop farming 
and grain farming (Semchuk et al. 1992). The results of the 21 studies examining 
exposure to farming as a variable are presented in Table B3 (Appendix B). Figures 
2.11.3-2.11.5 present the plotted odds ratios and 95% confidence intervals for 
published study results for general farming, crop farming and animal farming. A key 
to the figures (details of authors) are presented in Table C3 (Appendix C). 
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OR and 95% CI
0.1 1 10
Study. Exposure Location Size
1 Farm/horticulture Canada 7073
16 Lived/ worked on a farm US 608
16 Occup farming after age 18 US 608
16 Ag, fish, forestry US 608
2 Agricultural work adj for herbicides Canada 390
2 Agricultural work Canada 390
17 Farming US 300
3 Farming (women) Canada 266
3 Farming (men) Canada 266
3 Mixed Farming (Men) Canada 266
3 Mixed Farming (Women) Canada 266
3 Farming (women) Canada 263
3 Mixed Farming (Women) Canada 263
3 Farming (men) Canada 263
3 Mixed Farming (Men) Canada 263
19 Farming US 156
4 Farming Canada 126
20 Farming US 76
21 Farming US 56
8 Living on a farm Germany 759
8 Farm/agriculture Germany 759
8 Lived near farm Germany 759
8 Farm/agriculture Germany 756
8 Living on a farm Germany 756
8 Lived near farm Germany 756
11 Occup Farming Italy 408
14 Agriculture Sweden 376
7 Farming Finland 369
7 Parttime Farming Finland 369
7 Occup Farming Finland 269
12 Farmer Italy 216
13 Farming Italy 172
5 Farming China 528
15 Farming Taiwan 360
9 Farming 1-20 yrs  Hong Kong 140
9 Farming >20 yrs Hong Kong 140
10 Farming ≤ 10 yrs India 754
10 Farming >10 yrs India 754
 
 
Figure 2.11.3: Plotted Odds Ratios and 95% Confidence Intervals for “Mixed 
Farming” Arranged by Geographic Location 
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OR and 95% CI
0.1 1 10
Study. Exposure Location Size 
2 Grain Farming Canada 390 
2 Market Gardening Canada 390 
2 Grain Farming adjusted for Canada 390 
2 Field farming adj for herbicides Canada 390 
2 Field crop farming Canada 390 
3 Hard Fruit Orchard (women) Canada 266 
3 Soft Fruit Orchard (Women) Canada 266 
3 Crop farming (men) Canada 266 
3 Soft fruit orchard (men) Canada 264 
3 Hard fruit orchard (men) Canada 264 
3 Hard Fruit Orchard (women) Canada 263 
3 Soft Fruit Orchard (Women) Canada 263 
3 Hard Fruit Orchard (Men) Canada 263 
3 Soft Fruit Orchard (men) Canada 263 
3 Crop farming (men) Canada 263 
3 Ever worked (Orchard) Canada 179 
3 Orchard work Canada 179 
15 Growing Fruit Taiwan 360 
15 Growing Rice Taiwan 360 
6 Wheat growing China 300 
6 Corn growing China 300 
6 Soybean raising China 300 
6 Fruit growing China 300 
6 Rice growing China 300 
 
 
Figure 2.11.4: Plotted Odds Ratios and 95% Confidence Intervals for “Crop 
Farming” Arranged by Geographic Location 
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Pesticides  
Various case-control studies have examined exposure to insecticides, herbicides and 
fungicides as a risk factor for PD. Despite some studies reporting no association 
between PD and pesticide exposures (Ohlson and Hogstedt 1981; Koller et al. 1990; 
Zayed et al. 1990; Stern et al. 1991; Wong et al. 1991; Chan et al. 1998; McCann et 
al. 1998; Smargiassi et al. 1998; Kuopio et al. 1999b; Taylor et al. 1999), a number 
of studies have reported significant positive associations with pesticides (Ho et al. 
1989; Golbe et al. 1990; Hertzman et al. 1990; Butterfield et al. 1993; Hubble et al. 
1993; Semchuk et al. 1993; Hertzman et al. 1994; Seidler et al. 1996; Liou et al. 
1997; De Palma et al. 1998; Gorell et al. 1998; McCann et al. 1998; Menegon et al. 
1998; Zorzon et al. 2002). Non-significant, but elevated odds ratios have also been 
reported by some studies (Fall et al. 1999; Werneck and Alvarenga 1999; Herishanu 
et al. 2001). Since each of these studies have used the authors' own unique definition 
of what constitutes 'exposure', accurate comparisons between studies is difficult and 
may also explain differences in some study findings. 
OR and 95% CI
0.1 1 10
Study. Exposure Location Size
3 Animal farming (Women) Canada 266
3 Animal farming 
(men) 
Canada 266
3 Animal farming 
(men) 
Canada 263
3 Animal farming (Women) Canada 263
18 Exposure to farm 
animals
US 212
8 Farm animal 
contact
Germany 759
8 Farm animal contact Germany 756
15 Farming for 1-19 
years 
Taiwan 360
6 Pig raising China 300
6 Chicken raising China 300
6 Other livestock China 300
 
 
Figure 2.11.5: Plotted Odds Ratios and 95% Confidence Intervals for “Animal 
Farming” Arranged by Sample Size by Geographic Location 
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Evidence of a dose-response relationship has been demonstrated in some studies. For 
example, a German study involving 380 cases, 376 neighbourhood controls and 379 
regional controls found a significant dose-response relationship between PD and 
herbicide use (p for trend of years of exposure duration = 0.001) and insecticide use 
(p for trend of years of exposure duration = 0.001) (Seidler et al. 1996). The study 
had a number of strengths, such as the large sample size and use of a structured face 
to face interview and job exposure matrix to improve data quality and reduce recall 
bias. The study also used two population-based control groups selected by ‘random-
route method’, which were analysed separately. 
 
Relatively few studies have investigated a relationship between domestic pesticide 
exposure and risk of PD. Gorell et al. (1998) collected data on residential insecticide 
spraying and exposures to herbicides, insecticides and fungicides while gardening as 
a hobby, in a study of 144 PD cases and 464 controls. No statistically significant 
associations between any of these domestic pesticide exposures and PD were 
observed. A pilot study of occupational and environmental risk factors (Wechsler et 
al. 1991) found an increased number of cases using the home pesticide products, 
KLEENUP® grass and weed killer, Ortho TRIOX®, and PESTKIL®, although there 
were no overall clear trends or differences in use of pesticides by cases and controls. 
The study was very limited, however, by its small sample size.  
 
Of the case-control studies conducted, few have been able to identify specific 
pesticide agents that may be significantly associated with PD. Reasons for this may 
include the fact that most people with or without PD have limited ability to recall the 
specific pesticides to which they were exposed (Ho et al. 1989; Seidler et al. 1996; 
Liou et al. 1997; Gorell et al. 1998) or the simple failure to collect data about specific 
agents during the interview process (Stephenson 2000). 
 
The results of the 26 studies examining exposure to pesticides as a variable are 
presented in Table B4 (Appendix B). Figures 2.11.6-2.11.8 display the plotted odds 
ratios and 95% confidence intervals for the published results of mixed pesticide 
exposures, insecticide exposure and herbicide exposure. A key to the figures (details 
of authors) are presented in Table C4 (Appendix C). 
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OR and 95% CI
0.1 1 10
Study. Exposure Location Size
1 Herb/Pesticides Australia 534
2 
Pesticide > 
1/week for 6 mths Australia 191
3 Hobby gardening Canada 2157
3 
Hobby pest/ 
herbicide use Canada 2157
3 
Occup Pesticides 
/Fertilizers Canada 2157
3 
Occup defoliants, 
fumigants Canada 2157
4 Pesticide Canada 390
5 
Occup pesticide 
(women) Canada 266
5 
Ocup pesticide 
(men) Canada 266
5 
Occup pesticide 
(men) Canada 263
5 
Occup pesticide 
(women) Canada 263
5 
Chemical 
spraying Canada 179
12 Pesticide US 139
13 
Lived within ¼ 
mile of ag spray US 131
6 
Pesticides 1-10 
years Canada 126
6 
Pesticides 11-20 
years Canada 126
6 Pesticide Canada 126
6 
Pesticides >30 
years Canada 126
6 
Pesticides 21-30 
years Canada 96 
14 Herb/pesticide US 76 
16 Pesticide Italy 408
20 
Agricultural 
pesticides Sweden 376
20 Occup pesticide Sweden 376
19 
Regular pesticide 
use Finland 369
19 Pesticide Finland 369
19 
Occasional 
pesticide Finland 369
17 Pesticide Italy 300
21 Ag chemicals Sweden 199
18 
Pesticide & 
herbicide Italy 172
22 Farm pesticides China 528
22 
Pesticides # of 
years exposed China 528
23 
Herb/Pesticides 
1-19 years Taiwan 360
23 Herb/Pesticides Taiwan 360
23 
Herb/Pesticides 
>19 years Taiwan 360
24 Herb/pesticides Hong Kong 140
25 Herb/insecticide Rio de Janeiro 202
26 Pesticides Israel 186
 
Figure 2.11.6: Plotted Odds Ratios and 95% Confidence Intervals for “Mixed 
Pesticide Exposures” Arranged by Geographic Location  
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OR and 95% CI
0.1 1 10
Study Exposure Location Size 
7 Household insecticide US 608 
7 Farming Insecticides US 608 
7 Home gardening insecticides US 608 
7 Residential Insecticide US 608 
7 Occupational Insecticide <10 US 608 
7 Occupational insecticide US 608 
7 Occupational insecticide ≥ 10 US 608 
4 Occupational insecticide use Canada 390 
4 Insecticide use Canada 390 
9 Insecticide any US 298 
10 Insecticide (years of) US 287 
5 Occupational Organochlorine Canada 266 
5 Insecticide use in men Canada 266 
5 Insecticides in W omen Canada 266 
5 Occupational Organophosphate Canada 266 
5 Occupational Carbamate use in Canada 266 
5 Occupational Carbamate use in Canada 266 
5 Occupational Organochlorine Canada 266 
5 Occupational Carbamates in Canada 263 
5 Occupational Organophosphate Canada 263 
5 Occupational Organochlorine Canada 263 
5 Occupational Organochlorine Canada 263 
5 Occupational Organophosphate Canada 263 
5 Insecticides in Men Canada 263 
5 Insecticides in W omen Canada 263 
5 Occupational Carbamates in Canada 263 
11 Sprayed insecticides US 212 
9 Insecticides US 160 
9 Insecticides US 138 
13 Past residence in a fumigated house US 131 
13 Insecticide exposure (>10 US 131 
13 Insecticides (> 10 times in any one US 131 
15 Insecticide 41-80 yrs Germany 759 
15 Insecticide 1-40 years Germany 759 
15 Insecticide >80 years Germany 759 
15 Organochlorine use Germany 759 
15 Alkylated phosphate and Germany 759 
15 Insecticide >80 years Germany 756 
15 Insecticide 1-40 years Germany 756 
15 Alkylated 
phosphate and
Germany 756 
15 Insecticid  41-80 yrs Germany 756 
15 Organochlorine use Germany 756 
20 Agricultural insecticide Sweden 376 
19 Use of DDT Finland 369 
 
Figure 2.11.7: Plotted Odds Ratios and 95% Confidence Intervals for 
“Insecticide Exposures” Arranged by Geographic Location 
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OR and 95% CI
0.1 1 10
Study Exposure Location Size
7 Home gardening 
herbicides
US 608
7 Farming 
Herbicides
US 608
7 Occupational 
herbicide
US 608
4 Herbicide use Canada 390
4 Herbicide Use Canada 390
9 Herbicide any US 298
10 Herbicide (years 
of) 
US 287
5 Herbicide Use in 
Men 
Canada 266
5 Paraquat in Men Canada 266
5 Herbicide Use in 
Women 
Canada 266
5 Herbicide Use in 
Men 
Canada 263
5 Herbicides in 
Women 
Canada 263
5 Paraquat in Men Canada 263
9 Herbicides US 160
9 Herbicides US 138
13 Herbicide 
exposure (>10 
US 131
15 Herbicide 41-80 
years 
Germany 759
15 Herbicide 1-40 
years 
Germany 759
15 Herbicide >80 
years 
Germany 759
15 Herbicide 1-40 
years 
Germany 756
15 Herbicide >80 
years 
Germany 756
15 Herbicide 41-80 
years 
Germany 756
19 Regular herbicide 
use 
Finland 369
19 Occasional 
herbicide use 
Finland 369
19 Herbicide use - 
any 
Finland 369
23 Paraquat use 1-19 
Years 
Taiwan 360
23 Paraquat for >19 
years 
Taiwan 360
23 Paraquat 1-19 
years 
Taiwan 360
23 Paraquat Use Taiwan 360
23 Herbicides/Pestici
des >19 years 
Taiwan 360
 
Figure 2.11.8: Plotted Odds Ratios and 95% Confidence Intervals for “Herbicide 
Exposures” Arranged by Geographic Location 
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Metals 
Few case-control studies have included exposure to neurotoxic metals as a potential 
risk factor for PD (Uitti et al. 1989; Wechsler et al. 1991; Semchuk et al. 1993; 
Seidler et al. 1996; Gorell et al. 1997; Smargiassi et al. 1998; Fall et al. 1999; Gorell 
et al. 1999a; Gorell et al. 1999b). Significant positive associations between exposure 
to various metals and PD were found by Gorell et al. (1999a) and Seidler et al. 
(1996) while studies by Semchuk et al. (1993) and Wechsler et al. (1991) found no 
significant association between the exposure and PD. Another study conducted by 
Fall et al. (1999) also found a inverse association between metal-workers and PD. 
Smargiassi et al. (1998) had insufficient numbers of exposed participants to examine 
exposure to metals as only 4 out of 86 PD cases and none of the 86 controls reported 
occupational exposure to metals. A number of factors such as differences in types 
and severity of exposure and type of metal involved in the studies are likely to 
explain some of these conflicting results. Studies that divided the exposures into 
different categories according to length of exposure were more likely to find some 
significant associations (Gorell et al. 1999a.). A summary of the case-control studies 
that have examined metal exposures and risk of PD are presented in Table B5 
(Appendix B). 
 
Solvents 
Similar to metal exposure, few case-control studies have examined solvents as a 
potential risk factor for PD (Ohlson and Hogstedt 1981; Seidler et al. 1996; 
Smargiassi et al. 1998). Smargiassi et al. (1998) reported a greater than two-fold 
increased odds of PD with greater than 10 consecutive years of exposure to organic 
solvents (OR 2.78, 95% CI 1.23-6.26). Seidler et al. (1996) reported increased odds 
of PD with exposure to solvents at work and at home. Interestingly, the highest odds 
of PD were associated with non-occupational solvent use (OR 2.6, 95% CI 1.2-5.4). 
This could possibly be a result of less rigorous protective measures used in a hobby 
situation compared to in a workplace. However, domestic exposure is generally 
much less intense and on a smaller scale than occupational exposure. In contrast to 
these two studies, Ohlson and Hogstedt (1981) did not report an increased risk of PD 
with reported exposure to solvents (OR 1.1, 95% CI 0.4-2.9). 
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2.11.3.2 Case-Control Studies Published Since Systematic Review 
Since the systematic review was completed a number of additional case-control 
studies have been published. Details of these studies have been included in Tables 
B1-B6. Positive associations were reported between PD and pesticide exposure 
(Baldi et al. 2003a; Park et al. 2005b), agriculture (Park et al. 2005b), metals (Pals et 
al. 2003; Park et al. 2005b) and solvents (Park et al. 2005b). 
 
2.11.4 Cohort and Prospective Studies 
While the majority of epidemiological studies examining environmental exposures 
and PD aetiology are case-control studies, a small number of cohort and prospective 
studies have been published, mainly examining agricultural exposures. Prospective 
studies are the epidemiological “gold standard” as relative risk can be determined 
directly from estimates of incidence. As the exposure data are collected prospectively 
prior to development of disease, recall bias is avoided.  
 
While prospective cohort studies exist (Grandinetti et al. 1994; Morens et al. 1996a; 
Ross et al. 2000), these are nested within other studies, such as those investigating 
cardiovascular disease and are limited to lifestyle factors (e.g. smoking, caffeine and 
alcohol) of interest to the original study purpose. There are a number of barriers to 
conducting longitudinal cohort studies of PD. Firstly, PD is a relatively rare 
condition with estimated incidences ranging between 5.5 to 20.5 per 100, 000 person 
years (Rosati et al. 1980; Harada et al. 1983; Rajput 1984; Hofman et al. 1989a; 
Granieri et al. 1991; Mayeux et al. 1995; Kusumi et al. 1996; Bower et al. 1999). As 
such, a prospective cohort study would need to include a large number of participants 
in order to achieve sufficient numbers of cases. Secondly, PD generally has an onset 
late in life with highest incidence occurring after age 50. Therefore, participants in a 
cohort study would need to be followed up for a long period of time in order to avoid 
misclassification of the participants into PD cases and unaffected individuals. 
Thirdly, the importance of timing of exposure has not been established. If early life 
environmental exposures are important, as some authors have suggested (Rajput et 
al. 1986; Rajput et al. 1987b; Tanner et al. 1987; Golbe et al. 1988; Golbe et al. 
1990), then cohort study participants would need to be recruited and followed up for 
virtually their entire life. Retrospective cohort studies also present difficulties for 
investigating many of the potential risk factors for PD. The existence of sufficient 
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records on exposures such as an individual’s use of pesticides and other toxic 
substances and consumption of well water is unlikely. 
 
An incidence study of PD in the Local Health Service of Ferrara, in north-eastern 
Italy, found statistically significant differences in incidence rates in rural areas and 
amongst agricultural workers compared to the urban areas and non-agricultural 
workers (Granieri et al. 1991). The mean overall incidence of PD per year for the 
period from 1967 through 1987 was 10.01/100,000. However, amongst agricultural 
workers the incidence was 20.6/100,000. Also, rural areas had a higher incidence of 
people with young onset PD (6.32/100,000) than urban areas (3.11/100,000). 
 
An historical cohort study in Denmark used national population and hospitalisation 
registers to identify all agricultural workers in Denmark and to identify all 
hospitalisations related to PD during the study’s follow-up period between 1981 and 
1993 (Tüchsen and Jensen 2000). Relative to the overall national rates, elevated age-
standardised hospitalisation ratios (SHRs) were reported for men employed in 
agriculture and horticulture (SHR 1.34, 95% CI 1.09-1.62) and for men employed as 
paint and wallpaper dealers or pharmacists (SHR 7.52, 95% CI 2.44-17.54) and 
women employed in laundry and dry cleaning (SHR 15.55, 95% CI 3.21-45.44) and 
as cleaners (SHR 3.81, 95% CI 1.04-9.74). These results suggest that agricultural 
exposures, such as pesticides, and solvents, such as from paints and cleaning 
solutions may increase incidence of PD. However, elevated SHRs were also reported 
for men who were psychologists or welfare staff, lawyers, railway and transport staff 
and bus drivers. The connection between these occupations and environmental 
exposures is not clear, although transport staff and bus drivers may have elevated 
exposure to exhaust fumes, benzene or other solvents.  
 
The study was not without limitations. Prevalent cases of PD were not excluded; 
therefore hospitalisation rates would have included existing and new diagnoses of 
PD. Also, the study was unable to identify current occupation; therefore those who 
may have left agricultural work would be classified under different occupations. The 
reliance on occupational coding as a surrogate for exposure classification also creates 
a degree of misclassification if inferences concerning specific agents, such as 
pesticides, are to be drawn from the results. Finally, the study follow-up period was 
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only 12 years after which time the oldest members at the beginning of the cohort 
would be 71 and the youngest would be only 32. A longer follow-up time which 
would have seen more of the original cohort move into the typical age of diagnosis of 
PD (>55 years) may have given a more definitive result.  
 
The Honolulu Heart Program was a large prospective study of men of Japanese 
ancestry. While primarily designed to investigate cardiovascular diseases, new 
diagnoses of PD in the cohort were also measured by review of medical records, 
death certificates or examination by a study neurologist. In addition to lifestyle 
exposures such as smoking and coffee consumption, data concerning work on 
pineapple and sugarcane plantations and pesticide use were collected from the 
participants at baseline and the first follow-up examination (Petrovitch et al. 2002). 
Increasing risk of PD was observed with longer duration of work in plantations with 
a relative risk of 1.9 (1.0-3.5) observed for greater than 20 years of plantation work. 
Higher incidence of PD was also noted for greater years of self-reported exposure to 
pesticides. While this study collected information directly from the participants 
concerning their exposures, rather than relying on job classifications as a proxy, there 
were some limitations with the exposure data. Part-time, sporadic and full-time work 
on plantations were combined, therefore regularity and intensity of exposure were 
not able to be clearly determined. Furthermore, many of the participants did not 
provide information on pesticide exposures (14% of original cohort had this data 
missing), reducing the sample size on this exposure.  
 
Baldi et al. (2003b) reported a very strong relative risk of PD in men (adjusted RR 
5.63, 95% CI 1.47-21.58) with occupational exposure to pesticides in a prospective 
cohort study in France. There also appeared a trend towards increased risk with 
greater exposure. Women did not experience an excess of risk with this exposure, 
although the authors noted that pesticide treatment tasks are performed almost 
exclusively by males in the population under study. The study had a number of 
strengths including a very detailed and extensive exposure assessment, including the 
development of a job exposure matrix by a panel of six experts which included a 
measure of likely intensity of the pesticide exposure. 
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A recent historical cohort study in Denmark compared the hospitalisation rates for 
PD amongst welders in an established cohort to rates in the entire population of 
Denmark between 1977 and 2002 (Fryzek et al. 2005). The study reported similar 
SHRs in the welding cohort to those in the entire population, suggesting no increased 
risk of PD for people exposed to welding. The study also reported a similar onset age 
(67 years) in welders who developed PD to the average onset age for PD in the 
general population. The study was funded by a group of current and former 
manufacturers of welding consumables.  
 
2.12 What Can We Conclude From this Variability in Epidemiological Studies 
of PD? 
Estimated odds ratios both greater and less than unity for each of the main exposures 
studied (rural residency, well water consumption, farming and pesticides) have been 
reported. It is noteworthy that there is extensive heterogeneity in the epidemiological 
methods employed in these studies. Thus the heterogeneity in the results may be a 
reflection of methodological differences. Variability in subject selection and 
recruitment, geographic location, exposure definition and measurement quality and 
data analysis may explain a large degree of the variation in risk estimates.  
 
2.12.1 Sampling and Recruitment 
A number of methods of case and control selection were used in the published 
literature. Cases were generally recruited from hospitals, general practices or 
specialist clinics (Hertzman et al. 1990; Koller et al. 1990; Liou et al. 1997; Behari et 
al. 2001), although some studies obtained the cases directly from the population 
during prevalence surveys (Rocca et al. 1996; Kuopio et al. 1999b). Other studies 
used case registers (thought to contain all diagnosed cases in the geographical area 
studied) (Semchuk 1990; Zayed et al. 1990) and a health care system shown to be 
representative of the general population in the geographic area (Gorell et al. 1998). 
Other methods included recruitment of cases from a mixture of hospitals, residential 
care and community groups (McCann et al. 1998; Menegon et al. 1998). Cases 
recruited into case-control studies should be representative of the target population, 
which is generally the entire population of people with the condition of interest. This 
presents a particular difficulty with PD as there is no simple or efficient way of 
identifying all people with the condition in the community. Door-to-door prevalence 
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surveys often report that many of the cases identified in the survey had no previous 
diagnosis of PD (Rocca et al. 1990; Morgante et al. 1992).  
 
The gold standard for case-control studies of aetiology is the use of incident cases, 
rather than prevalent cases (Rothman and Greenland 1998a). This is because case-
control studies based on prevalent cases are unable to distinguish exposure effects on 
disease incidence from the effects on disease duration. The majority of the case-
control studies of PD use prevalent cases rather than incident cases due to the low 
incidence of PD. The definition of an ‘incident’ PD case is also not clear. PD has an 
insidious onset which can be present for many years before diagnosis (Koller et al. 
1991). Many people with PD suspect they are suffering from the condition for some 
time before consulting a doctor as the early symptoms are mild enough for the person 
to avoid medical treatment. Most studies use time of diagnosis as a surrogate for 
onset as it is difficult to determine when symptoms commenced. 
 
Another major issue is the method of control selection. The appropriateness of 
different control selection and recruitment methods has been debated widely in the 
literature on epidemiological study design (Schlesselman 1982; West et al. 1984; 
Miettinen 1985; Wacholder et al. 1992a; Wacholder et al. 1992c; Wacholder et al. 
1992b; Lasky and Stolley 1994; Gefeller et al. 1998; Agudo and Gonzalez 1999; 
Nishioka et al. 2001). A goal in the design of a case-control study is to sample both 
cases and controls randomly from the same population, or cohort, during a specified 
time period, to avoid selection bias (Schlesselman 1982; Nishioka et al. 2001). 
However, this cohort is not always easily identifiable, particularly if cases were 
sourced from hospitals or support groups. In the case-control studies examined, 
controls were often recruited from either the same general sampling frame as the 
cases, such as the same hospital or clinic, or from the general population with 
methods such as random selection from electoral rolls (Hertzman et al. 1994; Seidler 
et al. 1996), telephone books (Zayed et al. 1990) or random digit dialling (Semchuk 
1990). However, some studies used friends (Taylor et al. 1999) or spouses (Golbe et 
al. 1990) of cases, one used a mixture of friend controls and hospital controls (Stern 
et al. 1991), while another used a mixture of hospital and spouse controls (De 
Michele et al. 1996). Three studies used participants with other specific chronic 
ailments, namely cardiac disease (Hertzman et al. 1994), rheumatoid arthritis 
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(Butterfield et al. 1993) and essential tremor (Wong et al. 1991). Other studies using 
hospital controls also limited these to ‘neurologic’ conditions, although they did not 
restrict the definition to one specific ‘control’ disease (De Michele et al. 1996; 
Behari et al. 2001).  
 
The use of friend controls offers some advantages in terms of efficiency, a potentially 
higher response rate as these controls may be more likely to participate if they have a 
connection with a sufferer of the disease, and theoretically they should be similar to the 
cases. However, there are a number of disadvantages that make friend controls less 
than ideal. Friends can often be overmatched on environmental exposures as they share 
common interests, work histories or lifestyle habits. Cases are also more likely to 
suggest friends that are ‘out-going’ or extroverted than reclusive friends, this could 
bias the results as personality is often linked to exposures. Friendship groups are also 
not simple collectives in which all friends have an equal chance of being selected. 
Individuals with many friends have a greater likelihood of being chosen and therefore 
their exposures may become over-represented in the control series. For these reasons, 
friend controls are generally not recommended for case-control studies et al. 1989; 
Robins and Pike 1990; Kaplan et al. 1998; Ma et al. 2004). 
 
The use of controls who are also suffering from a chronic condition may have 
advantages over using healthy controls. Of all the limitations involved in assessing 
lifetime exposures, the potential for selective recall by people with chronic disease is 
the greatest threat to the validity of the data. People with chronic diseases may over-
estimate their exposure if they perceive it to be involved in the aetiology of their 
condition. Likewise, healthy people may underestimate their exposures as they 
perceive them to be unimportant. If the controls are also drawn from the same clinic 
as the cases, there is an assumption that these controls are from the same source 
population as the cases. This assumption is not necessarily correct as it does not take 
into account the referral patterns that exist for different diseases. Lower participation 
rates can also be expected amongst control participants that are also suffering from a 
chronic condition. Most importantly, if there is any connection between the control 
disease and the exposures of interest, the results will be biased towards the null, or 
possibly inverted if the relationship is stronger than the condition of interest 
(Rothman and Greenland 1998a).  
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One of the case-control studies examined recruited a control group of people with 
rheumatoid arthritis (Butterfield et al. 1993). Significantly elevated odds ratios were 
reported for a number of exposures, such as for past residence in a fumigated house 
(OR 5.25 p=0.045) and exposure to insecticides more than 10 times per year (OR 
5.75 p=0.001). As these risk estimates were greater than those obtained by the 
majority of case control studies for ‘insecticide exposure’, there was no evidence that 
use of healthy control subjects results in under-reporting of exposures. However, it 
should be noted that the study was relatively small in size (131 total participants) and 
no mention was made of the source of the cases and controls. Wong et al. (1991) 
used pairs of siblings concordant with essential tremor as controls for pairs of 
siblings concordant for PD. While the study found a statistically significant risk 
associated with rural residency (OR 4.3, p=0.01) and also an elevated risk with well 
water consumption (OR 2.8; p=0.07), no risk was associated with pesticide exposure 
(OR 1.0; p=1.0). As some case-control studies have suggested that family history of 
essential tremor is a risk factor for PD (Vieregge et al. 1994; De Michele et al. 1996), 
essential tremor controls may be overmatched on some exposures. As the authors did 
not include a ‘healthy’ control group or a control group with a different diagnosis in 
the design, it cannot be known if the lack of association between some of the 
exposures was due to the use of inappropriate controls. 
 
The case-control studies that have used two different controls groups have provided 
some insight into the effect of control selection on risk estimates for the 
environmental exposures studied. Seidler et al. (1996) recruited people with PD from 
nine neurology clinics and selected one control group from neighbours of the cases 
by visiting each house on a random route starting from the cases’ houses until a 
suitable control subject (matched for age and sex and willing to participate) was 
found. The second control group was selected in a similar manner, however the 
random route was commenced from a randomly selected house within the larger 
regional area to the case. In general, although not consistently, the risk estimates 
based on the regional control group were higher than those based on the 
neighbourhood controls. This may be evidence of ‘overmatching’ of controls to cases 
on the environmental exposures examined (pesticide, metal and solvent exposures). 
Hertzman et al. (1994) also used two separate control groups, which were kept 
separate in the data analysis. One hundred and forty-two (142) case participants were 
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recruited from general practitioners and medical specialists located in the study area. 
The first control group (124 controls) was a population-based group selected randomly 
from the area’s electoral roll. The second group (121 controls) consisted of people with 
cardiac disease from the same general practices and specialists as were recruited the 
case participants. Similar results were obtained for the two groups for most of the 
exposures (e.g. occupational pesticide use by male subjects (electoral roll controls OR 
2.32, 95% CI 1.10-4.88 versus cardiac disease controls OR 2.03, 95% CI 1.00-4.12).  
 
2.12.2 Exposure Assessment - Determination of Exposure Status 
The quality of the exposure data collected in the epidemiological studies is a possible 
source of error and heterogeneity between studies. An individual’s exposure to a given 
contaminant is the result of a complex interaction between internal and external factors 
(Table 2.12.1). The complexity of these factors which determine the ‘exposure dose’ 
may explain why not everyone who has contact with a particular agent will develop a 
particular medical condition (Axelson 1985). Measurement of some, but not all of 
these factors is usually possible. When historical exposures are involved, as in PD 
aetiological research, the depth of measurement possible is even more restricted. 
 
Table 2.12.1: Factors Involved in Exposure Dose 
External factors: 
Chemical agent (including form e.g. solid, liquid or gas) 
Duration of exposure 
Intensity of exposure 
Interaction of duration and intensity of exposure 
Timing of exposure  
Interaction of duration, intensity and time of exposure 
Internal factors 
Absorption of the agent (including mode of entry into body and into tissues) 
Distribution of the agent within the body 
Biotransformation of the agent 
Bioaccumulation/excretion of the agent or metabolites 
Interaction of agent or metabolite with other absorbed agents or protective factors (e.g. 
antioxidants) 
Individual variation with respect to absorption, metabolism and excretion of agent 
Interaction of external and internal factors 
(Axelson 1985) 
 
If the internal factors are ignored, the exposure dose can be considered as a 
composite of variation in intensity of exposure over time (Axelson 1985). While 
sophisticated equations have been developed to convert this variation over time into 
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a single measure of expected disease incidence, these are related to specific 
conditions such as cancerous tumours and incorporate the induction-latency time (i.e. 
the lag time from first exposure to development of disease) (Axelson 1985). 
Development of an equation such as these for PD would not be possible due to a lack 
of existing knowledge about the induction-latency time for most exposures and also 
the likely complexity and variability involved in the development of this disease. The 
ability to obtain historical data of sufficient detail about past exposures is also likely 
to be a limitation to their development and use. A simplified method of taking into 
account some of these external factors involved in exposure dose may be to 
subdivide exposed subjects into those with recent compared to remote exposures 
(Axelson 1985) or with those exposed at important life periods, such as childhood or 
adolescence. Subjects could also be subdivided according to different intensities of 
exposure or according to a cumulative exposure measurement. 
 
Obtaining sufficiently accurate and detailed information about environmental 
exposures is a major challenge in retrospective epidemiological studies. In addition 
to this is the difficulty of dealing with exposure of both varying intensity and 
duration (Siemiatycki 1979). Not to mention the next step of absorption and 
distribution of an agent in the body and biotransformation and excretion. 
 
2.12.2.1 Sources of Exposure Data 
Exposures of interest to PD which have been previously examined in the 
epidemiological literature include: 
• Pesticides 
• Rural residency 
• Neurotoxic metals 
• Solvents  
• Well water consumption 
• Electromagnetic radiation 
• Dietary factors, such as consumption of animal fats, total energy intake, 
vitamin deficiencies, etc 
• Coffee, tea and alcohol consumption 
• Tobacco smoking 
• Medication (e.g. NSAIDs) 
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In the main, records of these exposures are limited, difficult to obtain or non-existent. 
While some chemical exposures, such as pesticides, may be measurable by analysis 
of biological tissues, such results are likely to reflect recent exposure only; for 
example pyrethoid pesticides are rapidly metabolised and therefore specimens must 
be collected within days of exposure for detection (Aprea et al. 2002). These are also 
often costly to obtain. As such, exposure measurement has been largely reliant on 
self-reported data obtained by face-to-face interview or self-administered 
questionnaire.  
 
Questionnaires 
Self-administered questionnaires may offer certain advantages over face-to-face 
interviews, such as economy, wider geographical reach, greater privacy and 
anonymity for the respondent and avoidance of contamination of the data by the 
interviewer. They also provide the respondent the opportunity to refer to personal 
records, where available, to assist with recall. Indeed, a study comparing telephone, 
mail and home interview strategies with the same sampling frame yielded similar 
data quality from all three methods (Herzog and Kulka 1989). Comparison of the 
responses from the survey with existing validating information from health insurance 
records suggested the results of the mail survey had greater validity than telephone or 
personal interview. However, interviewer-delivered questionnaires have many 
advantages such as the ability for the participant to clarify questions, and allow for 
more questions to be asked and a greater level of detail obtained. As the timing and 
dose of environmental exposures may be important to PD risk, the more detailed data 
obtainable from an interview situation may be invaluable. The oral delivery of the 
questions/answers is also more accessible for those with low literacy, poor eyesight 
or other physical disability, a particular issue for elderly populations (Sherbourne and 
Meredith 1992). Face-to-face interviews may also be preferable for older age groups 
as respondent burden associated with self-administered questionnaires increases with 
age (Herzog and Kulka 1989) with older participants taking longer to complete 
questionnaires than younger respondents. Older age-groups who are more prone to 
social isolation may also find the personal contact with the researcher associated with 
face-to-face interviews enjoyable, possibly leading to higher participation rates for 
this method. Higher participation rates have been noted for face-to-face interviews 
compared with telephone and mail surveys (Herzog and Kulka 1989; Picavet 2001). 
 71 
A comparison of response rates for in-person and telephone surveys estimated that 
telephone surveys targeting the over-65 age bracket would miss almost half of the 
eligible participants (Herzog and Kulka 1989).  While there are some suggestions 
that data quality may be compromised by using telephone rather than face-to-face 
interviews, such as higher levels of missing data, response sets and fewer answers to 
open-ended questions, other research found no age-related difference between the 
two survey modes (Bouyer and Hemon 1993).  
 
Job-Exposure Matrices 
Two limitations of self-report exposure data are that many subjects know little about 
the nature of their current or past exposures (Olsen 1988; Kauppinen et al. 1992) and 
the possibility of recall bias. In an attempt to minimise the effect of recall bias, 
objective measures of exposure, such as job-exposure matrices, may be used. A job-
exposure matrix (JEM) is a method of estimating the probability of a certain 
exposure being experienced based on the job position provided by a worker. JEMs 
are developed by industrial hygienists based on typical exposures encountered in 
workers employed under the job title of interest. Unfortunately, the JEM approach 
usually groups exposed individuals with a large number of unexposed, which can 
attenuate any observable effect due to exposure misclassification (Basso et al. 1997). 
 
Despite this limitation, JEMs have been suggested as a means of detecting or 
reducing recall bias in case-control studies as they are a more objective method of 
assessing exposure than self-reported exposure data (Bouyer and Hemon 1993). This 
is based on the assumption that the misclassification that does occur with the JEM 
method is non-differential misclassification (i.e. the classification is not related to the 
disease status of the individual). However, use of this approach may be difficult in 
community studies, as the range of occupations and specific job titles encountered is 
generally very broad. Also, a study conducted within a specific occupation or work 
environment may lead to respondents providing greater detail about their job titles, 
than those in community studies who may only report a general job description rather 
than many specific job descriptions. Despite these limitations, JEMs can be utilised 
in population-based case-control studies by obtaining histories from participants on 
occupational job titles, tasks performed by the subjects and specific hazards 
encountered (Siemiatycki et al. 1989; Bouyer and Hemon 1993). A standard job 
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classification system is then used to code the occupations and a suitable existing or 
newly-developed JEM utilised (Sieber et al. 1991). Developing JEMs are typically 
costly and time-consuming involving a team of experts and occupational hygienists. 
In the absence of a suitable team of experts, viability of the JEM-method of exposure 
assessment is reliant upon a suitable existing JEM. While JEMs suitable for 
population-based studies, such as the American NIOSH JEM (Sieber et al. 1991) 
exist, their applicability to an Australian situation is unknown. 
 
2.12.2.3 Parkinson’s-Specific Issues Relating to Quality of Self-Reported 
Exposure Data 
Exposure assessment relying on recall of exposures may be particularly problematic 
in people with PD, due to the specific characteristics of this population.  
 
Age-Related Factors 
Firstly, PD generally affects those over age 60 (prevalence of PD increases with age, 
increasing from 0.6% in persons aged 65-69 to 2.6% in those aged 70-80 years) (de 
Rijk et al. 2000). Declining data quality with increasing age has been observed in 
self-report data from research involving general populations (Colsher and Wallace 
1989), although other research found no increased measurement error amongst 
interview responses by older age groups (Rodgers and Herzog 1987) or only small 
declines with age in reliability of self-report health data in a chronically ill 
population (Sherbourne and Meredith 1992). Both simple closed-end and open-ended 
questions appear to be suitable for questionnaires targeted at elderly participants, 
although some suggest that prompt cards should be used for multiple choice 
questionnaires in face-to-face interviews (Carp 1989), rather than relying on the 
participant to remember the options available, however this option faces limitations 
if the participants have visual or literacy difficulties.  
 
While unstructured interviews have been suggested as more appropriate for elderly 
respondents (Carp 1989), they can produce volumes of data which must be 
assembled into an appropriate format and produce data which are not comparable 
between subjects due to the non-systematic mode of administration. However, strict 
adherence to “yes/no” responses may also be inappropriate as the “either/or” forced 
choice may not allow the participant to give an accurate representation of their 
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experience. Elderly participants have also expressed a dislike for dichotomous 
questions, perceiving them as “too restrictive” (Carp 1989). These items also elicited 
more blank and “don’t know” responses from the participants.   
 
Insidious Onset of PD 
Secondly, PD has a slow and insidious onset. Therefore, exact timing of exposures in 
relation to PD onset may be difficult to establish or recall. For instance, whether an 
exposure occurred prior to, or after the commencement of symptoms may be 
indeterminable if initial symptoms were subtle and did not overly concern the person 
at the time.  
 
Cognitive Dysfunction in PD 
Thirdly, cognitive dysfunction is a recognised feature of PD. While 10-15% of 
people with PD are estimated to suffer from dementia (Brown and Marsden 1984; 
Taylor et al. 1985), specific cognitive impairments have also been noted in non-
demented people with PD (Growdon et al. 1990). Of specific concern to self-reported 
exposure measurements are those impairments which may affect memory of past 
events. Different types of memory impairment in non-demented people with PD have 
been described in the literature (Growdon et al. 1990; Pirozzolo et al. 1993), 
including: 
• Bradyphrenia; 
• Visuospatial impairment; 
• Paired-associate learning; 
• Delayed recall of paragraphs; 
• Delayed reproduction of designs; 
• Remote memory; 
• Serial word-list learning; 
• Delayed verbal memory;  
• Memory for dates but not content of public events; and 
• Verbal and non-verbal tests of long-term memory. 
 
The declarative, remote memory impairments seen in PD (Venneri et al. 1997; Ivory 
et al. 1999), which are characterised by similar memory loss across all decades of life 
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(Testa et al. 1998), are of most concern to recall of past exposures.  These types of 
memory deficits are most evident on effort-demanding tasks (Appollonio et al. 
1994). Studies of non-demented people with PD have found that remote memory 
involving recall of well-known public events and the dating of these events are both 
significantly impaired compared to age-matched controls (Venneri et al. 1997; Ivory 
et al. 1999). However, conflicting results have also been obtained in similar studies 
(Leplow et al. 1997; Fama et al. 2000), in which non-demented people with PD 
showed normal performance in both content and contextual components of remote 
memory compared to controls. Some have also suggested that memory involving 
retrieval of newly acquired information is most impaired in PD (Austin and Mitchell 
1996), rather than long-term memory. 
 
The common co-morbidity of depression often seen in PD (Mayeux et al. 1986; 
Santamaria et al. 1986a; Santamaria et al. 1986b; Shiba et al. 2000) is also known to 
affect memory and attention (Hickie 1996), thus adding to, or perhaps causing, these 
memory-deficits seen in PD (Norman et al. 2002). Indeed, there are many similarities 
in the memory dysfunction observed in people with PD as in people with endogenous 
depression (Austin and Mitchell 1996). Memory deficits have been show to be more 
prominent in those with depressive symptoms (Uekermann et al. 2003). As such, 
memory may be affected differentially amongst groups of people with PD according 
to their symptom profile, particularly if they experience clinical depression. 
 
It should be acknowledged, however, that inaccuracies in memory can also be 
expected in the general population aged 55 and over. As such, the level of error 
between a PD group and a healthy age-matched control group may not be 
substantially different. Whether any memory-related errors produce a systematic 
under- or over-reporting of exposures by people with PD, is most important in their 
potential influence on exposure assessment and ultimately, results and conclusions 
based upon them. While it is difficult to quantify the effect of potential memory 
impairments on recall of exposure history, they highlight the need to establish the 
repeatability of self-reported exposure data provided by people with PD in the 
population under examination. 
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2.13 Conclusions 
PD is a complex neurodegenerative disorder which is characterised by substantial 
heterogeneity in symptoms and disease prognosis. The condition is of public health 
significance due to its substantial economic burden on affected individuals and 
society and the significance decrease in health related quality of life of affected 
individuals and their families. 
 
The aetiology of PD remains unclear. Examination of age- and sex-specific incidence 
rates of PD suggest that advancing age is an important risk factor for PD and females 
appear to have slightly lower risk. Genetic factors alone appear to account for only a 
small percentage of PD cases, however genetic susceptibility is likely to play a role 
in conjunction with other factors for non-familial PD. Factors involving medical 
histories, such as infections, head injury, surgery involving general anaesthesia and 
use of NSAIDs have been considered as having a potential role in PD aetiology. Of 
these, regular use of NSAIDs appear to lower risk of PD, while some evidence 
suggests that head injury may increase risk of PD. Evidence for the involvement of 
infections and general anaesthesia in PD aetiology is limited and less convincing.  
 
Strong epidemiological evidence exists for an inverse relationship between smoking 
and coffee consumption and PD; however whether these factors are truly biologically 
protective is still a matter of debate. Weaker evidence exists for similar inverse 
relationships between tea and alcohol consumption and PD. Studies that have 
examined dietary factors, such as vitamin intake have reported very inconsistent 
results, such that no single factor is prominent as a convincing aetiological factor.  
 
There is evidence from a number of lines of inquiry, including laboratory studies, 
case studies and epidemiologic studies that environmental exposures may be 
involved in PD aetiology. While a progressive PD-like syndrome of purely 
environmental causation exists in the form of MPTP-induced parkinsonism, 
environmental exposures are most likely to be involved in PD aetiology through an 
interaction with genetic factors. However, the results of epidemiological studies of 
specific environmental exposures are inconsistent. The majority of these studies are 
case-control studies. Some of the heterogeneity in study results amongst 
epidemiological studies of environmental risk factors for PD may be due to 
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geographical differences in exposures, such as well-water composition, however, 
methodological issues are also likely to play a substantial role.  
 
The clinical characteristics of PD: a typical onset late in life which is slow and 
insidious in development of symptoms, a low incidence in the general population, 
variation in clinical diagnostic criteria, and lack of pathological confirmation other 
than autopsy, make epidemiological research into PD aetiology challenging. Self-
reported exposure measurement may be a source of substantial error, however 
records of exposure do not exist for most of the environmental factors of interest to 
PD epidemiology.   
 
Little attention has been paid to the contribution that study design and 
methodological issues such as exposure measurement may make to the inconsistency 
in results and few studies of PD aetiology have examined the validity or test-retest 
repeatability of their exposure measurement methods. An examination of this issue 
may assist in interpretation of existing epidemiological studies of PD aetiology. And, 
more importantly, assist in the design and conduct of epidemiological studies of 
environmental exposures and PD aetiology.  
 
In the following chapter, an existing unanalysed dataset from a previous case-control 
study of PD and environmental factors is examined as background for the new case-
control study of environmental factors and PD aetiology with an exposure 
measurement instrument of established test-retest repeatability. The results of the 
existing dataset will then be compared to the new results in an attempt to examine the 
contribution that study design and methodology may make to the heterogeneity of 
results amongst epidemiological studies of PD aetiology and environmental factors.  
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3.0 Analysis of an Existing Dataset of Environmental Exposures in PD Cases 
and Controls 
 
A previously unanalysed dataset of environmental exposures in PD cases and healthy 
controls was available to the candidate. The purpose of examining and analysing 
these data here were with a view to informing the design of a new case-control study, 
which is described in Chapter 6.  
 
3.1 Australian Studies of Environmental Exposures and PD Risk  
To date, there are few published Australian studies of PD and environmental 
exposures. Only two published studies, a case-control study (McCann et al. 1998) 
and a cross-sectional study (Chan et al. 2001) were identified. The former involved 
224 patients with PD and 310 frequency matched controls. Both patients and controls 
were recruited from hospitals, residential care centres and community groups in 
South-East Queensland and Central-West New South Wales. There were a number of 
limitations with this study. Firstly, the cases and controls were not selected by true 
random sampling from well-defined sampling frames, or other accepted methods, but 
appeared to be convenience samples sourced from a number of different populations, 
including support groups, hospitals and residential care centres. A number of 
participants were also recruited from the rural community of Orange, in Central New 
South Wales. No details were provided concerning how participants were located, 
selected and approached and no response rate was reported. The authors also omitted 
to report on exclusion criteria for control participants. These limitations may affect 
the generalisability of the study’s results. If certain types of people are more likely to 
be recruited than others, selection bias may be introduced into the study if particular 
exposures are more or less likely to be associated with these types of people. There is 
limited information available to determine which exposures may be influenced by 
these recruitment methods. The authors reported elevated odds ratios relating to risk 
of PD for Rural residency (OR 1.7, 95% CI 1.17-2.57) and Family history of PD (OR 
3.7, 95% CI 2.01-6.63), decreased odds ratios for Groundwater consumption (OR 
0.6, 95% CI 0.38-0.92), Cigarette smoking (OR 0.7, 95% CI 0.4-1.1) and History of 
hypertension (OR 0.3, 95% CI 0.18-0.42) or History of stroke (OR 0.2, 95% CI 0.1-
0.45), and neutral odds ratios for Exposure to herbicides and pesticides (OR 1.2, 
95% CI 0.8-1.5) and Head injury (OR 1.1, 95% CI 0.7-1.9).  
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The cross-sectional survey of environmental exposures performed by Chan et al. 
(2001) was conducted as part of a study of prevalence of PD in Randwick, an inner 
eastern suburb of Sydney. The results found higher prevalence of herbicide, pesticide 
and ‘chemical’ exposure amongst cases compared to controls. It should be noted, 
however, that while there were 508 participants without PD, there were only 19 
participants with PD. The results of analysis from such a small case group are of 
questionable precision as only one or two misclassified cases could change the 
estimates substantially, as suggested by the wide confidence intervals for the 
estimates. Being cross-sectional in nature and restricted to the inner Sydney suburb 
of Randwick, again, the generalisability of these results to the remainder of the 
Australian population is questionable. 
 
3.1.2 Exposure Definitions Used in Australian Studies 
McCann et al. (1998) defined regular exposure to herbicides and pesticides as “daily 
or weekly exposure to industrial herbicides and pesticides for a cumulative period of 
greater than 6 months”. Participants were asked to classify their pesticide exposure as 
hobby gardening, farming and industrial. No further information is provided as to 
what was included in the definition of “industrial” herbicides and pesticides. Chan et 
al. (2001) assessed exposure to pesticides (insecticides) and herbicides separately 
with the questions “Have you ever worked with or have direct contact with 
herbicides in farming?” and “Have you ever worked with or have direct contact with 
pesticides in farming?”. Participants were also asked to report the numbers of years 
or months of pesticide/herbicide use. 
 
3.1.3 Prevalence of Environmental Exposures in an Australian Context 
Very limited information is available on the nature and prevalence of environmental 
exposures in the Australian population, particularly with respect to historical 
exposures. McCann et al. (1998) report that 49% (95% CI 45-53%) of participants in 
their prevalence study conducted in the Nambour area of southeast Queensland 
reported occasional-to-regular exposure to herbicides or pesticides. As Nambour is a 
rural area with many farms, particularly sugarcane and pineapples, the 
generalisability of this level of pesticide exposure outside this small geographical 
area is questionable. In addition, the authors do not provide information on the 
breakdown of exposure into specific categories, such as domestic, farming, industrial 
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or occasional and regular exposure. Chan et al. (2001) reported 19% (95% CI 4-55%) 
of cases and 7% (95% CI 5-10%) of controls as Exposed to herbicides in farming and 
12% (95% CI 32-100%) of cases and 8% (95% CI 5-11%) of controls as Exposed to 
pesticides (insecticides) in farming. The difference in the prevalence of exposure 
reported by McCann et al. (45-53%), and Chan et al. (5-11%), demonstrates the 
variability in results between studies when presumably different exposure definitions 
and populations are involved. 
 
3.2 Background to the Unanalysed Dataset 
In addition to the two published Australian studies discussed, an unanalysed dataset 
of environmental exposure data from a case-control study of 435 PD cases and 317 
unaffected controls was available to the candidate. These data were collected 
between 1998-2001 by Dr George Mellick (School of Medicine, University of 
Queensland) and Dr Peter Silburn (private specialist neurologist practice) from 
participants throughout Queensland, although more than half were from Southeast 
Queensland (64%) and a further 12% were from the Bundaberg region. The focus of 
the research was on genetic risk factors for PD and the environmental exposure data 
were collected for the purpose of adjusting for potential confounding variables in the 
analysis. A quarter of the data (25.4%) were previously used in a case-control study 
of genetic polymorphisms to adjust for exposures such as smoking or ‘toxins’ 
(Menegon et al. 1998), however the environmental exposure data had not been 
examined in detail. There were also a substantial number of subjects that had not 
been included in any previous analysis.  
 
3.3 Aims and Objectives  
The purpose of examining and analysing these data here were two-fold. Firstly, the 
dataset provided information on the prevalence of environmental exposures 
(pesticides, rural residency, farming, bore water consumption, and smoking) of 
interest to PD aetiology within Southeast Queensland for the age-group relevant to 
PD research (approximately 40-90 years). Such information was not available from 
McCann et al.’s published results as only odds ratios were presented and no record of 
number of exposed participants was able to be located. This informed calculation of 
sample sizes required for the main case-control study. Secondly, the risk estimates 
for the exposures examined from this dataset could then be compared to those 
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obtained in the case-control study by McCann et al., and the case-control study 
which forms part of this thesis. This would facilitate an interpretative exploration of 
the impact of different epidemiological methods employed in these studies, all in a 
similar population, on the results obtained and conclusions reached.  
 
3.4 Research Question 
What are the relationships between environmental and lifestyle exposures associated 
with PD?  
 
3.5 Hypotheses 
The alternate hypotheses to be investigated in the analysis of the dataset were 
determined by examining the contents of the study’s risk factor questionnaire 
(Appendix C) and guided by the risk factors identified in the literature review in 
Chapter 2. Only previously examined relationships in epidemiological studies of PD 
aetiology were considered in this analysis.  
 
Environmental Exposures 
Rural Residency 
H1: The proportion of persons who had resided in a non-metropolitan area (i.e. rural 
area) for greater than 12 months, during their lifetime, is higher for those with PD 
than for those without. 
 
Groundwater Consumption 
H2: The proportion of persons who had drunk water from a groundwater supply for 
at least 6 continuous months during their lifetime is higher for those with PD than for 
those without. 
 
Farm Exposures 
H3: The proportion of persons who had resided or worked on a farm for 12 months 
or more during their lifetime is higher for those with PD than for those without. 
 
H4: The proportion of persons who had ever worked in an agricultural occupation 
during their lifetime is higher for those with PD than for those without. 
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Pesticide Exposures 
H5: The proportion of persons with any exposure to pesticides during their lifetime is 
higher for those with PD than for those without. 
 
H6 The proportion of persons with occasional exposure to pesticides during their 
lifetime is higher for those with PD than for those without. The proportion of persons 
with regular exposure to pesticides (at least weekly exposure for more than 6 
months) during their lifetime is higher for those with PD than for those without. 
 
H8: The proportion of persons with exposure to pesticides while hobby gardening 
during their lifetime is higher for those with PD than for those without. 
 
H9: The proportion of persons with exposure to pesticides while farming during their 
lifetime is higher for those with PD than for those without. 
 
Medical and Family History 
Head Injury 
H10: The proportion of persons who had experienced repeated head injury during 
their lifetime is higher for those with PD than for those without. 
 
Family History 
H11: The proportion of persons with a family history of PD is higher for those with 
PD than for those without. 
 
Lifestyle Exposures 
Tobacco Smoking  
H12: The proportion of persons who had smoked tobacco regularly during their 
lifetime is lower for those with PD than for those without. 
 
H13: The quantity of tobacco smoke actively consumed (pack-years) during their 
lifetime is lower for those with PD than for those without. 
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3.6 Methods 
3.6.1 Participants 
Cases had been recruited through public and private neurological clinics (invited to 
participate by Neurologists at Princess Alexandra Hospital and Dr Silburn’s private 
neurology clinics in Brisbane and Bundaberg) between 1998 and 2001. Participants 
had also been recruited through Parkinson’s Queensland Inc. support groups from 
throughout the state of Queensland. All the cases were diagnosed with PD by a 
neurologist. Diagnosis was confirmed as “clinically probable” or “definite PD” using 
the strict research criteria described by Calne et al. (1992). 
 
The participants were, therefore, a convenience sample as there had been no random 
or systematic sampling procedure. No details are available about the number of 
patients approached to participate in the research or how many declined to 
participate; therefore a response rate is unable to be estimated. While the clinicians 
attempted to ask as many patients as possible to participate in the research, a 
systematic recruitment protocol was not in place. Therefore, it is unknown if some 
types of patients may have been under-represented. The inclusion of patients 
recruited from support groups may also have resulted in a sample less representative 
of all PD cases, as those attending support groups are typically more likely to be 
willing to contribute to research such as this compared to those who don’t attend 
such groups. 
 
Controls had been identified; firstly, by asking spouses of PD cases to be involved, 
secondly, by asking patients if they had siblings or other family members who may 
be interested to be involved and thirdly, by asking if they could identify friends or 
neighbours who may have been willing to participate. No procedure was used to 
obtain a matched control sample. Controls were screened for symptoms of 
parkinsonism with a previously validated and published tool (Racette et al. 1999). 
Individuals who answered positively to more than one question on the screening test 
without having been fully examined by a neurologist with expertise in movement 
disorders were excluded from the analysis, as they were ineligible to be a control. 
However, most controls underwent neurological examination and were thus included. 
For this analysis, consanguinal relatives of PD cases in the study were removed from 
the dataset as family history of PD was a variable of interest. As their recruitment as 
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a control was due to having a family history of PD, it was inappropriate to include 
these controls in such an analysis. 
 
3.6.2 Data Collection 
A 10mL blood sample was obtained from the participants by venipuncture in EDTA 
(ethylenediaminetetraacetic acid) tubes for genetic analysis as part of a study of 
genetic risk factors for PD, and participants were given a self-administered 
questionnaire developed by Sally McCann, David Le Couteur and George Mellick, to 
complete (Appendix D). Some participants completed the questionnaire at the time 
of blood collection. However, other participants were forwarded the questionnaire by 
mail to complete at home. No details are available concerning how many completed 
the questionnaire during blood collection or at home. 
 
3.6.3 Data Entry and Cleaning 
The candidate entered the data from the written questionnaires into an excel 
spreadsheet. After each questionnaire was entered, the data were checked against the 
hardcopy for typing errors, which were corrected when identified. 
 
3.6.4 Data Analysis 
3.6.4.1 Derivation of Variables: 
The variable Main lifetime occupation was re-categorised as ‘Farming-related’ or 
‘Non-farming related’, as this was the main occupation of interest in the literature 
and the large number of different occupations listed by participants made 
uncategorised analysis difficult. Without further transformation of the data, sufficient 
numbers of participants were not available for many occupations to allow analysis. 
Head injury and Family history of PD were recoded as dichotomous rather than 
continuous to create variables that would be more comparable to previous studies. 
Little information was lost by dichotomizing these variables as few participants had 
more than one head injury or family member with PD. 
 
Pesticide exposure was analysed as an ordinal variable with the categories ‘no 
exposure’, ‘occasional exposure’ and ‘regular exposure’. The variable ‘mode of 
pesticide exposure’ was converted from a categorical variable to the separate 
dichotomous variables of Pesticide exposure in farming and Pesticide exposure in 
 84 
hobby gardening, as some participants chose more than one mode of exposure. A 
third category, Industrial pesticide exposure was omitted from the analysis due to the 
small number of participants (n=27) who reported this exposure and uncertainty 
about the validity of the responses. This was because the exposure was listed as a 
subset to a question concerning whether the participant had ever been exposed to 
pesticides generally and a number of the respondents who indicated that they had 
been exposed in an industrial setting had provided a negative response to the 
preceding question about whether they had been exposed to pesticides. This suggests 
that some of the participants may have misunderstood the question and were 
indicating that they had been exposed to something other than pesticides, such as 
solvents, in an industrial setting. While such an exposure may also be of interest to 
PD aetiology, it is not possible to ascertain if all participants would have interpreted 
this question in this manner. Therefore, it may be subject to reporting bias as PD 
cases with a history of exposure to industrial chemicals may have been looking for 
somewhere to record this exposure, whereas control subjects may simply have 
followed the skip pattern of the questions and skipped ‘industrial’ after answering 
negatively to exposure to pesticides.  
 
3.6.4.2 Analytical Methods 
All analyses, except power calculations, which were calculated with PS Power and 
Sample Size Program (Dupont and Plummer 1997), were performed with SAS V9.1 
and Enterprise Guide V2.1 (SAS Institute Inc., Cary, NC, USA). Descriptive 
information (gender ratios and mean ages) for cases and controls were calculated to 
determine if the control group was similar to the case group on these two 
demographic variables. 
 
The continuous variable Smoking packyears was also examined as a categorical 
variable to confirm if its relationship to PD was linear. A number of assessments 
were performed to determine if these continuous variables were Normally 
distributed. Some statistical procedures, such as the T-test require the assumption of 
Normality for the test to be valid. The data were assumed to be Normally distributed 
if the following criteria were met: 
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1. Kolmogorov-Smirnov test “D statistic” less than or equal to the critical “D 
statistic” for Normal distribution at the 0.05 level. The Kolmogorov-Smirnov test 
is a goodness-of-fit test for any statistical distribution, but was applied here to test 
if the data conformed to the Normal distribution (Weisstein 1999); given the 
sensitivity of the Kolmogorov-Smirnov statistic with large sample sizes, the 
following algorithm was used to assess ‘adequate’ Normality. 
2. The mean was within ± 10% of the median value; and 
3. The minimum value approximated the mean minus three standard deviations; and 
4. The maximum value approximated the mean plus three standard deviations; and 
5. The skewness coefficient was within ± 3; and 
6. The kurtosis coefficient was within ± 3; and 
7. The histogram of the distribution had a bell-shaped appearance; and 
8. The standard deviation was less than half the mean value, if the variable was 
positively scaled. 
 
Bivariate associations were explored by constructing cross-tabulations of the 
categorical explanatory variables (Rural residency, Pesticide exposure dose, 
Exposure to hobby gardening pesticides, Exposure to farming pesticides, Head 
injury, Farm work or residency, Farming occupation, Groundwater consumption, 
Smoking status) and (i) the confounding variable Sex and (ii) the outcome variable 
PD status. These analyses were then repeated stratified by Sex, as males and females 
were postulated to have potentially different risk factors for PD due to biological 
variation and differences in types of exposures experienced. Fisher’s exact test was 
calculated for all associations. There was potentially a degree of confounding for 
which there needed to be adjustment. Sex was likely to influence both the outcome 
variable (males may be at higher risk of PD; see Chapter 2, Section 2.7) and many of 
the explanatory variables, such as Farming occupation, Pesticide exposure and 
Smoking status. Likewise, Age was also likely to be an important confounder as PD 
risk is known to increase with increasing age; being an older age may also influence 
exposures such as groundwater consumption and farming occupation, as these 
exposures may have become less common over time. Many of the explanatory 
variables may influence PD risk independently, but are also likely to be related to 
other explanatory variables. Rural residency is likely to be associated with 
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groundwater consumption, farm work or residency, farming occupation, and possibly 
tobacco smoking11. Excessive collinearity between variables was explored by 
constructing cross tabulations of the variables that were likely to be highly 
correlated. As having a main lifetime occupation in a farming-related job was a 
subset of having lived or worked on a farm, there was a strong relationship between 
the two variables (100% of those who reported having a lifetime occupation in a 
farming-related job reported having lived or worked on a farm). There was an 
expected strong relationship between having drunk groundwater as a main supply of 
drinking water for 6 months or more and living in a non-metropolitan area for 12 
months or more (92% of those who reported drinking groundwater reported having 
lived in a non-metropolitan area). There was a strong relationship between having 
lived or worked on a farm and having lived in a non-metropolitan area for 12 months 
or more (98% of those who reported having lived or worked on a farm reported 
having lived in a non-metropolitan area). There did not appear to be a relationship 
between having been a smoker and having lived in a non-metropolitan area for 12 
months or more.  
 
Multivariable analyses were performed on the data to adjust for potential 
confounding between Age, Sex and the explanatory exposures. As the outcome 
variable (PD status) was dichotomous, binary logistic regression was used. The 
variables Age, Sex, Family history of PD, Rural residency, Head injury, Smoking 
packyears and Pesticide exposure were included in the final regression model. Ever 
having been a smoker was also examined in a regression model adjusted for the 
variables Age, Sex, Family history of PD, Rural residency, Head injury, and 
Pesticide exposure. Variables were excluded from the regression model if their 
adjusted odds ratio was approximately one and removal of the variable did not 
substantially alter the odds ratios of the remaining variables. 
 
Power Calculations 
A priori sample size calculations were not performed for this study. Therefore, 
meaningful odds ratios that did not alter statistical significance were used for power 
calculations to determine what power the study had. A power calculation was 
                                                 
11 Higher prevalence of smoking has been reported in non-metropolitan areas (Jong et al. 2002) 
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performed with PS Power and Sample Size Program (Dupont and Plummer 1997) to 
determine the power of this study to detect significant differences at the 0.05 level 
(two-tailed) for each of the hypotheses tested. Statistical significance was set at α = 
0.05, two-tailed. Statistically significant associations with an odds ratio of greater 
than 1.5 were considered important associations. Non-significant associations with 
an odds ratio greater than 1.5 were considered associations of interest. 
 
Power to Test Hypotheses 
The statistical power to detect odds ratios of 1.5, 2.0 and 2.5 for each of the 
exposures of interest are presented in Table 3.6.1. Calculations were based on the 
number of responses provided for each variable. There was greater than 95% power 
to observe an odds ratio of 2.0 for all other exposures except for the variables 
Regular Pesticide Exposure and Head Injury. For these, there was greater than 90% 
power to detect an odds ratio of 2.5.  
 
Table 3.6.1 Power to detect odds ratio of 1.5, 2.0 and 2.5 for identified risk 
factors for PD in secondary analysis 
 Exposed 
controls 
Power to detect odds 
ratio 
Exposure N (%) 1.5 2.0 2.5 
Rural Residency 176 (69.8) 0.59 0.95 1.00 
Groundwater Consumption 61 (24.3) 0.59 0.98 1.00 
Residency or Working on a Farm 94 (38.1) 0.69 0.99 1.00 
Main Lifetime Occupation in Farming 17 (7.4) 0.24 0.69 0.94 
Pesticide Exposure      
Occasional 102 (45.1) 0.70 0.99 1.00 
Regular 16 (7.1) 0.23 0.67 0.93 
Hobby Gardening Pesticides 47 (20.3) 0.54 0.96 1.00 
Farming Pesticides 43 (18.5) 0.51 0.95 1.00 
Head Injury 5 (2.0) 0.53 0.96 1.00 
Family History 60 (24.4) 0.59 0.98 1.00 
Smoker 98 (39.2) 0.69 0.99 1.00 
N number of exposed controls;  % percentage of exposed controls 
 
Prevalence of Exposures 
The prevalence of each of the exposures considered was calculated and the 95% 
confidence interval estimated. The prevalence of each of these exposures in the 
control sample was of particular interest for planning of the main case control study.  
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Comparison of Results of Two Studies 
In order to directly compare the results from this dataset with those of McCann et al. 
(1998), the secondary analysis here focused on the same factors that were considered 
in the previous study. The following variables as were analysed at the bivariate level: 
Rural residency, Exposure to herbicides and pesticides (‘occasional’ and ‘regular’ 
exposure categories combined), Previous head injury, History of treated depression, 
Ingestion of well, bore or spring water, Positive history of cigarette smoking, Past 
history of stroke, Past history of hypertension. The following variables per McCann 
et al. (1998) were analysed in a multivariable logistic regression model: Age, Sex, 
Family history (of PD), Rural residency, Ingestion of well, spring or bore water, 
Hypertension and Stroke. While having a history of depression, hypertension or 
stroke are not considered aetiologically relevant to PD, they were included in this 
particular analysis to produce results directly comparable to those of McCann et al. 
(1998). McCann et al. did observe an inverse relationship between History of 
hypertension and PD and between Having had a stroke and PD, however this may be 
due to recruitment of hospital outpatients for controls. Little information was 
provided concerning whether these outpatients were more likely to come from 
cardiovascular clinics. 
 
3.7 Results  
3.7.1 Participants 
A total of 435 cases and 253 controls had completed the self-administered risk factor 
questionnaire. As shown in Table 3.7.1, cases were 4.5 years older on average than 
controls and females were over-represented in the control group compared to the 
case group.  
 
Table 3.7.1 Characteristics of Participants in Case-Control Study of 
Environmental Exposures and Parkinson’s Disease, Secondary Analysis of 
Unpublished Data 
 Cases (n = 435) Controls (n = 253) 
Mean Age (SD) 66.9 (9.9) 62.5 (11.8) 
Males 251 (58%) 116 (37%) 
Females 184 (42%) 201 (63%) 
Mean Duration of PD in Years (SD) 7.0 (5.5) Not Applicable 
PD Parkinson’s disease; SD Standard deviation 
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3.7.2 Prevalence of Exposures in Control Group 
The prevalence of each of the exposures examined in the study in the control group 
and the 95% confidence intervals are presented in Table 3.7.2. Sex-specific 
prevalence rates are also presented. Differences in prevalence between males and 
females were observed for having been a regular smoker and having had a main 
lifetime occupation in farming. 
 
Table 3.7.2 Prevalence of Exposures Examined in the Case-Control Study in the 
Control Group  
 Prevalence of Exposure 
 All Males Females 
Exposure % (95% CI) % (95% CI) % (95% CI) 
Rural Residency 69.8 (64.2-75.5) 65.1 (55.0-75.2) 72.3 (65.5-79.1) 
Groundwater Consumption 24.3 (19.3-30.0) 30.2 (20.5-39.9) 21.2 (15.0-27.4) 
Residency or Working on a Farm 38.1 (32.0-44.1) 34.9 (24.7-45.2) 39.6 (32.1-47.1) 
Main Lifetime Occupation in Farming 7.4 (4.0-10.8) 15.6 (7.5-23.7) 3.3 (0.5-6.1) 
Pesticide Exposure     
Occasional 45.1 (38.6-51.6) 47.5 (36.6-58.4) 43.8 (35.8-51.9) 
Regular 7.1 (3.7-10.4) 10.0 (3.4-16.6) 5.5 (1.8-9.2) 
Hobby Gardening Pesticides 20.3 (15.1-25.4) 19.8 (11.1-28.4) 20.5 (14.1-27.0) 
Farming Pesticides 18.5 (13.5-23.5) 21.0 (12.1-29.9) 17.2 (11.2-23.2) 
Head Injury 2.0 (0.3-3.7) 4.7 (0.2-9.1) 0.6 (0-1.8) 
Family History 24.4 (19.0-29.8) 18.8 (10.5-27.1) 27.3 (20.4-34.2) 
Smoker 39.2 (33.1-45.3) 65.1 (55.0-75.2) 25.6 (18.9-32.3) 
% Percentage of controls exposed; CI Confidence Interval 
 
3.7.3 Bivariate Associations between PD and Selected Exposures 
The prevalence of exposures in PD cases and controls and the results of their 
bivariate associations are presented in Table 3.7.3. The associations stratified by Sex 
are also presented. Male gender was associated with increased odds of PD (OR 2.65, 
95% CI 1.92-3.66). No relationship was observed between PD and Rural residency, 
Drinking groundwater, Having worked or lived on a farm, Occasional exposure to 
pesticides (less than weekly exposure for 6 months or more), Exposure to pesticides 
while hobby gardening or Tobacco smoking. 
 
Regular exposure to pesticides (at least weekly exposure for 6 months or more) was 
associated with twofold increased odds of PD and Having experienced repeated head 
injury was associated with tenfold increased odds of PD. Exposure to pesticides 
while farming, Having a main lifetime occupation in a farming-related job and 
 90 
Having a family history of PD were associated with moderately increased odds of 
PD. 
 
When the associations were stratified by sex, increased odds of PD were observed 
for males for Ever lived in a rural area, Regular exposure to pesticides, Having a 
family history of PD. An inverse relationship between Tobacco smoking and PD was 
observed only in males. Increased odds were observed for females for Exposure to 
pesticides while farming and Having a main lifetime occupation in a farming-related 
job. 
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Table 3.7.3 Various Environmental and Demographic Exposures and Their Association 
with PD Overall and Within Groups Defined by Sex 
 Cases 
435 
N (%) 
Controls 
253 
N (%) 
 
Missing  
N (%) 
 
Odds Ratio  
(95% CI) 
 
 
Sig 
Sex (Male) 251 (57.7) 86 (34.0) 0 (0) 2.65 (1.92-3.66) <0.01 
Ever lived in a rural area 313 (72.1) 176 (69.8) 2 (0.3) 1.12 (0.79-1.57) 0.29 
Male 186 (74.1) 56 (65.1) 0 (0) 1.53 (0.91-2.59)  
Female 127 (69.4) 120 (72.3) 2 (0.6) 0.87 (0.55-1.38)  
Ever drank groundwater 45 (24.7) 35 (21.2) 4 (0.6) 1.10 (0.77-1.58) 0.33 
Male 68 (27.2) 26 (30.2) 1 (0.3) 0.86 (0.50-1.48)  
Female 45 (24.7) 35 (21.2) 4 (1.2) 1.22 (0.74-2.02)  
Ever lived or worked on 
a farm 
171 (42.4) 94 (38.1) 38 (5.5) 1.20 (0.87-1.66) 0.15 
Male 95 (41.0) 29 (34.9) 22 (6.5) 1.29 (0.77-2.18)  
Female 76 (44.4) 65 (39.6) 16 (4.6) 1.22 (0.79-1.88)  
Had a main life-time 
occupation in farming 
40 (10.1) 17 (7.4) 61 (8.9) 1.40 (0.78-2.54) 0.16 
Male 31 (13.5) 12 (15.6) 31 (9.2) 0.85 (0.41-1.75)  
Female 9 (5.4) 5 (3.3) 30 (8.5) 1.68 (0.55-5.11)  
Ever exposed to pesticides  229 (59.5) 118 (52.2) 77 (11.2) 1.34 (0.97-1.87) 0.05 
Nil 156 (40.5) 108 (47.8) 77 (11.2) 0.74 (0.53-1.04) 0.05 
Male 70 (31.7) 34 (42.5) 36 (10.7) 0.63 (0.37-1.06)  
Female 86 (52.4) 74 (50.7) 41 (11.7) 1.07 (0.69-1.68)  
Occasionally 172 (44.7) 102 (45.1) 77 (11.2) 0.98 (0.71-1.37) 0.49 
Male 105 (47.5) 38 (47.5) 36 (10.7) 1.00 (0.60-1.67)  
Female 67 (40.9) 64 (43.8) 41 (11.7) 0.89 (0.56-1.39)  
Regularly 57 (14.8) 16 (7.1) 77 (11.2) 2.28 (1.28-4.08) <0.01 
Male 46 (20.8) 8 (10.0) 36 (10.7) 2.37 (1.06-5.26)  
Female 11 (6.7) 8 (5.5) 41 (11.7) 1.24 (0.48-3.17)  
Ever exposed to hobby 
gardening pesticides  
63 (16.8) 47 (20.3) 82 (11.9) 0.80 (0.52-1.21) 0.17 
Male 41 (19.2) 16 (19.8) 36 (10.7) 0.96 (0.51-1.83)  
Female 22 (13.8) 31 (20.5) 41 (11.7) 0.62 (0.34-1.12)  
Ever exposed to farming 
pesticides 
92 (24.6) 43 (18.5) 82 (11.9) 1.43 (0.96-2.15) 0.05 
Male 54 (25.2) 17 (21.0) 36 (10.7) 1.27 (0.69-2.36)  
Female 38 (23.8) 26 (17.2) 41 (11.7) 1.50 (0.86-2.62)  
Experienced repeated 
head injury 
78 (18.1) 5 (2.0) 8 (1.2) 10.86 (4.33-27.21) <0.01 
Male 64 (25.8) 4 (4.7) 3 (0.9) 7.13 (2.51-20.24)  
Female 14 (7.7) 1 (0.6) 5 (1.4) 13.6 (1.77-104.48)  
Have family history of  PD 143 (33.3) 60 (24.4) 12 (1.7) 1.54 (1.08-2.20) <0.01 
Male 81 (32.8) 16 (18.8) 5 (1.5) 2.10 (1.15-3.85)  
Female 62 (33.9) 44 (27.3) 7 (2.0) 1.36 (0.86-2.16)  
Ever been a smoker 181 (42.1) 98 (39.2) 8 (1.2) 1.13 (0.82-1.55) 0.26 
Male 130 (52.6) 56 (65.1) 4 (1.2) 0.60 (0.36-0.99)  
Female 51 (27.9) 42 (25.6) 4 (1.1) 1.12 (0.70-1.81)  
* Cases + Controls; CI Confidence Interval ; Sig one-tailed statistical significance 
 
When examined as categorical variables, age was related to odds of PD in a linear 
relationship (Table 3.7.4). Lowest odds of PD were observed for those in the highest 
category of smoking, however the result was statistically non-significant. 
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Table 3.7.4 Categorical Analysis of Age of Participants, Packyears Smoked and 
Relative Odds of PD 
 Cases 
N (%) 
Controls 
N (%) 
OR  
(95% CI) 
Age (years)    
<59  82 (18.9) 77 (30.9) 1.00 
59-66  105 (24.3) 67 (26.9) 1.47 (0.95-2.28) 
67-73  124 (28.6) 59 (23.7) 1.98 (1.27-3.06) 
>73  122 (28.2) 46 (18.5) 2.49 (1.57-3.95) 
Smoking (packyears)    
<1  256 (63.7) 157 (65.7) 1.00 
1-9.45  48 (11.9) 16 (6.7) 1.84 (1.01-3.35) 
9.5-27.75  51 (12.7) 29 (12.1) 1.08 (0.66-1.77) 
>27.75  47 (11.7) 37 (15.5) 0.78 (0.49-1.25) 
Age category cut-offs determined by quartiles; Smoking category cut-offs determined by 
tertiles for packyears ≥1 
 
3.7.4 Multivariable Associations between PD and Selected Exposures 
The results of the multivariable analyses of the exposures and PD are presented in 
Table 3.7.5. In addition to the adjusted odds ratios, the crude odds ratios (to allow 
easy comparison with adjusted odds ratios) and the proportion of exposed cases and 
controls are also presented for the variables in the final regression model. The results 
of the multivariable regression generally reflected the results of the bivariate 
analysis. Males had increased relative odds of PD (adjusted OR 1.95, 95% CI 1.30-
2.93) compared to females. Increasing age was associated with steadily increasing 
odds of PD. After adjustment for confounders in the multivariable model, Having 
lived in a non-metropolitan area for at least a year or more was associated with 
decreased odds of PD. However, the result was statistically non-significant (adjusted 
OR 0.83, 95% CI 0.54-1.27). The bivariate association of Regular pesticide exposure 
as a risk factor for PD was confirmed in the multivariable model. Similarly, Repeated 
head injury remained associated with increased odds of PD after adjustment in the 
multivariable model. After adjustment in the multivariable model, Having been a 
smoker was only associated with slightly decreased odds of PD, however the result 
was statistically non-significant. Smoking packyears was associated with decreased 
odds of PD of 0.01 for each packyear smoked. The result was of borderline statistical 
significance.  
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Table 3.7.5: Various Demographic, Environmental and Lifestyle Factors and their 
Association with PD in a Multivariable Logistic Regression Model  
Exposure Cases 
N (%) 
Controls 
N (%) 
Crude OR  
(95% CI) 
Adjusted OR 
(95% CI) 
Sex (Male) 251 (57.7) 86 (34.0) 2.65 (1.92-3.66) 1.95 (1.30-2.93) 
Age   1.03 (1.02-1.05) 1.04 (1.02-1.06) 
Rural Residency 313 (72.1) 176 (69.8) 1.12 (0.79-1.57) 0.83 (0.54-1.27) 
Pesticide Exposure      
Nil 156 (40.5) 108 (47.8) 1.00 1.00 
Occasional 172 (44.7) 102 (45.1) 1.17 (0.83-1.65) 1.12 (0.75-1.68) 
Regular 57 (14.8) 16 (7.1) 2.47 (1.35-4.52) 1.92 (0.93-3.99) 
Head Injury 78 (18.1) 5 (2.0) 10.86 (4.33-27.21) 6.83 (2.62-17.82) 
Family History 143 (33.3) 60 (24.4) 1.54 (1.08-2.20) 1.60 (1.06-2.44) 
Smoker 181 (42.1) 98 (39.2) 1.13 (0.82-1.55) 0.90 (0.61-1.33) 
Smoking packyears   1.00 (0.99-1.01) 0.99 (0.98-1.00) 
NA Not Applicable; OR Odds Ratio 
* Multivariable model: sex, age, rural residency, pesticide exposure, head injury, family 
history, smoking packyears 
? Multivariable model: sex, age, rural residency, pesticide exposure, head injury, family 
history, Smoker 
 
 
3.7.5 Comparison of Two Queensland Case-Control Studies 
At the bivariate level, a similar neutral result was obtained for Exposure to 
herbicides and Pesticides, in both studies. Previous head injury, History of treated 
depression, and Past History of stroke were associated with increased odds of PD in 
the current dataset, while McCann et al. reported a null result for all these variables, 
except for Past history of stroke, for which an inverse relationship with PD was 
reported. McCann et al. reported increased odds of PD with Rural residency and 
decreased odds of PD with Ingestion of well, bore or spring water. No associations 
were observed for both these variables and PD in the current dataset. Similar to the 
current study, McCann et al. reported increased odds of PD with Family history (of 
PD), although there was a difference in the effect size. Similar results were obtained 
in the multivariable analysis to those of the bivariate analyses for variables included 
in both studies.  
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Table 3.7.6: Comparison of Results of Bivariate and Multivariable Logistic 
Regression Analysis of Two Datasets 
 Odds Ratio (95% CI) 
 McCann et al. 
N=534 
Current Study 
N=752 
Bivariate analysis 
Rural residency 1.8 (1.7-2.5) 1.1 (0.8-1.6)* 
Exposure to herbicides and pesticides 1.2 (0.8-1.5) 1.2 (0.9-1.7)* 
Previous head injury 1.1 (0.7-1.9) 8.5 (3.7-21.7)* 
History of treated depression 1.2 (0.7-2.2) 2.7 (1.6-4.3)* 
Ingestion of well, bore or spring water 0.7 (0.4-1.0) 1.1 (0.7-1.5)* 
Positive history of cigarette smoking 0.7 (0.4-1.1) 0.9 (0.6-1.2)* 
Past history of stroke 0.2 (0.1-0.5) 2.0 (0.7-5.5)* 
Past history of hypertension 0.2 (0.1-0.4) 0.7 (0.5-1.0)* 
   
Multivariable logistic regression analysis 
Age 1.0 (1.0-1.0) 1.0 (1.0-1.1) 
Sex 1.2 (0.8-1.7) 2.0 (1.4-2.9) 
Family history 3.7 (2.0-6.6) 1.7 (1.2-2.5) 
Rural residency 1.7 (1.2-2.6) 0.9 (0.6-1.4) 
Ingestion of well, spring or bore water 0.6 (0.4-0.9) 1.1 (0.8-1.7) 
Hypertension 0.3 (0.2-0.4) 0.6 (0.4-0.9) 
Stroke 0.2 (0.1-0.5) 1.4 (0.5-4.1) 
   
* Adjusted for age and sex 
Results to only one decimal place were available for McCann et al.’s study 
 
3.8 Discussion 
There were a number of similarities in the study designs and data collection protocols 
between this case-control study and that of McCann et al. (1998). In both studies, 
cases were approached from a number of different settings in an unsystematic 
manner, and no response rates were recorded. While there is little published detail 
available concerning the nature of McCann et al.’s control group, the authors 
reported that it contained a mixture of hospital and community controls. In contrast, 
those recruited for this study were only healthy community-based controls and none 
were recruited from clinics or hospitals. Many of the controls in this study were 
family members of cases (only affinal relatives were included in the analysis). The 
majority of participants for both studies were recruited from southeast Queensland. 
However, McCann et al. also recruited participants from central New South Wales 
(town of Orange) and participants were recruited from other areas of Queensland for 
the current dataset. Both studies used a self-administered risk factor questionnaire 
with near identical questions as the questionnaire used for this dataset had been based 
on that used by McCann et al., with only small changes made to some questions. The 
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main methodological difference between the two studies appears to be the selection 
and recruitment of the control group. Comparison of the results of this study with 
those obtained by McCann et al. may therefore, in most part, reflect the impact of 
different control group recruitment methods upon the results. 
 
The over-representation of females in the current study’s control group was most 
likely due to the recruitment of partners of cases as controls. This would account for 
the observed increased odds of PD associated with being male. While some 
incidence studies have suggested that males are at higher risk of PD (Bower et al. 
1999; Van Den Eeden et al. 2003), the use of non-random participant selection 
makes such a conclusion from these data difficult as there is a high likelihood of 
selection bias. The over-representation of females in the control group may also 
produce biased results as many exposures are influenced by gender. For example, 
females are less likely to be pesticides occupationally and are less likely to smoke 
than males.  
 
Having lived in a non-metropolitan area for a year or more (Rural residency) did not 
increase the odds of PD. This result is in contrast to that of McCann et al. (1998), 
who reported an increased odds of PD of 1.7 (95% CI 1.2-2.6) for this exposure. 
These conflicting results may be indicative of the inherent variability in the 
measurement of the exposure Rural residency. As discussed in Chapter 2, previous 
case-control studies have provided mixed results for this exposure. Some of the 
variability in these results may be due to differences in particular study definitions of 
Rural residency. However, the same definition for Rural residency was used for this 
dataset and by McCann et al. (1998). Therefore, this is unlikely to account for the 
conflicting results. Family members are likely to share residential history, 
particularly spouses. Friends and in-laws may also have common residential 
backgrounds. Therefore, the recruitment of family and friend controls for this dataset 
is a likely contributor to the null result on this variable as cases and controls are 
likely to be overmatched on this exposure. This demonstrates a major disadvantage 
associated with recruitment of family members for a control group as they are not 
representative of the general population. While it may be argued that family 
members may be more representative of the unique cohort from which the case 
participants originated, this is not strictly true. Family members may differ in terms 
 96 
of whether they would attend a particular treatment clinic or a support group, if they 
were diagnosed with PD. As these were the sources of the study cases, family 
controls differing on these parameters would be ineligible as cases in the study.  
 
Groundwater consumption was not related to PD and was subsequently omitted from 
the multivariable model due to the lack of association, and its strong correlation with 
Rural residency. Again, this result is in contrast to that of McCann et al. (1998), who 
reported decreased odds of PD for this exposure. It is not possible to determine the 
overlap in the exposures Rural residency and Groundwater consumption in McCann 
et al.’s sample. The reason for the null result in the current dataset is likely to be the 
same as that for the result for Rural residency as the two variables were highly 
correlated.  
 
Regular pesticide exposure was associated with a two-fold increased odds of PD in 
this dataset, however the result did not attain statistical significance. Out of the 
environmental exposures examined in relation to PD risk, pesticide exposure has 
been associated most consistently with increased PD risk (Priyadarshi et al. 2000). 
There is also substantial toxicological evidence to support a biologically plausible 
link between pesticides and PD aetiology (Thiruchelvam et al. 2000b). McCann et 
al.’s study did not report pesticide exposure as a risk factor for PD (OR 1.2, 95% CI 
0.8-1.5) and this variable was omitted from their multivariable logistic regression 
model, however the variable appeared to have been analysed as dichotomous rather 
than in the more refined original format in which the data were collected (never, 
occasional and regular exposure). McCann et al. did not provide any information to 
justify why the exposure was not analysed in the original format which included two 
levels of exposure intensity.  The lack of relationship may be due to this gross level 
of assessment.  When the ordinal variable of pesticide exposure in the current dataset 
was collapsed into ‘ever/never’ to mimic McCann et al.’s analysis, and re-analysed 
as a dichotomous variable, adjusting for age and sex, a similar odds ratio of 1.2 (0.9-
1.7) was obtained. This has important implications for measurement of 
environmental exposures, such as pesticides. Low level exposure may be insufficient 
to influence PD risk. Therefore, aggregation of minimal exposure with more 
extensive exposure may dilute any relationship that may be present with more intense 
exposure, in an exposure that has modest independent risk levels like this one. 
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Having been a regular smoker and Smoking packyears was not associated with PD in 
this study. A strong, statistically significant inverse relationship was observed 
between PD and Having been a regular smoker for men, although no relationship 
was present for women. McCann et al. (1998) also reported decreased odds of PD 
with ever smoking cigarettes regularly at the bivariate level. However, the authors 
concluded that the exposure was not related to PD as the result lacked statistical 
significance. Given the consistency of the inverse relationship between smoking and 
PD in the literature, and that McCann’s result nearly attained statistical significance, 
this conclusion seems inappropriate.   
 
The positive relationship between PD and having a family history of PD observed in 
the current study is consistent with previous case-control studies (Behari et al. 2001; 
Pals et al. 2003). However, the two studies reported different effect sizes for the 
association between Family history of PD and PD. The weaker relationship between 
Family history of PD and PD in this dataset may due to the large number of spouses 
and friends of PD patients for the control group. These people may have a greater 
awareness of PD and may therefore be more aware of people with PD amongst their 
consanguinal relatives, than people recruited from a hospital clinic.  
 
The conflicting results for head injury, which was associated with a large increase in 
odds of PD in this dataset, and was not associated with increased odds in McCann et 
al.’s dataset, may be a result of the use of hospital controls and nursing home 
residents by McCann et al. Limited information is available concerning these 
controls, although the authors’ state that the controls were ‘essentially healthy elderly 
volunteers with no neurological problems or terminal illness’. If the hospital controls 
were recruited from trauma sections of the hospital, they may have been more likely 
to have sustained a head injury than the general population. Falls, which are a 
common cause of head injury, are also more common in nursing home residents and 
hospitalised patients than the general community (Rubenstein and Josephson 2002). 
Whether head injury increases the risk of PD is a controversial issue. Certain 
diagnostic criteria, such as that of the UK PD Brain Bank, specifically exclude 
patients with a history of head trauma from the diagnosis of PD. 
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3.9 Conclusions 
This case-control study and the case-control study by McCann et al. (1998) share a 
number of similarities, such as geographic location (most participants were from 
southeast Queensland), exposure data (questions were nearly identical and both were 
collected in self-administered questionnaires) and case recruitment (both recruited 
participants in an unsystematic manner from a variety of sources). The main 
difference in methods between the two studies was the inclusion of hospital controls 
by McCann et al. (1998) and the recruitment of family and friend controls in this 
dataset. Both of these sources of controls have major disadvantages which may affect 
the generalisability of the results. Some similarities in the results were observed for 
the two studies, but also a number of conflicting results were also evident. Both of 
these existing studies were characterised by non-random selection of participants, 
lack of information on the representativeness of the sample and rudimentary 
exposure measurement, the latter has not been assessed for validity or reliability. 
Therefore, there are no existing studies of environmental exposures and PD aetiology 
that have been conducted with acceptable epidemiological methods in the Australian 
population. Comparison with a more rigorously designed study within similar 
geographic boundaries may provide an indication of the impact of these limitations 
upon the results of case-control studies of PD aetiology and provide a more 
epidemiologically sound examination of the role of environmental exposures in PD 
aetiology in an Australian population.  
 
The comparison of these two studies informed the design of the following case-
control study in two ways. The difference between study results highlighted the 
importance of appropriate case and control participant selection and recruitment.  
Comparison of the results for the variable pesticide exposure when examined as 
“ever/never” and with two dosage levels, suggests that frequency and/or duration of 
exposure should be included in the measurement of exposures of interest. 
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4.0 Aims and Methods of a New Case-Control Study of Risk Factors for PD 
 
This chapter outlines the aims, design and methods of a new case-control study of 
risk factors for Parkinson’s disease. This study was informed by the literature review 
and preceding secondary analysis. As discussed in Chapter 2, a number of different 
factors have been implicated in the aetiology of PD, including physiological, genetic, 
dietary, psychosocial, microbiological and environmental factors, such that the 
disease’s cause is generally considered to be multifactorial. Potential factors that may 
contribute to PD risk are shown in Figure 4.1.1 
 
The relative contributions of each of these potential factors to overall PD risk are 
unknown. Ideally, it would be desirable to study all potential factors that may modify 
risk of PD in the one study. However, for practical reasons, a comprehensive study is 
not possible due to the data collection burden it would place upon the participants. 
Therefore, this research has focussed on a particular aspect of PD aetiology, namely 
the environmental factors. While there are a number of lines of evidence to suggest 
environmental factors are involved in PD aetiology, there is substantial disagreement 
between epidemiological studies of these factors and PD risk, such that the issue is 
yet to be resolved. Some other non-environmental factors, such as sex, age, smoking 
PD 
RISK
Physiological 
Factors (eg 
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Factors (eg 
emotional stress) 
Microbiological   
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            Genetic    
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Figure 4.1.1 Conceptual Model of Parkinson’s Disease Aetiology 
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etc, were also included in the study design as these may be important confounding 
variables or effect modifiers of some environmental factors. Consideration of genetic 
factors was limited to family history of certain neurological conditions. 
 
This study aimed to examine the contribution that particular environmental 
exposures of interest, identified in Chapter 2, as potential risk factors, may make to 
the aetiology of Parkinson’s disease with a case-control study. Two major limitations 
of the previous Australian studies were: (i) poor participant sampling methods and, 
(ii) the use of untested exposure assessment instruments. In particular, these two 
issues have been addressed in an attempt to produce an optimally-designed case-
control study to improve upon the existing Australian studies, so as to further inform 
the aetiology of PD in the Australian context. 
 
4.1 Research Questions 
 
What is the relationship between PD, and environmental and lifestyle exposures 
encountered in an Australian setting?  
 
4.2 Hypotheses 
A number of potential environmental, lifestyle and medical exposures in both the 
domestic and occupational settings were chosen based on the results of the literature 
review presented in Chapter 2 and the data analysis in Chapter 3. These are outlined 
below. The hypotheses have been expressed in their alternative form, rather than as 
‘null’ hypotheses. Each of the hypotheses are expressed in the direction of the expected 
relationship, however all calculations of statistical significance (and 95% confidence 
intervals) were based on two-tailed comparisons at the 5% type I error level. 
 
4.2.1 Environmental Exposures 
Environmental exposures were related to rural residency, farming, groundwater 
consumption, pesticides, solvents, and metals.  
 
Rural Residency 
Rural residency has not been consistently established as a risk factor for PD due to 
the substantial discordance amongst previous studies. The measurement quality of 
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this exposure may be a potential source of variation between studies. Geographical 
differences in the nature of rural residency may also be a source of variation; 
however, the two previous Australian case-control studies produced conflicting 
results for this variable (see Chapter 3). Examination of this exposure with improved 
measurement and more epidemiologically appropriate case and control groups may 
further elucidate its relationship to PD risk. The following hypotheses concerning the 
relationship between PD and residence in non-metropolitan areas were tested: 
 
Ever having resided? in a rural or remote area12 is associated with increased relative 
odds of PD compared to never having resided? in a rural area or remote area.  
 
Farm Exposures 
Exposures related to farming activities have also not been consistently established as 
risk factors for PD in the literature. Similar to rural residency, farming is a 
heterogeneous exposure likely to have geographical and type of farming variations in 
nature. The following hypotheses concerning the relationship between PD and 
farming were tested: 
 
Ever having resided? on a farm13 is associated with increased relative odds of PD 
compared to never having resided? on a farm. 
 
Ever having worked on a farm is associated with increased relative odds of PD 
compared to never having worked on a farm. 
 
Groundwater Consumption 
Consumption of water from a groundwater supply, such as from wells, springs or 
bores, has also not been consistently established as a risk factor for PD.  
Consumption of groundwater is more common in rural than metropolitan areas. The 
composition of groundwater may also be geographically heterogeneous. The 
following hypotheses concerning the relationship between PD and consumption of 
groundwater were tested: 
                                                 
? For at least a year or more 
12Rural area defined as  RRMA categories R1, R2 and R3; Remote area defined as RRMA categories 
REM1 and REM2 (see section 4.7.2 for more on this classification system) 
13 A place that raises crops or live-stock and sells them to earn money 
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Ever having resided? at a home with a private ground drinking water supply is 
associated with increased relative odds of PD compared to never having resided? at 
a home with a private ground drinking water supply. 
 
Longer average duration of living at a home with a private ground drinking water 
supply over a lifetime is associated with an incremental increase in relative odds of 
PD compared to shorter average duration of drinking water from a private ground 
supply. 
 
Pesticide Exposure 
Of the environmental exposures examined in previous case-control studies of PD risk 
factors, pesticides have been implicated most consistently. A meta-analysis of 
pesticide exposure and PD risk estimated a combined odds ratio of approximately 
two (Priyadarshi et al. 2000). There is also biological plausibility for such a 
relationship (described in Chapter 2). However, there is still substantial variation in 
effect size between results of existing studies, including the two previous Australian 
case-control studies. Pesticides are a heterogeneous group of chemicals and 
disagreement between studies may be due to lack of specificity concerning the types 
of pesticides the participants were exposed to. Exposure dose may also be an 
important factor, as suggested in Chapter 2, which has not been considered in many 
previous studies. Hobby gardening was also examined as hobby gardeners may have 
a greater opportunity for exposure to pesticides than those who don’t garden for a 
hobby. Exposure to pesticides in domestic and occupational settings was examined. 
Different classes of pesticides (herbicides14, insecticides15 and fungicides16) were 
examined in both of these settings. The following hypotheses concerning the 
relationship between PD and pesticide exposure were tested: 
 
Ever having been a hobby gardener17 is associated with increased relative odds of 
PD compared to never having been a hobby gardener. 
 
                                                 
14 A chemical used for killing weeds and other plants  
15 A chemical used for killing insect pests 
16 A chemical used for killing mould, mildew and other fungi 
17 Tending plants in pots or garden beds, not general lawn maintenance such as just mowing the lawn 
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Ever having used (mixed or applied) pesticides18 in the home garden is associated 
with increased relative odds of PD compared to never having used pesticides in the 
home garden. 
 
Ever having used (mixed or applied) pesticides in a workplace is associated with 
increased relative odds of PD compared to never having used pesticides in a 
workplace. 
 
Metal Exposure 
Exposure to potentially neurotoxic metals have not been examined extensively in the 
previous studies of PD aetiology. Similar to solvents, there is biological plausibility 
and epidemiological evidence to support exposure to metals as a risk factor for PD. 
The following hypotheses concerning the relationship between PD and exposure to 
metals were tested: 
 
Ever having come into contact with metal fumes or processing metals in a workplace 
with increased relative odds of PD compared to never having come into contact with 
metal fumes or processing metals in a workplace. 
 
Solvent Exposure 
Exposure to solvents has not been examined extensively in previous studies of PD 
risk. However, there is biological plausibility and epidemiological evidence to 
support a possible role in PD aetiology. The following hypotheses concerning the 
relationship between PD and exposure to solvents were tested: 
 
Ever having come into contact with solvents in a workplace with increased relative 
odds of PD compared to never having come into contact with solvents in a 
workplace. 
 
4.2.2 Lifestyle Exposures 
The lifestyle exposures of smoking, and consumption of coffee, tea and alcohol were 
included as these have been reported to be inversely associated with PD and may be 
                                                 
18 Herbicides, insecticides or fungicides 
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important confounders for the environmental exposures examined in the study. These 
lifestyle exposures may be associated with all environmental exposures examined as 
certain behaviours including smoking and alcohol consumption are more common 
amongst certain occupations and amongst rural dwellers. For example, smoking may 
be more common amongst ‘blue collar’ workers who are more likely to be exposed 
to pesticides, solvents and metals occupationally than ‘white collar’ workers (Jong et 
al. 2002; Siahpush et al. 2005).  
 
Tobacco and caffeine may also be effect modifiers as there is evidence to suggest a 
biologically plausible interaction between chemical exposures, nicotine and caffeine 
and PD risk. (see Section 2.9.1 Tobacco Smoking: Biological Explanation and 
Section 2.9.2 Coffee and Tea Consumption). Substances present in tobacco (e.g. 
nicotine) may have a central action that improves the health of dopaminergic 
systems. Nicotine has been found to reduce MPTP-induced dopaminergic toxicity in 
animal models of Parkinson's disease (Maggio et al. 1998). Similarly, caffeine, at 
doses in mice comparable to those of typical human exposure, dose-dependently 
reverses the loss of striatal dopamine triggered by MPTP (Chen et al. 2001a).  
 
The inverse relationship between PD and smoking is epidemiologically well-
established. Similarly, an inverse relationship between PD and coffee-consumption is 
generally accepted as being well-established. These exposures were included in this 
study due to their potential impact upon the environmental exposures of interest, but 
also as a barometer of the appropriateness of the control group selection procedures. 
The absence of these well-established relationships in the data may indicate over-
matching between the case and control groups.  
 
Inverse relationships between consumption of tea, and alcohol have not been 
established as consistently in previous studies. However, these exposures have not 
been examined as thoroughly as smoking, in relation to PD risk. The following 
hypotheses concerning the relationship between PD and smoking, coffee 
consumption, tea consumption, and alcohol consumption were tested: 
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Tobacco Smoking  
Ever having been a regular tobacco smoker19 is associated with decreased relative 
odds of PD compared to never having been a regular tobacco smoker. 
Exposure to passive smoking through having resided with a smoker or worked in a 
smoky workplace20 is associated with decreased relative odds of PD compared to 
never having resided with a smoker. 
Tobacco smoking modifies the effect of environmental exposures on PD risk. 
 
Consumption of Caffeine-Containing Beverages 
Ever having been a regular coffee or tea drinker21 is associated with decreased 
relative odds of PD compared to never having been a regular coffee drinker. 
Consumption of caffeine-containing beverages modifies the effect of environmental 
exposures on PD risk. 
 
Consumption of Alcohol-Containing Beverages 
Ever having been a regular alcohol drinker22 is associated with decreased relative 
odds of PD compared to never having been a regular alcohol drinker. 
 
4.2.3 Medical Exposures 
Head injury was also included as it has featured prominently in many previous 
studies and had a strong relationship to PD in the dataset analysed in Chapter 2. 
Family history of Parkinson’s disease was included as it has often found to be 
associated with increased odds of PD in case-control studies and may be an 
important effect modifier of the relationship of PD to environmental and lifestyle 
exposures due to genetic susceptibility. Genetic polymorphisms associated with 
decreased detoxification or increased activation of toxic exposures may be inherited 
(see Chapter 2, section 2.8.3). A family history of Alzheimer’s disease, Motor 
Neurone Disease, other tremor-related disorders and Trisomy 21 (Down’s syndrome) 
were included as these may have shared genetic susceptibility to PD. Genetic 
                                                 
19 Ever smoked as often as once or twice a week regularly for six months or more or daily, or nearly 
every day, regularly for a month or more 
20 A workplace in which there is a lot of tobacco smoke, such as a bar, club or casino 
21 Drank more than once a week for a year or more 
22 Drank at least one alcoholic beverage per week 
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susceptibility may be a risk factor on its own or an effect modifier of the relationship 
of PD to environmental and lifestyle exposures, if these genes are involved with 
detoxification or activation of toxins.  
 
Head Injury 
Ever having received a serious head injury in one’s lifetime is associated with 
increased relative odds of PD compared to never having received a serious head injury.  
Ever having played contact sports during one’s lifetime is associated with increased 
relative odds of PD compared to never having played contact sports.  
 
Family History 
Having a first or second degree relative with PD, Alzheimer’s disease, Motor 
Neurone Disease, a tremor-related disorder or Trisomy 21 (Down’s Syndrome) is 
associated with increased relative odds of PD compared to not having a first or 
second degree relative with PD. 
 
4.3 Study Design 
The planned research was an observational study utilizing a 1:1 matched case-control 
design. Cases and controls were matched on the parameters of age, gender and 
current residential suburb. Matching was necessary to minimise confounding as there 
is evidence of a relationship between these factors and Parkinson’s disease and also 
the exposures of interest. For example, women are less likely to develop Parkinson’s 
disease and also less likely to work in many industries such as building or boiler-
making; older participants have had longer opportunity for exposure. Age is likely to 
influence lifestyle exposures such as whether a participant ever drank coffee or 
smoked regularly. Residential suburb is associated with socioeconomic status, which 
is associated with occupation. 
 
4.4 Participants 
The selection and recruitment procedure for participants in the case-control study and 
the test-retest repeatability study (Chapter 5) are outlined in the following sections 
and Figure 4.4.1. References (a-g) within the diagram at key points are linked to the 
relevant description of the process in the following text.  
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Ineligible 
patients 
Case Non-
participants 
N=5 
Test-Retest 
Study cases 
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Listed on the 
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directory
Case Non-
participants 
N=27 
Not listed on the 
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not consult 
neurologists
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study clinic 
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patients N=230 
Test-Retest 
Study Controls 
N=42
Case-Control 
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sampling 
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N=219 + 69 
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participants 
N=68 + 27 
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N=15+1 
 Eligible for Test-
Retest Study 
N=40 
Indicates flow of people Indicates flow of process 
a 
b 
c 
c 
d 
e 
f 
g 
Figure 4.4.1: Participant Selection and Recruitment Flowchart 
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4.4.1 Target Population 
The target population is people with idiopathic PD and people at risk of developing 
idiopathic PD. The selection of an appropriate study population is critical if results 
are to be generalisable beyond the study’s participants. While case-control studies 
can be done without a fully enumerated base population, the closer a study 
population represents the population to whom the results will be extrapolated (the 
‘target’ population), the more valid the results (Tanner and Ross 2004). A number of 
barriers make the target population difficult to define and locate in the case of PD: 
 
1. Many cases are unaware that they have PD. PD has a long latency and preclinical 
period, resulting in many cases being unaware of their condition early in the 
disease process. As diagnosis is based purely on clinical judgement, with 
confirmation requiring post-mortem examination, an accurate diagnosis is not 
assured even with examination by a neurologist. The reliance on clinical 
judgement for diagnosis poses the problem of differences in clinicians’ opinions 
concerning the definition of PD and also misdiagnoses in the early stages of the 
disease when PD is difficult to distinguish from a number of other neurological 
conditions (see Chapter 1, section 1.3).   
 
2. There is no central register of diagnosed PD cases. As in all countries, PD is not a 
notifiable disease in Australia (Tanner and Ross 2004). While some registers have 
been initiated in other countries (e.g. the PD Registry managed by the Muhammad 
Ali Parkinson Research Centre and the Mayo Clinic Brain Bank Registry), these 
are voluntary and generally only involve patients attending particular neurology 
clinics, specialising in research of neurodegenerative diseases. As such, 
identifying diagnosed PD cases in the community is difficult. To make the 
situation even more difficult, not all people with PD consult a neurologist as part 
of their medical care, relying instead on general practitioner services (people with 
PD symptoms that are severe or difficult to control may also be more likely to 
consult a neurologist than those with mild symptoms that are responsive to 
standard PD medications). Thus, even a coordinated effort between all practicing 
neurologists in a geographical area to identify all PD cases would still omit those 
with undiagnosed PD and those relying on GP treatment only. The percentage of 
patients in a given area who consult neurologists is likely to be dependent upon 
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factors such as accessibility, which may be low for those in rural areas, and 
severity of disease.  
 
3. Parkinson’s disease has a low prevalence within the general community. There 
have been few studies of PD prevalence in the Australian population, however 
one study estimated the prevalence at 146-248 per 100,000 (Peters et al. 2006). 
Therefore obtaining sufficient cases for a case-control study from the general 
population would be a lengthy and expensive process due to the number of people 
who would need to be approached and examined.  
 
4.4.2 Sample Size 
Sample size calculations for the main case-control study were informed by the 
prevalence of exposures reported by control subjects in the dataset analysed in 
Chapter 3. Required sample sizes were calculated to detect 20%, 25% and 30% 
absolute differences between cases and controls with 90% power for the 
environmental exposures examined in that study (see Table 4.4.1). A 20-30% 
difference was chosen as a difference less than this was considered to be of little 
public health importance. Based on these figures, a total sample size of 260 (130 
cases and 130 controls) was sufficient to detect a 20% difference for all exposures 
examined in the dataset analysed in Chapter 3, assuming similar prevalence would be 
obtained in this study. However, a size of 150 per group, adding a 15% contingency, 
was chosen to allow for the confounding that was anticipated and the consequent 
need to consider multivariable modelling. As such, a total sample size of 300 (150 
cases and 150 controls) was aimed for in this study. This was also the upper limit of 
sample size logistically possible within the study timeframe and with the limited 
resources available for a PhD study. No information was available to estimate the 
correlation coefficient for exposure between matched cases and controls. Therefore, 
unmatched sample size calculations were performed to be conservative. 
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Table 4.4.1: Required sample size (per group) to detect 20%, 25% and 30% 
absolute differences in exposure between cases and controls at 90% power and 
5% significance (one-tailed) 
Exposure (prevalence in PA Hospital controls)  
Odds 
Ratio 
Total sample size 
(2n + 15%) 
Well-water drinking (prevalence in controls 24.4%) 
20% difference between cases and controls  2.47 274 
25% difference between cases and controls  3.02 182 
30% difference between cases and controls  3.70 128 
 
Head injury (prevalence in controls 2.6%) 
20% difference between cases and controls  10.94 134 
25% difference between cases and controls  14.28 100 
30% difference between cases and controls  18.12 78 
 
Pesticide exposure - any intensity (prevalence in controls 51.9%) 
20% difference between cases and controls  2.37 286 
25% difference between cases and controls  3.09 178 
30% difference between cases and controls  4.19 120 
 
Pesticide exposure - high intensity (prevalence in controls 6.6%) 
20% difference between cases and controls  5.13 168 
25% difference between cases and controls  6.54 120 
30% difference between cases and controls  8.17 92 
 
Farm Residency (prevalence in controls 38.4%) 
20% difference between cases and controls  2.25 302 
25% difference between cases and controls  2.78 194 
30% difference between cases and controls  3.47 134 
 
Rural Residency (prevalence in controls 70.9%) 
20% difference between cases and controls  4.10 188 
25% difference between cases and controls  9.6 108 
30% difference between cases and controls NA 66 
 
Exposure to pesticides through farming (prevalence in controls 23.3%) 
20% difference between cases and controls  2.51 270 
25% difference between cases and controls  3.08 180 
30% difference between cases and controls  3.76 128 
 
Farming occupation (prevalence in controls 6.2%) 
20% difference between cases and controls  41.64 166 
25% difference between cases and controls  55.21 118 
30% difference between cases and controls  70.74 90 
2n = number of cases and controls estimated in the sample size calculation; NA Not Applicable 
15% inflation factor applied to 2n as a contingency to allow for confounding 
 
4.4.3 Sampling Frame 
Both cases and controls were drawn from the population in the Australian Electoral 
Commission Federal Divisions of Blair, Bowman, Brisbane, Dickson, Fadden, 
Fairfax, Fisher, Forde, Griffith, Hinkler, Lilley, Longman, McPherson, Moncrieff, 
Moreton, Oxley, Petrie, Rankin, Ryan and Wide Bay, which encompasses a 
geographic area approximately from southeast Queensland up to the town of 
Bundaberg (.a.). Maps of these electorates are located in Appendix E. 
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4.4.3.1 Cases 
For the case-control study, a case series from a private neurology clinic was chosen 
as the sampling frame for cases (.b.). While this is not an ideal or ‘gold standard’ 
sampling frame (a random sample obtained directly from the general population 
would be preferable), there were a number of advantages. Firstly, all cases were 
examined by the same neurologist, who has specialised in PD, ensuring a higher 
diagnostic accuracy than if cases were sourced from different neurology clinics or 
from non-PD specialists. Standard research criteria were used to diagnose PD 
supplemented by long-term clinical observation. Potential for misdiagnoses during 
life, while a common problem for clinical research into any syndrome, is reduced by 
long-term follow-up which can produce high accuracy for clinical diagnosis, 
particularly by specialist clinicians (up to 98% accuracy) (Hughes et al. 2001). As the 
clinic specialises in treatment of PD, it was possible to obtain the required sample 
size of 150 patients from this one clinic. The use of one neurology clinic also 
allowed the study population to be defined better than if cases were recruited from 
numerous sources on a ‘convenience’ basis.  
 
The previous Australian case-control studies have relied upon convenience samples. 
A convenience sample is difficult to define with respect to its representation of those 
cases with more severe, unusual or difficult to treat symptoms, relationship to the 
entire PD population and what selection biases may be present. The limitations with 
a private neurologist’s cases series are easier to identify. Firstly, less affluent cases 
are likely to be under-represented at a private clinic. Secondly, there may be an over-
representation of patients with unusual symptoms, advanced disease or disease not 
responding to typical treatment regimens or GP treatment. The results obtained from 
a clinic-based case series would only be non-generalisable to the general population 
if there were aetiologically-relevant differences between cases who attend the clinic 
and cases who do not. Cases were restricted to those living in the general 
community, rather than in an institutional care facility, as those requiring this level of 
care were likely to have difficulty completing the data collection requirements.  
 
4.4.3.2 Controls 
Another limitation is the identification of an appropriate control group. The ideal 
control group would consist of people unaffected by PD who would attend the 
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selected neurologist’s clinic if they developed PD, as controls should be eligible to 
be cases if they were diagnosed with the disease of interest during recruitment 
(Rothman and Greenland 1998a). There are likely to be a number of factors involved 
in a person who develops PD being treated at a particular neurologist’s clinic. These 
may include residential location (access to clinic), referring GP (may also be related 
to residential location), reputation of the neurologist, interaction of the patient with 
other patients through social contacts including support groups, the individual 
personality of the patient, and affluence. 
 
While non-PD patients from the same clinic could be recruited as control 
participants, this would introduce problems involved with a control population also 
suffering a neurological condition. Such patients may be unrepresentative of the 
exposure distribution in the source population if any of the exposures involved in PD 
aetiology are also common to other neurological conditions (Rothman and Greenland 
1998a). In such a scenario, any effect on PD for these exposures would be 
unobservable due to the overmatching phenomenon. There is also potential for a 
lower response rate amongst an unhealthy population for a study not concerning their 
particular condition. Healthy partners of cases may represent a population free of 
disease and likely to be clinic-attendees. However, they are likely to be over-matched 
on exposures of interest to PD and mismatched on gender. Controls sought from 
cases’ neighbourhoods take into consideration both the geographic and 
socioeconomic factors that determine the use of a particular clinic (Olson et al. 
2000). Neighbourhood controls can be a convenient substitute for population-based 
sampling, even when the study is not population-based or the source population 
cannot be enumerated (Rothman and Greenland 1998a), as in this case. 
 
The Australian Electoral Commission was able to provide residential and postal 
addresses and gender of voters in 2-year age bands, which was an adequate level of 
precision for this study as finer age-matching (e.g. 1-year age bands) would be 
unlikely to affect the results and would reduce the number of potential controls 
available. As voting enrolment is compulsory for Australian adults, and older 
populations are generally more stable in their current residence than younger 
populations, the electoral roll is a good source of community-based controls for PD 
cases. While matching on residential suburb may result in over-matching on 
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particular environmental exposures, this risk is reduced in the case of PD as past 
exposures are of interest rather than present exposures. The Australian 
Commonwealth Electoral roll was used as the source of controls for the study. 
Controls were required to be listed in the Telstra Whitepages Telephone Directory, to 
facilitate a follow-up phone call as part of the recruitment process. Therefore, 
potential cases also needed to be listed in the Whitepages directory to be eligible for 
recruitment and represent the same theoretical population catchment (.c.).  
 
4.4.4 Eligibility Criteria for Cases 
Potential cases (.d.) in the study fulfilled the following criteria: 
• Consulted the study neurologist between October 2003 and October 2004 and 
diagnosed with idiopathic PD (determined clinically by the study 
neurologist), without dementia; 
• Living in the general community (i.e. not in residential care); 
• Physically and mentally capable of completing the risk factor questionnaire in 
a personal interview;  
• Currently listed in the Commonwealth Electoral Roll and the Telstra 
Whitepages Telephone Directory (online); and 
• Resided within the study area (Electorates of Blair, Bowman, Brisbane, 
Dickson, Fadden, Fairfax, Fisher, Forde, Griffith, Hinkler, Lilley, Longman, 
McPherson, Moncrieff, Moreton, Oxley, Petrie, Rankin, Ryan and Wide Bay; 
See Appendix E for maps of study electorates). 
 
4.4.5 Eligibility Criteria for Controls 
Potential controls (.f..) in the study fulfilled the following criteria: 
• Screened negative for parkinsonism (Chan et al. 2000) and not previously 
diagnosed with idiopathic PD or other PD-like condition (e.g. Parkinson-plus 
syndromes) as determined by self-report; 
• Listed on the Commonwealth Electoral Roll and the Telstra Whitepages 
Telephone Directory (online) between October 2003 and October 2004; 
• Living in the general community (i.e. not residing in a residential care facility); 
• Physically and mentally capable of completing the risk factor questionnaire in 
a personal interview; and 
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• Of the same age (+/- 2 years) and sex as their allocated case participant in the 
study. 
 
4.4.6 Matching Procedure 
For each eligible case participant successfully recruited, a potential control 
participant was selected by random sampling from all enrolled voters in the 
Commonwealth Electoral Roll of the same sex, 2-year age band and residential 
suburb as the case participant. The selected voter’s name was then checked in the 
Telstra Whitepages Telephone Directory (online). If the electoral roll surname and 
street address of the voter matched an entry in the Whitepages Directory, the voter 
was sampled as a potential control (.g.).  
 
4.4.7 Recruitment 
Letters of invitation to participate in the research study with information about the 
research were sent to potential case participants from their treating neurologist. It 
was noted that participation would be confirmed with a telephone call two weeks 
after they received the letter. The letter also invited participants to contact the clinic 
receptionist, or a member of the research team (the candidate) directly if they did not 
wish to receive the follow-up telephone call. Potential participants residing in the 
Brisbane area were offered the opportunity to be interviewed either at the private 
Neurology clinic, the Princess Alexandra Hospital, or at another venue of their 
choosing, such as their own home or workplace. Regional potential participants were 
offered the opportunity, depending on their travel plans, to be interviewed either at 
the private Neurology clinic, the Princess Alexandra Hospital, a particular retirement 
village in Bundaberg, or at another venue of their choosing, such as their own home 
or workplace. Potential case participants were classified into residential zones and 
were recruited in groups according to the zone in which they resided. This procedure 
was chosen for economy as the interviewer would be able to reduce travel time for 
in-home interviews by organising interviews within the same geographical area on 
the same or consecutive days, thus reducing travel between interviews.  
 
Letters were posted in batches of approximately twenty to enable data collection to 
be performed close to the time of recruitment, typically within two weeks of 
confirming participation. Control participants were similarly recruited in groups 
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alternating with each group of case participants recruited. For each case participant 
successfully recruited, a control participant was selected by simple random sampling 
from the Australian Commonwealth Electoral Roll of the same sex, age (within 2 
years) and residing in the same suburb as the case participant. A letter of invitation 
was sent from the candidate and supervisors followed by a telephone call, in a similar 
protocol to that used for case participants. The follow-up telephone calls were made 
over a maximum of three weeks on different days of the week and different times of 
the day. If no telephone contact was able to be made in this timeframe, the control 
was marked ‘uncontactable’ and a new potential control was selected. The 
recruitment procedure was repeated until a suitable control participant was recruited 
up to a maximum of five potential controls for an individual case.  
 
This type of rolling recruitment resulted in most of the matched controls being 
interviewed close to the time of their corresponding case. An advantage of this is that 
should the interviewing techniques have changed throughout the course of the study, 
due to the interviewers gaining experience or becoming fatigued, they would be 
similar for each matched case and control pair as the interviews were conducted at a 
similar point in the study timeline.  
 
4.5. Study Instrument  
Many of the questions for the study questionnaire (Appendix F) were drawn from 
previously used questionnaires. 
 
1. Australian Census Questionnaire 2001 (Australian Electoral Commission). The 
Census of Population and Housing is a statistical collection that aims to accurately 
measure the number of persons in Australia on Census Night, their key 
characteristics, and the dwellings in which they live. It is the largest statistical 
operation undertaken by the Australian Bureau of Statistics (ABS). The Census 
questionnaire’s standard questions about demography, ethnicity and employment 
were included in the questionnaire developed for the current study (Questions 1-
3(b); 14). 
 
2. Farming Pesticide Exposure and Breast Cancer in North Carolina by Duell (1999). 
This structured interviewer-delivered questionnaire measured exposure to 
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pesticides and farming via self-report. The agreement estimates obtained in the 
assessment of reproducibility are similar to those for other types of exposure 
information typically collected in epidemiologic studies (Duell et al. 2001). A 
farm-by-farm method of exposure assessment was found to be preferable to an 
ever/never determination in this study. Therefore, this approach was adopted for 
the current study’s questionnaire. (Questions 4b-4f; 6;16) 
 
3. Parkinson’s Disease Risk Factor Questionnaire by Nelson et al. (2000). This 
structured interviewer-delivered questionnaire was used in a large case-control 
study involving 496 PD cases and 541 age- and sex-matched population controls. 
Cases and controls were recruited from the Kaiser Permanente Medical Care 
Program in Northern California between the years 1994 and 1995 (Question 15; 
27; 28).  
 
4. Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA-OZ) (1993). 
The Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA) is an 
instrument designed to assess physical, psychological and social manifestations of 
alcoholism and related disorders. It is a semi- structured interview which 
capitalises on prior research in psychiatric epidemiology. As such, it relies heavily 
on items previously validated by other research interviews, including DIS (Robins 
et al. 1981), CIDI (Wittchen 1994), HELPER (Coryell et al. 1978), SAM (Cottler 
et al. 1989), SADS (Endicott and Spitzer 1978) and SCID (Spitzer et al. 1992). 
The SSAGA has been shown to be a highly reliable and valid instrument 
(Hesselbrock et al. 1999). The SSAGA-OZ is an Australian adaptation of the 
SSAGA. The questions drawn from the SSAGA-OZ for the current questionnaire 
related to smoking behaviour (Question 29). 
 
During the development of the questionnaire, a timeline method was initially 
considered in which all residences, occupations, and environmental and lifestyle 
exposures would be plotted on a timeline of the participant’s life along with dates of 
life events of personal importance to the individual (e.g. marriage, birth of child), 
similar to the Life Grid method discussed by Blane (1996). However, the method 
was not employed for the final questionnaire as it was considered too time-
consuming and burdensome for the participants.  
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As discussed in Chapter 1, the potential for recall bias is considered a major 
disadvantage of case-control studies. To attempt to assess this, the questionnaire 
included two “dummy” variables (exposure to asbestos and electromagnetic 
radiation), which have no known or likely association with PD or other suspected 
risk factors for PD, but are generally viewed as being “toxic” and/or associated with 
chronic diseases. These variables were included to provide an indication of ‘response 
bias’ in the measurement of environmental exposures with the instrument. One 
previous study (Ohlson and Hogstedt 1981) was identified that included exposure 
questions without relevance to the study to check for “suggestion effects”, however 
the authors omit to report on the results of these questions, or what the ‘irrelevant’ 
exposures were. The “dummy” variables for the current questionnaire were chosen 
by the candidate, who also wrote all the questions for assessment of these variables.  
 
4.5.1. Face Validity 
Associate Professor Lorene Nelson of Stanford University’s School of Medicine 
qualitatively reviewed the questionnaire. Associate Professor Nelson’s research 
interest includes the epidemiology of neurodegenerative disorders, including 
Parkinson's disease, amyotrophic lateral sclerosis and multiple sclerosis, with 
particular interest in certain gene polymorphisms and environmental toxicants as 
they contribute to the risk of these disorders. Associate Professor Nelson has 
published widely in the field of neuroepidemiology and edited the text 
Neuroepidemiology: From Principles to Practice (Nelson et al. 2004).  
 
Other validity assessment was not possible for the exposures assessed in the 
questionnaire as no gold standards existed.  
 
4.5.2 Pilot 
The questionnaire was tested on a convenience sample of ten PD patients and five 
controls for its comprehensibility. Patients in a non-metropolitan area (Bundaberg) 
and Brisbane participated in the questionnaire trial. Some adjustments were made to 
the wording of the questions after the trial. The pre-test was to determine the 
acceptability of the questions to participants, and if participants were able to provide 
an answer for the questions. The pilot testing also allowed observation of the 
participants’ response to the “dummy” variables, which appeared to be accepted by 
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the participants as ‘legitimate’ exposures to include in the research as none of the 
participants queried their relevance to PD. The completed pilot questionnaires were 
also used to develop and test the data coding scheme, the data storage database and 
data entry. 
 
4.5.3 Test-Retest Repeatability  
The developed questionnaire was assessed for test-retest repeatability prior to use in 
the case control study. Full details of the test-retest repeatability study are presented 
in Chapter 5. 
 
4.6 Data Collection  
4.6.1 Interviews 
Two interviewers, the candidate and an associate supervisor (GM), performed all 
interviews for the study. Three hundred (300) of the 314 interviews (95.5%) in the 
main case-control study were performed by the candidate. Whoever interviewed a 
particular case participant would also interview the corresponding control to 
maximise consistency of interviews for each matched pair. The majority of 
interviews (90%) were conducted in the participant’s home (Appendix G), with only 
5% conducted at the PA Hospital and 5% at participants’ workplaces. Refreshments 
(tea or coffee) were often offered by the participants during home interviews; the 
interviewer accepted, to help the participant to relax and enjoy the interview. 
Interviews typically took between one and one and a half hours. The shortest 
interview took only 45 minutes, while the longest took approximately 3 hours. Most 
of the interviews (75.5%) were conducted with just the participant and interviewer 
present. When another person was present during the interview, typically a spouse, 
and offered information, only the participant’s responses were recorded. This 
protocol was enforced to achieve more consistency between participants with and 
without a support person present. While the presence of another person may have 
influenced some responses of participants, it was decided that the advantage of 
having the participant feeling relaxed and comfortable about their participation 
outweighed this potential disadvantage. Insisting that partners be excluded from the 
interview room would have led to some discomfort for some participants. Typically, 
four interviews were completed each day (two in the morning and two in the 
afternoon). Occasionally another two interviews were performed in the evening, and 
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sometimes fewer interviews were performed when there were no participants 
available for the vacant timeslots. This schedule generally allowed sufficient time for 
the interview and travel between interview locations. A mobile phone was taken to 
each interview to allow the interviewer to contact the participants for directions etc, 
and also for safety during the interviews. An identifying code was entered on the 
questionnaire during the interview, rather than the participant’s name, for reasons of 
confidentiality. 
 
4.6.2 Non-Participants 
Potential case and control participants who declined to participate in the in-person 
interview were asked if they would mind answering a few questions on the phone 
about smoking habit, occupations, exposure to certain substances, whether they knew 
anyone with PD and screening questions for parkinsonism (Appendix H). The 
purpose was to collect key information with which to compare participants and non-
participants for systematic differences to inform interpretations about 
generalisability. An identifying code was entered on the questionnaire rather than the 
participant’s name, for confidentiality. 
 
4.7 Data Management 
4.7.1 Recruitment 
Details of the recruitment process including participant ID codes; dates letters were 
posted; dates and times of phone calls; outcomes of phone calls; and dates, times and 
locations of interviews were recorded in a Microsoft Access 2000 database. This 
database was maintained separately from the questionnaire data for the purpose of 
tracking participants during fieldwork. 
 
4.7.2 Data Coding, Entry and Cleaning 
The Rural, Remote and Metropolitan Areas (RRMA) classification system was used 
to classify the residential history data into levels of rurality. The RRMA 
classification was developed in 1994 by the Department of Primary Industries and 
Energy (DPIE) and the then Department of Human Services and Health (DHSH) 
(1994). It is used as the framework by which various data sources can be analysed 
for metropolitan, rural and remote zones. The classification is based on Statistical 
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Local Areas23 (SLA) and allocates each SLA in Australia to a category based 
primarily on population numbers and an index of remoteness (DPIE & DHSH 1994). 
The seven categories that form the classification are listed in Table 4.7.1 (Australian 
Institute of Health and Welfare 2004). 
 
Table 4.7.1 Structure of the Rural, Remote and Metropolitan (RRMA) 
Classifications 
Zone Classification Category 
Metropolitan M1 Capital Cities 
 M2 Other metropolitan centres (urban centre population > 
100,000) 
 
Rural R3 Large rural centres with population 25,000 - 99,000 
 R4 Small rural centres with population 10,000 - 24,999 
 R5 Other rural areas with population < 10,000 
 
Remote REM6 Remote centres with population > 5,000 
 REM7 Other remote areas with population < 5,000 
 
All towns and localities were located in Appendix II Statistical Local Areas by State 
by RRMA (Strong et al. 1998) by the candidate and assigned their relevant RRMA 
code24. If a town name was not listed in the index, ABS documents and where 
necessary, local government internet websites, were searched to identify and confirm 
the name of the appropriate SLA. A major limitation of this approach is that the 
RRMA classifications listed in the index are based on 1991 population figures. These 
1991 figures may not correctly reflect the rurality of the residential location at the 
time the participant lived there. However, this potential error would be consistent 
across case and control participants. While there may be some movement over time 
of locations between categories, the majority of locations in Australia would not be 
expected to have changed sufficiently to move between categories at the broadest 
level of classification (Metropolitan, Rural and Remote). 
 
The questionnaire responses were then entered into a Microsoft Access 2000 
database. The majority of questionnaires were entered by a research assistant (JB), 
the remainder by the candidate. A random sample of twenty percent (20%) of the 
                                                 
23 The SLA ‘is the base spatial unit used by the Australian Bureau of Statistics (ABS) to collect and 
disseminate statistics other than those collected in Population Censuses’ 
24 Initially the residential history data for all towns and localities listed by the participants were 
assigned an RRMA classification by the participant, who was shown the list of available codes with 
corresponding descriptions. However, this method was found to have low test-retest repeatability 
(Chapter5). Therefore, the procedure was changed. 
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questionnaires that were entered by JB were re-entered by the candidate to check for 
accuracy in data entry. Discrepancies in data entry were only found in one section of 
the questionnaire that covered coffee, tea and alcohol consumption. The discrepancy 
indicated that a proportion of the data had been entered into the wrong fields of the 
database. This section of the questionnaire was re-entered by the candidate for all 
questionnaires. Outliers (i.e. values that lay outside the normal range of values of 
other subjects) were checked by inspecting frequency distributions of the continuous 
variables and the lowest and highest values. Consistency checks were performed by 
checking that there were no answers within each individual’s questionnaire that were 
contradictory to each other across questions. For example, participants were asked in 
the background information section of the questionnaire how many children they 
had, and in the family history section they were asked how many sons and how many 
daughters they had. For each residence, in the residential history section of the 
questionnaire, participants were asked to nominate if the residence had been a farm 
and if so, if they had worked on a farm. In another section, the participants were 
asked if they had ever worked on a farm.  
 
4.8 Data Analysis 
4.8.1 Composite Variables 
Some variables required a derived variable to be calculated from the data before 
analysis. For residential history data, the number of years spent residing at each 
residence was calculated by subtracting the age the participant arrived at the 
residence from the age the participant left the residence. This figure was then 
assigned to a column corresponding to the appropriate RRMA category for the 
residence. The total number of years spent in each of the seven RRMA 
classifications was calculated by summing the number of years for each RRMA 
column for each participant. These in turn were collapsed into years spent in 
metropolitan (RRMA codes M1 and M2), rural (RRMA codes R3, R4 and R5) and 
remote areas (RRMA codes REM6 and REM7). As what level of detail would be 
meaningful and viable, with respect to the number of exposed participants, was not 
known prior to analysis, the data were initially examined at a high level of detail and 
then in less detailed categories, as required/appropriate. 
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4.8.2 Bivariate Associations 
The relationship between the independent variables (exposures) and the dependent 
variable (PD status) was estimated with the odds ratio, as an approximation for 
relative risk. Odds ratios approximate relative risk estimates in case-control studies 
when the disease of interest is rare in the population (Greenland and Thomas 1982). 
To account for the individual matching on age, sex and current residential suburb in 
the study design, odds ratios were calculated with conditional logistic regression for 
matched sets in SAS version 8/Enterprise Guide version 1 (Vierkant et al. 1999).  
 
4.8.2.1 Relationship between Explanatory Variables 
The relationship between explanatory variables was explored by constructing cross 
tabulations of the independent variables that were likely to be highly correlated. 
When independent variables were found to be highly correlated, they were not 
included together in the same regression model to avoid multicollinearity25. 
 
These potential relationships were:  
• Non-metropolitan residency and farm residency 
• Non-metropolitan and farm work 
• Non-metropolitan residency and occupational pesticide use 
• Farm work and farm residency 
• Farm residency and occupational pesticide use 
• Farm work and occupational pesticide use 
• Rural residency and groundwater consumption 
• Hobby gardening and domestic pesticide use 
• Tobacco smoking and coffee consumption 
• Tobacco smoking and alcohol consumption 
• Coffee consumption and tea consumption 
 
4.8.2.2 Effect Modification 
Effect modification was explored by analysing explanatory variables and PD 
stratified by the potential effect-modifiers. Only explanatory variables that might be 
                                                 
25 Multicollinearity occurs when a regressor (an explanatory variable in the regression model) is 
nearly a linear combination of other regressors in the model. In this situation, the affected estimates 
are unstable and have high standard errors. 
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directly associated with chemical exposures were examined (e.g. pesticides, metals 
and solvents). Potential effect modifiers in the dataset were: 
• Tobacco smoking 
• Coffee consumption 
• Family history of PD 
 
However, there was an insufficient number of participants with a family history of 
PD for meaningful examination of this potential effect modifier. While gender and 
age are likely to be potential confounders for the relationship between many 
environmental exposures and PD, these variables were controlled in the study 
through the matching process employed during participant selection and recruitment. 
 
4.8.3 Multivariable Modelling 
The exposures of interest were considered in a multivariable logistic regression 
model (conditional for matched sets according to the same procedure undertaken for 
the bivariate associations) to determine their independent influences on Parkinson’s 
disease. As there was a large number of exposures examined in the study, the 
statistical model was not able to examine all exposures in the one model with 
sufficient degrees of freedom. A number of key variables were identified based on 
their clinical significance (identified in Chapter 1) and in the results of the bivariate 
analyses. These key variables were coffee (average cups per day), alcohol (average 
drinks per day), tea (regular drinking), tobacco smoking (packyears), family history 
of PD and hobby gardening. While hobby gardening has not been identified as an 
important exposure in the existing literature, it was an important variable in this 
dataset due to its strong association with PD. A base model was constructed of the 
key exposures. Exposures of interest were then examined by adding them to this base 
model to adjust for potential confounding from these key variables (coffee, alcohol, 
tea, tobacco smoking, family history of PD and hobby gardening).  
 
4.8.4 Adjustment for Multiple Comparisons 
As the current study examined a number of individual hypotheses (and many sub-
analyses), the issue of multiple comparisons and the potential for ‘false positive’ 
results must be addressed. A study that examines a large number of individual 
hypotheses has a greater probability of generating some false-positive results due to 
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random error than a study with only a single hypothesis. If all individual null 
hypotheses are true, then the probability that at least one of them will be found 
statistically significant is 1-(1-alpha)n, where n is the number of hypotheses tested 
(Bland and Altman 1995). The inappropriate reporting of statistically significant 
results from studies with a large number of comparisons in the absence of supporting 
evidence, known as ‘data dredging’, should be avoided (Mills 1993).  However, for 
many complex diseases there are legitimate reasons to examine multiple exposures. 
The disease may have a multifactorial aetiology or there may be little known about 
likely risk factors, in which case a ‘hypothesis generating’ study could be 
appropriate. 
 
There has been a vigorous debate as to the most appropriate approach to dealing with 
this issue (Rothman 1990; Savitz and Olshan 1995; Manor and Peritz 1997; 
Goodman 1998; Thompson 1998). Some have suggested that formal adjustment of 
tests of statistical significance, such as Bonferroni adjustment, are necessary (Bland 
and Altman 1995). However, this method is considered inappropriate by many 
epidemiologists, particularly for testing of a priori hypotheses based on previous 
evidence (Rothman 1990; Greenland and Rothman 1998; Perneger 1998). Whilst the 
current study examined a large number of independent variables for their relationship 
to PD, these relationships were selected a priori based on previous literature, rather 
than random observations. Therefore, multiple comparison adjustment was not 
performed. 
 
The issue of multiple comparisons would be a problem for this study if the null 
hypothesis being tested was very broad, such as “PD is associated with any 
environmental exposure”, rather than addressing each specific exposure separately. 
The strategy followed in this thesis was to present the results of all single-inference 
procedures performed rather than just the positive or statistically significant results. 
This approach allows assessment of the percentage of positive findings among the 
total number of analyses performed and comparison with the other existing evidence, 
such as the results of previous epidemiological or toxicological investigations and 
biological plausibility (Savitz and Olshan 1995; Rothman and Greenland 1998d).  
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The quality of the study (design, participant sampling and recruitment, exposure 
measurement, and appropriate statistical analysis including adjustment for 
confounders) and the strength of the existing evidence for the relationship (previous 
studies and biological plausibility) are of far greater value in assessing whether the 
result may be a false positive due to random error than the number of different 
hypotheses examined in the study (Savitz and Olshan 1995). Replication of 
epidemiological studies is extremely valuable in this respect as a false positive result 
due to random error for a particular exposure is unlikely to be replicated in multiple 
studies. 
 
4.9 Reporting of Results 
The Neyman-Pearson form of hypothesis testing is based on rejection of the null 
hypothesis at the arbitrary point of α=0.05 by convention. Whilst use of this form of 
hypothesis testing has become ingrained in the scientific literature (Rothman and 
Greenland, 1998d), there is substantial debate about the appropriateness of strict 
adherence to this principle for epidemiological research (Goodman and Royall 1988; 
Greenland 1990; Goodman 1993).  
 
The emphasis in the reporting of the results of this research was on the practical 
significance of the result and the observed magnitude of the effect. Statistical 
significance, indirectly, in the form of 95% confidence limits of the true value, was 
reported to give an indication of the (im)precision of the effect estimates. Results of 
interest were reported if they were equivalent to approximately twofold or higher 
increased odds of PD or half-fold or lower as equivalent. Where the result did not 
attain statistical significance, the result was treated as tentative but worthy of 
reporting. Results were described as ‘unstable’ if low numbers of exposed 
participants resulted in very wide (uninformatively so) 95% confidence intervals. 
 
4.10 Ethics, Health and Safety 
Ethical approval was granted for this case-control study by the QUT University 
Human Research Ethics Committee (QUT Ref No 2510H). The ethical approval 
covered: 
• Recruitment of cases from the chosen Neurology clinic and controls from the 
Commonwealth Electoral Roll; 
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• Collection of data with the developed questionnaire in an interview; 
• Access to medical records about patients participating in the study (with 
patients’ written consent) to confirm date of diagnosis and presenting 
symptom(s). 
 
Correspondence confirming the aforementioned Human Research Ethics Committee 
approvals and access to the Commonwealth Electoral Roll are located in Appendix I. 
Relevant health and safety issues were discussed with the School of Public Health 
Workplace Health and Safety Officer, and health and safety approval for the project 
was granted.  
 
Prior to conducting each interview, the participant was required to read an 
information package about the research which included details of how to contact the 
QUT Human Research Ethics Committee if they had concerns, and to sign a consent 
form indicating that they had read and understood the information provided and were 
a willing participant in the research project (Appendix I). The interviewer also 
offered to read the information package to participants who had difficulty reading, 
such as due to vision-impairment. A copy of the information package was left with 
each participant. 
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5.0 Test-Retest Repeatability of a New Interviewer-Delivered Risk Factor 
Questionnaire26 
 
5.1 Introduction 
The quality of exposure measurement will largely determine the validity of an 
environmental epidemiology study (Hertz-Picciotto 1998). As discussed in Chapter 2 
(Section 2.12.2.3) exposure assessment relying on participant recall may be 
particularly problematic for people with PD. Given the potential for poor data quality 
to influence the results of epidemiological research, and the high opportunity for 
error in these data, particularly in the context of PD, surprisingly few 
epidemiological studies appear to have adequately addressed the issue of data quality.  
 
Validation of self-reported exposures against metabolites in biological specimens or 
field monitoring is desirable as a criterion standard. However, these methods are 
generally impractical in PD research due to the time lag between exposures of 
interest, disease diagnosis, and recruitment into case-control studies. In the absence 
of an objective and validated alternative for exposure measurement, the assessment 
of questionnaire data quality is confined to assessment of repeatability.  
 
Published studies on the repeatability of exposure data in the context of PD are 
extremely limited. Only two published test-retest repeatability studies of risk factor 
questionnaires for aetiological studies of PD were identified (Butterfield et al. 1995; 
Reider and Hubble 2000). Both of these surveys obtained information on 
demographics, medical history, places of residence, and occupations. Butterfield et 
al.’s (1995) study recruited only 11 participants of unknown case status. Seven of the 
participants completed the repeat questionnaire, which was mailed only 2 weeks after 
the first questionnaire was completed. Two weeks is a short time between the initial 
and repeat measurements as participants may be able to remember what they stated at 
the initial measurement rather than answering the questions again in a similar way 
they did at the initial measurement time. Another limitation of this study was the use 
of an abridged questionnaire in the repeatability study, rather than the full 
questionnaire that was to be used in the case-control study. Therefore, only those 
                                                 
26 A version of this chapter has been published (Gartner et al. 2005). 
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questions included in the abridged version of the questionnaire were tested. Using a 
different format may also have elicited different responses from the participants. 
While the authors’ report high kappa statistics for many variables, they do not 
mention which variables these relate to and do not report the numbers of exposed 
individuals in their sample for these variables. A sample size of only seven is 
unlikely to be sufficient to establish repeatability for many exposures that have low 
prevalence in the general community. The study by Reider and Hubble (2000) 
examined the repeatability of a questionnaire which obtained information on 
demographics, medical history, places of residence, and occupations. This study 
involved 22 subjects (11 pairs of twins discordant for PD), although only 20 
completed the self-administered retest (Reider and Hubble 2000). This study also had 
a short time of 4 weeks between completion of the initial and follow-up 
questionnaire and the authors’ also do not report the number of exposed individuals 
in the sample.  
 
While some previous studies have mentioned the inclusion of a retest to assess the 
repeatability of measures (Tanner et al. 1988; Golbe et al. 1990; Hertzman et al. 
1990; Koller et al. 1990; Hubble et al. 1993a; Marder et al. 1998), most involved a 
small number of participants and many do not report the results. Tanner et al. (1988) 
report a test-retest repeatability of 0.88 for recall of dates of exposures and 0.75 for 
recall of environmental conditions for their instrument used in a case-control study in 
China, however these figures are based on only 12 participants (7 people with PD 
and 5 controls) and the authors do not specify if the figures relate to crude 
agreement, kappas, intraclass correlations or Pearson correlation coefficients. 
Although Golbe et al. (1990) collected data on a range of exposures, including 
pesticides, rural living and use of well water, they only performed a test-retest 
repeatability study on the dietary component of the questionnaire with 24 
participants. They reported kappa values between 0.23 and 0.82 with good agreement 
reported for only two of the 31 items tested and poor agreement for nearly half of the 
items. Hertzman et al. (1990) conducted a “repeatability check” 1 month after return 
of their self-administered questionnaires. While the check included the entire 57 
cases involved in the study and 24 of the controls, it was limited to re-asking them 6 
questions “selected from the questionnaire”. The authors omit to report the type of 
questions that were re-asked, whether the same 6 questions were re-asked of all these 
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subjects and the degree of consistency between the questionnaire results and the re-
asked questions. Hubble et al. (1993a) checked the repeatability of their self-
administered questionnaire with a follow-up phone call to 14 of the subjects. Again, 
the authors omit to report on the results of this repeatability check. Marder et al. 
(1998) and Koller et al. (1990) “established” repeatability in a subsample of 20 of 89 
cases and 20 of 150 cases respectively, however again, no specific results for the 
repeatability assessment are reported for either study. 
 
Nearly every case-control study that has examined the role of environmental 
exposures in the aetiology of PD has employed its own exposure measurement 
instrument and unique definitions of “exposure”. This is likely due to lack of co-
ordination between research teams. Differences in study populations, designs and 
procedures are important sources of variation in results. However, differences in 
exposure definition and measurement between the studies, of apparently similar 
exposures may also be an important contributor to variation in their subsequent 
results. This is potentially a large source of variation and may explain some of the 
conflicting results between existing environmental epidemiology studies of PD. In an 
effort to understand whether different exposure measurement instruments are a 
significant source of variation in results, participants were administered two exposure 
measurement questionnaires. The responses obtained from the two instruments were 
then compared.  
 
5.2 Objectives 
The test-retest repeatability study aimed to establish the test-retest repeatability of the 
exposure assessment instrument to be used in the case-control study. 
 
5.3 Methods 
5.3.1 Participant Recruitment 
Case and control participants were selected and recruited according to the methods 
described in Chapter 4 and outlined in Figure 4.4.1. A subset of cases from the entire 
series of cases eligible for participation in the case-control study (eligibility criteria 
are described in Chapter 4) were selected as potential participants in the test-retest 
repeatability study based on their prior involvement in a study of environmental and 
genetic risk factors for PD (analysed and discussed in Chapter 3) and residence 
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within the greater Brisbane area (Scarborough to Redcliffe) to allow easier access for 
retesting. Matched controls were recruited according to the procedure described in 
Chapter 4. 
 
5.3.2 Data Collection 
The structured questionnaire was delivered to participants in personal interviews as 
described in Chapter 4. Two interviewers, the candidate and an associate supervisor 
(GM), performed all interviews for the study. Sixty-two of the 77 (80.5%) interviews 
in the repeatability study were performed by the candidate. Whoever interviewed a 
particular case participant would also interview the corresponding control to 
maximise consistency of interviews for each matched pair. The same interviewer 
completed the initial and repeat interviews for each participant. Repeat interviews 
with the interviewer-delivered questionnaire were completed at least 6 weeks after 
initial interviews (See Table 5.5.1).  
 
5.3.3 Data Analysis 
To determine the test-retest repeatability of the questionnaire, the proportion in exact 
agreement to a range of questions was calculated. For categorical variables, percent 
agreement and Cohen’s kappa coefficient (a measure of agreement beyond chance) 
was calculated (Cohen 1960). A weighted kappa was calculated for the ordinal 
variable, smoking using Cicchetti–Allison weights (Cicchetti and Allison 1971). This 
variable had five levels of exposure, and a weighted kappa was appropriate as 
selection of a different exposure level on the repeat interview would indicate only 
partial disagreement with the initial interview response. Cicchetti–Allison weights 
gradually reduce the amount of agreement registered the more categories away the 
repeat interview response is from the response given in the initial interview. For 
continuous variables, intraclass correlation coefficients (ICC) (Bartko 1966), the 
mean of the differences between responses on the initial and repeat interviews and 
the ‘limits of agreement’ were calculated (Bland and Altman 1986). Qualitative 
interpretation of kappa and ICC values were taken as ‘high repeatability’ for values 
in the range 0.75–1.00, ‘fair to moderate repeatability’ for 0.40–0.74 and ‘low 
repeatability’ for <0.40 (Fleiss 1981). Repeatability statistics were calculated in 
Microsoft Excel 2000 (ICC and Bland-Altman method), and SAS version 
8/Enterprise Guide version 1 (kappa and weighted kappa).  
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5.4 Results 
5.4.1 Cases 
Forty (40) potentially eligible PD cases were identified. Letters of invitation to 
participate in the current study were posted to all of these individuals. Two letters 
were returned stamped ‘Not known at this address’. One declined to participate due 
to illness and two refused to participate without stating a reason. Thus, there was a 
sample of thirty-five (35) recruited PD cases.  
 
Representativeness of Cases 
A comparison of the cases in the test-retest repeatability study to the remainder of the 
case series who participated in the main study confirmed they were similar in age, 
sex distribution, education, country of birth and several exposure variables examined 
(Table 5.4.1).  
 
Table 5.4.1 Comparison of Test-Retest Cases to Case-Control Cases 
 Test-Retest Study 
Cases  
Case-Control Study 
Cases 
N 35 163 
Age Mean (s.d.) 
       Range 
65.5 (8.1) 
51-81 
67.3 (9.2) 
40-89 
Gender  n (%) Males 21 (60%) 103 (63.2%) 
                        Females 14 (40%) 60 (36.8%) 
Country of Birth n (%)   
         Australia 30 (85.7) 138 (84.7%) 
         Other 5 (14.3) 25 (15.3%) 
Education n (%)   
       Did not complete high school 23 (65.7) 106 (65) 
       Completed high school 12 (34.3) 57 (35) 
       Completed tertiary education 23 (65.7) 105 (64.4) 
Married/De Facto 26 (74.3%) 136 (83.4) 
Exposure Variables n (%)   
Ever smoked regularly 13 (37.1%) 61 (37.4%) 
Hobby gardener 20 (57.1%) 83 (51.9%) 
Used pesticides at home 23 (67.7%) 114 (69.9%) 
Used pesticides at work 6 (17.7%) 29 (17.8%) 
Worked with metal fumes 10 (31.3%) 56 (34.6%) 
s.d. Standard Deviation; n Number 
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5.4.2 Controls 
Thirty-five (35) healthy controls matched to the cases on the parameters of age, sex 
and residential suburb were selected from the Australian Commonwealth Electoral 
Roll. A further seven (7) controls were recruited by the same procedure due to 
follow-up interviews not being possible for some of the original controls (reasons 
provided: moved out of region, became ill, not convenient). Sixty-nine (69) potential 
controls were approached to obtain the forty-two respondents (Chapter 4, Figure 
4.4.1). Twenty-nine (29) of the forty-two (42) recruited control participants 
completed initial and repeat interviews.  
 
Representativeness of Controls 
A comparison of the controls in the test-retest repeatability study to the controls who 
participated in the case-control study confirmed they were similar in age and sex 
distribution (Table 5.4.2). However, there were a number of differences between 
controls in the test-retest repeatability study and controls in the case-control study. 
Controls in the test-retest repeatability study were less likely to be born in Australia 
or to have used pesticides occupationally than controls in the case-control study. 
They were also more likely to have completed high school, to have smoked 
regularly, to have been a hobby gardener, or to have used pesticides in the home 
garden and to have worked with metal fumes or dusts, than controls in the case-
control study.  
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Table 5.4.2 Comparison of Test-Retest Repeatability Study Controls to Case-
Control Controls 
 Test-Retest Study 
Controls 
Case-Control Study 
Controls 
Number in study 42 151 
Age Mean (s.d.) 
       Range 
65.4 (8.0) 
50-81 
66.8 (8.9) 
42-89 
Gender  n (%)  Males  24 (57.1) 94 (62) 
                         Females 18 (42.9) 57 (38) 
Country of Birth n (%)   
         Australia 30 (71.4) 123 (81.5) 
         Other 12 (28.6) 28 (18.5) 
Education n (%)   
       Did not complete high school 23 (54.8) 95 (63.8) 
       Completed high school 19 (45.2) 54 (36.2) 
       Completed tertiary education 26 (61.9) 89 (59.3) 
Married/De Facto n (%) 32 (76.2) 111 (73.5) 
Exposure Variables n (%)   
Ever smoked regularly 25 (59.5) 73 (48.7) 
Hobby gardener 30 (71.4) 94 (62.3) 
Used pesticides at home 39 (92.9) 113 (74.8) 
Used pesticides at work 4 (9.5) 27 (17.9) 
Worked with metal fumes 16 (38.1) 41 (27.2) 
s.d. Standard Deviation 
n Number 
  
 
 
5.5 Demographics 
A comparison of case and control participants on a number of demographic variables 
confirmed that cases and controls were similar (Table 5.5.1). Similar proportions of 
cases and controls were currently married or in a de facto relationship (74.3% and 
76.2%, respectively). Similar proportions of cases and controls completed further 
education in the form of a trade certificate or university degree, although 
proportionately fewer cases had completed secondary school. While more cases were 
born in Australia than were controls, the majority of cases and controls were 
Caucasian. Sixty-nine percent (69%) of cases and 69% of controls had both parents 
with British (English, Scottish and/or Irish) ancestry, while 78% of cases and 86% of 
controls had at least one parent of British ancestry. More cases than controls 
completed the follow-up interviews.  
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Table 5.5.1: Demographic Profile of Participants in the Test-Retest 
Repeatability Study 
 Cases 
(n=35) 
Controls 
(n=42) 
Age Mean (s.d.) 
       Range 
65.5 (8.1) 
51-81 
65.4 (8.0) 
50-81 
Gender  Males 21 (60) 24 (57) 
              Females 14 (40) 18 (43) 
Country of Birth N (%)   
         Australia 30 (85.7) 30 (71.4) 
         Other 5 (14.3) 12 (28.6) 
Education n (%)   
       Did not complete high school 23 (65.7) 23 (54.8) 
       Completed high school 12 (34.3) 19 (45.2) 
       Completed tertiary education 23 (65.7) 26 (61.9) 
Married/De Facto 26 (74.3) 32 (76.2) 
   
Number completed 1st interview 35 (100) 42 (100) 
Number completed 2nd interview 32 (91.4) 29 (69.0) 
Median days between first and second 
interview (range) 
60 (41-251) 67 (40-142) 
s.d. Standard Deviation 
n Number 
  
 
 
5.6 Test-Retest Repeatability of Exposure Variables 
Key variables were examined for test-retest repeatability. These variables were 
chosen based on their status as a main exposure of interest and/or whether sufficient 
numbers of exposed participants allowed the variable to be examined.  
 
5.6.1 Domestic Exposure to Pesticides, Rural Residency, Groundwater 
Consumption, Asbestos and Electromagnetic Radiation 
The proportion of “ever” (+) and “never” (-) responses recorded at both interviews, 
number of missing responses, percentage agreement and kappa values for exposures 
in the domestic environment measured on a categorical scale according to case-
control status are presented in Tables 5.6.1.  The proportion in perfect agreement, the 
number of missing responses, intraclass correlation coefficients, the mean of 
differences and the limits of agreement for these exposures examined on a 
continuous scale are presented in Table 5.6.2.  Environmental exposures involving 
active participation by the person, such as occupationally applying pesticides and 
those of a habitual nature, such as hobby gardening were recalled with the highest 
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repeatability. In contrast, “background” exposures, such as living within a mile27 (1.5 
km) of an agricultural area treated with pesticides or the type of household drinking 
water supply, were recalled with only moderate to fair repeatability. 
 
Whether or not a participant had gardened for a hobby was recalled with high 
repeatability by cases and controls, as was whether the participants had used 
pesticides in their home garden. Differentiation between types of pesticides 
(herbicides, insecticides and fungicides) used in the home garden proved more 
difficult with only moderate to high repeatability (kappas ranged from 0.63-0.92). 
Whether a participant had lived in a rural centre (RRMA categories R1, R2 and R3) 
or a remote centre or area (RRMA categories REM1 and REM2) were recalled with 
fair to moderate repeatability (kappas ranged from 0.39-0.63). Kappas improved 
slightly when residences were examined as metropolitan or non-metropolitan (kappas 
ranged 0.70-0.74). 
 
 
 
 
 
 
 
 
 
 
                                                 
27 In Australia, the unit of distance in current use is the kilometre. However, many of the participants 
would still be comfortable with the imperial system which was in place prior to conversion to the 
metric system in the 1970’s. As this question was asked concerning homes that the participants lived 
in prior to Australia’s conversion to the metric system, the candidate chose to use ‘mile’ to assist 
participants’ recall. Participants were also given 1.5 kilometres as the equivalent metric distance for 
this question. This decision was based on the candidate’s own casual observation of the use of ‘mile’ 
by persons describing distances in the context of life events that occurred pre-metric conversion.  
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Table 5.6.1: Response at initial and repeat interview, percent agreement and kappa 
values for exposures in the domestic environment measured on categorical scale, 
according to case status 
 Case 
Prevalence at first and 
repeat interview Missing Percent Kappa (95% 
Exposure  status ++ +- -- -+ (%) agreement confidence interval) 
 
Case 3 0 28 0 1 (3) 1.00 1.00  (1.00-1.00)Did Laundry for farm 
worker Control 1 2 25 1 0 (0) 0.90 0.35  (-0.22-0.92)
Case  15 3 13 1 0 (0) 0.88 0.75  (0.52-0.98)Hobby gardener* 
Control 19 1 9 0 0 (0) 0.97 0.92  (0.77 -1.00)
Case 19 2 10 1 0 (0) 0.91 0.80  (0.58-1.00)Used pesticides in 
home garden* Control 26 1 2 0 0 (0) 0.97 0.78  (0.37-1.00)
Case 27 1 2 0 2 (6) 0.97 0.78  (0.37-1.00)Home treated by pest 
control operator Control 28 0 0 1 0 (0) 0.97 -  
Case 17 2 11 2 0 (0) 0.88 0.74 (0.50-0.98)Lived in a non-
metropolitan area Control 21 1 5 2 0 (0) 0.90 0.70 (0.39-1.00)
Case 11 5 12 4 0 (0) 0.72 0.44  (0.13-0.75)Lived in a rural centre 
Control 11 2 9 7 0 (0) 0.69 0.39  (0.08-0.71)
Case 13 1 13 5 0 (0) 0.81 0.63  (0.37-0.89)Lived in a remote 
centre or area Control 13 4 8 4 0 (0) 0.72 0.43  (0.10-0.76)
Case 14 5 10 3 0 (0) 0.75 0.49  (0.19-0.79)Lived within a mile of 
a pesticide sprayed 
agricultural area Control 13 1 11 4 0 (0) 0.83 0.66  (0.39-0.92)
Case  7 1 22 2 0 (0) 0.91 0.76  (0.50-1.00)Lived on a farm* 
Control 8 1 20 0 0 (0) 0.97 0.92  (0.76-1.00)
Case  7 1 23 1 0 (0) 0.94 0.83  (0.61-1.00)Worked on a home 
farm* Control 6 0 23 0 0 (0) 1.00 1.00  (1.00-1.00)
Case  7 3 22 0 0 (0) 0.91 0.74  (0.47-1.00)Drank groundwater 
Control 5 3 19 2 0 (0) 0.83 0.55  (0.20-0.90)
Case** 10 5 5 0 12 (38) 0.75 0.50  (0.17-0.83)Lived in house 
containing asbestos Control 19 2 6 1 1 (3) 0.89 0.73  (0.44-1.00)
Case 23 1 4 1 3 (9) 0.93 0.76  (0.44-1.00)Used an electric 
blanket* Control 22 2 5 0 0 (0) 0.93 0.79  (0.52-1.00)
Case 7 1 22 1 1 (3) 0.94 0.83  (0.61-1.00)Received an electric 
shock  Control 5 1 22 0 1 (3) 0.96 0.66  (0.36-0.96)
Case 5 2 22 1 2 (6) 0.90 0.71  (0.39-1.00)Lived close to high 
voltage power lines Control 2 0 25 1 1 (3) 0.96 0.78  (0.37-1.00)
++ ‘ever’ exposed response at first and repeat interviews; +- ‘ever’ exposed response at first and ‘never’ 
exposed at repeat interview; -- ‘never’ exposed response at first and repeat interviews; -+ ‘never’ response at 
first and ‘ever’ at repeat interview 
* Exposure recalled with high repeatability (kappa >0.74) by both cases and controls 
** Result should be interpreted with caution as more than 10% of responses missing for this exposure 
- undeterminable 
 
More than 10% of the data were missing for several domestic exposures measured on 
a continuous scale, therefore caution should be used when interpreting these results. 
These were the number of years that herbicides, insecticides and fungicides were 
applied; the number of years lived in a rural or remote centres or areas; the number 
of years that groundwater was drunk for; the number of years living near high 
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voltage power lines and the number of years of sleeping with an electric blanket. The 
number of years spent hobby gardening was recalled with high repeatability by both 
cases and controls. For those who were able to estimate the number of years they had 
applied herbicides or insecticides in the home garden for, they recalled these with 
high repeatability. The number of years the participants had lived on a farm was also 
recalled with high repeatability. The mean of the differences in responses between 
the initial and repeat interviews was generally small and not of clinical significance. 
However, there was a substantial average difference between the number of years of 
electric blanket use estimated in the repeat interview compared to the initial 
interview for both cases and controls (mean of differences for cases and controls 
were -8.5 and -8.7 years, respectively). 
Table 5.6.2: Comparison of participant responses for exposures in the domestic environment 
at initial and repeat interviews measured on continuous scale, intraclass correlation 
coefficients and mean of differences 
Exposure 
Case 
status 
Perfect 
Agreement 
n (%)   
Lower in 
repeat 
interview 
Higher in 
repeat 
interview 
Missing 
n (%) 
ICC (95% 
confidence 
interval) 
Mean of differences
(limits of agreement)
 
Cases 20 (67) 7 3 2 (6) 0.80 (0.62-0.90) 1.03 (-24.43-50.92)Years hobby 
gardening Controls 14 (48) 10 5 0 (0) 0.86 (0.73-0.93) 4.24 (-14.83-23.21)
Cases** 16 (59) 8 3 5 (16) 0.89 (0.76-0.95) 2.30 (-12.24-16.83)Years applied 
herbicides at home Controls** 9 (53) 6 2 12 (41) 0.79 (0.50-0.92) 3.24 (-12.55-19.02)
Case** 14 (54) 5 7 6 (19) 0.86 (0.71-0.94) -1.27 (-13.20-10.66)Years applied 
insecticides at home Controls** 13 (65) 4 3 9 (31) 0.72 (0.41-0.88) 3.05 (-16.16-22.26)
Cases** 24 (86) 1 3 4 (13) 0.90 (0.80-0.95) -0.93 (-7.92-6.06) Years applied 
fungicides at home Controls** 21 (88) 0 3 5 (17) 0.51 (0.13-0.76) -2.50 (-18.10-13.10)
Cases** 17 (74) 4 2 9 (28) 0.57 (0.21-0.80) -1.09 (-10.58-8.41) Years living in a 
large rural centre Controls** 15 (71) 3 3 8 (28) 0.93 (0.83-0.97) 0.10 (-4.19-4.38) 
Cases** 14 (61) 5 4 9 (28) 0.78 (0.54-0.90) 0.48 (-12.90-13.85)Years living in a 
small rural centre Controls** 15 (71) 3 3 8 (28) 0.45 (0.02-0.74) -0.24 (-14.08-13.60)
Cases** 19 (83) 3 1 9 (28) 0.93 (0.83-0.97) 0.43 (-9.85-10.72) Years living in a 
remote area Controls** 13 (62) 2 6 8 (28) 0.21 (-0.24-0.59) 2.71 (-11.23-16.66)
Cases 25 (83) 2 3 2 (6) 0.93 (0.86-0.97) 0.66 (-10.81-12.12)Years living on a 
farm* Controls 22 (81) 2 3 2 (6) 0.99 (0.98-1.00) 0.18 (-1.71-2.07) 
Cases** 20 (83) 4 0 8 (25) 0.98 (0.95-0.99) -1.31 (-9.17-6.55) Years drank 
groundwater Controls** 16 (67) 3 5 5 (17) 0.66 (0.36-0.84) -0.93 (-10.31-8.45) 
Cases** 26 (96) 1 0 5 (16) 0.84 (0.68-0.93) -0.37 (-4.22-3.48) Years lived near high 
voltage powerlines Controls 26 (93) 1 1 1 (3) 0.32 (-0.06-0.62) 1.11 (-19.36-21.57)
Cases** 11 (39) 11 6 4 (13) 0.64 (0.36-0.82) -8.46 (-31.08-14.15)Years using an 
electric blanket Controls 12 (43) 9 7 1 (3) 0.94 (0.87-0.97) -8.71 (-32.17-14.74)
Cases 27 (90) 1 2 2 (6) 0.99 (0.98-1.00) 0.07 (-0.83-0.97) Number of electric 
shocks received Controls 24 (92) 2 0 3 (10) 0.21 -0.19-0.55) -0.54 (-5.28-4.20) 
* Exposure recalled with high repeatability (kappa >0.74) by both cases and controls 
** Result should be interpreted with caution as more than 10% of responses missing for this exposure 
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5.6.2 Occupational Exposure to Pesticides, Farmwork, Metals, Solvents, 
Asbestos and Electromagnetic Radiation 
The proportion of “ever” (+) and “never” (-) responses recorded at both interviews, 
number of missing responses, percentage agreement and kappa values for exposures 
in the occupational environment measured on a categorical scale according to case-
control status are presented in Tables 5.6.3.  The proportion in perfect agreement, the 
number of missing responses, intraclass correlation coefficients, the mean of 
differences and the limits of agreement for these exposures examined on a 
continuous scale are presented in Table 5.6.4.  
 
Occupational exposures were generally recalled with higher repeatability than 
domestic exposures by both cases and controls. The proportion exposed for the 
majority of occupational exposures was less than 15%, with only the variables Ever 
worked with metals, Ever worked with solvents and Ever worked with 
electromagnetic radiation having 30% or higher exposure prevalence. The variable 
Ever had skin sprayed with pesticide also recorded a proportion exposed of 25-31%, 
however this variable also included pesticide spills in the domestic environment. 
Occupational exposure to metal fumes and dusts, solvents and electromagnetic 
radiation was recalled with high repeatability by both cases and controls (kappas 
ranged from 0.78-1.00). Exposure to specific metals and solvents were more difficult 
to recall and resulted in more missing responses (data not shown). Occupational 
exposures to herbicides, insecticides and fungicides were recalled with high 
repeatability by cases when assessed as ever/never exposed (kappas ranged 0.82-
1.00). However, the fact that no controls were exposed to fungicides occupationally 
made repeatability indeterminable, for that group. 
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Table 5.6.3: Response at initial and repeat interview, percent agreement and kappa 
values for exposures in the occupational environment measured on categorical scale, 
according to case status 
 Case 
Prevalence at first and 
repeat interview Missing Percent Kappa (95% 
Exposure  status ++ +- -- -+ (%) agreement confidence interval) 
Occupational Exposure 
Case 10 0 21 1 0 (0) 0.97 0.93  (0.79-1.00)Worked with metals* 
Control 9 1 18 1 0 (0) 0.93 0.85  (0.64-1.00)
Case 12 0 19 1 0 (0) 0.97 0.93  (0.81-1.00)Used solvents* 
Control 10 0 18 1 0 (0) 0.97 0.93  (0.78-1.00)
Case 6 0 24 2 0 (0) 0.94 0.82 (0.58-1.00)Used pesticides 
Control 1 1 27 0 0 (0) 0.97 0.65 (0.02-1.00)
Case 4 0 28 0 0 (0) 1.00 1.00  (1.00-1.00)Applied herbicides  
Control 0 1 28 0 0 (0) 0.97 -  
Case 6 0 23 2 1 (3) 0.94 0.82  (0.58-1.00)Applied insecticides* 
Control 1 0 28 0 0 (0) 1.00 1.00  (1.00-1.00)
Case 2 0 30 0 0 (0) 1.00 1.00  (1.00-1.00)Applied fungicides  
Control 0 0 28 0 1 (3) 1.00 -  
Case 8 1 20 2 1 (3) 0.90 0.77  (0.53-1.00)Skin was sprayed 
with pesticide* Control 10 0 18 1 0 (0) 0.97 0.93  (0.78-1.00)
Case 8 2 22 0 0 (0) 0.94 0.84  (0.64-1.00)Worked on a farm 
Control 6 0 20 2 1 (3) 0.90 0.81  (0.56-1.00)
Case 3 1 28 0 0 (0) 0.97 0.84  (0.54-1.00)Worked on a non-
residential farm  Control 1 2 23 2 1 (3) 0.86 0.25  (-0.27-0.78)
Case 6 2 23 1 0 (0) 0.91 0.74  (0.46-1.00)Worked with asbestos 
Control 5 0 24 0 0 (0) 1.00 1.00  (1.00-1.00)
Case 13 0 17 1 1 (3) 0.97 0.93  (0.81-1.00)Worked with EMR*  
Control 16 2 10 1 0 (0) 0.90 0.78  (0.55-1.00)
++ ‘ever’ exposed response at first and repeat interviews; +- ‘ever’ exposed response at first and ‘never’ 
exposed at repeat interview; -- ‘never’ exposed response at first and repeat interviews; -+ ‘never’ response at 
first and ‘ever’ at repeat interview 
EMR = Electromagnetic radiation 
* Exposure recalled with high repeatability (kappa >0.74) by both cases and controls 
 
The number of years spent working with metal fumes or dusts and applying 
insecticides occupationally were recalled with high repeatability by both cases and 
controls. Cases also recalled the number of years they applied herbicides or 
fungicides occupationally and the number of years they worked with solvents, 
asbestos or electromagnetic radiation, with high repeatability. The mean of the 
differences in the reported length of time spent exposed at the initial and repeat 
interviews were small and not clinically significant for these occupational exposures.  
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Table 5.6.4: Comparison of participant responses for exposures in the occupational 
environment at initial and repeat interviews measured on continuous scale, intraclass 
correlation coefficients and mean of differences 
Exposure 
Case 
status 
Perfect 
Agreement 
n (%)   
Lower in 
repeat 
interview 
Higher in 
repeat 
interview 
Missing 
n (%) 
ICC (95% 
confidence 
interval) 
Mean of differences
(limits of agreement)
 
Cases 25 (81) 1 5 1 (3) 0.85 (0.71-0.93) 1.32 (-12.76-15.20)Years worked with 
metals* Controls 22 (85) 2 2 3 (10) 0.95 (0.90-0.98) -0.50 (-7.43-6.43) 
Cases 25 (81) 1 5 1 (3) 0.92 (0.84-0.96) 1.10 (-9.83-12.02)Years worked with 
solvents Controls 22 (81) 0 5 2 (6) 0.68 (0.41-0.84) 3.15 (-15.02-21.32)
Cases 31 (97) 1 0 0 (0) 1.00 (1.00-1.00) 0.03 (-0.32-0.39) Years applied 
herbicides at work Controls 28 (97) 1 0 0 (0) 0.00 (-0.37-0.37) 0.07 (-0.67-0.81) 
Cases 24 (83) 2 3 3 (9) 0.93 (0.92-0.98) -0.31 (-5.50-4.88) Years applied 
insecticides at 
work* Controls 28 (97) 1 0 0 (0) 0.92 (0.84-0.96) 0.03 (-0.34-0.41) 
Cases 30  (94) 1 1 0 (0) 0.96 (0.92-0.98) -0.13  (-1.94-1.69) Years applied 
fungicides at work Controls 29  (100) 0 0 0 (0) -  -  
Cases 25  (86) 2 2 3 (9) 0.90 (0.80-0.95) -0.03  (-3.03-2.97) Years worked with 
asbestos Controls 25  (86) 1 3 0 (0) 0.42 (0.06-0.68) 1.27  (-12.25-14.78)
Cases 19  (61) 7 5 1 (3) 0.85 (0.70-0.92) -1.52  (-16.72-13.69)Years worked with 
EMR Controls 18  (62) 7 4 0 (0) 0.61 (0.31-0.80) 0.55  (-22.42-23.52)
* Exposure recalled with high repeatability (kappa >0.74) by both cases and controls 
- undeterminable 
5.6.3 Lifestyle-related Exposures – Tobacco Smoking, Coffee Consumption, Tea 
Consumption and Alcohol Consumption 
The proportion of “ever” (+) and “never” (-) responses recorded at both interviews, 
number of missing responses, percentage agreement and kappa values for lifestyle-
related exposures measured on a categorical scale according to case-control status are 
presented in Tables 5.6.5. The proportion in perfect agreement, the number of 
missing responses, intraclass correlation coefficients, the mean of differences and the 
limits of agreement for these exposures examined on a continuous scale are 
presented in Table 5.6.6. In general, lifestyle exposures were recalled with high 
repeatability when assessed as “ever/never” (kappa statistic >0.75). This was 
particularly true for behaviours that required active participation by the person and 
were habitual in nature, such as daily cigarette smoking or coffee drinking. 
Relatively lower repeatability was seen for very light smoking (only 1-2 cigarettes 
per week). Measures of passive smoking at home (living with a smoker) and work 
(working in a ‘smoky workplace, such as a bar, club or casino’) were reproduced 
with moderate to high repeatability (kappas ranged from 0.60-0.77).  
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Table 5.6.5: Response at initial and repeat interview, percent agreement and kappa 
values for lifestyle-related exposures measured on categorical scale, according to case 
status 
 Case 
Prevalence at first and 
repeat interview Missing Percent Kappa (95% 
Exposure  status ++ +- -- -+ (%) agreement confidence interval) 
 
Case 23 0 8 1 0 (0) 0.97 0.92  (0.77-1.00)Drank coffee 
regularly Control 21 1 5 2 0 (0) 0.90 0.70  (0.39-1.00)
Case 26 1 5 0 0 (0) 0.97 0.89  (0.68-1.00)Drank tea regularly 
Control 24 1 3 1 0 (0) 0.93 0.71  (0.33-1.00)
Case 20 0 11 1 0 (0) 0.97 0.93  (0.80-1.00)Drank alcohol 
regularly * Control 20 0 9 0 0 (0) 1.00 1.00  (1.00-1.00)
Case 10 2 19 1 0 (0) 0.91 0.80  (0.58-1.00)Ever smoked 
regularly *W Control 17 0 12 0 0 (0) 1.00 1.00  (1.00-1.00)
Case 20 1 8 2 1 (3) 0.90 0.77  (0.53-1.00)Lived with a smoker 
Control 21 1 3 2 2 (6) 0.89 0.60  (0.19-1.00)
Case 4 0 24 4 0 (0) 0.88 0.60  (0.26-0.94)Worked in a smoky 
workplace Control 5 3 19 1 1 (3) 0.86 0.62  (0.29-0.95)
++ ‘ever’ exposed response at first and repeat interviews; +- ‘ever’ exposed response at first and ‘never’ 
exposed at repeat interview; -- ‘never’ exposed response at first and repeat interviews; -+ ‘never’ response at 
first and ‘ever’ at repeat interview 
* Exposure recalled with high repeatability (kappa >0.74) by both cases and controls 
W Weighted Kappa Case 0.90; Control 0.93 (Never smoked; Only smoked once or a few times; Only smoked 
occasionally; Smoked as often as 1-2/week for ≥6 months; Smoked daily or nearly every day for ≥month) 
 
The packyears of smoking, coffee consumption, tea consumption and alcohol 
consumption were recalled with high repeatability (ICCs >0.80). The mean of the 
differences between responses for lifestyle exposures on the initial and repeat 
interviews were generally small and not clinically significant. Of potential concern 
was the recall of the number of years that controls had lived with a smoker. On 
average, controls reported a shorter length of time living with a smoker by 
approximately eight years on the repeat interviews.  
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Table 5.6.6: Comparison of participant responses for lifestyle-related exposures at initial and 
repeat interviews measured on continuous scale, intraclass correlation coefficients and mean 
of differences 
Exposure 
Case 
status 
Perfect 
Agreement 
n (%)   
Lower in 
repeat 
interview 
Higher in 
repeat 
interview 
Missing 
n (%) 
ICC (95% 
confidence 
interval) 
Mean of differences
(limits of agreement)
 
Cases 12 (40) 10 8 2 (6) 0.91 (0.81-0.96) -1.70 (-19.40-16.00)
Years drank coffee* 
Controls 8 (30) 7 12 2 (6) 0.88 (0.75-0.94) 1.89 (-18.52-22.30)
Cases 16 (53) 6 8 2 (6) 0.87 (0.74-0.93) 1.41 (-21.14-23.95)Years drank tea* 
Controls 12 (44) 8 7 2 (6) 0.84 (0.68-0.93) 0.67 (-22.00-23.33)
Cases 16 (53) 8 6 2 (6) 0.91 (0.82-0.96) -1.50 (-17.91-14.91)Years drank alcohol* 
Controls 19 (70) 6 2 2 (6) 0.99 (0.98-1.00) 0.48 (-6.09-7.05) 
Cases 21 (72) 4 4 3 (9) 0.98 (0.97-0.99) 0.23 (-5.08-5.54) Pack-years* 
Controls 20 (69) 4 5 0 (0) 0.99 (0.98-1.00) 0.31 (-4.93-5.56) 
Cases 14 (45) 9 8 1 (3) 0.88 (0.77-0.94) -0.94 (-18.63-16.75)Years lived with a 
smoker* Controls 12 (44) 11 4 2 (6) 0.84 (0.68-0.93) -7.79 (-32.36-16.78)
Cases 25 (78) 1 6 0 (0) 0.79 (0.62-0.90) 0.83 (-8.19-9.84) Years worked in 
smoky workplaces* Controls 20 (71) 4 4 1 (3) 0.79 (0.60-0.90) -1.12 (-13.31-11.07)
* Exposure recalled with high repeatability (kappa >0.74) by both cases and controls 
 
5.6.4 Medical Exposures – Head Injury and Family History of Neurological 
Disorders 
The proportion of “ever” (+) and “never” (-) responses recorded at both interviews, 
number of missing responses, percentage agreement and kappa values for medically-
related exposures measured on a categorical scale according to case-control status are 
presented in Tables 5.6.7. The proportion in perfect agreement, the number of 
missing responses, intraclass correlation coefficients, the mean of differences and the 
limits of agreement for these exposures examined on a continuous scale are 
presented in Table 5.6.8.  Whether the participants had ever received a serious head 
injury, been knocked unconscious or played contact sports were recalled with high 
repeatability. Likewise, family history of PD, Alzheimer’s disease, Motor Neurone 
disease and tremor were recalled with high repeatability, by both cases and controls 
(kappas >0.90). 
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Table 5.6.7: Response at initial and repeat interview, percent agreement and kappa 
values for medical exposures measured on categorical scale, according to case status 
 Case 
Prevalence at first and 
repeat interview Missing Percent Kappa (95% 
Exposure  status ++ +- -- -+ (%) agreement confidence interval) 
 
Case 6 2 23 1 0 (0) 0.91 0.74  (0.46-1.00)Received a serious 
head injury Control 9 1 17 2 0 (0) 0.91 0.78  (0.54-1.00)
Case 5 2 24 0 1 (3) 0.94 0.79  (0.53-1.00)Knocked 
unconscious* Control 4 1 22 0 2 (7) 0.96 0.87  (0.61-1.00)
Case 10 0 21 0 1 (3) 1.00 1.00  (1.00-1.00)Played contact 
sports* Control 10 0 16 2 0 (0) 0.93 0.85  (0.65-1.00)
Case 12 0 20 0 0 (0) 1.00 1.00 (1.00-1.00)Family History of 
Parkinson’s Disease Control 3 0 26 0 0 (0) 1.00 1.00 (1.00-1.00)
Case 3 0 29 0 0 (0) 1.00 1.00 (1.00-1.00)Family History of 
Alzheimer’s Disease Control 7 1 21 0 0 (0) 0.97 0.91 (0.74-1.00)
Case 1 0 31 0 0 (0) 1.00 1.00 (1.00-1.00)Family History of 
Motor Neuron 
Disease Control 1 0 28 0 0 (0) 1.00 1.00 (1.00-1.00)
Case 0 0 32 0 0 (0) 1.00 -  Family History of 
Tremor Control 3 0 26 0 0 (0) 1.00 1.00 (1.00-1.00)
++ ‘ever’ exposed response at first and repeat interviews; +- ‘ever’ exposed response at first and ‘never’ 
exposed at repeat interview; -- ‘never’ exposed response at first and repeat interviews; -+ ‘never’ response at 
first and ‘ever’ at repeat interview 
* Exposure recalled with high repeatability (kappa >0.74) by both cases and controls 
- undeterminable 
 
The number of head injuries experienced and the number of years contact sports 
were played were recalled by controls with high repeatability (ICCs >0.90). 
However, cases only recalled the number of head injuries they had received with fair 
to moderate repeatability (ICC 0.65). 
 
Table 5.6.8: Comparison of participant responses for exposure to occupational, domestic, 
lifestyle and medical exposures at initial and repeat interviews measured on continuous 
scale, intraclass correlation coefficients and mean of differences 
Exposure 
Case 
status 
Perfect 
Agreement 
n (%)   
Lower in 
repeat 
interview 
Higher in 
repeat 
interview 
Missing 
n (%) 
ICC (95% 
confidence 
interval) 
Mean of 
differences 
(limits of 
agreement) 
Cases 25 (83) 3 2 2 (6) 0.65 (0.38-0.82) -0.17 (-2.21-1.87)Number of head 
injuries Controls 25 (89) 1 2 1 (3) 0.92 (0.84-0.97) 0.04 (-0.63-0.70)
Cases 25 (81) 5 1 1 (3) 0.99 (0.98-0.99) -0.06 (-1.85-1.72)Years played contact 
sports* Controls 20 (77) 4 2 3 (10) 0.99 (0.98-1.00) -0.15 (-1.62-1.31)
* Exposure recalled with high repeatability (kappa >0.74) by both cases and controls 
** Result should be interpreted with caution as more than 10% of responses missing for this exposure 
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5.6.5 Non-Differential Exposure Measurement Error  
A summary of exposure variables for which both cases and controls recalled with 
high, fair to moderate and low repeatability is presented in Table 5.6.9.  
 
Table 5.6.9: Summary of Variables with Non-Differential Exposure 
Measurement Error Between Cases and Controls 
High Recall (kappa/ICC>0.74) 
Pesticides Applied insecticides at work 
Years applied insecticides at work 
Days per year applied insecticides 
Applied fungicides at work 
Years applied fungicides at work 
Skin was sprayed with pesticide  
Hobby gardener 
Years hobby gardening 
Used pesticides at home 
Years applied herbicides at home 
Agriculture Lived on a farm 
Years living on a farm 
Worked on home farm 
Lived on a sugarcane farm 
Metals Worked with metals Years worked with metals 
Solvents Used solvents Used thinners 
Dummy 
Exposures 
Worked with asbestos Sheets 
Worked with EMR 
Days per week working with EMR 
Used an electric blanket 
Lifestyle Drank alcohol 
Ever smoked regularly 
Years drank coffee 
Years drank tea 
Years drank alcohol 
Pack years 
Years lived with a smoker 
Years worked in smoky workplace 
Medical Received a serious head injury 
Knocked unconscious 
Played contact sports 
Years played contact sports 
Fair to Moderate Recall (kappa/ICC 0.40-0.74) 
Agriculture Lived within mile of agricultural area 
which was sprayed with pesticides 
Years within mile of agricultural area 
which was sprayed 
Metals Welding Soldering 
Residential Private drinking water supply 
Private groundwater supply 
Lived in a rural centre 
Lived in a remote centre or area 
Dummy Worked on a switchboard Exposed to electric welding at work 
Lifestyle Worked in a smoky workplace  
Low Recall (kappa/ICC<0.40) 
Metals Grinding metal 
Steel 
Aluminium 
Copper 
Lifestyle Lived with smoker who regularly 
smoked in the same room 
Number of cigars per year 
EMR = Electromagnetic Radiation 
 
 
5.6.6 Differential Exposure Measurement Error 
Differential exposure measurement error between cases and controls has important 
implications for the validity of a case-control study as it may result in a systematic 
bias in the results. Exposure variables for which cases and controls demonstrated 
recall which fell into two different repeatability categories (e.g. high and fair to 
moderate) are shown in Table 5.6.10. 
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Table 5.6.10: Summary of Variables with Differential Recall between Cases and 
Controls 
   
Pesticides Applied herbicides at work* 
Years applied herbicides at work* 
Did laundry for a farm worker* 
Years applied insecticides at home* 
Years applied fungicides at home* 
Metals Worked in vicinity of metal work* Worked with lead* 
Solvents Worked in vicinity of solvents* Years worked with solvents* 
Dummy Years worked with asbestos*  
Years worked with EMR*  
Years living near high voltage lines* 
Total days working with asbestos? 
Years using an electric blanket? 
Number of electric shocks received* 
Residential Years living in a large rural centre? 
Years living in a small rural centre* 
Years living in a remote area* 
Years drinking groundwater* 
Medical Number of serious head injuries?  
Lifestyle Hours/week in a smoky workplace?  
EMR = Electromagnetic Radiation 
* Cases with higher recall than controls ? Controls with higher recall than cases 
 
 
 
5.7 Comparison of Participants with Short and Long Intervals between Initial 
and Repeat Interviews 
As the range of the time intervals between initial and repeat interviews was wide 
(Median 65 days, Range 40-251 days), participants who completed their repeat 
interview within a shorter time from the initial interview were compared to those 
with a longer time from the initial interview on key demographic and exposure 
variables. The two time intervals chosen were 64 days or less and 65 days or more, 
based on the median time interval of 65 days. The mean age and range of ages of the 
two groups were similar (Table 5.7.1). Participants with a longer interval between 
initial and repeat interviews tended to be female, born in Australia and less educated 
than those who completed the two interviews in a shorter timeframe. Of the 
demographic variables examined, age is the only variable likely to affect recall, 
therefore ability to remember past events should be similar between the two groups. 
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Table 5.7.1: Comparison of participants with short and long intervals between 
initial and repeat interview  
 Interval 1 
40-64 days 
(N=31) 
Interval 2 
65-251 days 
(N=30) 
Age Mean (s.d.) 
       Range 
65.8 (6.8) 
53-80 
65.0 (8.5) 
51-81 
Gender n % Males 21 (67.7) 15 (50) 
                    Females 10 (32.3) 15 (50) 
Country of Birth n (%)   
         Australia 21 (67.7) 26 (86.7) 
         Other 10 (32.3) 4 (13.3) 
Education n (%)   
       Did not complete high school 17 (54.8) 20 (66.7) 
       Completed high school 14 (45.2) 10 (33.3) 
       Completed tertiary education 21 (67.7) 18 (60.0) 
Married/De Facto 22 (71.0) 23 (76.7) 
N Number   
 
 
Recall was similar between the two groups for most of the exposures compared 
(Table 5.7.2). Participants with a shorter interval between the initial and repeat 
interviews did not demonstrate higher recall than those with a longer interval 
between interviews. 
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Table 5.7.2: Response at initial and repeat interview, percent agreement and kappa 
values for categorical exposures according to interval between initial and repeat 
interviews 
 Case 
Prevalence at first and 
repeat interview Missing Percent Kappa (95% 
Exposure  status ++ +- -- -+ (%) agreement confidence interval) 
Domestic Exposures 
Interval 1 24 1 6 0 0 0.97 0.90 0.72-1.00 Used Domestic 
Pesticides Interval 2 18 1 6 1 13 0.92 0.80 0.55-1.00 
Interval 1 19 3 7 0 6 0.90 0.75 0.50-1.00 Used an Electric 
Blanket Interval 2 25 0 2 1 6 0.96 0.78 0.37-1.00 
Interval 1 18 3 5 1 13 0.85 0.62 0.28-0.95 Lived in a Home 
containing asbestos Interval 2 10 4 6 0 33 0.80 0.60 0.28-0.92 
Occupational Exposures 
Interval 1 3 1 26 0 3 0.94 0.71 0.34-1.00 Used Pesticides  
Interval 2 4 0 23 1 7 0.96 0.87 0.62-1.00 
Interval 1 14 0 16 1 0 0.97 0.94 0.81-1.00 Worked with Metals 
Interval 2 5 1 23 1 0 0.93 0.79 0.52-1.00 
Interval 1 11 0 19 1 0 0.97 0.93 0.80-1.00 Used Solvents 
Interval 2 11 0 18 1 0 0.97 0.93 0.79-1.00 
Lifestyle Exposures 
Interval 1 12 1 17 1 0 0.94 0.87 0.69-1.00 Smoker 
Interval 2 15 1 14 0 0 0.97 0.93 0.81-1.00 
Interval 1 22 1 6 2 0 0.90 0.74 0.46-1.00 Coffee Drinker 
Interval 2 22 0 7 1 0 0.97 0.91 0.74-1.00 
Interval 1 24 1 5 1 0 0.94 0.79 0.52-1.00 Tea Drinker 
Interval 2 26 1 3 0 0 0.97 0.84 0.53-1.00 
Interval 1 18 0 13 0 0 1.00 1.00 1.00-1.00 Alcohol Drinker 
Interval 2 22 0 7 1 0 0.97 0.91 0.74-1.00 
++ ‘yes’ response at first and repeat interviews; +- ‘yes’ response at first and ‘no’ at repeat interview; -- ‘no’ 
response at first and repeat interviews; -+ ‘no’ response at first and ‘yes’ at repeat interview 
** More than 10% of responses missing for this exposure 
 
5.8 Discussion 
 
Repeatability of the lifestyle exposures, smoking, and coffee and tea consumption 
obtained in this study compared favourably with previous studies (Pron et al. 1988; 
Kelly et al. 1990; Leibenluft et al. 1993; Blair et al. 2002), although care must be 
taken when comparing results of different studies in which there may be a different 
prevalence of exposure and inherent differences in study populations. We obtained 
higher repeatability for a number of variables, including Number of years smoked, 
Lifetime number of cigarettes smoked, Current coffee-drinker (yes/no), and Current 
number of cups of coffee drunk per day than obtained in a study of bladder cancer 
cases and controls with benign urological conditions (Donato et al. 1998). It is 
difficult to determine if the differences in repeatability are due differences in the data 
instruments used, the populations studied or the study methods. However, there were 
 148 
several important differences between the current study and that of Donato et al. 
(1998) that may have contributed to the differences in results, in addition to 
differences in the populations and the medical conditions. There was a much longer 
time interval between the initial and repeat interviews in Donato et al.’s study (2-3 
years). In the current study, all repeat interviews were performed by the same 
interviewer who facilitated the initial interview for that particular participant. In 
Donato et al.’s study, one interviewer completed all initial interviews, however a 
second interviewer completed approximately half of the re-interviews. The authors 
noted that there was slightly better agreement among subjects interviewed twice by 
the same interviewer than by two different interviewers.  
 
The repeatability results for caffeine consumption (regular coffee/tea drinking) and 
alcohol consumption in the current study were similar to those obtained in a sample 
of people with depressive disorders (Leibenluft et al. 1993). However, lower 
repeatability than observed in the current study was reported for the healthy 
volunteers, who showed only moderate agreement for alcohol consumption. 
Leibenluft et al. re-administered the questionnaire only two weeks after the initial 
questionnaire administration, which is a much shorter time interval than used in the 
current study. Higher repeatability for these lifestyle exposures was observed in the 
current study than found in a general hospital sample (Kelly et al. 1990). The study 
by Kelly et al (1990) had a number of differences from the current study that may 
explain the lower repeatability observed in the former study. The study by Kelly et 
al. was not a planned test-retest repeatability study, but rather analysed data obtained 
from patients attending hospitals that had undergone two data collection interviews 
due to being admitted to hospital on more than one occasion or had been mistakenly 
interviewed twice during the same hospital stay. The length of time between 
interviews was highly variable and ranged from 9 days to 6.5 years. As the questions 
related to current beverage consumption and smoking habits, changes in habits 
between the first and repeat interviews may have accounted for some of the 
discrepancy between responses. Unlike the current study, in which the same 
interviewer conducted both the initial and repeat interviews, in Kelly et al.’s study, 
only half the repeat interviews were conducted by the same interviewer who 
conducted the initial interview.  
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The repeatability of the current study’s measures of passive smoking were similar to 
those reported by Pron et al (1988) for residential (kappa 0.66) and occupational 
environments (kappa: current study 0.62 vs. Pron et al. 0.46). Duration of exposure 
to residential passive smoke was reported with high repeatability by the current study 
(ICC 0.84), although Pron et al. (1988) report only fair repeatability for this variable 
(ICC 0.45). There were a number of similarities between the current study and Pron 
et al.’s study. Both studies conducted interviews in participants’ homes, used the 
identical questionnaire for the repeat interviews as the initial interviews and collected 
exposure data concerning active smoking prior to passive smoking data. The 
questions used to measure passive smoking at home were similar in both studies 
(“Have you ever lived with someone who smoked?” and “Have you ever lived in the 
same household as a regular smoker?”). However, the differences in questions used 
for determination of occupational passive smoking may have contributed to the lower 
repeatability of this variable on a continuous scale in Pron et al.’s study compared to 
the current study (“Have you ever worked in a workplace in which there was a lot of 
tobacco smoke, such as in a bar, club or casino?” and “Have you ever worked in a 
place where you were more or less continually exposed to the tobacco smoke of 
other people?”). Other methodological differences were present between the two 
studies, such as use of a different interviewer for the repeat interview than the initial 
interviewer, and different study populations.  
 
High repeatability was obtained for various occupational pesticide exposures, 
including mixing and applying herbicides, insecticides and fungicides in our PD 
cases when measured as ever/never exposed and for duration and frequency of use. 
However, the prevalence of occupational pesticide exposure was low in the sample, 
which resulted in wide confidence intervals for these estimates. Duell et al. (2001) 
reported moderate-to-high repeatability for “Ever applied pesticides to crops” in a 
case-control study of women with breast cancer and healthy controls for the 
exposure. Exposure measurement was similar in the current study to Duell et al.’s 
study for these variables as many of the assessment questions were derived or based 
on Duell et al.’s exposure assessment questionnaire. However, the study populations 
were different, particularly with respect to gender, as Duell et al.’s study was 
restricted to women.  
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A large study of 4,088 people applying for pesticide certification compared 
responses on a questionnaire concerning life-style and agricultural factors 
administered twice, approximately one year apart (Blair et al. 2002). The study 
reported low repeatability for ever mixed or applied pesticides (Kappa 0.15, 95% CI 
0.08-0.22), only moderate kappa statistics in the order of 0.50 to 0.60 for use of 
specific pesticides, and low repeatability for specific application practices (kappa 
0.11-51). Only moderate repeatability was reported for duration and frequency of 
mixing or applying pesticides (weighted kappa: years 0.56, days/year 0.45). Higher 
repeatability for these variables may have been obtained in the current study 
compared to Blair et al.’s study (2002) due to fewer exposed individuals in the 
current study. As Blair et al.’s study population consisted of people applying for 
certification to apply pesticides, there were few who had not worked with pesticides 
previously, thus the prevalence of non-pesticide use was very low. This may have 
affected the calculation of kappa. Those who had not mixed or applied pesticides at 
the first administration of the questionnaire may have been new applicators applying 
for their first pesticide certification. As their second questionnaire administration was 
likely to be during re-certification, the discrepancy in responses from the initial and 
repeat questionnaires may be due to them commencing work with pesticides since 
obtaining their initial pesticide certification. As the sample was of people currently 
involved in pesticide work, it is possible that some of the discrepancy between 
results for specific pesticide names and practices may be due to changes in their 
methods between the initial and repeat interviews. In contrast, there were no 
participants in the current test-retest study who were still working with pesticides 
occupationally at the time.  
 
The results for repeatability of exposure to agriculture in the current study were 
comparable to those obtained by Duell et al. (2001). The current study yielded 
similar kappas (case 0.76, control 0.92) for Ever lived on a farm as obtained in the 
previous study (case 0.78, control 0.87). However, while the results for Ever worked 
on a non-residential farm and Ever laundered clothes for a farm worker in control 
participants (kappas 0.25 and 0.35) were also similar to Duell et al.’s control results 
(kappas 0.26 and 0.43), the current study’s PD cases reported these exposures with 
much higher repeatability (kappas 0.84 and 1.00) than the women with breast cancer 
(0.15 and 0.53). This difference may have been due to the lower occurrence of 
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laundering farm worker clothing in the current study’s community-based study 
compared to Duell et al.’s study population which only included participants with a 
history of working or living on a farm. 
 
Of the environmental exposures examined in previous case-control studies of PD, 
rural residency and well-water consumption have yielded the most inconsistent 
results between studies. The current study found these variables to have only fair to 
moderate repeatability in the sample. Likewise, exposures such as smoking, pesticide 
exposure, solvent exposure, metal exposure and head injury, which have displayed 
more consistency between studies, demonstrated high repeatability. It is possible that 
a greater exposure measurement error from difficulty in obtaining reliable, valid 
measures of some exposures has contributed to the inconsistency in results for these 
exposures between studies. 
 
In any case-control study based on questionnaire data, the possibility of case 
response bias or recall bias should be considered. This can arise when cases recall 
exposures more or less accurately than controls or if cases report false contact with 
the exposure due to media publicity of a potential link with their medical condition. 
As the possible link between pesticide exposure and PD has been the most publicised 
potential risk factor for the disease, a higher prevalence of reported pesticide 
exposure by cases must be carefully considered in this context. However, the higher 
reported usage of occupational pesticides by cases (19%) compared to controls (7%) 
is unlikely to be solely an artefact due to over-reporting by cases when the result for 
domestic pesticide use is examined, as more controls (93%) reported ever using 
pesticides in their home gardens than cases (69%), because cases would be expected 
to over-report on both rather than just on occupational exposure. 
 
The higher use of home garden pesticides amongst controls may be partially 
explained by the higher number of hobby gardeners in the control group. However, 
the higher prevalence of home garden pesticide use amongst controls persisted after 
stratifying the sample by hobby gardening. All (100%) control hobby gardeners 
reported using home garden pesticides compared to 72% of case hobby gardeners. A 
higher rate of home pesticide use was also reported by controls compared to cases in 
participants who did not consider themselves hobby gardeners. Reasons for the 
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higher prevalence of hobby gardening and home garden pesticide use amongst 
controls are not readily apparent. As the majority of hobby gardeners in both groups 
had this hobby for many years (on average 33 years in both groups), the difference 
doesn’t appear to be due to less uptake of gardening by cases in the years following 
PD onset. 
 
While the proportions exposed to most of the ‘dummy’ variables were not 
substantially different between the two groups, cases (23%) did report a higher rate 
of domestic electromagnetic radiation (EMR), in the form of ever having lived close 
to high voltage power lines or an electricity supply substation, than controls (10%). 
As this was a highly subjective measure, the higher reporting rate by cases may be 
indicative of a level of recall bias. However, amongst those who reported ever having 
lived close to high voltage power lines or an electricity supply substation, the median 
number of years was similar for cases (median 10 years; range 1-12 years) and 
controls (9.5 years; range 3-39 years). Higher reporting of EMR exposures by cases 
was not evident for other EMR variables such as working close to EMR, having a 
hobby involving EMR, use of electric blankets, or experiencing an electric shock. 
While, these results do not preclude the existence of recall bias in our data, they do 
suggest against a generalised over-reporting of exposures by cases. 
 
In general, case participants did not demonstrate lower or higher repeatability or a 
higher rate of missing responses, compared to control participants. Also, among 
those individual exposures with differential recall between cases and controls, no 
clear pattern was evident, suggesting that differences in recall repeatability between 
cases and controls were random in nature rather than due to systematic differences 
between cases and controls. Such non-differential exposure misclassification is more 
likely to result in dilution of the observed relationship by biasing the odds ratio 
towards the null value rather than produce spurious associations. The size of this bias 
will be greatest for measures with low sensitivity and for exposures with low 
prevalence in the cases and controls (Copeland et al. 1977). This also suggests that 
any PD-specific memory deficits present in the case group were not sufficient to 
impact substantially on exposure data repeatability compared to age-matched 
controls. 
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While the test-retest repeatability study cases were not randomly selected from the 
complete case series, their similarity on demographic and exposure variables 
suggests they were representative of the remaining cases of the population. Controls 
in the test-retest repeatability study were also similar, overall, to controls recruited 
for the main case-control study in age, gender and marital status. However, a number 
of differences were apparent. More controls in the test-retest repeatability study than 
those in the case-control study had completed high school, had smoked regularly, 
had been a hobby gardener, had used pesticides at home and had worked with metal 
fumes or processed metals at work. However, there were fewer controls in the test-
retest repeatability study who had worked with pesticides occupationally than in the 
case-control study. Some of these differences may have been due to the small 
geographic area that the test-retest repeatability study controls were drawn from, 
which was the greater Brisbane area. Those living in Brisbane may have been more 
likely to complete high school than those recruited from a rural area if current 
residence is reflective of childhood or lifetime residential history. Likewise, lower 
use of pesticides occupationally may be due to less exposure to farming occupations 
amongst those in metropolitan areas compared to rural areas. It is difficult to 
determine the impact of these differences upon extrapolation of the test-retest 
repeatability study results to the case-control study population. The main impact was 
likely to be in the area of occupational pesticide exposure, where low prevalence of 
exposure in the test-retest repeatability study controls made test-retest repeatability 
difficult to estimate.  
 
5.9 Conclusions 
High recall was observed for the majority of exposures examined with test-retest 
repeatability, particularly lifestyle behaviours such as smoking and coffee and tea 
consumption. Environmental exposures involving active participation by the subject 
had the highest repeatability.  PD cases did not demonstrate lower repeatability in 
recall of exposures than healthy age-matched controls. Therefore, the interviewer-
delivered questionnaire was deemed suitable to use for data collection for the case-
control study of environmental risk factors for PD. As only fair-to-moderate 
repeatability was obtained for measures of rural residency when participants were 
asked to classify their former residences into RRMA categories, the procedure was 
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modified for the case-control study to classification of the residences into RRMA 
categories performed by the candidate using Appendix II Statistical Local Areas by 
State by RRMA (see Chapter 4, Section 4.7.2). 
 
The majority of studies into environmental risk factors for PD rely on self-reported 
exposure data. Considering the additional difficulties involved in aetiological 
research into PD, such as a slow and insidious onset typically late in life and memory 
deficits due to the disease, accurate and reliable measurement of lifetime exposure to 
various environmental agents is a challenge. Assessment of exposure measurement 
instruments for test-retest repeatability and validity (where possible) should be 
performed in the study population prior to their use in epidemiological research to 
ensure the quality of the exposure data.  
 
 
 
 155 
6.0 Case-Control Study of Parkinson’s Disease Aetiology 
 
The methods for participant selection and recruitment, data collection and analysis 
for this study are outlined in Chapter 4.  
 
6.1. Participants 
6.1.1 Response Rate 
Of the 190 eligible PD patients invited to participate, 163 (85.8%) completed face to 
face interviews (Two invited cases were recently deceased and, therefore removed 
from the total of eligible participants). Suitable matched controls were successfully 
recruited for 151 of the case participants. Twelve potential control participants who 
agreed to participate were deemed ineligible (Six who were uncontactable 
telephoned the research team to participate after the standard 3 week contact period 
had elapsed and after a replacement control participant had been recruited; four were 
ineligible to participate due to having an existing diagnosis of PD; Another two were 
ineligible due to screening positive for possible parkinsonism and declined 
examination by the study neurologist). For one case, a suitable potential control was 
not available from the sampling frame. For eleven cases, a control could not be 
recruited from the available potential controls in the sampling frame. Table 6.1.1 
below details how many potential controls were approached per case. In total, 151 
controls were recruited from 228 approaches (66.2%). While it is not possible to 
quantify the total number of non-responders who were ineligible to participate due to 
lack of information, at least 9 approached potential controls who declined 
participation were known to be ineligible (2 deceased; 7 screened positive for 
parkinsonism in a phone interview). Removing these ineligibles re-expresses the 
above as 151 controls from 219 potential controls approached (68.9%) and is likely 
to underestimate the control response rate. 
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Table 6.1.1 Recruitment of Controls for Case-Control Study of Risk Factors for 
Parkinson’s Disease 
Number of 
potential controls 
approached per 
case 
Number of 
potential 
controls 
approached 
Number of 
Controls recruited
Number of Cases 
for which suitable 
control unable to 
be recruited 
Nil* 0 0 1 
One 110 106 4 
Two 82 36 5 
Three 27 7 2 
Four 4 1 0 
Five 5 1 0 
Total 228 151 12 
* There were no persons that met the selection criteria for a potential control 
for this case listed on the Commonwealth Electoral Roll (i.e. the same sex, age 
within +/- 2 years and same residential suburb). 
 
6.1.2 Demographics of Sample 
Demographic details of participants are presented in Table 6.1.2. Mean age of the 
sample was 67.3 years (standard deviation, SD = 9.2 years) for cases and 66.8 years 
(SD = 8.9 years) for controls. Thirty-seven per cent of cases (n=60) and 38% of 
controls (n=57) were female. A similar proportion of cases and controls completed 
secondary school, however slightly more cases (64.4%) completed tertiary education 
than controls (59.3%). The majority of participants were born in Australia (84.7% of 
cases and 81.5% of controls) and approximately 10% of cases and controls were born 
in the United Kingdom. Four cases (2.4%) and two controls (1.3%) spoke a language 
other than English at home. 
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Table 6.1.2: Participant Demographics for Cases and Controls in Case-Control 
Study of PD 
 Cases 
(N=163) 
Controls 
(N=151) 
Sex   Male 
         Female 
103 (63) 
60 (37) 
94 (62) 
57 (38) 
Age Mean (s.d.) 
        Range 
67.3 (9.2) 
40-89 
66.8 (8.9) 
42-89 
Years since diagnosis of PD (Median) 
Range 
6 
0-33 
NA 
NA 
Marital status   
Married 133 (81.6%) 109 (72.2%) 
De facto 3 (1.8%) 2 (1.3%) 
Separated 1 (0.6%) 1 (0.7%) 
Divorced 6 (3.7%) 14 (9.3%) 
Widowed 18 (11%) 18 (12%) 
Never married 4 (2.5%) 7 (4.6%) 
   
Country of birth   
Australia 138 (84.7%) 123 (81.5%) 
United Kingdom 17 (10.4%) 14 (9.3%) 
   
Usually speak English at home 159 (97.6%) 149 (98.7%) 
   
Education n (%)   
Did not complete high school 106 (65.0%) 95 (63.8%) 
Completed high school 57 (35.0%) 54 (36.2%) 
Completed post-secondary education*  105 (64.4%) 89 (59.3%) 
*trade certificate, degree or any other educational qualification  
 
Representativeness of Participants 
Representativeness of the sampling frame to the target population was not possible 
due to lack of available information. A comparison of non-participants to participants 
was made on the available data. When a potential control declined participation 
during the follow-up phone call any reasons provided for declining to participate 
were recorded. These non-participants were also asked if they would be prepared to 
answer a limited number of questions over the phone. Reasons provided by potential 
controls for not participating are presented in Table 6.1.3. Reasons for non 
participation of cases were difficult to obtain as most relayed their desire not to 
participate to the neurology clinic staff rather than the research team. Due to the busy 
nature of the neurology clinic, the staff were not asked to collect additional 
information during phone calls. A small number of the non-participating cases 
contacted the candidate directly, rather than the clinic. Of these, two relayed their 
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reasons for non-participation during the phone call. Where cited, poor health was the 
most frequently provided reason for non-participation amongst controls (Table 
6.1.3).  
 
Table 6.1.3: Characteristics of Non-Participating Potential♦ Control Subjects 
 N 
Ineligibles  9 
Deceased  2 
Agreed to participate, but ineligible (existing PD 
diagnosis/screened positive) 
5 
Declined to participate, but ineligible due to screening 
positive in phone interview. 
2 
Contacted research team with positive response after 
replacement control had been recruited 
6 
Reason for non-participation*  
No reason provided 14 (18%) 
Poor health 23 (30%) 
‘Not interested’ 11 (14%) 
‘Too old’ 6 (8%) 
Going overseas/moving away 2 (3%) 
Difficulty understanding English 2 (3%) 
Family problems 1 (1%) 
Partner/family member answered on behalf of invited person 8 (10%) 
Non-contactable 2 (3%) 
Completed phone interview 26/68 (38.2%) 
  
♦Eligibility status was not known for all potential participants at this point 
N Number; % percentage; *Note some non-participants provided more than one reason for 
non-participation, in this case all reasons provided are shown in the table 
 
Responses on a limited number of variables were obtained from control non-
participants who agreed to complete a phone interview (38.2%). These and the 
responses provided by the control participants are presented in Table 6.1.4. 
 
Similar rates of ever having smoked regularly, ever having worked with metal fumes, 
ever having worked with solvents, and ever having had a serious head injury were 
reported by control participants and non-participants who completed the phone 
interview. More non-participants than participants reported ever having been a hobby 
gardener, ever having lived and ever having worked on a farm, and ever having 
applied herbicides and ever having applied insecticides occupationally. Fewer non-
participants than participants reported ever having applied pesticides in the home 
garden and fewer personally knew someone with PD. 
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Table 6.1.4: Comparison of Characteristics of Non-Participating Potential♦ 
Control Subjects and Participating Control Subjects 
 Non-Participants 
N=68 
Participants 
N=151 
Variables N (%) N (%) 
   
Sex Male 
       Female 
41 (60.3) 
27 (39.7) 
94 (62.3) 
57 (37.7) 
Age Mean (SD) 
        Range 
68.6 (11.0) 
40-89 
66.8 (8.9) 
42-89 
   
Completed phone interview N=26  
Ever been a regular smoker 13 (50.0) 73 (48.7) 
Current smoker 1 (3.8) 19 (12.7) 
Ever been a hobby gardener 20 (76.9) 94 (62.3) 
Ever applied pesticides in home garden 13 (50.0) 113 (74.8) 
Ever lived on a farm 14 (53.8) 50 (33.1) 
Ever worked on a farm 15 (57.7) 58 (38.7) 
Ever applied herbicides at work 5 (16.2) 14 (9.3) 
Ever applied insecticides at work 9 (34.6) 21 (14.1) 
Ever applied fungicides at work 0 (0) 3 (2.0) 
Ever exposed to metal fumes at work 8 (30.8) 41 (27.2) 
Ever exposed to solvents at work 6 (23.1) 44 (29.1) 
Ever had a serious head injury 8 (30.8) 49 (32.7) 
Personally know a person with PD 11 (42.3) 91 (60.9) 
♦Eligibility status was not known for all potential participants at this point 
N Number; % percentage;  
 
6.2 Preliminary Examination of Data for Multicollinearity 
To determine if any of the explanatory variables were strongly associated with each 
other which may indicate multicollinearity, cross-tabulations of the variables likely 
to be correlated were examined (Table 6.2.1). Strong relationships were evident 
between several of the explanatory variables. Residing or working on a farm, using 
pesticides occupationally and drinking from a private groundwater supply were more 
common amongst those who had resided in non-metropolitan areas than those who 
had not. However, many of those who had resided in a non-metropolitan area did not 
report these exposures. Ninety-two per cent of participants who had ever resided on a 
farm, eighty-three per cent of participants who had worked on a farm, and ninety-two 
percent of participants who had consumed groundwater from a private supply on a 
regular basis had resided in a non-metropolitan area. Seventy-eight per cent of 
participants who had used pesticides occupationally had resided in a non-
metropolitan area. Most hobby gardeners (79%) reported using pesticides in the 
home garden. However, home pesticide use was also common amongst non-
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gardeners (64.5%). Independent variables that were highly correlated were not 
included in the same regression model to avoid multicollinearity. These were ever 
resided in a non-metropolitan area and ever resided on a farm; ever resided in a non-
metropolitan area and ever used pesticides occupationally; ever resided in a non-
metropolitan area and ever drank groundwater; and ever worked on a farm and ever 
used pesticides occupationally. 
 
Table 6.2.1 Correlation Between Variables Examined in a Case-Control Study of 
PD to Determine Presence of Multicollinearity (n=314) 
 ++ 
N (%) 
+- 
N (%) 
-- 
N (%) 
-+ 
N (%) 
Missing 
N (%) 
Resided in a non-metropolitan area &      
• Resided on a farm 101 (32.2) 127 (40.5) 77 (24.5) 9 (2.9) 0 (0) 
• Ever worked on a farm 103 (32.9) 125 (39.9) 64 (20.5) 21 (6.7) 1 (0.3) 
• Ever used pesticides occupationally 43 (13.8) 184 (59.0) 73 (23.4) 12 (3.9) 2 (0.6) 
      
Ever resided on a farm &  83 (26.5) 27 (8.6) 162 (51.8) 41 (13.1) 1 (0.3) 
• Ever worked on a farm      
• Drank groundwater 57 (18.2) 171 (54.5) 81 (25.8) 5 (1.6) 0 (0) 
      
Ever resided on a farm & ever used 
pesticides occupationally 
36 (11.5) 74 (23.7) 183 (58.7) 19 (6.1) 2 (0.6) 
      
Ever worked on a farm & ever used 
pesticides occupationally 
45 (14.4) 78 (25.0) 179 (57.4) 10 (3.2) 2 (0.6) 
      
Ever been a hobby gardener & ever 
used pesticides domestically 
138 (44.8) 36 (11.7) 47 (15.3) 87 (28.2) 6 (1.9) 
      
Ever worked with solvents &      
• Ever worked with metal fumes 66 (21.2) 36 (11.6) 179 (57.6) 30 (9.6) 3 (1.0) 
• Ever used pesticides occupationally 27 (8.7) 75 (24.2) 181 (58.4) 27 (8.7) 4 (1.3) 
      
Ever smoked &      
• Ever drank alcohol 101 (32.4) 78 (25.0) 77 (24.7) 56 (17.9) 2 (0.06) 
• Ever drank coffee 125 (40.1) 54 (17.3) 32 (10.3) 101 (32.4) 2 (0.6) 
++ Participant reported exposure to both variables; +- Participant reported exposure to first but not 
second variable; -- Participant did not report exposure to either variable; -+ Participant reported 
exposure to second, but not first variable 
 
6.3. Exposure Analysis 
In the tabular presentation of the results (Tables 6.3.1-6.6.1), unmatched proportions 
of exposed individuals (number and percentage) in the case and control groups are 
presented rather than at the matched level. This presentation was chosen to simplify 
the information presented to aid readability while still presenting the prevalence of 
each exposure in the sample. However, odds ratios presented were calculated with 
the case-control matching accounted for, using conditional logistic regression for 
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matched sets. Thus, occasionally, odds ratio estimates do not appear to reflect the 
prevalence distributions of cases and controls across particular exposures. 
 
The exposure variables of interest were first examined at the bivariate level and then 
considered in a multivariable logistic regression model (conditional for matched sets) 
to determine their independent influences on risk for PD. As there were a large 
number of environmental and lifestyle exposures examined in the study, the 
statistical model was not able to examine all exposures in the one model with 
sufficient power. Therefore, a base model was constructed of the key exposures of 
coffee (average cups per day), alcohol (average drinks per day), tea (regular 
drinking), tobacco smoking (packyears), family history of PD and hobby gardening, 
based on the results of the bivariate analysis (crude odds ratios are presented in 
Tables 6.3.1-6.3.12 with the adjusted odds ratios). Each of the exposure variables 
were then examined by adding them to this base model to adjust for potential 
confounding from these key variables. There was evidence of confounding of the 
earlier-identified crude associations for many of the added exposure variables. 
However, the multivariable adjustment confirmed most of the crude associations 
identified in the bivariate model.  
 
Environmental and lifestyle exposures that were directly related to chemicals or 
metals were examined with conditional logistic regression for matched sets, stratified 
by history of regular tobacco smoking and history of regular coffee drinking to 
determine if these variables were effect modifiers (Tables 6.4.1-6.4.3). 
 
6.3.1 Environmental Exposures 
Gardening and Pesticides 
The results of the bivariate and multivariable analyses of potential risk factors for PD 
relating to domestic pesticide exposure, and the proportions of exposed cases and 
controls, are presented in Table 6.3.1. More controls identified themselves as ever 
having been a hobby gardener than cases, resulting in a substantial protective 
association between hobby gardening and PD (OR 0.58, 95% CI 0.36-0.94)28. 
                                                 
28 As hobby gardening may be affected by PD symptoms (ie those with decreased mobility may be 
less inclined to ‘take up’ gardening for a hobby), the variable was also examined only considering 
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Adjustment for confounding in the multivariable model did not substantially change 
the bivariate conclusion for ever having been a hobby gardening. A similar 
proportion of cases and controls had ever used pesticides in the home garden. Ever 
having used any type of home gardening pesticide was not associated with increased 
relative odds of PD at the bivariate level. There was also no apparent dose-response 
effect either with increased intensity (days of use per year) or duration (years) of use. 
However, these results should be viewed with caution as more than ten percent of the 
data were missing for duration and intensity of home gardening pesticide use. 
 
Herbicides were the most common form of garden pesticide that had been used, with 
approximately 63% of participants reporting their use, followed by insecticides 
(approximately 49%) and fungicides (approximately 24%). There was no 
relationship between ever using herbicides or insecticides in the home garden and 
risk of PD either at the bivariate level or after adjustment for confounding in the 
multivariable model. However ever having used fungicides in the home garden 
relative to never having used fungicides in the home garden was associated with a 
two fold increased relative odds of PD after adjustment for confounding in the 
multivariable model. The result was statistically significant for ever having applied 
fungicides (adjusted OR 2.08, 95% CI 1.02-4.26). After adjustment for confounding 
in the multivariable model, ever having used pesticides inside the home, other than 
household aerosol sprays, was associated with greater than twofold increased odds of 
PD relative to never having used pesticides inside the home. However the result was 
statistically non-significant at the prescribed level. Ever having had home pest 
control treatments applied by a professional pest control operator and ever having 
laundered clothes worn by farm workers were not associated with increased relative 
odds of PD.  
 
 
 
                                                                                                                                          
those hobby gardeners who had gardened for more than 20 years to avoid the influence of PD. In this 
analysis, the inverse relationship remained, although without statistical significance.  
 163 
Table 6.3.1: Risk Factors for Parkinson’s Disease: Home Gardening and Domestic 
Pesticides 
Exposure Variable 
Cases 
163 
N (%)b 
Controls 
151 
N (%)b 
Crude OR 
(95% CI) a 
Adjusted OR 
(95% CI) a, c 
Gardening     
Ever been a hobby gardener 83 (51.9) 94 (62.3) 0.58 (0.36-0.94) 0.51 (0.29-0.92) 
Average days/week worked in 
home garden 
Nil 
<1 
1-2 
3+ 
 
 
80 (54.1) 
11 (8.2) 
37 (27.4) 
20 (14.8) 
 
 
57 (41.3) 
10 (7.6) 
44 (33.3) 
27 (20.5) 
 
1.00 (1.00-1.00)? 
1.00 
0.51 (0.15-1.67) 
0.59 (0.29-1.21) 
0.31 (0.13-0.76) 
 
1.00 (1.00-1.00)? 
1.00 
0.21 (0.02-1.91) 
0.29 (0.04-2.33) 
0.17 (0.02-1.61) 
Years of hobby gardening 
Nil  
1-20 
21-40 
41+ 
 
77 (49.0) 
17 (10.8) 
30 (19.1) 
33 (21.0) 
 
58 (40.0) 
27 (18.6) 
32 (22.1) 
28 (19.3) 
0.99 (0.98-1.00) 
1.00 
0.40 (0.18-0.87) 
0.63 (0.34-1.17) 
0.72 (0.35-1.49) 
0.99 (0.98-1.01) 
1.00 
0.27 (0.10-0.69) 
0.37 (0.15-0.89) 
0.75 (0.33-1.73) 
Garden pesticides     
Ever used pesticides in garden 
<1 per year* 
1-10 times per year* 
>10 times per year* 
 
Nil* 
1-10 years* 
>10 years* 
114 (69.9) 
55 (38.7) 
48 (33.8) 
39 (27.5) 
 
47 (33.6) 
34 (24.3) 
59 (42.1) 
113 (74.8) 
45 (33.6) 
52 (38.8) 
37 (27.6) 
 
37 (27.8) 
35 (26.3) 
61 (45.9) 
0.85 (0.49-1.49) 
1.00 
0.82 (0.43-1.54) 
0.98 (0.49-1.98) 
 
1.00 
0.80 (0.38-1.69) 
0.75 (0.38-1.50) 
1.01 (0.49-2.12) 
1.00 
0.84 (0.36-1.97) 
1.20 (0.48-3.02) 
 
1.00 
0.96 (0.36-2.53) 
0.72 (0.28-1.84) 
Ever mixed herbicides for 
home garden 82 (50.9) 69 (45.7) 1.36 (0.81-2.28) 1.16 (0.61-2.21) 
Ever applied herbicides in 
home garden 102 (63.8) 97 (64.2) 1.04 (0.61-1.76) 1.34 (0.67-2.67) 
Ever mixed insecticides for 
home garden 48 (30.2) 46 (40.5) 1.00 (0.60-1.67) 1.23 (0.65-2.32) 
Ever applied insecticides in 
home garden 76 (47.5) 78 (52.0) 0.83 (0.53-1.31) 0.93 (0.52-1.68) 
Ever mixed fungicides for 
home garden 30 (18.8) 24 (16.0) 1.20 (0.66-2.17) 2.04 (0.94-4.44) 
Ever applied fungicides in 
home garden 43 (26.7) 33 (22.2) 1.33 (0.76-2.35) 2.08 (1.02-4.26) 
Household pesticides     
Ever used insecticides other 
than household spray cans 
inside home 13 (8.6) 19 (11.7) 1.50 (0.72-3.11) 2.40 (0.89-6.49) 
Ever had home treated by a 
pest control operator 131 (82.4) 122 (81.3) 1.13 (0.57-2.21) 1.41 (0.58-3.41) 
Ever did laundry for a farm 
worker 23 (14.1) 23 (15.2) 0.91 (0.49-1.68) 1.13 (0.50-2.54) 
Number of years washed 
clothing for farm worker   1.00 (0.96-1.03) 0.99 (0.94-1.04) 
aConditional logistic regression analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
cCovariates in multivariable model:- Smoking packyears, Ever been a regular tea drinker, Average 
cups of coffee per day, Average alcohol per day, Family history of PD, Hobby gardener 
*More than 10% of data missing; ? Linear dose-response trend 
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The results of the bivariate and multivariable analyses of potential risk factors for PD 
relating to occupational pesticide exposure, and the proportions of exposed cases and 
controls, are presented in Table 6.3.2. At the broadest level of exposure, ever having 
used pesticides occupationally was not associated with PD (OR 0.91, 95% CI 0.50-
1.67). There was a greater than two-fold increased relative odds of PD associated 
with ever having used pesticides occupationally for the equivalent of at least weekly 
exposure for 6 months or more, compared to less intense exposure (OR 2.33, 95% CI 
0.60-9.02). However, the result was statistically non-significant at the prescribed 
level due to the low number of participants with this level of exposure. Longer 
duration of exposure to pesticides occupationally was not associated with increased 
odds of PD. Insecticides were the most common form of pesticides used in the 
occupational setting (approximately 15% of participants exposed), followed by 
herbicides (approximately 8% of participants exposed) and fungicides 
(approximately 3% of participants exposed). Only use of fungicides occupationally 
was associated with increased odds of PD. However the result was statistically non-
significant due to the low prevalence of exposure in the sample. Similar proportions 
of case and control participants reported having had a pesticide sprayed accidentally 
on their skin either at home or at work. 
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Table 6.3.2: Risk Factors for Parkinson’s Disease: Occupational Pesticides 
Exposure Variable 
Cases 
163 
N (%)b 
Controls 
151 
N (%)b 
Crude OR 
(95% CI)a 
Adjusted OR 
(95% CI)a, c 
Ever used pesticides 
occupationally 29 (17.8) 27 (17.9) 0.91 (0.50-1.67) 1.30 (0.61-2.81) 
Average days/year used 
pesticides occupationally 
Nil 
1-25 
26+ 
 
 
134 (85.4) 
13 (8.3) 
10 (6.4) 
 
 
123 (84.2) 
20 (13.7) 
3 (2.1) 
 
 
1.00 
0.50 (0.23-1.11) 
2.33 (0.60-9.02) 
 
 
1.00 
0.86 (0.34-2.22) 
2.57 (0.50-13.15) 
Number of years used 
pesticides occupationally 
Nil 
1-9 years 
10+ years 
 
 
134 (82.2) 
13 (8.0) 
16 (9.8) 
 
 
123 (83.1) 
12 (8.1) 
13 (8.8) 
 
 
1.00 
1.06 (0.48-2.34) 
0.84 (0.36-1.96) 
 
 
1.00 
2.25 (0.65-7.75) 
1.02 (0.41-2.51) 
Ever mixed herbicides 
occupationally 11 (6.8) 14 (9.3) 0.58 (0.23-1.48) 0.74 (0.22-2.46) 
Ever applied herbicides 
occupationally 12 (7.4) 14 (9.3) 0.67 (0.27-1.63) 0.77 (0.25-2.32) 
Ever mixed insecticides 
occupationally 12 (7.4) 14 (9.3) 0.73 (0.29-1.81) 0.88 (0.28-2.82) 
Ever applied insecticides 
occupationally 27 (16.6) 21 (14.1) 1.12 (0.58-2.15) 1.42 (0.63-3.21) 
Ever mixed fungicides 
occupationally 5 (3.1) 1 (0.7) 3.00 (0.31-28.84) 5.29 (0.28-99.70) 
Ever applied fungicides 
occupationally 7 (4.3) 3 (2.0) 1.33 (0.30-5.96) 1.83 (0.32-10.48) 
Ever had skin sprayed with 
a pesticide*  46 (28.8) 45 (30.4) 0.86 (0.50-1.48) 0.92 (0.46-1.85) 
Ever swallowed a 
pesticide* 2 (1.4) 5 (3.4) 0.50 (0.09-2.73) 0.50 (0.06-4.52) 
aConditional logistic regression  analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
cCovariates in multivariable model:- Smoking packyears, Ever been a regular tea drinker, 
Average cups of coffee per day, Average alcohol per day, Family history of PD, Hobby gardener 
*Includes exposure in domestic and occupational settings 
 
Metals 
The results of the bivariate and multivariable analyses of potential risk factors for PD 
relating to occupational exposure to metal fumes and metal processing, and the 
proportions of exposed cases and controls, are presented in Table 6.3.3. While the 
general exposure of working with metals occupationally was not associated with PD, 
welding metal occupationally was associated with nearly two-fold increased odds of 
PD (OR 1.92, 95% CI 0.95-3.85). The relationship was similar after adjustment in 
the multivariable model (adjusted OR 2.32, 95% CI 0.98-5.51). Other ways of being 
exposed to metals, such as soldering or grinding metal, were not associated with PD. 
No dose response relationship was evident for duration or intensity of exposure for 
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the broad exposure of working with metal fumes or dusts. Increased odds of PD was 
associated with shorter duration of welding (1-15 years) and with greater intensity of 
welding (>3.5 days per week). 
 
Table 6.3.3: Risk Factors for Parkinson’s Disease: Metals 
Exposure Variable 
Cases 
163 
N (%)b 
Controls 
151 
N (%)b 
Crude OR 
(95% CI) a 
Adjusted OR (95% 
CI) a, c 
     
Ever exposed to metal 
fumes at work 56 (34.6) 41 (27.2) 1.36 (0.79-2.36) 1.26 (0.64-2.47) 
Number of years exposed 
to metal fumes at work 
Nil 
1-10 years 
>10 years 
 
107 (65.6) 
22 (13.5) 
26 (16.0) 
 
110 (72.8) 
18 (11.9) 
20 (13.3) 
1.00 (0.98-1.03)? 
1.00 
1.35 (0.63-2.90) 
1.06 (0.51-2.21) 
0.99 (0.96-1.02)? 
1.00 
1.28 (0.47-3.46) 
0.78 (0.31-1.97) 
Average days/week exposed 
to metal fumes at work 
Nil 
1-3.5 days/week 
>3.5 days/week 
 
107 (69.0) 
17 (11.0) 
22 (14.2) 
 
110 (75.3) 
12 (8.2) 
20 (13.7) 
1.00 (1.00-1.00)? 
1.00 
0.93 (0.39-2.21) 
1.04 (0.51-2.15) 
1.05 (0.89-1.24)? 
1.00 
0.57 (0.18-1.73) 
1.39 (0.56-3.43) 
Ever welded metal at work 38 (23.3) 22 (14.6) 1.92 (0.95-3.85) 2.32 (0.98-5.51) 
Number of years welded 
metal at work 
Nil 
1-15 years 
>15 years 
 
125 (77.2) 
20 (12.4) 
14 (8.6) 
 
129 (85.4) 
9 (6.0) 
12 (8.0) 
1.02 (0.99-1.04) 
1.00 
2.68 (1.04-6.93) 
1.05 (0.39-2.78) 
1.01 (0.98-1.04) 
1.00 
4.15 (1.10-15.64) 
0.79 (0.24-2.66) 
Average days/week 
welded metal at work 
Nil 
Up to 3.5 days/week 
>3.5 days/week 
 
 
125 (80.1) 
15 (9.6) 
13 (8.3) 
 
 
129 (88.4) 
8 (5.5) 
9 (6.2) 
 
1.08 (0.91-1.28)? 
1.00 
1.61 (0.62-4.20) 
1.80 (0.67-4.87) 
 
1.22 (0.97-1.53)? 
1.00 
1.14 (0.35-3.73) 
5.27 (1.29-21.59) 
Ever soldered metal at work 13 (8.0) 18 (11.9) 0.72 (0.35-1.47) 0.52 (0.21-1.32) 
Ever ground metal at work 17 (10.4) 18 (11.9) 0.73 (0.34-1.60) 0.64 (0.25-1.65) 
aConditional logistic regression  analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
cCovariates in multivariable model:-Smoking packyears, Ever been a regular tea drinker, 
Average cups of coffee per day, Average alcohol per day, Family history of PD, Hobby gardener 
?Test for linear dose-response trend for continuous variable 
 
Solvents  
The results of the bivariate and multivariable analyses of potential risk factors for PD 
relating to occupational exposure to solvents, and the proportions of exposed cases 
and controls, are presented in Table 6.3.4. The general exposure of working with 
solvents occupationally was also only associated with slight increased odds of PD at 
the bivariate level (OR 1.39, 95% CI 0.84-2.29) and multivariable analysis (adjusted 
OR 1.53, 95% CI 0.82-2.86). Using lacquers at work and using petrol as a solvent 
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(for cleaning grease from equipment or skin) were associated with twofold increased 
odds of PD (lacquers OR 2.00, 95% CI 0.60-6.64; petrol OR 2.33, 95% CI 0.60-
9.02), however the results were statistically non-significant at the required level and 
the 95% confidence intervals were wide, reflecting the low prevalence of these 
exposures. After adjustment in the multivariable model, working with cleaning 
solvents was associated with increased odds of PD (adjusted OR 3.37, 95% CI 1.05-
10.77) as did working with thinners, which almost attained statistical significance 
(adjusted OR 2.85, 95% CI 0.92-8.85).  
 
 
Table 6.3.4: Risk Factors for Parkinson’s Disease: Solvents 
Exposure Variable 
Cases 
163 
N (%)b 
Controls 
151 
N (%)b 
Crude OR 
(95% CI) a 
Adjusted OR (95% 
CI) a, c 
     
Ever exposed to solvents at 
work 59 (36.7) 44 (29.1) 1.39 (0.84-2.29) 1.53 (0.82-2.86) 
Number of years exposed 
to solvents at work 
Nil 
1-10 years 
>10 years 
 
104 (63.8) 
22 (13.5) 
26 (16.0) 
 
107 (71.9) 
18 (11.9) 
20 (13.3) 
1.01 (0.99-1.03)? 
1.00 
1.35 (0.63-2.90) 
1.06 (0.51-2.21) 
1.01 (0.98-1.04)? 
1.00 
1.28 (0.47-3.46) 
0.78 (0.31-1.97) 
Average days/week  
exposed to solvents at 
work 
Nil 
1-3 days/week 
>3 days/week 
 
 
104 (63.8) 
13 (8.3) 
21 (12.9) 
 
 
107 (71.9) 
9 (6.2) 
15 (9.9) 
0.97 (0.83-1.12)? 
1.00 
1.38 (0.65-2.93) 
0.89 (0.45-1.75) 
0.96 (0.79-1.16)? 
1.00 
1.11 (0.39-3.20) 
1.10 (0.47-2.57) 
Ever worked with cleaning 
solvents 17 (10.5) 12 (8.0) 1.50 (0.67-3.34) 3.37 (1.05-10.77) 
Ever worked with lacquers 8 (4.9) 4 (2.7) 2.00 (0.60-6.64) 2.15 (0.51-9.06) 
Ever worked with thinners 19 (11.7) 12 (8.0) 1.56 (0.67-3.59) 2.85 (0.92-8.85) 
Ever used petrol as a 
solvent at work 7 (4.3) 3 (2.0) 2.33 (0.60-9.02) 2.15 (0.42-11.04) 
Ever worked with paint 17 (10.5) 15 (9.9) 1.00 (0.46-2.16) 1.31 (0.48-3.57) 
aConditional logistic regression  analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
cCovariates in multivariable model:- Smoking packyears, Ever been a regular tea drinker, 
Average cups of coffee per day, Average alcohol per day, Family history of PD, Hobby gardener 
? Test for linear dose-response trend for continuous variable 
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Rural Residency and Drinking Water Supply  
The results of the bivariate and multivariable analyses of potential risk factors for PD 
relating to rural residency and type of drinking water supply, and the proportions of 
exposed cases and controls, are presented in Table 6.3.5. Having resided in a 
metropolitan area was associated with increased odds of PD in the multivariable 
model, however the result was very unstable and highly confounded. Having resided 
in a rural or a remote area was not associated with increased odds of PD. There was 
also no evidence of a dose-response relationship with longer duration of residence in 
a rural or remote area. Drinking from a private water supply and, specifically, from 
groundwater such as bore water was not associated with PD. 
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Table 6.3.5: Risk Factors for Parkinson’s Disease: Rural Residency 
Exposure Variable 
Cases 
163 
N (%)b 
Controls 
151 
N (%)b 
Crude OR 
(95% CI) a 
Adjusted OR (95% 
CI) a, c 
Rurality     
Ever residedc in 
metropolitan area 151 (92.6) 145 (96.0) 0.67 (0.19-2.36) 2.00 (0.38-10.63) 
Number of years residedc 
in a metropolitan area 
Nil 
1-10 years 
11-30 years 
31-50 years 
>50 years 
 
 
12 (7.4) 
8 (4.9) 
29 (17.8) 
47 (28.8) 
67 (41.1) 
 
 
6 (4.0) 
11 (7.3) 
19 (12.6) 
42 (27.8) 
73 (48.3) 
1.00 (0.98-1.01)? 
1.00 
0.51 (0.12-2.07) 
0.94 (0.23-3.84) 
0.71 (0.16-3.17) 
0.61 (0.14-2.70) 
1.00 (0.99-1.02)? 
1.00 
1.61 (0.26-9.86) 
2.63 (0.39-17.50) 
2.88 (0.40-20.88) 
2.42 (0.33-17.97) 
Ever residedc in rural area 111 (68.1) 94 (62.3) 1.11 (0.66-1.85) 0.78 (0.40-1.53) 
Years residedc in rural area 
Nil 
1-10 years 
11-20 years 
>20 years 
 
52 (31.9) 
33 (20.3) 
27 (16.6) 
51 (31.3) 
 
60 (39.7) 
30 (19.9) 
26 (17.2) 
38 (25.2) 
1.00 (0.98-1.01)? 
1.00 
1.10 (0.59-2.07) 
0.93 (0.45-1.96) 
0.26 (0.65-2.42) 
0.99 (0.97-1.01)? 
1.00 
0.61 (0.27-1.40) 
0.88 (0.34-2.30) 
0.96 (0.41-2.24) 
Ever residedc in remote area 38 (23.3) 37 (24.5) 0.90 (0.54-1.51) 0.62 (0.32-1.21) 
Years residedc in remote 
area 
Nil 
1-10 years 
11-20 years 
>20 years 
 
125 (76.7) 
23 (14.1) 
8 (4.9) 
7 (4.3) 
 
114 (75.5) 
29 (19.2) 
5 (3.3) 
4 (2.7) 
1.01 (0.99-1.04)? 
1.00 
0.69 (0.37-1.29) 
1.09 (0.33-3.62) 
1.70 (0.50-5.81) 
1.00 (0.97-1.04)? 
1.00 
0.45 (0.20-1.02) 
1.19 (0.28-5.12) 
1.09 (0.28-4.66) 
Water supply     
Ever residedc in a home 
with private water supply  94 (57.7) 92 (60.9) 0.75 (0.47-1.20) 0.83 (0.46-1.48) 
Number of years residedd 
in a home with a private 
water supply   1.00 (0.99-1.02) 1.01 (0.99-1.03)? 
Ever residedc in a home 
with a private 
groundwater supply 35 (21.5) 27 (17.9) 1.15 (0.68-1.95) 1.36 (0.71-2.62) 
Number of years residedd 
in a home with a private 
groundwater supply 
Nil 
1-10 years 
11-20 years 
>20 years 
 
 
 
128 (78.5) 
17 (10.4) 
10 (6.1) 
8 (4.9) 
 
 
 
125 (82.8) 
12 (8.0) 
12 (8.0) 
2 (1.3) 
 
 
1.02 (0.99-1.06)? 
1.00 
1.27 (0.58-2.80) 
0.75 (0.32-1.78) 
3.50 (0.73-16.85) 
 
 
1.03 (0.99-1.08)? 
1.00 
1.09 (0.41-2.90) 
1.13 (0.40-3.20) 
3.81 (0.67-21.77) 
aConditional logistic regression  analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
cCovariates in multivariable model:- Smoking packyears, Ever been a regular tea drinker, 
Average cups of coffee per day, Average alcohol per day, Family history of PD, Hobby gardener 
dResided at home for at least a year or more 
? Test for linear dose-response trend for continuous variable 
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Agricultural Exposures 
The results of the bivariate and multivariable analyses of potential risk factors for PD 
relating to agricultural exposures, and the proportions of exposed cases and controls, 
are presented in Table 6.3.6. Ever having lived or worked on a farm was not 
associated with increased relative odds of PD compared to never having lived or 
worked on a farm. Elevated odds ratios were observed for ever having worked on 
farms on which oats, bananas, citrus fruit and stone fruit were cultivated, relative to 
not having worked on any farms. However, low prevalence of these exposures make 
these estimates unstable. An elevated odds ratio was reported for working on a farm 
on which beef cattle were raised. After adjustment in the multivariable model, 
drenching, applying herbicide and planting were associated with elevated odds of 
PD. However, these were statistically non-significant due to the low number of 
exposed participants.  
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Table 6.3.6: Risk Factors for Parkinson’s Disease: Agricultural Exposures 
Exposure Variable 
Cases 
163 
N (%)b 
Controls 
151 
N (%)b 
Crude OR 
(95% CI) a 
Adjusted OR (95% 
CI) a, c 
Ever livedc on a farm 60 (36.8) 50 (33.1) 1.16 (0.72-1.88) 1.38 (0.74-2.57) 
Number of years livedd 
on a farm 
Nil 
1-10 years 
11-20 years 
>20 year 
 
104 (63.8) 
26 (16.0) 
16 (9.8) 
17 (10.4) 
 
99 (65.6) 
27 (17.9) 
12 (8.0) 
13 (8.6) 
1.02 (0.99-1.05)? 
1.00 
0.96 (0.51-1.78) 
1.26 (0.58-2.74) 
1.04 (0.44-2.49) 
1.03 (0.99-1.07)? 
1.00 
0.96 (0.45-2.05) 
2.50 (0.79-7.89) 
1.19 (0.41-3.46) 
Ever worked on a farm 66 (40.5) 58 (38.7) 0.97 (0.61-1.55) 1.23 (0.68-2.25) 
     
Crops cultivated on any farm where participants worked 
Wheat 16 (9.8) 10 (6.6) 1.75 (0.73-4.17) 1.83 (0.62-5.39) 
Vegetables 15 (9.2) 13 (8.6) 0.91 (0.39-2.14) 1.26 (0.45-3.50) 
Sugarcane 10 (6.1) 8 (5.3) 1.14 (0.41-3.15) 1.56 (0.43-5.59) 
Corn 5 (3.1) 5 (3.3) 1.00 (0.29-3.45) 1.25 (0.24-6.54) 
Oats 6 (3.7) 3 (2.0) 1.67 (0.40-6.97) 3.49 (0.47-26.07) 
Lucerne 6 (3.7) 1 (0.7) 5.00 (0.58-42.79) 1.81 (0.16-21.10) 
Tropical fruits 4 (2.5) 3 (1.3) 1.50 (0.25-8.98) 1.28 (0.15-10.78) 
Grapes 3 (1.8) 3 (2.0) 1.00 (0.20-4.96) 0.75 (0.07-8.05) 
Citrus 5 (3.1) 1 (0.7) 4.00 (0.45-35.79) 2.78 (0.25-31.14) 
Barley 3 (1.8) 2 (1.3) 1.00 (0.14-7.10) 0.61 (0.02-18.35) 
Stone Fruit 2 (1.2) 2 (1.3) 0.50 (0.05-5.51) 2.46 (0.12-48.75) 
Banana 1 (0.6) 1 (0.7) 1.00 (0.06-15.99) 3.25 (0.18-58.49) 
     
Animals raised on any farm where participant worked 
Dairy cattle 27 (16.6) 26 (17.2) 0.95 (0.50-1.81) 1.02 (0.45-2.30) 
Beef cattle 24 (14.7) 14 (9.3) 1.80 (0.83-3.90) 2.29 (0.92-5.66) 
Sheep 13 (8.0) 21 (13.9) 0.53 (0.25-1.13) 0.57 (0.22-1.46) 
Pigs 9 (5.5) 9 (6.0) 0.88 (0.32-2.41) 1.23 (0.38-3.97) 
Poultry 7 (4.3) 6 (4.0) 1.00 (0.32-3.10) 0.84 (0.23-3.03) 
     
Farm tasks ever performed 
Mustering 12 (7.4) 13 (8.6) 0.73 (0.29-1.81) 0.93 (0.29-3.04) 
Harvesting 12 (7.4) 11 (7.3) 0.67 (0.34-1.87) 0.58 (0.16-2.09) 
Planting 11 (6.8) 5 (3.3) 2.33 (0.60-9.02) 7.42 (0.76-72.35) 
Applying insecticide 9 (5.5) 5 (3.3) 1.60 (0.52-4.89) 1.50 (0.33-6.75) 
Dipping 7 (4.3) 7 (4.6) 0.67 (0.19-2.36) 0.62 (0.10-3.75) 
Applying herbicide 6 (3.7) 5 (3.3) 1.20 (0.37-3.93) 3.16 (0.48-20.96) 
Picking fruit 5 (3.1) 6 (4.0) 0.40 (0.08-2.06) 0.39 (0.04-4.02) 
Drenching 3 (1.8) 2 (1.3) 1.50 (0.25-8.98) 2.08 (0.12-35.58) 
Packing fruit 1 (0.6) 2 (1.3) 0.50 (0.05-5.51) 1.64 (0.10-27.35) 
aConditional logistic regression  analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
cCovariates in multivariable model:- Smoking packyears, Ever been a regular tea drinker, 
Average cups of coffee per day, Average alcohol per day, Family history of PD, Hobby gardener 
dLived for at least a year or more 
? Test for linear dose-response trend for continuous variable 
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6.3.2 Lifestyle Exposures 
 
Tobacco 
The results of the bivariate and multivariable analyses of potential risk factors for PD 
relating to tobacco, and the proportions of exposed cases and controls, are presented 
in Table 6.3.8. Overall, 37% of cases and 48.7% of controls had smoked cigarettes 
‘regularly’ (daily or nearly every day for a month or more) during their lives. 
Amongst those who had been smokers, controls smoked more (median 30.0 
packyears, range 0.1-210 packyears) than cases (median 15.8, range >0-156 
packyears). Although statistically non-significant, ‘passive smoking’ as measured by 
ever having lived with a smoker and ever having worked in a smoky workplace (such 
as a bar, club or casino), was also associated with decreased odds of PD (Table 
6.3.8). The results for years of living with a smoker were statistically significant and 
suggestive of a weak dose-response relationship. There was evidence of confounding 
of all the crude associations for passive smoking. 
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Table 6.3.7: Risk Factors for Parkinson’s Disease: Tobacco  
Exposure Variable 
Cases 
163 
N (%)b 
Controls 
151 
N (%)b 
Crude OR 
(95% CI) a 
Adjusted 
OR (95% CI)a, c 
Active smoking     
Ever been a regular smoker 60 (37.0) 73 (48.7) 0.57 (0.33-0.99) 0.66 (0.45-1.23) 
Smoking status 
Never smoked 
Ex-smoker 
Current Smoker 
 
102 (63.0) 
57 (35.2) 
3 (1.9) 
 
75 (50.0) 
54 (36.0) 
19 (12.7) 
 
1.00 
0.70 (0.40-1.25) 
0.13 (0.04-0.45) 
1.00 
0.82 (0.43-1.59) 
0.17 (0.04-0.63) 
Packyears smoked 
Nil 
1-14 
15-39 
40+ 
 
93 (60.0) 
28 (18.1) 
25 (16.1) 
9 (5.8) 
 
68 (46.3) 
23 (15.7) 
26 (17.7) 
30 (20.4) 
0.98 (0.97-0.99)? 
1.00 
0.96 (0.42-2.18) 
0.63 (0.29-1.37) 
0.22 (0.08-0.55) 
0.98 (0.97-0.99)? 
1.00 
1.40 (0.52-3.76) 
0.65 (0.25-1.66) 
0.24 (0.08-0.72) 
Passive smoking     
Ever lived with a smoker 122 (75.8) 113 (76.4) 0.92 (0.53-1.61) 0.58 (0.29-1.17) 
Number of years lived with 
a smoker 
Nil 
1-15 years 
15-25 years 
>25 years 
 
 
28 (20.1) 
38 (25.5) 
42 (28.2) 
31 (20.8) 
 
 
44 (29.5) 
28 (20.1) 
44 (31.7) 
33 (23.7) 
 
0.99 (0.98-1.01)? 
1.00 
1.03 (0.48-2.22) 
0.84 (0.42-1.71) 
0.77 (0.36-1.62) 
 
0.98 (0.96-1.00)? 
1.00 
0.69 (0.23-2.04) 
0.35 (0.12-0.96) 
0.42 (0.15-1.19) 
Ever worked in a smoky 
workplace 39 (25.2) 49 (33.6) 0.66 (0.41-1.07) 0.65 (0.35-1.20) 
Number of years worked in 
a smoky workplace  
Nil 
1-10 years 
> 10 years 
 
 
104 (74.8) 
16 (10.7) 
19 (12.7) 
 
 
108 (72.0) 
23 (16.6) 
19 (13.7) 
0.99 (0.96-1.01)? 
1.00 
0.71 (0.36-1.43) 
0.69 (0.36-1.35) 
0.98 (0.95-1.02)? 
1.00 
0.69 (0.29-1.62) 
0.62 (0.25-1.56) 
aConditional logistic regression  analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
cCovariates in multivariable model:- Smoking packyears, Ever been a regular tea drinker, 
Average cups of coffee per day, Average alcohol per day, Family history of PD, Hobby gardener 
? Test for linear dose-response trend for continuous variable 
 
To further examine the relationship between active and passive smoking and PD, 
‘living with a smoker’ and ‘working in a smoky workplace’ were examined stratified 
by ‘ever been a regular smoker’. This was performed because there may be a 
confounding between active smoking and passive smoking. For example, active 
smokers may be more likely to also live with another smoker or to tolerate a smoky 
workplace. While the sample size was insufficient to obtain a statistically significant 
result at the prescribed level, the point estimates suggested an inverse relationship 
between PD and these ’passive smoking’ variables regardless of active smoking 
status.  
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Table 6.3.8: Relationship Between Passive Smoking and Parkinson’s Disease 
Stratified by Active Smoking and Parkinson’s Disease  
Exposure Variable 
Cases 
163 
N (%)b 
Controls 
151 
N (%)b 
Crude OR 
(95% CI) a 
Adjusted OR  
(95% CI)a, c 
     
Ever lived with a smoker 
 
Ever been a regular 
smoker 
 
Never been a regular 
smoker 
 
122 (75.8) 
 
 
50 (83.3) 
 
 
72 (71.3) 
113 (76.4) 
 
 
59 (81.9) 
 
 
54 (71.1) 
0.92 (0.53-1.61) 
 
 
1.20 (0.37-3.93) 
 
 
0.73 (0.34-1.60) 
0.58 (0.29-1.17) 
 
 
0.75 (0.18-3.17) 
 
 
0.52 (0.19-1.38) 
Ever worked in a smoky 
workplace 
 
Ever been a regular 
smoker 
 
Never been a regular 
smoker 
 
 
39 (25.2) 
 
 
17 (29.3) 
 
 
22 (22.9) 
 
49 (33.6) 
 
 
25 (35.7) 
 
 
24 (31.6) 
 
0.66 (0.41-1.07) 
 
 
0.58 (0.23-1.48) 
 
 
0.71 (0.32-1.61) 
 
0.65 (0.35-1.20) 
 
 
0.59 (0.20-1.71) 
 
 
0.80 (0.31-2.07) 
aConditional logistic regression  analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
cCovariates in multivariable model:- Smoking packyears, Ever been a regular tea drinker, 
Average cups of coffee per day, Average alcohol per day, Family history of PD, Hobby 
gardener 
 
Coffee, Tea and Alcohol  
The results of the bivariate and multivariable analyses of potential risk factors for PD 
relating to consumption of coffee, tea and alcohol, and the proportions of exposed 
cases and controls, are presented in Table 6.3.10. Similar to smoking, more controls 
(78.2%) than cases (66.9%) reported drinking coffee regularly at some time in their 
life with controls also reporting higher number of cups of coffee per day consumed 
on average (median 2.6 cups/day, range 0.2-28.4 cups/day) compared to cases 
(median 2.0 cups/day, range 0.4-10.0 cups/day). Regular consumption of tea and 
regular consumption of alcohol were both reported only slightly more frequently by 
controls than cases. Inverse dose-response relationships (decreasing risk of PD with 
increasing consumption) were evident for smoking cigarettes, coffee consumption 
and alcohol consumption, although not for tea consumption. The multivariable model 
confirmed the bivariate associations for all lifestyle variables. There was evidence of 
confounding of the crude associations for coffee drinking and passive smoking. 
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Table 6.3.9: Risk Factors for Parkinson’s Disease: Coffee, Tea and Alcohol 
Consumption 
Exposure Variable 
Cases 
163 
N (%)b 
Controls 
151 
N (%)b 
Crude OR 
(95% CI) a 
Adjusted 
OR (95% CI)a, c 
Coffee     
Ever been a regular 
coffee drinker 109 (66.9) 118 (78.2) 0.63 (0.37-1.07) 0.57 (0.30-1.10) 
Average number  of cups 
of coffee drunk per day 
<1 cup 
1-2 cups 
>2-4 cups 
>4 cups 
64 (39.2) 
49 (31.1) 
28 (17.2) 
22 (13.5) 
 
38 (25.1) 
48 (31.8) 
32 (21.2) 
34 (22.5) 
0.72 (0.57-0.89)? 
 
1.00 
0.68 (0.34-1.12) 
0.55 (0.28-1.09) 
0.38 (0.18-0.78) 
0.86 (0.76-0.98)? 
 
1.00 
0.53 (0.25-1.14) 
0.37 (0.16-0.85) 
0.35 (0.14-0.87) 
Tea     
Ever been a regular tea 
drinker 129 (79.1) 131 (86.8) 0.62 (0.35-1.12) 0.64 (0.30-1.36) 
Average number of cups 
of tea drunk per day 
<1 cup 
1-2 cups 
>2-4 cups 
>4 cups 
 
37 (21.9) 
42 (25.8) 
52 (31.9) 
28 (17.2) 
 
24 (15.9) 
50 (33.1) 
49 (62.5) 
28 (18.5) 
0.94 (0.85-1.04)? 
 
1.00 
0.49 (0.25-0.97) 
0.64 (0.34-1.20) 
0.64 (0.31-1.31) 
1.01 (0.89-1.15)? 
 
1.00 
0.54 (0.22-1.29) 
0.80 (0.37-1.72) 
0.87 (0.36-2.12) 
Alcohol     
Ever been a regular 
alcohol drinker 90 (55.2) 90 (59.6) 0.83 (0.48-1.42) 0.90 (0.46-1.77) 
Average number of 
alcoholic drinks per day 
<1 drink 
1-2 drinks 
3-4 drinks 
>4 drinks 
 
 
87 (53.4) 
38 (23.3) 
18 (11.0) 
17 (10.4) 
71 (47.0) 
33 (21.9) 
18 (11.9) 
26 (17.2) 
0.86 (0.76-0.97)? 
 
1.00 
0.88 (0.46-1.69) 
0.86 (0.38-1.96) 
0.42 (0.17-1.01) 
0.86 (0.74-0.99)? 
 
1.00 
0.80 (0.36-1.78) 
0.62 (0.23-1.68) 
0.41 (0.14-1.19) 
aConditional logistic regression  analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
cCovariates in multivariable model:- Smoking packyears, Ever been a regular tea drinker, 
Average cups of coffee per day, Average alcohol per day, Family history of PD, Hobby 
gardener 
? Test for linear dose-response trend for continuous variable 
 
Consumption of coffee, tea and alcohol were examined stratified by sex as previous 
studies have suggested different relationships between PD and these variables in men 
and women. The results of the bivariate and multivariable analyses of potential risk 
factors for PD relating to consumption of coffee, tea and alcohol, and the proportions 
of exposed cases and controls in men and women, are presented in Tables 6.3.11 and 
6.3.12. Ever having been a regular coffee drinker was associated with decreased odds 
of PD in men in the multivariable model. There was also a linear dose-response 
relationship with decreasing odds of PD with increasing average number of cups of 
coffee drunk per day. Similarly, ever having been a regular coffee drinking was also 
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associated with decreased odds of PD in women. However, the dose-response 
relationship appeared to follow a “U” shape rather than a linear relationship with 
increasing average number of cups of coffee drunk per day. However, the small 
number of participants made the result unstable. 
 
Table 6.3.10: Risk Factors for Parkinson’s Disease: Coffee Consumption 
Stratified by Sex 
Exposure Variable 
Cases 
N (%)b 
Controls 
N (%)b 
Crude OR 
(95% CI) a 
Adjusted 
OR (95% CI)a, c 
Men N=103 N=94   
Ever been a regular 
coffee drinker 76 (73.8) 76 (80.9) 0.88 (0.43-1.79) 0.72 (0.30-1.74) 
Average number  of cups 
of coffee drunk per day 
<1 cup 
1-2 cups 
>2-4 cups 
>4 cups 
 
33 (32) 
33 (32.0) 
22 (21.4) 
15 (14.6) 
 
21 (22.3) 
27 (28.7) 
19 (20.2) 
27 (28.7) 
0.87 (0.77-0.99) 
 
1.00 
0.97 (0.44-2.13) 
0.93 (0.39-2.22) 
0.42 (0.18-1.02) 
0.87 (0.76-1.01) 
 
1.00 
0.88 (0.34-2.32) 
0.61 (0.22-1.72) 
0.42 (0.15-1.18) 
Women N=60 N=57   
Ever been a regular 
coffee drinker 33 (55) 42 (73.7) 0.44 (0.19-1.02) 0.42 (0.13-1.42) 
Average number  of cups 
of coffee drunk per day 
<1 cup 
1-2 cups 
>2-4 cups 
>4 cups 
 
 
31 (51.7) 
16 (26.7) 
6 (10.0) 
7 (11.7) 
 
 
16 (28.1) 
21 (36.8) 
13 (22.8) 
7 (12.3) 
0.84 (0.68-1.03) 
 
1.00 
0.39 (0.14-1.07) 
0.26 (0.08-0.91) 
0.48 (0.11-1.99) 
0.87 (0.66-1.15) 
 
1.00 
0.26 (0.05-1.23) 
0.21 (0.04-1.09) 
0.49 (0.06-4.01) 
aConditional logistic regression analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
cCovariates in multivariable model:- Smoking packyears, Ever been a regular tea drinker, 
Average cups of coffee per day, Average alcohol per day, Family history of PD, Hobby 
gardener 
? Test for linear dose-response trend for continuous variable 
 
While ever having been a regular tea drinker was also associated with decreased odds 
of PD in men, the odds of PD appeared to increase with increasing average number 
of cups of tea drunk per day in the multivariable model. While ever having been a 
regular tea drinker was also associated with decreased odds of PD in women, the 
odds of PD did not follow a clear dose-response relationship with increasing average 
number of cups of tea drunk per day. 
 177 
 
Table 6.3.12: Risk Factors for Parkinson’s Disease: Tea Consumption 
Stratified by Sex 
Exposure Variable 
Cases 
N (%)b 
Controls 
N (%)b 
Crude OR 
(95% CI) a 
Adjusted 
OR (95% CI)a, c 
Men N=103 N=94   
Ever been a regular tea 
drinker 83 (80.6) 79 (84.0) 0.82 (0.41-1.67) 0.84 (0.34-2.07) 
Average number of cups 
of tea drunk per day 
<1 cup 
1-2 cups 
>2-4 cups 
>4 cups 
 
 
29 (28.2) 
30 (29.1) 
29 (28.2) 
15 (16.0) 
 
 
14 (14.9) 
34 (36.2) 
26 (27.7) 
20 (19.4) 
1.02 (0.89-1.16) 
1.00 
0.70 (0.32-1.56) 
0.91 (0.41-2.01) 
1.04 (0.42-2.55) 
1.16 (0.96-1.39) 
1.00 
0.90 (0.31-2.58) 
1.34 (0.47-3.79) 
1.77 (0.55-5.72) 
Women N=60 N=57   
Ever been a regular tea 
drinker 46 (76.7) 52 (91.2) 0.33 (0.11-1.03) 0.37 (0.08-1.76) 
Average number of cups 
of tea drunk per day 
<1 cup 
1-2 cups 
>2-4 cups 
>4 cups 
 
 
12 (20.0) 
12 (20.0) 
23 (38.3) 
13 (22.8) 
 
 
10 (17.5) 
16 (28.1) 
23 (40.4) 
8 (13.3) 
0.83 (0.70-1.00) 
1.00 
0.22 (0.06-0.86) 
0.30 (0.10-0.96) 
0.22 (0.06-0.85) 
0.86 (0.66-1.13) 
1.00 
0.13 (0.02-1.05) 
0.23 (0.05-1.06) 
0.32 (0.05-1.99) 
aConditional logistic regression analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
cCovariates in multivariable model:- Smoking packyears, Ever been a regular tea drinker, 
Average cups of coffee per day, Average alcohol per day, Family history of PD, Hobby 
gardener 
? Test for linear dose-response trend for continuous variable 
 
Ever having been a regular alcohol drinker was associated with decreased odds of PD 
in men. The odds of PD decreased in linearly with increasing average number of 
drinks consumed per day. Ever having been a regular alcohol drinker was not 
associated with decreased odds of PD in women. There were insufficient numbers of 
exposed individuals to examine a dose-response in women. 
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Table 6.3.12: Risk Factors for Parkinson’s Disease: Alcohol Consumption 
Stratified by Sex 
Exposure Variable 
Cases 
N (%)b 
Controls 
N (%)b 
Crude OR 
(95% CI) a 
Adjusted 
OR (95% CI)a, c 
Men N=103 N=94   
Ever been a regular 
alcohol drinker 68 (66.0) 72 (76.6) 0.65 (0.32-1.31) 0.67 (0.27-1.61) 
Average number of 
alcoholic drinks per day 
<1 drink 
1-2 drinks 
3-4 drinks 
>4 drinks 
 
 
 
27 (26.2) 
16 (15.5) 
17 (16.5) 
 
 
 
19 (20.2) 
17 (18.1) 
25 (26.6) 
 
0.86 (0.76-0.98) 
1.00 
1.06 (0.49-2.30) 
0.83 (0.371.84) 
0.46 (0.19-1.11) 
0.86 (0.74-1.00) 
1.00 
1.08 (0.40-2.92) 
0.72 (0.26-1.97) 
0.48 (0.16-1.42) 
Women N=60 N=57   
Ever been a regular 
alcohol drinker 22 (36.7) 18 (31.6) 1.22 (0.51-2.95) 1.20 (0.34-4.18) 
Average number of 
alcoholic drinks per day   0.85 (0.53-1.36) 0.49 (0.21-1.15) 
<1 drink 
1-2 drinks 
3-4 drinks 
>4 drinks 
Insufficient numbers of exposed individuals to calculate 
 
 
 
aConditional logistic regression analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
cCovariates in multivariable model:- Smoking packyears, Ever been a regular tea drinker, 
Average cups of coffee per day, Average alcohol per day, Family history of PD, Hobby 
gardener 
? Test for linear dose-response trend for continuous variable 
 
6.3.3 Medical and Family History  
Head Injury 
The results of the bivariate and multivariable analyses of potential risk factors for PD 
relating to head injury, and the proportions of exposed cases and controls, are 
presented in Table 6.3.14. Head injury, measured as ‘sustaining a serious head 
injury’, ‘being knocked unconscious’ or ever ‘playing contact sports’ was not 
associated with PD. Neither playing soccer nor boxing were associated with 
increased odds of PD. 
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Table 6.3.13: Risk Factors for Parkinson’s Disease: Head Injury  
Exposure Variable 
Cases 
163 
N (%)b 
Controls 
151 
N (%)b 
Crude OR 
(95% CI) a 
Adjusted OR  
(95% CI)a, c 
Head injury     
Ever had a serious head 
injury 57 (35.0) 49 (32.7) 1.03 (0.62-1.72) 1.18 (0.62-2.25) 
Number of head injuries 
received 
Nil 
1  
> 1 
 
106 (65.0) 
34 (20.9) 
16 (9.8) 
 
102 (67.5) 
32 (21.2) 
17 (11.3) 
 
1.00 
0.81 (0.43-1.53) 
0.95 (0.44-2.09) 
 
1.00 
1.13 (0.52-2.45) 
0.96 (0.35-2.63) 
Ever knocked 
unconscious 34 (21.0) 30 (20.3) 1.10 (0.60-2.02) 1.47 (0.68-3.17) 
Number of times knocked 
unconscious 
Nil 
1 
>1 
 
 
129 (79.1) 
21 (12.9) 
19 (12.6) 
 
 
121 (80.1) 
9 (5.5) 
9 (6.0) 
1.00 
0.99 (0.47-2.09) 
0.93 (0.43-1.99) 
 
 
1.00 
1.86 (0.71-4.91) 
1.53 (0.37-6.33) 
Ever played contact 
sports 62 (40.8) 60 (40.0) 1.00 (0.56-1.78) 0.91 (0.43-1.90) 
Ever played football 50 (30.7) 56 (37.1) 0.69 (0.38-1.26) 0.64 (0.30-1.35) 
Ever boxed 19 (11.7) 12 (8.0) 1.55 (0.72-3.30) 1.28 (0.49-3.35) 
aConditional logistic regression  analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
cCovariates in multivariable model:- Smoking packyears, Ever been a regular tea drinker, 
Average cups of coffee per day, Average alcohol per day, Family history of PD, Hobby 
gardener 
 
Family History of Neurological and Genetic Disorders 
The results of the bivariate and multivariable analyses of potential risk factors for PD 
relating to family history of specific conditions, and the proportions of cases and 
controls with these family histories, are presented in Table 6.3.15. Family history of 
each of the conditions examined (PD, Alzheimer’s disease, Motor Neurone Disease, 
Downs syndrome and Tremor), was deemed present if the condition was reported in 
parents, siblings, sons, daughters, aunts, uncles, first cousins, nieces, nephews, 
grandparents, or grandchildren of the participant. Other relationships, such as second 
cousins or great grandparents were not included to reduce error in reporting of distant 
relatives and to restrict consideration to those genetically close to the participant. 
Family history of PD was reported more frequently by cases (25.2%) than controls 
(11.3%) and was associated a greater than twofold increased odds of PD (OR 2.83, 
95% CI 1.47-5.47). Family history of unspecified tremor disorders, which may 
include undiagnosed PD was reported only slightly more by cases (11.1%) than 
controls (9.3%). Family history of Alzheimer’s disease was reported less frequently 
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by cases (9.8%) than controls (15.4%), though family history of Trisomy 21 (Down’s 
syndrome) was reported more frequently by cases (6.1%) than controls (0.7%), 
though very few participants (n=10) had this family history. Similarly, very few 
participants reported a family history of Motor Neurone Disease (n=6).  
 
Table 6.3.14: Risk Factors for Parkinson’s Disease: Family History of 
Neurological Disorders 
Variable 
Cases 
163 
N (%)b 
Controls
151 
N (%)b 
Crude OR 
(95% CI) a 
Adjusted 
OR (95% CI)a, c 
Family history      
Family history of PD 41 (25.2) 17 (11.3) 2.83 (1.47-5.47) 2.30 (1.06-5.00) 
Family history of ALZ 16 (9.8) 23 (15.4) 0.57 (0.28-1.61) 0.45 (0.18-1.13) 
Family history of MND 2 (1.2) 4 (2.7) 0.50 (0.09-2.73) 0.63 (0.09-4.53) 
Family history of Downs 10 (6.1) 1 (0.7) 9.00 (1.14-71.04) 3.64 (0.41-32.45) 
Family history of tremor 18 (11.1) 14 (9.3) 1.25 (0.59-2.67) 2.10 (0.84-5.25) 
aConditional logistic regression  analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
cCovariates in multivariable model:- Smoking packyears, Ever been a regular tea drinker, 
Average cups of coffee per day, Average alcohol per day, Family history of PD, Hobby 
gardener 
 
 
6.4 Effect Modification 
Environmental and lifestyle exposures that were directly related to chemicals or 
metals were examined with conditional logistic regression for matched sets, stratified 
by history of regular tobacco smoking and history of regular coffee drinking to 
determine if these variables were effect modifiers (Tables 6.4.1-6.4.2). Regular 
tobacco smoking appeared to be an effect modifier for several variables (home 
fungicide use, occupational herbicide use, working with metals, welding metals, 
regular tea consumption and regular alcohol consumption). However, the small 
numbers following stratification made meaningful comparisons difficult. 
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Table 6.4.1: Risk Factors for Parkinson’s Disease: Environmental and Lifestyle 
Exposures  Stratified by Active Smoking  
Exposure Variable 
Cases 
163 
N (%)b 
Controls 
151 
N (%)b 
Crude OR 
(95% CI) a 
Domestic pesticide exposure    
Ever used pesticides in home garden 
Ever been a regular smoker 
Never been a regular smoker 
114 (69.9) 
45 (75.0) 
69 (67.7) 
113 (74.8) 
55 (75.3) 
57 (74.0) 
0.85 (0.49-1.49) 
1.60 (0.52-4.89) 
0.73 (0.29-1.81) 
Ever applied herbicides at home 
Ever been a regular smoker 
Never been a regular smoker 
102 (63.8) 
42 (70.0) 
60 (60.6) 
97 (64.2) 
48 (65.8) 
48 (62.3) 
1.04 (0.61-1.76) 
1.57 (0.61-4.05) 
1.11 (0.45-2.73) 
Ever applied insecticides at home 
Ever been a regular smoker 
Never been a regular smoker 
76 (47.5) 
30 (50.9) 
46 (46.0) 
78 (52.0) 
37 (51.4) 
40 (52.3) 
0.83 (0.53-1.31) 
0.75 (0.32-1.78) 
0.71 (0.34-1.48) 
Ever applied fungicides at home 
Ever been a regular smoker 
Never been a regular smoker 
43 (26.7) 
17 (28.8) 
26 (25.7) 
33 (22.2) 
19 (26.8) 
14 (18.2) 
1.33 (0.76-2.35) 
1.00 (0.32-3.10) 
2.17 (0.82-5.70) 
Occupational pesticide exposure    
Ever used pesticides occupationally 
Ever been a regular smoker 
Never been a regular smoker 
29 (17.8) 
14 (23.3) 
15 (14.7) 
27 (17.9) 
14 (19.4) 
12 (15.8) 
0.91 (0.50-1.67) 
1.40 (0.44-4.41) 
0.75 (0.26-2.16) 
Ever used pesticides occupationally 
weekly for 6 months or more 
Ever been a regular smoker 
Never been a regular smoker 
 
10 (6.4) 
5 (8.9) 
5 (5.0) 
 
3 (2.1) 
2 (2.9) 
1 (1.3) 
 
2.33 (0.60-9.02) 
3.00 (0.31-28.84) 
2.00 (0.18-22.05) 
Ever applied herbicides at work 
Ever been a regular smoker 
Never been a regular smoker 
12 (7.4) 
7 (11.7) 
5 (4.9) 
14 (9.3) 
8 (11.0) 
6 (7.9) 
0.67 (0.27-1.63) 
2.00 (0.37-10.92) 
0.17 (0.02-1.39) 
Ever applied insecticides at work 
Ever been a regular smoker 
Never been a regular smoker 
27 (16.6) 
13 (21.7) 
14 (13.7) 
21 (14.1) 
10 (13.9) 
11 (14.5) 
1.12 (0.58-2.15) 
1.50 (0.42-5.32) 
0.86 (0.29-2.55) 
Ever applied fungicides at work 
Ever been a regular smoker 
Never been a regular smoker 
7 (4.3) 
4 (6.7) 
3 (2.9) 
3 (2.0) 
2 (2.7) 
1 (1.3) 
1.33 (0.30-5.96) 
- 
2.00 (0.18-22.05) 
Occupational metal and solvent exposure 
Ever worked with metal fumes 
Ever been a regular smoker 
Never been a regular smoker 
56 (34.6) 
19 (31.7) 
37 (36.6) 
41 (27.2) 
23 (31.5) 
18 (23.4) 
1.36 (0.79-2.36) 
0.78 (0.29-2.09) 
1.88 (0.80-4.42) 
Ever welded metal at work 
Ever been a regular smoker 
Never been a regular smoker 
38 (23.3) 
14 (23.3) 
24 (23.5) 
22 (14.6) 
13 (17.8) 
9 (11.7) 
1.92 (0.95-3.85) 
1.20 (0.37-3.93) 
2.50 (0.78-7.97) 
Ever worked with solvents 
Ever been a regular smoker 
Never been a regular smoker 
59 (36.7) 
25 (42.4) 
34 (33.7) 
44 (29.1) 
35 (34.3) 
19 (24.7) 
1.39 (0.84-2.29) 
0.88 (0.32-2.41) 
1.33 (0.56-3.16) 
Ever worked with thinners 
Ever been a regular smoker 
Never been a regular smoker 
19 (11.7) 
8 (13.3) 
11 (10.9) 
12 (8.0) 
6 (8.2) 
6 (7.8) 
1.56 (0.67-3.59) 
1.50 (0.25-8.98) 
1.33 (0.30-5.96) 
Ever worked with cleaning solvents 
Ever been a regular smoker 
Never been a regular smoker 
17 (10.5) 
9 (15.0) 
8 (7.9) 
12 (8.0) 
6 (8.2) 
6 (7.8) 
1.50 (0.67-3.34) 
1.00 (0.20-4.96) 
0.75 (0.17-3.35) 
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Lifestyle exposures    
Ever been a regular coffee drinker 
Ever been a regular smoker 
Never been a regular smoker 
109 (66.9) 
44 (73.3) 
65 (63.7) 
118 (78.2) 
57 (78.1) 
60 (77.9) 
0.63 (0.37-1.07) 
0.88 (0.32-2.41) 
0.43 (0.17-1.12) 
Ever been a regular tea drinker 
Ever been a regular smoker 
Never been a regular smoker 
129 (79.1) 
52 (86.7) 
67 (87.0) 
131 (86.8) 
63 (86.3) 
76 (74.5) 
0.62 (0.35-1.12) 
1.20 (0.37-3.93) 
0.60 (0.22-1.65) 
Ever been a regular alcohol drinker 
Ever been a regular smoker 
Never been a regular smoker 
90 (55.2) 
35 (58.3) 
54 (52.9) 
90 (59.6) 
42 (57.5) 
47 (61.0) 
0.83 (0.48-1.42) 
2.40 (0.85-6.81) 
0.46 (0.16-1.31) 
- Not able to be calculated 
aConditional logistic regression  analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
 
Ever having been a regular coffee drinker appeared to be an effect modifier for the 
relationship between PD and home fungicide use. However, the low prevalence of 
some variables may have made the risk estimates unstable and many could not be 
calculated due to insufficient number of exposed participants. The stratified 
relationships were also examined adjusted for ever having been a regular smoker 
(data not shown). The adjustment did not substantially alter the results. 
 
 
Table 6.4.2: Risk Factors for Parkinson’s Disease: Environmental and Lifestyle 
Exposures  Stratified by Coffee Drinking 
Exposure Variable 
Cases 
163 
N (%)b 
Controls 
151 
N (%)b 
Crude OR 
(95% CI) a 
Domestic pesticide exposure    
Ever used pesticides in home garden 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
114 (69.9) 
81 (74.3) 
33 (61.1) 
113 (74.8) 
89 (75.4) 
24 (72.7) 
0.85 (0.49-1.49) 
1.08 (0.51-2.29) 
0.25 (0.03-2.24) 
Ever applied herbicides at home 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
102 (63.8) 
75 (70.1) 
27 (50.9) 
97 (64.2) 
76 (64.4) 
21 (63.6) 
1.04 (0.61-1.76) 
1.36 (0.63-2.97) 
0.33 (0.04-3.21) 
Ever applied insecticides at home 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
76 (47.5) 
52 (48.2) 
24 (46.2) 
78 (52.0) 
60 (50.9) 
18 (56.3) 
0.83 (0.53-1.31) 
0.75 (0.41-1.38) 
1.00 (0.06-15.99) 
Ever applied fungicides at home 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
43 (26.7) 
32 (29.4) 
11 (21.2) 
33 (22.2) 
25 (21.4) 
8 (25.0) 
1.33 (0.76-2.35) 
1.23 (0.59-2.56) 
3.00 (0.31-28.84) 
Occupational pesticide exposure    
Ever used pesticides occupationally 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
29 (17.8) 
19 (17.4) 
10 (18.5) 
27 (17.9) 
18 (15.4) 
8 (25.0) 
0.91 (0.50-1.67) 
1.50 (0.67-3.34) 
- 
Ever used pesticides occupationally 
weekly for 6 months or more 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
 
10 (6.4) 
6 (5.7) 
4 (7.7) 
 
3 (2.1) 
3 (2.6) 
0 (0) 
 
2.33 (0.60-9.02) 
1.67 (0.40-6.97) 
- 
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Ever applied herbicides at work 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
12 (7.4) 
4 (3.7) 
8 (14.8) 
14 (9.3) 
8 (6.8) 
6 (18.2) 
0.67 (0.27-1.63) 
0.80 (0.22-2.98) 
- 
Ever applied insecticides at work 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
27 (16.6) 
18 (16.5) 
9 (16.7) 
21 (14.1) 
14 (12.0) 
7 (21.9) 
1.12 (0.58-2.15) 
2.00 (0.81-4.96) 
- 
Ever applied fungicides at work 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
7 (4.3) 
4 (3.7) 
3 (5.6) 
3 (2.0) 
2 (1.7) 
1 (3.0) 
1.33 (0.30-5.96) 
2.00 (0.18-22.05) 
- 
Occupational metal and solvent exposure 
Ever worked with metal fumes 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
56 (34.6) 
43 (39.8) 
13 (24.1) 
41 (27.2) 
32 (27.1) 
9 (27.3) 
1.36 (0.79-2.36) 
1.82 (0.87-3.79) 
2.00 (0.18-22.05) 
Ever welded metal at work 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
38 (23.3) 
29 (26.6) 
9 (16.7) 
22 (14.6) 
17 (14.4) 
5 (15.2) 
1.92 (0.95-3.85) 
2.83 (1.12-7.19) 
1.00 (0.06-15.99) 
Ever worked with solvents 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
59 (36.7) 
46 (42.6) 
13 (24.5) 
44 (29.1) 
34 (28.8) 
10 (30.3) 
1.39 (0.84-2.29) 
1.38 (0.72-2.62) 
0.50 (0.05-5.51) 
Ever worked with thinners 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
19 (11.7) 
18 (16.5) 
1 (1.9) 
12 (8.0) 
8 (6.8) 
4 (12.1) 
1.56 (0.67-3.59) 
2.75 (0.88-8.64) 
- 
Ever worked with cleaning solvents 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
17 (10.5) 
13 (11.9) 
4 (7.6) 
12 (8.0) 
8 (6.8) 
4 (12.1) 
1.50 (0.67-3.34) 
1.33 (0.46-3.84) 
- 
Lifestyle exposures    
Ever been a regular smoker 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
109 (66.9) 
44 (40.4) 
16 (30.2) 
118 (78.2) 
57 (48.7) 
16 (48.5) 
0.63 (0.37-1.07) 
0.71 (0.34-1.48) 
0.67 (0.11-3.99) 
Ever been a regular tea drinking 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
129 (79.1) 
87 (79.8) 
42 (77.8) 
131 (86.8) 
99 (83.9) 
32 (97.0) 
0.62 (0.35-1.12) 
0.65 (0.30-1.38) 
- 
Ever been a regular alcohol drinker 
Ever been a regular coffee drinker 
Never been a regular coffee drinker 
90 (55.2) 
67 (61.5) 
23 (42.6) 
90 (59.6) 
70 (59.3) 
20 (60.6) 
0.83 (0.48-1.42) 
1.06 (0.54-2.10) 
- 
- Not able to be calculated 
aConditional logistic regression  analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation 
 
6.5 Age at Diagnosis  
The average age at diagnosis of PD in cases exposed to smoking, welding, pesticides, 
solvents and having a family history of PD compared to those without these 
exposures are presented in Table 6.5.1. PD cases who had ever been smokers, or 
were exposed to welding, pesticides, or solvents, occupationally were diagnosed at a 
similar average age than those who were not exposed. Similarly, PD cases with a 
family history of PD were diagnosed at a similar average age as those cases without a 
family history.  
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Table 6.5.1: Comparison of Age at Parkinson’s Disease (PD) Diagnosis for 
Exposed and Unexposed Cases 
 
 
Exposure Variable 
Exposed Cases 
Mean Age of PD 
Diagnosis (SD) 
Unexposed Cases 
Mean Age of PD 
Diagnosis (SD) 
Ever been a regular smoker 61.6 (9.6) 59.4 (10.1) 
Ever welded metal at work 59.1 (10.5) 60.6 (9.7) 
Ever used pesticides occupationally  58.8 (9.0) 60.5 (10.1) 
Ever exposed to solvents at work 58.4 (9.8) 61.1 (9.8) 
Have a family history of PD 59.0 (9.0) 60.7 (10.2) 
SD Standard Deviation 
 
 
6.6 ‘Dummy’ Exposures 
A number of questions relating to exposures which have no known link to PD 
aetiology were included in the questionnaire, to check for generalised systematic 
over-reporting of environmental exposures by cases. These ‘dummy’ exposures were 
electromagnetic radiation and asbestos. Having received an electric shock was 
associated with reduced odds of PD (OR 0.60, 95% CI 0.35-1.01). Exposure to 
Electromagnetic Fields (EMF) through working as an electrician was associated with 
increased odds of PD (adjusted OR 3.78, 95% CI 0.44-32.56). However, there were 
only 8 participants in the sample who reported this exposure. Occupational exposure 
to EMF from electric welding was associates with increased odds of PD (adjusted 
OR 2.20, 95% CI 0.65-7.50). As exposure to metals through welding was associated 
with increased odds of PD, the odds of PD was calculated with exposure to EMF 
other than through welding. This variable was not associated with PD risk at 
bivariate (crude OR 1.08, 95% CI 0.63-1.86) or multivariable level (adjusted OR 
1.48, 95% CI 0.73-3.01). 
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Table 6.6.1: Dummyc Risk Factors for Parkinson’s Disease: EMF and Asbestos 
Exposure Variable 
Cases 
163 
N (%)b 
Controls 
151 
N (%)b 
Crude OR 
(95% CI) a 
Cases 
163 
N (%)b 
EMF 
Ever lived close to high 
voltage powerlines 25 (16.2) 26 (17.3) 0.88 (0.44-1.77) 0.97 (0.41-2.32) 
Ever used an electric blanket 131 (81.4) 123 (82.6) 0.94 (0.49-1.83) 0.93 (0.41-2.08) 
Ever thrown backwards or 
required medical treatment 
due to an electric shock  39 (24.2) 50 (33.1) 0.60 (0.35-1.01) 0.58 (0.30-1.11) 
Ever worked with EMF 
 
60 (37.7) 
 
49 (32.9) 
 
1.27 (0.76-1.12) 
 
1.83 (0.92-3.64) 
1.49 (0.72-3.12)* 
Ever worked as  an electrician 5 (3.1) 3 (2.0) 1.67 (0.40-6.97) 3.78 (0.44-32.56) 
Ever worked with mechanical 
motors 14 (8.7) 11 (7.3) 1.22 (0.51-2.95) 1.05 (0.37-3.28) 
Ever worked with a computer  8 (5.0) 9 (6.0) 0.89 (0.34-2.30) 1.05 (0.31-3.58) 
Ever exposed to electric 
welding 15 (9.3) 9 (6.0) 1.83 (0.68-4.96) 2.20 (0.65-7.50) 
Ever worked with EMF other 
than welding 44 (27.9) 40 (26.9) 1.08 (0.63-1.86) 1.48 (0.73-3.01) 
Asbestos     
Ever lived in house 
constructed of asbestos 79 (52.3) 79 (54.8) 0.91 (0.56-1.48) 1.00 (0.54-1.85) 
Ever had direct contact with 
asbestos sheets at home 41 (29.3) 48 (32.7) 0.90 (0.53-1.52) 0.86 (0.45-1.62) 
Ever worked with asbestos 42 (26.4) 29 (19.9) 1.26 (0.69-2.31) 1.48 (0.69-3.16) 
Number of years worked with 
asbestos - - 1.01 (0.97-1.05) 0.99 (0.94-1.04) 
Average number of days per 
year worked with asbestos - - 1.00 (1.00-1.00) 1.00 (1.00-1.01) 
aConditional logistic regression  analysis for matched sets  
bUnmatched proportions of exposed individuals displayed to simplify data presentation  
cAn exposure with no established link to PD aetiology included in questionnaire to assess over-
reporting of environmental exposures by PD cases. 
*Adjusted for exposure to metals through welding, packyears, coffee, tea, alcohol, family history of 
PD and hobby gardening. 
 
6.7 Discussion 
Statistically significant relationships between exposure and PD odds were only 
observed for ever gardened for a hobby, ever applied fungicides in the home garden, 
ever exposed to cleaning solvents occupationally, packyears smoked (trend), average 
number of cups of coffee drunk per day (trend), average number of alcoholic 
beverages consumed per day (trend) and having a family history of PD. While many 
of the results observed did not reach statistical significance in the multivariable 
model (e.g. occupational exposure to pesticides, metal fumes and solvents, farming, 
and groundwater consumption), the odds ratios were generally in the direction 
expected from the literature. However, the relative odds of PD observed for the 
exposures of hobby gardening and rural residency were in the opposite direction to 
that expected from the previous literature. 
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Smoking 
The current study confirmed the well-established inverse association between 
cigarette smoking and PD . While the result for ‘ever smoking on a regular basis’ lost 
statistical significance after adjustment for confounders, the point estimate did not 
change substantially (unadjusted OR 0.57, 95% CI 0.33-0.99; adjusted OR 0.66, 95% 
CI 0.45-1.23). A statistically significant linear dose-response relationship with 
decreasing odds for every pack-year smoked (adjusted OR 0.98, 95% CI 0.97-0.99) 
was also observed. The results of a reduced odds associated with Ever smoking and 
decreasing odds with increasing pack-years smoked, are consistent with the majority 
of case-control and prospective cohort studies, such as Checkoway et al. (2002) and 
Grandinetti et al. (1994). The odds ratio point estimates for Ever smoking (OR 0.66, 
95% CI 0.45-1.23) and Past smoking (OR 0.82, 95% CI .43-1.59) were similar in 
magnitude to the pooled relative risks (RRs) reported by Hernán, et al. (2002) from a 
meta-analysis of case-control studies (Ever smoking RR 0.60, 95% CI 0.55-0.65; 
Past smoking RR 0.88, 95% CI 0.69-0.93). While the observed point estimate was 
greater for current smoking (OR 0.17, 95% CI 0.04-0.63) than the pooled risk 
estimate from the meta-analysis (RR 0.39, 95% CI 0.32-0.47), the 95% confidence 
interval included the pooled RR estimate. 
 
Mayeux, et al. (1994) only found decreased odds of PD with being a current smoker 
rather than being an ex-smoker. The authors interpret this finding as evidence that 
smoking is not protective against PD, but rather that developing PD causes patients 
to quit smoking. Unfortunately, Mayeux et al. did not report on when the ex-smokers 
had quit with respect to their diagnosis of PD (or likely year of onset). In the current 
study, smoking status was assigned to participants according to their smoking status 
at time of diagnosis (or for controls, the year of diagnosis of the matched case). This 
method should limit the influence of PD diagnosis on smoking status, although it is 
possible that undiagnosed PD may have caused some patients to cease smoking, for 
example if cigarette smoke negatively affects PD symptoms. Similar to these results, 
the majority of existing studies report a greater reduction in odds of PD amongst 
current smokers than ex-smokers (Zayed et al. 1990; Nuti et al. 2004).  
Age of diagnosis for patients with a history of smoking was similar to patients who 
had never smoked (smokers: mean 61.6, s.d. 9.6 years; non-smokers: 59.4, s.d. 10.1 
years). Other studies have also reported that the age-of-onset of PD was identical for 
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smokers and non-smokers (Golbe et al. 1986; Mayeux et al. 1994). This finding 
suggests that smoking does not delay the onset of symptoms in those who will 
ultimately develop PD. In contrast to these results, Rajput et al (1987a) found onset 
of PD to be earlier in smokers than in non-smokers, although the difference was only 
5 years (ever-smoked mean age 68.8 years; never-smoked mean age 73.8 years). The 
reason for this difference in result is not readily apparent, however Rajput et al.’s 
(1987a) sample appears older than the current study’s sample, and the study was 
conducted more than 20 years before the current study, therefore some inherent 
differences in smoking patterns between the two populations may contribute to this 
discrepancy. It should also be noted that Rajput et al.’s study had 12% of the data on 
smoking status for cases missing. No information is provided concerning which age 
groups the data were missing from, however, if more smokers with an older onset 
had missing data than non-smokers with an older onset, then the reported difference 
in age of smokers and non-smokers may not be valid. It is more likely that the 
missing data would contain more smokers than non-smokers as abstainers would find 
it easier to report their smoking history than smokers. Older age has also been 
associated with lower recall, therefore the missing responses may be reflective of 
older participants’ difficulty in recalling details of smoking habits (Colsher and 
Wallace 1989). 
 
Passive Smoking 
Exposure to passive smoking (environmental tobacco smoke) was measured in both 
the home and workplace environments. We found a clinically significant relationship 
between environmental tobacco smoke and PD, both at home and at work, although 
there was no dose-response pattern observable and the results were statistically non-
significant. The relationships observed between living with a smoker (OR 0.58, 95% 
CI 0.29-1.17) and working in a smoky workplace and PD (OR 0.65, 95% CI 0.35-
1.20) were of a similar magnitude to ever being an active smoker (OR 0.66, 95% CI 
0.45-1.23). As there are no previously published reports of a relationship between 
passive smoking and PD, this may be the first time the relationship has been 
identified (Mellick et al. 2006). This finding is of great importance as it is highly 
suggestive of a biological reason, such as through prevention of neurotoxic effects of 
chemicals through changes in enzymatic activity, for the relationship between 
tobacco smoking and PD. An alternative explanation, that PD patients are adverse to 
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the habit of tobacco smoking due to a common personality trait, could also be 
applied to the passive smoking scenario in some situations, i.e. people who dislike 
smoking may be less likely to marry a smoker, the explanation is somewhat weaker 
as PD cases have less control over other people’s behaviours than their own. This is 
particularly true when the smoker is a parent. 
 
Exposure to environmental tobacco smoke in the workplace was measured with the 
question “Have you ever worked in a smoky workplace, such as a bar, club or 
casino?”, and follow up questions regarding number of years and average hours per 
week worked in these environments. An accurate historical measure of workplace 
environmental tobacco smoke is very difficult to obtain due to the many factors that 
can influence exposure, such as ventilation, proximity of work station to the source 
of smoke, and number of smokers in the workplace. Prior to the introduction of 
controls on workplace smoking, many office environments were likely to contain 
substantial amounts of environmental tobacco smoke. The definition was restricted to 
bars, clubs and casinos, as these are environments that typically contain chronic high 
concentrations of environmental tobacco smoke. It is acknowledged that some 
participants may have included other types of workplaces, such as offices, if they felt 
that the workplace had been as smoky as a bar environment. These factors may 
contribute to measurement error in the data for these variables. Both of these 
‘background’ exposures exhibited lower test-retest repeatability compared to active 
smoking, which reflects the difficulty involved in obtaining accurate recall of 
background exposures (Ever lived with a smoker kappa 0.60-0.77, 95% CI 0.19-1.00; 
working in a smoky workplace kappa 0.60-0.62, 95% CI 0.26-0.95; Ever having 
been a regular smoker kappa 0.80-1.00, 95% CI 0.58-1.00) (Gartner et al. 2005). 
Difficulty in getting an accurate and precise measurement of these exposures may 
have contributed the lack of a dose-response relationship in the findings. Therefore, 
the result of an inverse relationship between passive smoking and PD should be 
considered as preliminary evidence of a relationship between environmental tobacco 
smoke and PD, needing confirmation with future studies, such as prospective or 
retrospective cohort studies where more accurate measurement of passive smoke 
exposure, such as through records of employment in bars and clubs, is possible.  
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Coffee 
The study also confirmed the well-established inverse association between regular 
coffee consumption and PD (Benedetti et al. 1998; Ascherio et al. 2001). Similar to 
the result for Ever been a regular smoker, the result for Ever been a regular coffee 
drinker did not reach statistical significance at the prescribed level (adjusted OR 
0.57, 95% CI 0.30-1.10), although a statistically significant dose-response effect was 
evident with the number of cups of coffee drunk per day (adjusted OR 0.86, 95% CI 
0.76-0.98). When the relationship was examined in men and women separately, a 
pattern similar to that observed in prospective studies of coffee and PD risk, namely 
a linear relationship in men and a ‘U’-shaped relationship in women, was observed 
(Ascherio et al. 2001).  
 
As discussed in Chapter 2 (section 2.10.2), coffee contains a number of 
biochemically active substances, one of the most important being caffeine (1,3,7-
trimethylxanthine). The primary biological effect of caffeine on the nervous system 
is competitive antagonism with the adenosine receptors, particularly the A1 and A2A 
subtypes. Data from studies using the MPTP animal model of PD suggest that 
caffeine’s protective action against dopaminergic toxicity is by antagonism of A2A 
adenosine receptors (Chen et al. 2001a). However, other constituents of coffee, such 
as kahweol and cafestol, may also be neuroprotective by causing various beneficial 
modifications to xenobiotic metabolism, particularly through enhancement of 
glutathione-S-transferase (GST) and inhibition of N-acetyltransferase (NAT) 
detoxification pathways. Coffee components such as polyphenols and K/C-free 
coffee are also capable of increasing GST and partially of inhibiting NAT, although 
to a somewhat lesser extent. Furthermore, Coffee is also a rich source of many other 
ingredients that may contribute to its biological activity, such as heterocyclic 
compounds that exhibit strong antioxidant activity (Manach et al. 2004). 
 
Tea 
An inverse relationship between PD and tea consumption has been observed in some 
studies, but with less consistency than the relationship between PD and coffee 
consumption. The current study did not observe a dose-response relationship 
between PD and the number of cups of tea drunk per day. These results are 
consistent with those of Paganini-Hill (2001) who also did not observe a dose-
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response relationship between PD and tea drinking. One possible explanation for the 
lack of a dose-response relationship in the current study’s results and those of 
Paganini-Hill (2001) is that the strength of tea may vary to a greater extent per cup 
than coffee. Factors affecting strength of tea include how much water is added, 
temperature of the water, quantity of tea, variety of tea and infusion time. 
Anecdotally, some participants in the current study reported using a single tea bag to 
make more than one cup of tea which would produce a less concentrated tea 
compared to those made with one tea bag per cup. Tea made with loose leaf may be 
even more inconsistent in strength due to variation in amount of tea added and the 
size of the teapot. 
 
An inverse relationship of similar magnitude to that of coffee consumption and PD 
was observed for tea consumption and PD (OR 0.64, 95% CI 0.30-1.36). This is in 
contrast to the results reported by Checkoway, et al. (2002) who found no such 
relationship. That study also did not find any relationship between coffee 
consumption and PD, although they did report a dose-response effect for tea 
consumption. Likewise, others have reported an inverse relationship with tea 
consumption, but not with coffee (Ayuso-Peralta et al. 1997). The study by 
Checkoway, et al., had a number of strengths, such as the use of incident cases 
(‘newly diagnosed’) rather than prevalent cases, the use of a well-defined population 
base, and a participation rate considered high for population-based epidemiological 
studies (71% for cases and 66% for controls). However, unlike the data collection for 
smoking history, this study did not elicit information about changes in consumption 
of coffee, tea and alcohol throughout life, which may have led to exposure 
misclassification. In the current study, changes in consumption patterns were 
accounted for by asking about current consumption and then whether the participant 
had always drunk this amount. If not, the previous quantity was also recorded and a 
lifetime average calculated. The study by Ayuso-Peralta (1997), had a number of 
differences to the current study. Importantly, the researchers used spouse controls, 
therefore the case and control group may have been over-matched on dietary items, 
while being mismatched on gender. While the result for ever drinking alcohol 
regularly was weak and statistically non-significant at the prescribed level, there was 
a statistically significant dose-response relationship for average number of drinks per 
day, similar in magnitude to that observed for coffee drinking.  
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Alcohol 
Previous studies have not consistently found a relationship between alcohol 
consumption and PD. Galanaud, et al. (2005) reported a reduced OR with daily 
alcohol consumption, while Paganini-Hill (2001) reported a statistically significant 
decreased odds for PD only in those who drank at least 2 or more alcoholic drinks 
per day, though no result was seen for those who consumed less than this. Similarly, 
we found no result for those who drank less than 1 alcoholic beverage per day. 
Benedetti, et al. (2000) also only reported a statistically non-significant inverse 
relationship between heavy alcohol drinking and PD, and a statistically significant 
inverse relationship with diagnosis of alcoholism, but no relationship with lighter 
consumption. A inverse dose-response trend was evident for increasing quartiles of 
beer consumption in Hellenbrand, et al.’s study (1996), though the relationship 
between increasing quartiles of ethanol is unclear. Regular consumption of liquor, 
wine or beer was associated with decreased odds of PD in a Swedish population, 
with a statistically significant test for trend with increasing quantity of wine and 
liquor drunk per week (Fall et al. 1999). Hernán, et al.  did not find any relationship 
between alcohol intake and PD in two large prospective cohorts, except for men who 
consumed ≥30 gm/day of alcohol (OR 0.6, 95% CI 0.4-1.1), which is approximately 
equivalent to 3 standard alcoholic drinks per day. (Ragonese et al. 2003) in a study 
design nearly identical to ours reported a strong inverse relationship between alcohol 
consumption and PD (adjusted OR 0.61, 95% CI 0.39-0.97), however they did not 
observe evidence of dose-response relationship when the data were examined as 
years of consumption, drinks per day or drink-years.  
 
The reasons for the inconsistency between the results of previous studies and the 
current study are not clear, although exposure measurement may play a role. For 
example, Benedetti et al. (2000) ascertained alcohol consumption from medical 
records, for which quantitative information was not homogenously available. While 
the authors assessed reliability of the medical records data for cigarette smoking by 
interviewing a sub-sample of the participants, they did not collect data on alcohol 
consumption in the interview. As the medical records data on alcohol consumption 
was not recorded in a consistent manner, there may have been substantial exposure 
misclassification. Other studies, such as Hernán et al. (2003) and Ragonese et al. 
(2003) collected very detailed data on alcohol consumption, including changes in 
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quantity consumed and calculation of grams of alcohol consumed according to type 
of alcoholic beverage. The current study did not attempt to examine different types 
of alcoholic beverages or grams of alcohol consumed, but limited exposure 
measurement to number of ‘drinks’. This may have led to lack of precision in the 
measurement, however detailed lifetime consumption data may be overly difficult for 
participants and may result in exposure misclassification due to lower recall of 
detailed data. Reproducibility of the alcohol consumption data obtained in the current 
study was high (Gartner et al. 2005), however reproducibility of the data collected by 
Hernán et al.  is difficult to compare as the authors report Spearman correlation 
coefficients rather than more acceptable measures of reproducibility such as intra-
class correlation coefficients or the limits of agreement by the Bland-Altman method. 
Ragonese et al. (2003) did not report on the reproducibility of their data. 
 
Hobby Gardening  
Hobby gardening was explored as a risk factor for PD as hobby gardeners are more 
likely to have regular exposure to home gardening pesticides than those who do not 
maintain a garden for a hobby. As expected, hobby gardeners (79.3%) were more 
likely to report using pesticides in the home garden than non-gardeners (64.5%). 
However, in contrast to the expected direction of the relationship, hobby gardening 
was inversely related to PD. This relationship was first identified in the test-retest 
repeatability study (Chapter 5) and appeared again in the main case-control study. 
The difference may be due to fewer PD cases than controls taking up hobby 
gardening at retirement age due to commencement of PD symptoms. To test this 
theory, the variable was analysed considering only those hobby gardeners who had 
gardened for more than twenty years as being exposed to hobby gardening. This 
should have excluded any influence of PD symptoms over whether a participant was 
a hobby gardener or not. However, even when only long-term hobby gardeners were 
considered, the variable was still associated with decreased odds of PD, suggesting 
that fewer PD cases taking up gardening later in life cannot fully explain the inverse 
relationship between hobby gardening and PD.  
 
Few previous studies have examined hobby gardening as a risk factor for PD. Gorell 
et al. (1998) did not observe a group difference for hobby gardening in a large case-
control study in the Detroit area. The prevalence of gardening amongst control 
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subjects (67%) was comparable to our study (62%). Hobby gardening was relatively 
rare in a study by Marder, et al. (1998), although two different figures are provided 
by the authors.  The highest of these two figures is 14 out of 271 subjects (5.1%), 12 
of these being PD cases, resulting in a high odds ratio (adjusted OR 13.8, 95% CI 
2.4-79.5), albeit with wide confidence intervals. This is a much lower prevalence of 
hobby gardening than in our sample and may reflect either a difference in how 
subjects were asked about hobby gardening or a real difference in the popularity in 
this hobby between the two populations. Marder, et al.’s (1998) study sample was 
recruited from an urban suburb in Manhattan and featured a large number of 
participants with Hispanic background. There may be practical (e.g. fewer homes 
with gardens) or cultural reasons for a lower prevalence of hobby gardening in this 
sample of people. A study by Chaturvedi, et al. (1995) observed a similar prevalence 
of hobby gardening in their sample to that observed in the current study. The study 
was a large cross-sectional study (the Canadian Study of Health and Ageing) which 
recruited participants from all provinces in Canada. Sixty-two percent (62.3%) of 
participants with PD and 54.2% of participants without PD reporting gardening as a 
hobby, compared to 51.9% of PD cases and 62.3% of controls in the current study’s 
sample. The study reported a statistically non-significant moderately increased odds 
of PD for hobby gardeners. 
 
Hertzman (1994) reported a reduced odds of PD for ‘gardening’ in a case-control 
study of PD patients and electoral roll controls in British Columbia. In this study, 
54.9% of male and 57.1% of female PD patients reported ‘gardening’ compared to 
66.7% of male and 84.4% of female electoral roll controls. The authors do not 
specify, however, if “gardening” refers to hobby gardening or employment as a 
gardener. The prevalence of gardening in this study is similar, although higher, than 
hobby gardening was in the current study. Although this inverse relationship between 
‘gardening’ and PD is reported in a table of results, Hertzman et al. neglect to discuss 
or explain the result. The reason for the inverse relationship between PD and hobby 
gardening observed in the current study and that of Hertzman et al. (1994) is not 
clear. Some possible explanations are: 
1. Workers in occupations that are associated with increased risk of PD (e.g. 
farming etc) may be less likely to become hobby gardeners.  
2. People more prone to developing PD are less likely to take up hobby 
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gardening (e.g. personality reasons, ‘workaholics’ may have little time for 
gardening etc).  
3. Hobby gardeners may be more careful with their use of pesticides (e.g. use 
protective equipment) than casual users of these products, thereby reducing 
their exposure to gardening pesticides compared to those with less interest in 
growing plants. 
4. Hobby gardening has a physiologically protective effect, such as through 
reducing stress (Smith et al. 2002) or improving physical fitness which may 
help the body to cope with cellular stressors or by priming metabolic 
pathways through low level exposures which may enhance the body’s ability 
to detoxify chemical exposures. 
5. People at increased risk of PD may experience a physical aversion to 
gardening, such as due to allergies to pollen or other plant material. 
Inflammation involving activation of microglia has been implicated in the 
pathogenesis of PD (see Chapter 2, Section 2.5.3). If this inflammation is due 
to immunological dysfunction or over-activation, then other consequences, 
such as allergies may also be expressed. 
 
Pesticides 
In the current study the relationship between PD and pesticide exposure was not 
clear. Use of home gardening pesticides, in general, was not associated with 
increased odds of PD (Ever used pesticides in home garden OR 1.01, 95% CI 0.49-
2.12). Use of any pesticide in an occupational setting was only associated with PD 
for those exposed to the equivalent of at least weekly exposure for six months or 
more (OR 2.57, 95% CI 0.50-13.15). However, the result was statistically non-
significant and the confidence interval was wide due to the low prevalence of the 
exposure in the sample (10 exposed cases and 3 exposed controls). The point 
estimate of the odds ratio was similar to that observed in Chapter 3 for this level of 
pesticide exposure (OR 1.92, 95% CI 0.93-3.99). Longer duration of exposure to 
pesticides was not associated with increasing odds of PD (OR 1.02, 95% CI 0.41-
2.51). Rather, there was a twofold increased odds of PD in those exposed to 
pesticides occupationally for less than 10 years (OR 2.25, 95% CI 0.65-7.75), 
although again the result was statistically non-significant. While the greater odds of 
PD associated with higher intensity of pesticide use may be interpreted as a ‘dose-
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dependent’ effect, the greater odds with shorter duration of exposure appears 
contradictory to a dose-dependent relationship. A possible explanation for fewer 
years duration of pesticide exposure being associated with PD is that those adversely 
affected by pesticides may cease working in their occupations due to a negative 
reaction to the exposure, whereas those less affected have less reason for ceasing this 
workplace task. The intensity and nature of exposure may change over time for those 
who are exposed for many years, as they possibly become more senior in the 
workplace, or develop better techniques which reduce exposure. Therefore, a linear 
dose-response trend may not apply for years of exposure, which was also suggested 
in the current study’s results. As newly employed staff may be given the dirtiest jobs 
and be less skilled at avoiding exposure, those who cannot biologically tolerate these 
intense exposures may leave the employment after a shorter period of time (Beard et 
al. 2003). A short-term negative reaction to pesticide use may be due to higher 
exposure from poor health and safety techniques, differences in pesticides used, or 
genetic susceptibility through reduced ability to metabolise toxic substances. The 
observation in one study that people with genetic polymorphisms associated with 
increased activation and/or decreased detoxification/elimination of environmental 
mutagens (CYP2E1, GSTM1, GSTT1 and PON genes) were under-represented in a 
group exposed to pesticides, compared to an unexposed group, lends support to this 
theory (Au et al. 1999). Furthermore, an Australian cohort study looking at pesticide 
exposure and different health outcomes reported a number of positive associations in 
the shortest duration of exposure groups rather than for longer exposure duration 
(Beard et al. 2003).  
 
When specific classes of pesticides were examined only exposure to fungicides were 
found to be positively associated with PD. This relationship was observed for 
domestic and occupational exposure to fungicides (mixed fungicides domestically 
OR 2.04 95% CI 0.94-4.44; applied fungicides domestically OR 2.08, 95% CI 1.02-
4.26 mixed fungicides occupationally OR 5.29, 95% CI 0.28-99.70; applied 
fungicides occupationally OR 1.83, 95% CI 0.32-10.48), although only domestic 
fungicide exposure reached statistical significance due to the low usage of fungicides 
occupationally in the sample. The result for fungicides is particularly interesting 
given that some common fungicide formulations contain manganese, a known 
neurotoxin, such as the dithiocarbamates, mancozeb and maneb. Unfortunately, as 
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other studies have found, most of the participants had difficulty remembering the 
names of the specific pesticides they have used (Ho et al. 1989; Seidler et al. 1996; 
Liou et al. 1997; Gorell et al. 1998; Baldi et al. 2003a). Therefore, it is only possible 
to speculate as to whether these manganese-containing compounds were used by the 
participants in the current study. Certainly, mancozeb and captan were reported as 
the two most significant fungicides used in Australia in a review of pesticide use in 
Australia (Radcliffe 2002). Other fungicides containing metals have also been used 
extensively in Australia. Bordeaux mixture is a copper compound that was one of the 
earliest fungicides in use and mercury was used in many important fungicides, such 
as phenyl mercury acetate which was used on turf (Radcliffe 2002). 
 
In contrast to these findings, Engel, et al. (2001) did not find an increased prevalence 
of parkinsonism amongst workers exposed to any fungicides, any pesticides 
containing manganese, any dithiocarbamates, mancozeb, maneb or zineb. It should 
be noted that the study did report a higher prevalence of parkinsonism amongst those 
exposed to the pesticides for the longest time period (which also corresponded to 
older age), and there were no associations reported with any specific pesticide. 
Compatibility of the current study’s results to those of Engel, et al. (2001) may be 
limited due to differences in study design and methods. Engel et al. (2001) assessed 
‘parkinsonism’, via a nurse rather than consider neurologist-diagnosed PD. 
Parkinsonism can include a number of different conditions, including drug-induced 
parkinsonism (e.g. from metoclopramide use), which may have different aetiologies 
to PD. Their study was cross-sectional in nature, rather than the current study’s 
matched-case-control design, and utilised subjects who had participated in a previous 
cohort study of workers exposed to pesticides. Unfortunately, only 310 of the 
original 1300 subjects (24%) participated in the cross-sectional survey; a large 
proportion were deceased (34%), could not be contacted (19%), were lost to follow-
up (9%) or refused to participate (12%). While the original cohort was a strong study 
design, the large percentage of participants lost to follow-up greatly weakens this 
subsequent study. If PD cases amongst the original cohort group were more likely to 
be deceased or uncontactable, then prevalence of PD and/or parkinsonism in the 
original cohort could be underestimated.  
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The case-control studies by Semchuk et al. (1992) and Gorell et al. (1998) are more 
comparable to the current study’s design; however both these previous studies did 
not report a strong relationship between fungicides and PD risk (fungicides OR 1.63, 
95% CI 0.81-3.29; OR 1.60, 95% CI 0.47-5.45, respectively). Gorell et al. (1998) 
also did not report a relationship between fungicide use while hobby gardening and 
PD. 
 
Differences in the type of pesticides used in Canada and the United States compared 
to Australia, could account for one source of variation. Australia appears to have a 
higher usage of fungicides than Canada or the United States, although herbicides, 
followed by insecticides account for most of the pesticide sales in all three countries. 
Limited data were available on the specific pesticides used in Alberta, the location of 
Semchuk et al.’s (1992) study, however a report based on 1998 sales of pesticides in 
the province indicated that dithiocarbamates constitute 1% of pesticide sales (Byrtus 
2000) and a report of 1999 pesticide sales in neighbouring British Columbia 
indicated that, like Australia, mancozeb and captan are the most used fungicides 
(ENKON Environment Limited 2001).  
 
The dithiocarbamate fungicides have been associated with parkinsonism in case 
reports (Ferraz et al. 1988; Meco et al. 1994) and a number of toxicological studies 
have also been highly suggestive of a link between dithiocarbamates and the 
pathological process of PD (Thiruchelvam et al. 2000a; Thiruchelvam et al. 2000b; 
Fitsanakis et al. 2002; Thiruchelvam et al. 2002; Thiruchelvam et al. 2003; Zhang et 
al. 2003b). The apparent discrepancy between the toxicological evidence and the 
epidemiological studies by Semchuk et al. (1992) and Gorell et al. (1998) could be 
due to the use of fungicides other than dithiocarbamate compounds in these studies. 
Unfortunately, the difficulty of correctly identifying specific pesticides or classes of 
pesticides in retrospective assessment based on recall is a major limitation to 
confirming this relationship in a human population.  
 
Dithiocarbamates have been implicated as risk factors for PD in some previous 
epidemiological studies. A case-control study by Hertzman et al. (1994) in British 
Columbia did not observe a relationship between PD and fungicides as a group. 
However, more case participants than control participants reported use of 
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dithiocarbamates (7% versus 1%). Baldi et al. (2003b) reported a very strong relative 
risk of PD in men (adjusted RR 5.63, 95% CI 1.47-21.58) with occupational 
exposure to pesticides in a prospective cohort study in France. There also appeared a 
trend towards increased risk with greater exposure. Women did not experience an 
excess of risk with this exposure, although the authors noted that pesticide treatment 
tasks are performed almost exclusively by males in the population under study. The 
study had a number of strengths including a very detailed and extensive exposure 
assessment, including the development of a job exposure matrix by a panel of six 
experts which included a measure of likely intensity of the pesticide exposure. This 
same research team also conducted case-control control study in the same geographic 
area. Cases were recruited from hospitals, and controls were obtained from the 
cohort study, which initially recruited people randomly from electoral rolls. A 
matched design was used matching on the variables of age and sex. The conditional 
logistic regression analysis revealed an OR of 2.20 (1.11-4.34) for occupational 
pesticide exposure. A pilot study of winegrowers in the region, the main form of 
farming, found that 80% of the pesticides used were fungicides and dithiocarbamates 
accounted for 37% of the organic substances applied. Given this information, the 
results of the cohort and case-control studies suggest that fungicides may be 
aetiologically relevant to PD.  
 
Use of herbicides and insecticides did not appear to be associated with increased risk 
of PD in the current study (applied herbicides domestically OR 1.34, 95% CI 0.67-
2.67; applied herbicides occupationally OR 0.77, 95% CI 0.25-2.32; applied 
insecticides domestically OR 0.93, 95% CI 0.52-1.68; applied insecticides 
occupationally OR 1.42, 95% CI 0.63-3.21). In contrast, case-control studies by 
Semchuk et al. (1992) and Gorell et al. (1998) reported strong associations with PD 
for herbicide use (OR 3.06, 95% CI 1.34-7.00; 4.10, 95% 1.37-12.24, respectively) 
and insecticide use (OR 2.05, 95% CI 1.03-4.07; 3.55, 95% 1.75-7.18, respectively). 
Although Gorell et al. (1998) also did not observe a relationship between PD and 
herbicide or insecticide use while hobby gardening (herbicides adjusted OR 1.39, 
95% CI 0.84-2.28; insecticides adjusted OR 0.90, 95% CI 0.58-1.38). The reasons 
for the difference between the current study’s results and those of these previous 
studies are not readily apparent, but may reflect differences in specific types of 
herbicides and insecticides used in Australia compared to the US/Canada.  
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Metals 
The current study was the first study to examine metals as a risk factor for PD in an 
Australian population. A significant association was not observed between PD and 
the general exposure of working with “metal dusts or fumes” (adjusted OR 1.26. 
95% CI 0.64-2.47). Similarly, other studies have reported no association (Hertzman 
et al. 1994), or only moderate associations (OR in the order of 1.5) (Liou et al. 1997; 
McDonnell et al. 2003; Pals et al. 2003). Studies that have shown a relationship 
between metal exposure and PD have examined specific metals (Zayed et al. 1990; 
Gorell et al. 1997) or metal-working tasks, such as welding. It is possible that the 
lack of an association between ‘metals’ and PD observed in this and other studies is 
due to dilution of the result by combining different specific metal exposures with 
varying degrees of risk. Different types of metals and also the physical form of the 
exposure may determine if a certain metal exposure is neurotoxic. For example, a 
fume given off by heating metal to welding temperatures may be more biologically 
active than a dust produced by grinding metal.  
 
When asked to identify specific metals they had worked with, none of the 
participants in the current study reported exposure to manganese, a metal of 
particular interest to PD aetiology. Previous case-control studies have also failed to 
find an association between manganese exposure and PD (Hertzman et al. 1990; 
Semchuk et al. 1993; Seidler et al. 1996). As in this study, these measured 
manganese exposure via self report, rather than use of a job-exposure matrix or an 
industrial hygienist. In contrast to these findings, Gorell, et al. (1996) reported 
elevated odds of PD with exposure to lead, copper and manganese for more than 20 
years. They reported that the association between metal exposure and PD found in 
their sample was dependent upon the method of exposure assessment used. The 
significant associations identified were based on an industrial hygienist’s assessment 
of likely exposure from reported job tasks. When the data were analysed according to 
self-reported exposure status alone, no relationship was apparent. Many workers 
would not be aware of all the metals they are exposed to, particularly with respect to 
compounds such as welding rods, which can contain many different metal 
combinations, and may therefore be unable to report these exposures accurately. For 
example, in the current study, approximately 30% of participants reported a history 
of welding in their employment, yet none reported exposure to manganese. Given 
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that manganese is a constituent of the commonest types of welding rods (Wyckoff 
and McBride 2004), it is very likely that at least some of these participants had been 
exposed to manganese, even though they failed to report this exposure.  
 
When individual metal working activities were examined separately, a positive 
association between PD and exposure to welding metal at work (adjusted OR 2.32, 
95% CI 0.98-5.51) was observed. This result nearly attained statistical significance. 
Additionally, on questions concerning exposure to electromagnetic radiation, more 
cases than controls identified that they had been exposed to electric welding 
producing an odds ratio greater than two (adjusted OR 2.20, 95% CI 0.65-7.50). Both 
of these results should be treated with caution as only fair-to-moderate recall was 
observed for these two exposures in the test-retest repeatability study in Chapter 5. 
Similar to the relationship between exposure to pesticides and PD, greater odds of 
PD were associated with more frequent exposure (more than 3.5 days per week), but 
also with shorter overall duration of exposure (15 years or less).  
 
Welding involves joining metals by electric arc or flame with a filler material (or 
consumable). This process typically produces concentrated particulate fumes and 
gases containing elements such as manganese, silica, arsenic, nickel, chromium, 
beryllium, cadmium, copper, lead, cobalt, zinc, and selenium29. Gases released 
include carbon monoxide, carbon dioxide, ozone, phosgene, and fluorine 
compounds. The presence of manganese in welding fumes is of particular interest to 
PD as manganese poisoning is associated with a neurodegenerative syndrome 
including features of parkinsonism (Huang et al. 1998; Discalzi et al. 2000). This 
syndrome has also been noted to occur in welders (Ono et al. 2002; Sadek et al. 2003) 
as have elevated blood serum levels for manganese (Ono et al. 2002; Li et al. 2004). 
 
Exposure to high levels of welding fume has been shown to induce acute systemic 
inflammation. There is also evidence that smoking may modify the effect of welding 
fume exposure on specific inflammatory markers. In non-smokers, welding fume 
                                                 
29 There are many different forms of welding. Forms of welding that utilise a rod or filler material that 
may contain manganese include arc welding, gas metal arc welding, shielded metal arc welding, gas 
tungsten arc welding, submerged arc welding, flux cored metal arc welding, plasma arc welding, 
carbon arc welding, metal inert gas welding, electroslag welding, electro gas welding, manual metal 
arc welding, tungsten inert gas welding and stand welding. 
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exposure was associated with a significant increase in white blood cell and 
neutrophil counts immediately following exposure. However, no significant changes 
in white blood cell, neutrophil, and fibrinogen levels were found in smokers. C-
reactive protein30 (CRP) levels were increased in both smokers and non-smokers 
sixteen hours after welding exposure. The ambient fine particulate matter 
concentrations were found to be significantly associated with absolute neutrophil 
counts in non-smokers, and CRP levels in both non-smokers and smokers (Kim et al. 
2005). Interestingly, when exposure to welding in the current study was examined 
stratified according to smoking history, only non-smokers had an increased odds of 
PD for welding (OR 2.50, 95% CI 0.78-7.97) while no relationship was evident in 
smokers (OR 1.20, 95% CI 0.37-3.93). While systemic inflammation has been linked 
to increased risk of cardiovascular disease, there is also some suggestion that a 
systemic challenge that promotes a systemic inflammatory response, may contribute 
to the outcome or progression of chronic neurodegenerative diseases, such as PD 
(Perry 2004). There is already evidence that chronic inflammation plays a role in PD 
aetiology (Gao et al. 2003b) and regular users of non-steroidal anti-inflammatory 
drugs (NSAIDs) have been shown to have lower risk of PD (RR 0.55, 95% CI 0.32-
0.96) in a large prospective cohort study (Chen et al. 2003a).  
 
A connection between exposure to welding and PD aetiology is particularly 
controversial due to legal action in progress by current and former welders seeking 
compensation from manufacturers of welding materials for parkinsonism they allege 
was caused by their exposure to welding fumes. While some epidemiological studies 
have suggested a link between welding and PD, results have been inconsistent. A 
study often cited as evidence of a link between PD and welding was conducted by 
Racette et al. (2001). The study compared the clinical aspects of a series of 15 
welders who were diagnosed with parkinsonism to a case series of 100 patients with 
idiopathic PD. The study suggested that the two groups were nearly identical in 
terms of prevalence of tremor, bradykinesia, rigidity, asymmetric onset, postural 
instability, family history, clinical depression, dementia, or drug-induced psychosis 
and response to levodopa therapy. The main difference noted was that the welders 
                                                 
30 CRP is a type of protein produced by the liver that is only present during episodes of acute 
inflammation. The most important role of CRP is its interaction with the complement system, which is 
one of the body's immunologic defense mechanisms. 
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tended to have a younger onset age. The authors did not report any of the 
abnormalities that are usually associated with manganism (Calne et al. 1994) in the 
welders, suggesting that their condition was more consistent with PD than 
manganism. The conclusion drawn is that welding is a cause of PD or induces PD at 
an earlier age in susceptible individuals. A younger age of onset amongst PD patients 
with a history of welding compared to those with no history of welding was not 
observed in the current study. A limitation of Racette et al.’s study design is that the 
risk of developing PD amongst welders is not able to be determined.  
 
Recently, a prevalence study by Racette, et al. (2005) reported a higher prevalence of 
parkinsonism in welders compared with a general population. However, the studies 
limitations may have produced biased results. For example, the ‘affected’ welders 
may have been biased to over-report their symptoms and exposures as they were part 
of a litigation case in which the welders were alleging their parkinsonism was caused 
by exposure to welding and had been sourced from the legal firm representing them. 
The comparison rate used to compare the rate of parkinsonism in the welders to the 
general population was inappropriate as it was restricted to idiopathic PD rather than 
the much broader diagnosis of ‘parkinsonism’ and was obtained in a different 
geographic area (Schoenberg et al. 1985). 
 
A case-control study utilising death certificate data reported an increased mortality 
odds ratio (MOR 1.77, 95% CI 1.08-2.75) for PD amongst occupations where arc-
welding of steel is performed, although only for those who died before age 65 (Park 
et al. 2005b). This finding would fit with the theory that welding-related PD 
produces a younger onset age or accelerates the disease process, however it does not 
provide strong evidence that welding causes PD. While using existing records 
reduces recall bias, there are many limitations with mortality studies utilising death 
records which may affect the validity of the results and the conclusions that may be 
drawn from them. The results may reflect factors that increase mortality associated 
with a particular disease, rather than aetiology, if for instance, welders with PD are 
more likely to die due to complications than the general PD community. Also, PD is 
often not reported on death certificates. This may be more likely in cases where 
multiple serious diseases are present, which could be caused by occupational 
exposures. A recent survey found that among decedents with PD reported during life, 
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nearly half did not have PD recorded on the death certificate (Pressley et al. 2005). 
Death certificate data has also been shown to be an unreliable source for exposure 
information (McGuire et al. 1998; Andrews and Savitz 1999), as job titles listed may 
reflect last position held, rather than the main occupation. 
 
In a large case-control study in Korea, significantly fewer cases reported working in 
occupations with potential exposure to manganese such as welder, smelter, welding 
rod manufacturer, manganese miner, workers in the iron and steel industries, and dry 
cell battery manufacturers (Park et al. 2005a). The study was clinic based, utilising 
patients with cerebrovascular disease as controls. As inflammation may be involved 
in the pathological process for both PD and cerebral ischemia (Kohutnicka et al. 
1998), there may be some overlap of environmental risk factors for these diseases. 
As discussed previously, exposure to welding fumes appears to induce an 
inflammatory response (Kim et al. 2005). Furthermore, the authors grouped many 
occupations (with the potential for manganese exposure) into one variable rather than 
analysing these separately. As the nature of the exposures encountered in each of 
these different occupations may be quite different (e.g. fumes, fine particulate, or 
large particulate), it is possible that a welding specific relationship to PD may not be 
observable due to dilution with other exposures. 
 
Two recently published retrospective cohort studies did not observe an increased risk 
of PD or other basal ganglia disorders for occupational welders (Fryzek et al. 2005). 
The first of these compared the hospitalisation rates for PD amongst welders in an 
established cohort in Denmark to rates in the entire population of Denmark between 
1977 and 2002 using the Danish population and hospitalisation linkage system (Fryzek 
et al. 2005). Similar rates of hospitalisation for PD and parkinsonism were observed 
for the welding cohort to the general population. The second study identified men 
employed as a welder or flame cutter in either the 1960 or 1970 Swedish national 
censuses and a comparison group of gainfully employed males not recorded as welders 
or flame cutters in any census and individually matched on year of birth and county of 
residence to the welders and flame cutters in a 10 to 1 match. Hospitalisations for PD 
and other disorders of interest to the study were identified in the Swedish Hospital 
Discharge Register. The study reported a reduced relative risk of hospitalisation for PD 
for welders and flame cutters (adjusted rate ratio 0.89, 95% CI 0.79-0.99). 
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Differences between the populations of these previous studies and the current case-
control study may partially explain the disagreement in results. A different smoking 
prevalence was observed in the current study compared to these retrospective cohort 
studies. The proportion of Danish welders that had ever smoked (82%) was nearly 
twice that observed amongst welders in the current study (45%). Only data on 
current smoking behaviours at one time point were reported in the Swedish study. 
The ‘current smoking’ prevalence of 42% which was reported for welders was based 
on a survey of 112 male welders and 8474 employed men from the general 
population . However, the prevalence of ‘ever smoking’ is likely to be higher than 
this estimate. National survey data of the prevalence of current and ever smoking in 
Sweden for 1991 report a similar prevalence of current smoking in the general male 
population (30%) as the survey by Sjögren et al. (2002)(29%). The national survey 
reported a prevalence of ‘ever smoking’ of 68.7% for men aged 45-74 years 
(Cavelaars et al. 2000). Therefore, prevalence of ever smoking appears higher in the 
Swedish population than in the current study’s sample. 
 
The current study had the advantage over the two retrospective cohort studies of 
measuring co-exposures, such as tobacco smoking, that may interact with welding to 
alter PD risk, in both cases and controls. As mentioned previously, when 
environmental exposures were examined stratified by smoking status in the current 
study, welding was only associated with increased odds of PD in non-smokers. 
Smoking is known to be associated with occupation and higher prevalence of 
smoking is observed amongst ‘blue-collar’ workers compared to ‘white-collar’ 
workers in most countries (Hill et al. 1998; Barbeau et al. 2004; Wen et al. 2005). If 
smoking prevalence is higher in occupational welders than the general population, 
then this may, in part, explain the failure to observe a relationship between PD and 
welding in some studies. In a study of current smoking habits in European countries, 
the highest prevalence of smoking was amongst metal makers and workers, although 
smoking prevalence amongst welders and solderers were similar to ‘professional, 
administrative, clerical, and service’ industry workers (McCurdy 2003). The Danish 
retrospective cohort study included smoking data that was collected at one timepoint 
in the welding exposed cohort only. Stratification of the results by smoking status 
showed an almost twofold elevated standardised hospitalisation ratio (SHR) for 
welders who were non-smokers compared to the general population, which included 
 205 
smokers and non-smokers (Fryzek et al. 2005). The result lacked statistical 
significance due to the small numbers following stratification (less than 20% of 
welders were non-smokers). Comparison of SHRs for PD in non-smoking welders to 
the non-smoking general population would be more informative. However, 
individual smoking data for the general population was not available. The authors 
suggest that smoking was unlikely to be responsible for the overall null result for 
welders as the prevalence of ‘current’ smoking reported for the general male 
population (53%) was similar to that observed in the welding cohort (58%), however 
it does not address the issue of whether welding is associated with increased risk 
amongst non-smokers only. The Swedish retrospective cohort study did not have 
individualised information on smoking habit for either the exposed or unexposed 
members of the cohort (Fored et al. 2006). The study did address the potential impact 
of differential smoking prevalence in the exposed and unexposed cohorts using 
indirect methods based on ‘current smoking’ prevalence. The smoking adjusted 
relative rate was approximately one for the association between welding and PD. 
However, the study is also unable to address the issue of whether welding is only a 
risk factor for PD in non-smokers.  
 
The current study’s observed positive association between PD risk and welding 
should be considered tentative as previous studies that have also reported a positive 
association have substantial potential for bias (Park et al. 2005a), whilst better-
designed studies have failed to observe an association (Fored et al. 2006). The 
potential for smoking to modify the effect of welding on PD risk may explain the 
null result observed in the two historical cohort studies.  
 
Solvents 
Relatively few epidemiological studies have examined exposure to solvents as a risk 
factor for PD and this is the first study to examine the exposure in an Australian 
population. The current study observed only moderate increased odds of PD with 
having been exposed to solvents in the occupational environment, which was 
statistically non-significant (OR 1.53, 95% CI 0.82-2.86). The odds of PD were not 
increased for those with higher intensity of exposure (more than three days per week 
OR 1.10, 95% CI 0.47-2.57) or longer duration of exposure (more than 10 years OR 
0.78 95% CI 0.31-1.97). An early study by Ohlson and Hogstedt (1981) in Sweden 
 206 
also did not observe increased odds of PD with exposure to organic solvents. These 
results conflicted with those of Smargiassi et al. (1998), who reported a greater than 
two-fold increased odds of PD with more than ten consecutive years of exposure to 
organic solvents (OR 2.78, 95% CI 1.23-6.26), and Seidler et al. (1996) who reported 
increased odds of PD with exposure to solvents at work and at home. The reason for 
these conflicting results is not readily apparent. Solvents comprise a large number of 
chemical compounds which are used in many different industrial processes. It is 
possible that the differences in results are due to variation in specific chemicals used 
in the previous studies compared to the current study. The previous studies were 
conducted in Europe (Italy and Germany), where different solvents may be used than 
in Australia.  
 
When specific types of solvents were examined, increased odds of PD were 
associated with working with cleaning solvents (OR 3.37, 95% CI 1.05-10.77), 
lacquers (OR 2.15, 95% CI 0.51-9.06), thinners (OR 2.85, 95% CI 0.92-8.85) and 
petrol (OR 2.15, 95% CI 0.42-11.04). Only the association between cleaning solvents 
and PD was statistically significant at the prescribed level.   
 
Farming exposures 
The current study did not observe statistically significantly increased odds of PD for 
living or working on a farm, at the broadest level (Ever lived on a farm OR 1.38, 
95% CI 0.74-2.57; Ever worked on a farm OR 1.23, 95% CI 0.68-2.25). Similarly, 
many studies have observed no increase in odds of PD associated with farming 
(Tanner et al. 1989; Koller et al. 1990; Zayed et al. 1990; Butterfield et al. 1993; 
Rocca et al. 1996; Seidler et al. 1996; Kuopio et al. 1999b; Behari et al. 2001). When 
individual crops were considered, elevated odds of PD were associated with some 
crops raised (oats OR 3.49, 95% CI 0.47-26.07; bananas OR 3.25, 95% CI 0.18-
58.49; citrus fruit OR 2.78, 95% CI 0.25-31.14; and stone fruit OR 2.46, 95% CI 
0.12-48.75). However, the low prevalence of exposure to each of these crops make 
these estimates unstable (n ranged between 1 and 6 exposed per group). When herds 
were considered, only raising beef cattle was associated with elevated odds of PD 
(OR 2.29, 95% CI 0.92-5.66), which nearly attained statistical significance. Few 
studies have examined the relationship between animal farming and PD. Of those 
that have, none have examined beef cattle-raising. As this may be the first study to 
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observe increased odds of PD with working on a beef cattle farm, it should be treated 
as tentative and requiring further confirmation 
 
The most likely aspect of farming to have aetiological relevance to PD is the use of 
pesticides. In Australia, cattle are often treated chemically to control insect pests, 
including cattle ticks, lice and buffalo fly. These pests are not evenly distributed 
throughout the country, therefore treatment regimens and practices vary 
geographically. A variety of pesticides have been used to treat pests in cattle, 
including arsenic, organochlorines (e.g. DDT), organophosphates (e.g. chlorpyrifos), 
carbamates (e.g. carbaryl) and synthetic pyrethroids (e.g. cypermethrin). Different 
methods of application used in Australia include plunge-dip, hand-spray, spray-race 
or pour-on (Jonsson 1997). Different application methods and individual practices 
would impact upon the amount of pesticide exposure received by workers 
administering the cattle treatments. For example, a worker standing close to a 
plunge-dip may be covered in pesticide, while a worker applying a pour-on treatment 
may only experience minimal or insignificant exposure. Also, not all workers on 
cattle properties assist with pesticide treatments. Only 37% of those in the current 
study who reported having worked on a farm that raised beef cattle reported applying 
insecticides at work. Although, this would not include those participants who may 
have been indirectly exposed to pesticides while performing other tasks, such as 
herding cattle through a plunge-dip. 
 
When specific farms tasks were examined, those with elevated odds of PD were 
applying herbicide (OR 3.16, 95% CI 0.48-20.96), drenching stock with pesticide 
(OR 2.08, 95% CI 0.12-35.58) and planting (OR 7.42, 95% CI 0.76-72.35). While 
there were an insufficient number of exposed participants to obtain stable and 
statistically significant results for any of these tasks, it should be noted that all of 
these involve exposure to pesticides either directly or indirectly. Grain seeds and 
sugarcane setts are often treated with insecticides and/or fungicides, therefore farm 
workers handling these during planting (such as when loading the seed/sett into the 
hopper, may contact the insecticide or fungicide). 
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Rural Residency 
After adjustment in the multivariable model, there were decreased odds of PD with 
having resided in a remote area (OR 0.62, 95% CI 0.32-1.21). This result was in 
contradiction to a prevalence study of PD in Queensland . While the study by Peters 
et al. (2006) was different in design from the current study, in that it assessed the 
current prevalence of PD in metropolitan, rural and remote areas, rather than the risk 
of PD associated with having lived in a remote area prior to diagnosis, the study used 
the same classification system as the current study (RRMA). Peters et al. (2006) 
observed a trend of increasing prevalence of PD within increasing levels of 
rurality/remoteness. It is possible that this simply reflects movement of PD patients 
to rural and remote areas after diagnosis. However, this seems counterintuitive as 
resources and specialist medical services (e.g. access to neurologists) which are often 
required by people with PD are located in metropolitan areas. Therefore, the results 
are difficult to explain in light of a lack of positive association between rural or 
remote area residency and PD in the current study. 
 
One of the issues with the exposure of rural residency is its heterogeneity. Not all 
rural areas are comparable in terms of local industry, or water supply etc. Definitions 
of rurality are also highly variable, but are typically based on population density 
within a given geographical area. In terms of assessing residency as a risk factor for 
PD, it might be more informative to consider specific exposures, such as proximity to 
heavily sprayed crops (e.g. cotton) or specific industries (e.g. mining), rather than 
broad categories based on population density and/or isolation. However, a lack of 
consistent information, such as location of crops during specific timeframes, may 
make this approach logistically impossible. 
 
Groundwater Consumption 
A statistically non-significant increased odds of PD was only associated with PD in 
the current study for more than twenty years of consumption (OR 3.81, 95% CI 0.67-
21.77). However, as only ten participants in total had consumed groundwater for this 
duration, resulting in a wide confidence interval for the odds ratio estimate, the result 
is at best, tentative. Most case-control studies have not observed an increased risk of 
PD associated with consumption of water from groundwater supplies. The exceptions 
have been studies performed in Italy, where three out of the four studies to examine 
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consumption of well water as a risk factor for PD have reported an increased odds of 
PD (De Michele et al. 1996; Smargiassi et al. 1998; Zorzon et al. 2002). These 
positive results may indicate a particular aspect of groundwater in specific 
geographic locations (e.g. contamination with pesticides, metals, microorganisms 
etc) which is generally absent from groundwater supplies in other locations is 
responsible for the increased risk of PD observed. An increased risk of PD associated 
with consumption of contaminated groundwater may be of particular concern in Italy 
as the country relies on groundwater as their main source of potable water and 
pesticides in groundwater have been detected (Fortina et al. 1993). 
 
Groundwater can be found beneath most land in Australia; however, its quality is 
extremely variable (Ball et al. 2001). There are many well-documented cases of 
groundwater pollution in Australia (Bauld 1994; Jiwan and Gates 1994). The most 
significant diffuse contaminant of groundwater in Australia is nitrates. Nitrate 
contamination of groundwater is widespread throughout Australia and in many areas 
nitrate concentrations in groundwater exceed drinking water guidelines. The major 
causes of diffuse nitrate contamination are over-fertilisation of agricultural land, 
clearfelling and grazing. Diffuse pesticide contamination of groundwater resources in 
some areas is also significant, with pesticides detected in over 20% of samples from 
aquifers beneath intensively cropped land (Ball et al. 2001). However, the full extent 
of pesticide contamination of groundwater in Australia is unknown as systematic 
monitoring is limited and there is inadequate data on the quantities, locations and 
types of pesticides used, as well as knowledge gaps in the fate of pesticides in local 
environments (Schofield and Simpson 1996). 
 
In addition to diffuse contamination of groundwater, point-source contaminants can 
also affect localised supplies of groundwater. The most significant point-source 
contaminants include underground storage tanks (hydrocarbons), septic tanks, 
landfills (various), intensive rural industries (nitrate), cattle and sheep dips 
(pesticides), manufacturing spills (pesticides, organochloride solvents), gas works 
(coal, tars, ash, coke) and mining-related activities (heavy metals, acid, 
hydrocarbons) (Ball et al. 2001). Unreticulated domestic groundwater supplies in 
eastern Australian can also become contaminated with arsenic which can be released 
from the crystal matrix of oxidised pyrite by the drawdown of water levels by 
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pumping from coastal sand-dune systems. There are many other potential 
contaminants and sources of contamination of groundwater; however, little is known 
about their extent (Ball et al. 2001). 
 
Head Injury 
Whether head injury increases the risk of developing PD has been a controversial 
issue and conflicting results have been reported from previous studies. In the current 
study, suffering a serious head injury, being knocked unconscious, playing football 
and boxing were not associated with increased odds of PD (serious head injury OR 
1.18, 95% CI 0.62-2.25; knocked unconscious OR 1.47, 95% CI 0.68-3.17; football 
OR 0.64, 95% CI 0.30-1.35; and boxing OR 1.28, 95% CI 0.49-3.35). There also did 
not appear to be increased risk with multiple head injuries (OR 0.96, 95% CI 0.35-
2.63). Similarly, McCann et al. (1998) did not observe an increased odds of PD with 
history of repeated head injury.  
 
A head injury is any trauma that leads to injury of the scalp, skull, or brain. These 
injuries can range from a minor bump on the skull to a fatal brain injury. Loss of 
consciousness is an indicator of a serious head injury as it indicates involvement of 
the brain. Duration of unconsciousness is an indicator of the severity of the injury to 
the brain. Approximately sixty per cent of the participants in the current study who 
reported having suffered a serious head injury also reported being knocked 
unconscious with the injury. Unfortunately, details concerning the duration of 
unconsciousness was not collected and so those with transient unconsciousness were 
included with those with longer duration of unconsciousness. Anecdotally, most 
participants described their loss of consciousness as only brief, although one PD case 
described being unconscious for more than a day following a horse riding accident. 
Accurate information concerning the duration of unconsciousness may be difficult 
for the affected individual to recall as they would need to rely on others present 
during the injury to tell them how long they were unconscious for. Therefore, 
medical records may be needed to objectively assess this level of detail. 
 
Bower et al. (2003) observed that only severe head injury (longer loss of 
consciousness and brain bruising visible in a CT scan) rather than mild head injury 
(no or only a brief loss of consciousness) was associated with increased odds of PD 
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in a case-control study utilising medical records. As such, the current study may not 
have observed association between PD and head injury due to those with transient 
loss of consciousness being included with those with longer periods of 
unconsciousness. As Bower et al. measured head injury with medical records rather 
than self-report, only head injuries that were attended to by a doctor would have been 
included, which would have further restricted the head injuries to those of a more 
severe nature, than those included in the current study.  
 
Family History 
The current study confirmed the well-established association between family history 
of PD and increased odds of PD (OR 2.30, 95% CI 1.06-5.00) (Kuopio et al. 2001). 
Shared genetic risk factors may account for all or part of this increased risk amongst 
family members. Shared environment should also be considered as a possible 
contributor.  
 
An unusual finding in the study was an increased odds of PD associated with having 
a family member with Down’s syndrome (Trisomy 21) (OR 3.64, 95% CI 0.41-
32.45), but not with Alzheimer’s disease (OR 0.45, 95% CI 0.18-1.13). A 
relationship between PD and a genetically-determined chromosomal abnormality, 
such as Down’s syndrome, may be evidence of a genetic risk factor for PD. 
However, the low prevalence of family history of Down’s syndrome amongst study 
participants makes this result unstable. The putative association between Alzheimer’s 
disease and Down’s syndrome has been reported in a number of studies. However, 
there is only limited evidence to suggest a relationship between Down’s syndrome 
and PD (see Chapter 1 Section 1.10.5). As such, this result should be considered 
tentative, requiring further confirmation.  
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7.0 Integrated Discussion and Conclusions 
 
PD is a complex neurodegenerative disorder featuring a range of physical and 
psychological symptoms. While primarily sporadic in nature, familial forms of PD 
exist. The pathogenesis of PD is not fully understood, but multiple factors and 
pathological processes, such as oxidative stress, mitochondrial dysfunction, 
excitotoxicity, neuroinflammation, and apoptosis, appear to be involved. Given the 
complexity of the disorder, it is perhaps unsurprising that its aetiology also appears 
to be complex and multifactorial in nature. A number of factors may influence PD 
risk including physiological, genetic, dietary/lifestyle, psychosocial, microbiological 
and environmental factors. The focus of this thesis was on contributing to the 
epidemiological research on the environmental aspects of PD aetiology through an 
optimally designed study within the constraints of a PhD timeline and limited 
resources. In addition to environmental exposures, a number of lifestyle factors were 
also considered (tobacco smoking and consumption of coffee, tea and alcohol), as 
these may modify the effect of environmental exposures on PD risk. 
 
7.1 Contribution of the Current Study to Epidemiological Research of 
Environmental and Lifestyle Risk Factors for PD 
The current study makes a contribution both to Australian research in this field and 
internationally. While there is substantial evidence that environmental factors may be 
involved in PD aetiology, consensus has not been reached on the specific exposures 
previously considered in epidemiological studies of PD aetiology. Possible reasons 
for the heterogeneity in results between previous studies include geographical 
variation in exposures and methodological differences between studies. The quality 
of the previous case-control studies has been highly variable and many have been 
limited by inappropriate participant selection and recruitment methods (e.g. use of 
spouse and friend controls) and/or rudimentary exposure measurement (e.g. no 
testing of the quality of the measurement and ambiguous exposure measurement 
questions which may result in substantial exposure misclassification). The current 
study also considered many more exposures than the previous Australian studies, 
thereby providing data on exposures (e.g. metals, solvents, coffee, and alcohol) 
previously not examined in an Australian population.  
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Factors with an Established Relationship with PD Risk 
Tobacco Smoking, Coffee Consumption and Family History of PD 
The inverse associations between tobacco smoking, and coffee consumption and PD 
risk and the positive association with family history of PD observed in the current 
study are consistent with the consensus of international research on these factors. The 
inverse association between tobacco smoking and PD and the positive association 
between family history of PD and PD were also observed in the two previous 
Australian studies (McCann et al. 1998; and Chapter 3), although the relationship 
between smoking and PD was only observed in males in the study analysed in 
Chapter 3. The relative consistency in results between different studies for these 
factors may be due to them being easy to measure and qualitatively consistent across 
different geographic areas (e.g. tobacco smoking is similar in all countries, however 
definitions of rurality and the specific exposures encountered in rural environments 
differs between countries). Alternatively, these may be the only factors with a true 
relationship to PD risk, with the other relationships that have been observed 
inconsistently, simply being findings due to chance or exposure misclassification, 
such as recall bias. 
 
Factors with a Likely Relationship with PD Risk 
Pesticide Exposure 
The current study observed increased odds of PD with pesticide use, however this 
was dependent upon the type of pesticide used (fungicides). There was also 
suggestion of increased odds of PD associated with greater intensity of exposure in 
an occupational setting (equivalent to at least weekly exposure for six months or 
more), however the result was statistically non-significant due to the small number of 
participants exposed at this level and thus should be viewed with caution. Similar to 
the two previous Australian studies, when pesticide exposure was examined without 
regard for frequency or duration of exposure, no increased risk of PD was observed. 
There was no evidence of a dose-response relationship. However, when exposure to 
pesticides was examined as no exposure, irregular exposure and regular exposure 
(equivalent to at least weekly exposure for six months or more), both the current 
study and the study analysed in Chapter 3 reported elevated odds of PD for regular 
exposure, although without statistical significance. Unfortunately, while McCann et 
al. also collected data on pesticide exposure at this level of detail, the variable was 
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only analysed as “ever/never”. The elevated odds of PD with greater intensity of 
exposure compared to less frequent exposure may be evidence of a ‘threshold’ effect 
and demonstrates the importance of considering some degree of exposure dose in 
measurement of environmental exposures. On their own, incidental exposure to the 
environmental exposures examined in the current study did not appear to 
substantially increase risk of PD. 
 
An increased risk of PD with exposure to pesticides has been the most consistent 
environmental exposure to be associated with increased risk of PD in the 
epidemiological literature. The better quality case-control studies (Semchuk et al. 
1992; Gorell et al. 1998) and also two prospective cohort studies (Petrovitch et al. 
2002; Abbott et al. 2003; Baldi et al. 2003b), have reported increased risk of PD with 
exposure to pesticides.  
 
Tea Consumption 
The current results indicated reduced odds of PD for regular tea drinkers, 
independent of coffee intake, but without a clear dose-response relationship. The 
relationship between PD risk and consumption of tea has not been established 
consistently in the literature and therefore remains controversial. Tea drinking was 
associated with decreased risk of PD and also decreasing risk with increasing number 
of cups consumed per day in some studies. However, the majority do not report a 
clear dose-response relationship. A prospective study of tea consumption and PD risk 
only observed an inverse relationship in men and no effect in women (Ascherio et al. 
2001). In contrast to Ascherio et al.’s results, the current study suggested reduced 
odds of PD for women who drink tea, but not for men. 
 
Alcohol Consumption 
The current study observed a dose-dependent relationship between PD risk and 
consumption of alcohol. The lowest odds of PD observed were amongst those who 
consumed more than four alcoholic beverages per day on average. The current study 
did not observe a relationship between ever being a regular alcohol drinker and PD 
risk overall. However, when men and women were considered separately, an inverse 
relationship was seen in men, but not in women. These results are consistent with 
most previous studies, including a prospective cohort study , which have not 
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observed a relationship between regular alcohol consumption and PD risk, but 
decreased risk of PD with heavier consumption of alcohol compared to lighter 
consumption. The sex-specific relationships observed in the current study were also 
observed by Hernán et al. (2003). 
 
Factors Exhibiting an Equivocal Relationship with PD Risk 
Rural Residency 
The current results were suggestive of an inverse relationship rather than increased 
risk of PD for having resided in a remote area. This result is in contrast to the 
previous Australian study by McCann et al. (1998), which reported increased odds of 
PD for having lived in a non-metropolitan area for 12 months or more. Among the 
environmental exposures previously examined, the most inconsistent results have 
been reported for rural residency. The nature of this exposure is likely to be highly 
heterogeneous both between countries and within countries, which may explain the 
inconsistency between studies. The different definitions of rural residency that have 
been used between studies are also likely to be substantial contributors to the lack of 
consensus. Furthermore, studies that rely on the participants to classify their previous 
residences as ‘rural’ themselves may be subject to substantial exposure 
misclassification. In the current research, when participants were asked to classify 
each previous residence according to whether it was ‘rural’ or ‘remote’,31 only poor 
to moderate test-retest repeatability was achieved (kappa 0.39-0.63). 
 
Population density is unlikely to be a causal factor in PD aetiology. It is more likely 
that some other factor which was common to rural areas in some previous studies is 
related to increased risk of PD. As rural environments can be very disparate in 
Australia, the failure to observe a relationship between living in a rural area and PD 
may be due to combining exposures to aetiologically irrelevant environments with 
those of aetiological relevance to PD, thus diluting or masking any effect that may be 
present. Therefore to explore this association further, it may be more appropriate to 
examine particular aspects of rural living separately. For example, residence within 
close proximity to particular crops or industries may be more important to PD 
aetiology than population density. Therefore, further examination of residential 
                                                 
31 Participants were provided with a list of the RRMA classifications and the definition of each category. 
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history as a risk factor for PD should concentrate on such factors rather than crude 
markers of population density alone. 
 
Groundwater Consumption 
The current study did not observe a clear relationship between consumption of 
groundwater and PD risk. While the results suggested slightly increased odds of PD 
for ever having a private groundwater supply, and greater increased odds of PD for 
having a private groundwater supply for more than 20 years, the results were 
statistically non-significant and very few participants were exposed for this length of 
time. Few studies have observed a positive relationship between consumption of 
water from ground supplies and PD risk. The previous international studies that have 
reported a positive relationship between consumption of groundwater and PD were 
conducted in Italy and India. These positive relationships may have been chance 
findings or may reflect a difference in the composition of groundwater in these 
countries compared to Australia (e.g. mineral content or microbiological/chemical 
contamination). As groundwater is the main potable water supply for Italy, more of 
the population are exposed, which may explain why three out of four studies in that 
country have reported an increased risk of PD with well water consumption (De 
Michele et al. 1996; Smargiassi et al. 1998; Zorzon et al. 2002) when studies in other 
countries with lower prevalence of groundwater consumption have observed no 
relationship. 
 
Metals and Welding Fumes 
The current results did not observe a clear increased risk of PD associated with 
working with metals in general. This result is similar to other case-control studies 
that assessed exposure to metals solely via self-report (Semchuk et al. 1993). The 
current study appears to be the first well-designed case-control study to suggest an 
increased risk of PD for welding. Unlike the retrospective cohort studies (Fryzek et 
al. 2005; Fored et al. 2006), the odds ratios were adjusted for participant smoking 
status. There is biological plausibility for a relationship between welding and PD 
risk, however there is an absence of supportive evidence from well-designed 
epidemiological studies.  
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Solvents 
The current study only observed slightly elevated increased odds of PD lacking 
statistical significance for ever working with any type of solvent, and no evidence of 
a dose-response relationship with greater intensity or longer duration of exposure. 
Only working with cleaning solvents was associated with statistically significant 
increased odds of PD, while the relationship between PD risk and working with 
thinners nearly attained statistical significance. Few epidemiological studies have 
examined solvents as a risk factor for PD. Similar to the current study, most of those 
that examined these exposures have reported positive associations for some, but not 
all types of solvent exposures (Seidler et al. 1996; Smargiassi et al. 1998; McDonnell 
et al. 2003).  
 
7.2 Strengths and Limitations of the Current Study 
Participant Selection and Recruitment 
The case-control study, described in the preceding chapter of this thesis, attempted to 
improve and expand upon the two previous Australian case-control studies of PD and 
environmental exposures. The first of these was conducted by McCann et al (1998) 
and the second, which has not been published previously, was described and 
analysed in Chapter 3 of this thesis. Both these existing studies had a number of 
potential limitations, discussed previously, which may affect the validity of their 
results. A number of differences in study design and methodology were employed in 
the current study compared to these previous studies, to overcome these potential 
limitations. The current study recruited cases from a defined population (one 
neurology clinic) rather than from multiple sources of unknown size and attributes. A 
community-based control group was obtained by random sampling of persons from 
the Commonwealth Electoral Roll, and individually matched to the cases on age, sex 
and residential suburb. Thus, the problems inherent to clinic-based controls and 
family/friend controls were minimised.  
 
There are a number of reasons why these potential sources of controls can be 
unsuitable for case-control studies. The assumption that controls drawn from the 
same clinic as the cases are also originally from the same source population as the 
cases is not always valid as it does not take into account the referral patterns that 
exist for different diseases. The lower participation rates that can be expected 
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amongst control participants that are also suffering from a medical condition can 
reduce the representativeness of the control sample. Furthermore, if there is any 
connection between the medical conditions of controls and the exposures of interest, 
the results will be biased towards the null or possibly inverted if the relationship 
between the control ‘disease’ and the exposure is stronger than the relationship 
between the condition of interest and the exposure (Rothman and Greenland 1998a). 
Family members can also be inappropriate controls as they are often overmatched on 
environmental exposures due to shared residential history, and can be mismatched on 
sex, in the case of spouse controls. Similarly, friends can often be overmatched on 
environmental exposures as they share common interests, work histories or lifestyle 
habits (Kaplan 1998). Cases are also more likely to suggest friends that are ‘out-
going’ or extroverted than reclusive friends. This could bias the results as personality 
is often linked to exposures. Friendship groups are also not simple collectives in 
which all friends have an equal chance of being selected. Individuals with many 
friends have a greater likelihood of being chosen and therefore their exposures may 
become over-represented in the control series. For these reasons, family and friend 
controls are generally not recommended for case-control studies (Flanders and 
Austin 1986; Austin et al. 1989; Robins and Pike 1990; Kaplan et al. 1998; Ma et al. 
2004). The previous Australian case-control studies did not employ formal selection 
and recruitment procedures. This may have led to inconsistency in how the potential 
participants were approached and the possibility that certain types of participants 
were over-represented. In the current study, a standardised protocol was employed 
and the number of approaches to potential cases and controls were recorded. This 
allowed response and participation rates to be examined with quantification of 
potential selection bias, unlike the previous Australian studies that did not collect 
such data.  
 
The recruitment of cases from a private neurology clinic for the current study is a 
potential limitation. While the recruitment of participants with PD from a neurology 
clinic that specialises in the disorder was an efficient sampling frame, attendees of 
this clinic may not be representative of all people with PD. The closer a study 
population represents the population to whom the results will be extrapolated (the 
‘target’ population), the more valid the results (Tanner and Ross 2004). Therefore, 
generalisability of the studies results may have been reduced if there are important 
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differences between the clinic attendees and people with PD who do not attend this 
clinic. Two main potential limitations to this sampling frame were identified. Firstly, 
there may be an over-representation of patients with unusual symptoms, advanced 
disease or disease not responding to typical treatment regimens or GP treatment. 
Secondly, less affluent cases are likely to be under-represented at a private clinic. 
However, the results obtained from a clinic-based case series would only be non-
generalisable to the general population if there were aetiologically-relevant 
differences between cases who attend the clinic and cases who do not.  
 
Representativeness of Sample 
Unfortunately, no information was available on the prevalence of exposures in the 
case non-participants and most of the control non-participants. Limited information 
from a phone interview was available for approximately 30% of potential controls 
who did not participate in the case-control study. The percentage of these potential 
controls who reported exposure to several variables (smoking, working with metal 
fumes and working with solvents) was similar to the participating controls. However, 
there were some dissimilarities concerning pesticide use and living or working on a 
farm. Use of home pesticides was lower amongst these non-participants than the 
participants (50% versus 75%), however the use of herbicides and insecticides at 
work was higher (16% versus 9% and 35% versus 14%, respectively). Ever having 
lived or worked on a farm was also more common amongst these non-participants, 
than participants (54% versus 33%; 58% versus 39%). The differences in prevalence 
of use of home gardening pesticides and ever having lived or worked on a farm may 
have changed the direction of the associations.  
 
Exposure Measurement 
An important feature of the current study was the inclusion of a test-retest 
repeatability study of the exposure measurement instrument prior to its use for data 
collection. High test-retest repeatability was observed for the majority of general 
exposures examined, particularly lifestyle behaviours such as smoking and coffee 
and tea consumption. Environmental exposures involving active participation by the 
subject (e.g. applying pesticides) had the highest repeatability rather than recall of 
background exposures (e.g. if pesticides had been sprayed near the participants’ 
residence). Importantly, PD cases did not demonstrate lower repeatability in recall of 
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exposures than did healthy age-matched controls. Such non-differential exposure 
misclassification between cases and controls is more likely to result in a dilution of 
any relationships between environmental exposures and PD risk than bias towards 
spurious associations (Rothman and Greenland 1998b).  
 
While some previous studies of PD risk and environmental exposures have 
mentioned the inclusion of a retest to assess the repeatability of measures (Tanner et 
al. 1988; Golbe et al. 1990; Hertzman et al. 1990; Koller et al. 1990; Hubble et al. 
1993a; Marder et al. 1998), most involved a small number of participants and many 
do not report the results. Apart from the current research’s test-retest repeatability 
study (Gartner et al. 2005), only two test-retest repeatability studies of risk factor 
questionnaires for aetiological studies of PD have been published (Butterfield et al. 
1995; Reider and Hubble 2000). Both of these studies had small samples sizes (seven 
and twenty participants, respectively) and short follow up times (two and four weeks, 
respectively). 
 
While the exposure measurement instrument used in the current study generally 
exhibited good test-retest repeatability in the sample, the reliance on self-report data 
for exposure measurement remains a major limitation of the current study. Many 
participants in the current study who indicated they had been exposed to metals or 
chemical agents (including pesticides) could not recall the names of specific metals 
or chemical agents to which they were exposed. As a greater level of detail may be 
required to observe modest relationships between exposure and PD risk, self report 
may not be able to adequately examine these exposures.  
 
Sample Size 
The majority of this study’s results lacked statistical significance as the study was 
under-powered to examine most of the exposures considered. However, a larger 
sample size was not possible due to the substantial time and budget constraints. No 
external funding was available for employment of additional interviewers to collect 
data from more participants and the time restrictions of the PhD program restricted 
the number of participants that could be interviewed by the candidate. It should be 
noted that in addition to the exposure data collected and presented in this thesis, 
blood specimens were also collected from the participants by the candidate during 
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the interviews for concurrent research into genetic risk factors for PD for a 
colleague’s study (Deng et al. 2004). This added to the time required for data 
collection as in addition to collecting the specimens, they also needed to be 
transported to the laboratory for storage.  
 
7.3 Public Health Significance 
 
7.3.1 Risk Factors 
While a clear relationship was not observed between PD risk and many of the 
environmental exposures examined, some of the results were suggestive of an 
increased risk of PD for particular exposures (e.g. occupational and domestic 
exposure to fungicides, occupational exposure to cleaning solvents, regular 
occupational exposure to pesticides, welding fumes etc). A clear relationship may 
have been difficult to observe for these exposures as subsets of highly exposed 
individuals may have been hidden within the broad definitions of exposure utilised in 
this study. A substantially higher sample size would be required to adequately 
examine subsets of exposure via interaction terms. Further investigation of some of 
these exposures, such as fungicides may require an industrial cohort of 
manufacturing workers to obtain sufficient numbers of highly exposed individuals. 
 
The influence of individual variability in risk between exposed individuals may also 
make observation of a clear relationship between environmental exposures and PD 
risk with a standard case-control design difficult. For example, some environmental 
exposures may only be associated with substantial increases in risk of PD for 
subgroups of the population, such as those with poor toxin-metabolising ability. 
Recent studies by Deng et al. (2004) and Elbaz et al. (2004), which showed greater 
risk of PD associated with pesticide exposure for CYP2D6 poor metabolisers 
compared to extensive metabolisers, support this theory.  
 
As it is not possible to identify all individuals in the population with decreased toxin 
metabolising ability, efforts should be made to minimise exposure to these potential 
PD risk factors for the whole population. Workplaces need to employ appropriate 
engineering features to decrease exposure to their employees, such as through 
increased ventilation and removal of airborne particles, or if all other options are 
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impractical, the use of personal protective equipment (PPE). Those with non-
occupational exposure to these potential risk factors need to be educated in ways to 
reduce their exposure, such as the use of PPE and adequate ventilation during use. In 
addition to PD, many of these potential environmental risk factors (e.g. pesticides, 
solvents and welding fumes) have been linked to increased risk of other serious 
diseases, including cancer. Therefore, while a causal link between these 
environmental exposures and PD has not been established, minimising exposure to 
these agents to best practice standards is important to reduction of global burden of 
disease.  
 
7.3.2 Protective Factors 
The inverse relationships between smoking habit and coffee consumption and PD, 
observed in the current study, are of public health significance as they may represent 
avenues of future treatment and prevention strategies, if a protective component of 
tobacco smoke can be identified and extracted from its otherwise toxic components. 
The current study also provides preliminary evidence that exposure to environmental 
tobacco smoke (passive smoking) is associated with decreased risk of PD. The 
inverse relationship between passive smoking and PD that was observed in the 
current study independent of active smoking suggests that the basis for the inverse 
relationship between tobacco smoking and PD may be biological, rather than a 
decreased desire to take up smoking for personality reasons, as suggested by some. 
As discussed in Chapter 2, a number of potential biological pathways have been 
proposed as an explanation for the inverse relationship between PD and tobacco 
smoking. These include neuroprotection through: 
• reduction of enzymatic activity of monoamine oxidase B in the brain (which 
may reduce activation of neurotoxicants) (Chiba et al. 1984; Fowler and 
Volkow 1996); 
• reduced neuronal uptake of neurotoxicants (e.g. MPP+) by displacement with 
dopamine due to nicotine-induced increases in its release (Snyder and 
D'Amato 1986; Zhou et al. 2001); 
• Enhanced elimination of neurotoxicants (Quik and Di Monte 2001); or 
• suppression of endogenous toxin formation by acting as an antioxidant or by 
alternating monoamine oxidase activity (Fowler and Volkow 1996; 
Castagnoli and Murugesan 2004). 
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In the current study, there was a suggestion that ever having been a regular tobacco 
smoker modified the risk of PD associated with some environmental exposures 
(exposure to fungicides and welding fumes). This finding is consistent with the 
theory that tobacco smoke is neuroprotective. 
 
While these findings are suggestive of a protective effect of tobacco smoking against 
PD, they need to be considered within the public health context. Tobacco smoking is 
the second major cause of death in the world, and the leading cause of preventable 
disease in developed countries. Therefore, promotion of uptake of tobacco smoking 
to protect against PD cannot be recommended. Similarly, tobacco smoking to slow 
progression of PD symptoms is not advised as there is no conclusive evidence of a 
benefit (Alves et al. 2004; Papapetropoulos et al. 2005). Advice about cessation of 
smoking provided to people with PD who are existing smokers should consider the 
potential health benefits to them and any cohabiting family members. 
 
The inverse relationship of coffee consumption to PD risk observed in the current 
and previous epidemiological studies is an example of how epidemiological research 
can progress our understanding of PD pathological processes and potential target 
sites for therapeutic drugs. The results of epidemiological studies have been backed 
up by toxicological research that indicates that blockade of adenosine A2A receptors 
with A2A receptor antagonists, including caffeine, attenuates MPTP toxicity in animal 
models (Chen et al. 2001a; Ikeda et al. 2002). As blockade of A2A receptors also 
enhances activity of dopamine receptors, A2A receptor antagonists may exert both 
acutely anti-symptomatic and chronically neuroprotective activities for people with 
PD. Theophylline, a metabolite of caffeine, has already been investigated in clinical 
trials for its therapeutic potential in PD treatment (Kulisevsky et al. 2002). 
 
In addition to caffeine, other constituents of coffee may also have neuroprotective 
properties that may be worthy of further investigation for therapeutic use. These 
include antioxidants, such as polyphenols (chlorogenic acid), and phytoestrogens 
(Huber and Parzefall 2005). Other chemoprotective properties of coffee components 
and whole coffee are associated with modifications of the glutathione-S-transferase 
(GST) and N-acetyltransferase (NAT) detoxification pathways. Kahweol and 
cafestol, two constituents of unfiltered coffee, cause various modifications of 
xenobiotic metabolism that are beneficial, including induction of GST and inhibition 
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of NAT. Other coffee components such as polyphenols and kahweol/cafestol-free 
coffee are also capable of increasing GST and partially of inhibiting NAT, although 
to a somewhat lesser extent (Huber and Parzefall 2005).  
 
In addition to Parkinson’s disease, regular coffee consumption is associated with 
reduced risk of a number of diseases, including certain cancers (colorectal, liver, 
breast) (Giovannucci 1998; Gelatti and Brescia HCC Study Group 2005; Kurozawa 
2005; Nkondjock 2006), type 2 diabetes (van Dam 2005), symptomatic gallstone 
disease (Leitzmann et al. 1999) and Alzheimer’s disease (Lindsay et al. 2002). 
However, adverse health effects have also be associated with coffee consumption. 
For example, some reports have suggested regular high intake of coffee (five or more 
cups per day) increases risk of acute coronary events (Palmer et al. 1995; Tofler et al. 
2001). A number of physiological effects of whole coffee and its constituents have 
been suggested as responsible for this increased risk of cardiovascular disease. 
Cafestol and kahweol, two components of unfiltered coffee, have been shown to 
promote increased plasma concentration of cholesterol in humans. Caffeine has also 
been shown to cause an acute increase in the arterial wave reflection which can 
increase the pulsatile load of the heart. Increased cardiac contractility which could 
lead to plaque rupture in blood vessels has also been suggested as a possible effect of 
caffeine (Chang et al. 1995). Furthermore, elevated homocysteine levels, an 
independent risk factor for cardiovascular disease, have been reported in men and 
women drinking large quantities of coffee (more than nine cups of coffee per day) 
(Nygård et al. 1997). This negative effect on homocysteine levels appears to be due 
to chlorogenic acid, a polyphenol found in large quantities in coffee (Olthof et al. 
2001). However, the relationship between coffee consumption and cardiovascular 
disease is controversial due to a number of cohort studies showing no increased risk 
(Wilson et al. 1989; Willett et al. 1996). Nevertheless, recommendations to people 
with PD concerning consumption of coffee should consider the possibility that coffee 
may induce or exacerbate cardiovascular disease, particularly in those with existing 
conditions. Furthermore, the negative effects of chlorogenic acid on homocysteine 
levels is concerning as homocysteine exacerbates MPTP-induced dopamine 
depletion, neuronal degeneration, motor dysfunction and exacerbates oxidative 
stress, mitochondrial dysfunction and apoptosis in human dopaminergic cells 
exposed to the pesticide rotenone or the pro-oxidant Fe2+ (Duan 2002). 
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7.4 Future Research 
Environmental Tobacco Smoke 
The inverse association between PD risk and exposure to environmental tobacco 
smoke observed in the current study should be considered as a preliminary finding. 
Furthermore, the possibility that a component of tobacco smoke may reduce risk of 
PD associated with environmental toxins is worthy of further research. Further 
examination of the exposure and PD risk is needed with both epidemiological and 
animal studies to confirm the relationship. Future epidemiological studies should be 
designed with this in mind to ensure a sufficient number of exposed individuals will 
be recruited to allow consideration of interaction effects between active and passive 
smoke exposure and genetic polymorphisms and environmental exposures (e.g. 
pesticides, welding fumes, solvents etc). Similarly, exposure to environmental 
tobacco smoke should be investigated in more detail with more refined exposure 
measurement including age at which exposure occurred and, if possible, intensity of 
dose. A prospective cohort study is recommended to examine the relationship 
between passive smoking and PD risk as this is the best epidemiological research 
design to examine aetiology within practical constraints. It is possible that an existing 
cohort study, such as Whincup et al. (2004), which also included a biomarker of 
overall passive exposure to tobacco smoke (serum cotinine concentration) in the 
exposure measurement, could be utilised by following up the cohort for PD diagnoses.  
 
Fungicides 
The increased odds of PD associated with use of fungicides that was observed in the 
current study may represent confirmation of toxicological studies that have reported 
dopaminergic neurodegeneration in laboratory animals exposed to the fungicide 
maneb (Thiruchelvam et al. 2000a; Zhang et al. 2003b). However, apart from the 
current results, there is little existing epidemiological evidence to support these 
findings in human populations. Therefore, replication of this finding would be highly 
desirable for confirmation. A prospective cohort study utilising biological monitoring 
of the participants for exposure to fungicides of particular interest to PD aetiology 
(e.g. maneb and mancozeb) would be the optimal study to confirm this relationship. 
As occupational fungicide use is relatively low in the general population, an 
industry-based study encompassing a large geographical area (e.g. Australia-wide) 
may be necessary to obtain sufficient numbers of exposed participants.  
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Welding Fumes 
While only limited evidence exists, including a toxicological study (Yu et al. 2003), 
to support a relationship between exposure to welding fumes and PD, the observed 
relationship between exposure to welding fumes and PD risk observed in the current 
study is worthy of further investigation as it is a common workplace exposure in 
construction and other industries. This may include both toxicological and 
epidemiological studies. Furthermore, the possible interaction of smoking and 
welding warrants examination as this may explain the discrepancy between the 
current results and those of previous studies, such as the two recently published 
retrospective cohort studies (Fryzek et al. 2005): particularly as the results of Fryzek 
et al. (2005) also suggest increased risk of PD for welders who are non-smokers. A 
well-designed case-control study or, preferably, a prospective cohort study which 
includes data on both welding and smoking habits, is needed. 
 
The current result should be treated with caution in the absence of further 
confirmation in well-designed epidemiological studies with high-quality exposure 
measurement, as the exposure was only recalled with fair-to-moderate test-retest 
repeatability in the current research (Chapter 5). While participants in the current 
study were offered ‘welding’ as an example of a possible exposure in the category of 
Exposure to metal fumes, the question from which exposure to welding was 
measured was an open-ended question (“How did you have contact with metal fumes 
or working with metals? What tasks were you doing?”). Closed-ended questions 
about specific exposures, such as welding, may help to ‘jog’ participants’ memories 
and standardise the opportunity to respond to the question. Closed-ended questions 
have been also shown to have greater sensitivity in measuring environmental 
exposures than open-ended questions in some studies (Teschke et al. 1994). 
Therefore, it may be more appropriate to ask closed-ended questions specifically 
about exposure to welding and include information about intensity and duration of 
exposure, should this exposure be examined again in future studies.  
 
Exposure Measurement  
Relationships were not observed in the current study between PD and exposure to 
general classes of chemicals, such as ever having worked with pesticides, metal 
fumes/dusts, or solvents. However, relationships were observed between particular 
types of pesticides (fungicides), metal working activities (welding), and solvents 
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(e.g. cleaning solvents, thinners). These may simply be chance findings; however 
they may indicate that specific exposures, such as manganese (a common constituent 
of both fungicides and welding fumes), may increase PD risk and analysing disparate 
chemicals together as one exposure would result in dilution of any moderate effects. 
Therefore, future studies should attempt to obtain more refined data concerning 
potential agents of interest rather than broad categories of exposures.  
 
As self-report data may be unable to obtain a sufficient level of detail concerning 
specific chemicals and metals, future studies may need to consider other methods of 
measuring exposure, such as assessment by industrial hygienists based on job titles 
and descriptions (Siemiatycki et al. 1989). This method is not without limitations and 
is time-consuming and costly. They may also be a source of measurement error as 
low inter-rater agreement between expert assessors has been reported by a number of 
studies . The level of detail of the workplaces and job processes performed by the 
participants to enable an accurate hygienist assessment may be overly burdensome 
for some participants and still relies on a certain amount of self-report data. Domestic 
exposures, which can be a substantial source of the exposures considered here, are 
also neglected by such methods. Therefore, it is unlikely that self-report can be 
completely eliminated from exposure assessment for epidemiological studies of PD 
aetiology; however a combination of self-report and expert assessment may improve 
assessment of specific industrial exposures. This may require future studies to be 
based within certain industries and to focus on a smaller number of potential agents. 
 
In the current study, cases were considered ‘exposed’ if their exposure occurred prior 
to their diagnosis of PD. This method did not take into account an induction period 
for PD and was due to the lack of definitive information on the length of this 
induction period. While information concerning the timing of the exposures was 
collected for some factors in this study (e.g. residences, occupations, smoking habit), 
this information was not collected for every exposure examined to reduce the 
interview time and the burden on participants. For those factors where timing of the 
exposure in the participant’s life is available in the current study, the data could be 
explored in the light of various potential induction periods to consider the impact on 
the results of timing of the exposure. This may provide information that could inform 
data collection for future studies of PD aetiology.  
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7.5 Conclusions 
The current results suggest that environmental exposures are modest contributors to 
PD risk. However, some exposures (e.g. fungicides and welding) were associated 
with greater than twofold increased risk of PD. While the current study also 
considered some of the other non-environmental factors that may contribute to or 
moderate PD risk (e.g. age, sex, smoking, family history of PD), other factors which 
may interact with environmental exposures, such as genetic polymorphisms related 
to toxin metabolising ability were not considered due to time and budget constraints. 
The possibility that interaction with genetic factors may additively or synergistically 
increase risk should be considered. For example, individuals with CYP2D6 poor 
metaboliser genotypes who are exposed to pesticides may have much greater risk of 
PD than those with extensive metaboliser genotypes as they are less able to convert 
toxins to inert substances. Further investigation of potential interaction between 
multiple factors (e.g. smoking, genetic polymorphisms, gender and environmental 
exposures) in epidemiological and toxicological studies may contribute to our 
understanding of causal pathways and potential avenues for neuroprotection.  
 
This research also addressed the important, and often over-looked, issue of exposure 
data quality. The test-retest repeatability study reported in this thesis is currently the 
largest published test-retest repeatability study of an exposure measurement 
questionnaire for PD risk factors.  
 
Whilst an inverse relationship between active smoking and PD risk has been 
consistently reported in the literature, this study was the first to observe and report an 
inverse relationship between passive smoking and PD risk.  
 
The results of this research support the theory that PD has a multifactorial aetiology 
and that environmental exposures are some of a number of factors to contribute to 
PD risk. There was also evidence of interaction between some factors (e.g. smoking 
and welding) to moderate PD risk.  
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Table A.1 United Kingdom Parkinson’s Disease Society Brain Bank 
Diagnostic Criteria 
Step 1 - Diagnosis of Parkinsonian syndrome 
Bradykinesia plus at least one of the following… 
Muscular rigidity 
Rest tremor 
Postural instability 
Step 2 - Exclusion criteria including  
History of repeated strokes 
History of repeated head injury 
History of definite encephalitis 
Step 3 - Supportive prospective criteria (at least three required) 
Unilateral onset 
Rest tremor present 
Evidence of progression 
Persistent asymmetry 
Excellent response to L-dopa 
Severe L-dopa-induced chorea 
L-dopa response for 5+ years 
Clinical course of 10+ years 
 
Table A.2: Categories of Idiopathic Parkinsonism (IP) according to Calne, Snow 
and Lee (1992) 
 
1. Clinically possible IP.  
The presence of any one of the salient features: tremor, rigidity, or bradykinesia. 
Impairment of postural reflexes is not included because it is too nonspecific. The tremor 
must be of recent onset, but may be postural or resting.  
 
2. Clinically probable IP.  
A combination of any two of the cardinal features: resting tremor, rigidity, bradykinesia, 
or impaired postural reflexes. Alternatively, asymmetrical resting tremor, asymmetrical 
rigidity, or asymmetrical bradykinesia are sufficient.  
 
3. Clinically definite IP.  
Any combination of three of the features: resting tremor, rigidity, bradykinesia, or 
impairment of postural reflexes. Alternatively, sufficient are two of these features, with 
one of the first three displaying asymmetry. 
(Calne et al. 1992) 
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Summary of Case Control Studies of Environmental Risk Factors for 
PD 
 
Table B1: Summary of Case-Control Studies of Rural Residency as a Risk Factor for Parkinson’s Disease 
Authors     Location 
No. 
Cases 
No. 
Controls Case Group Control Group 
Mode of 
Measurement 
Delivery Exposure OR 95% CI P
           
Tanner et al. (1989) China      100 200 Hospital Hospital Interview Village residence 0.57 0.33-0.98 <0.05 
Study design: Matched case-control study. Question: Life histories obtained, including population of each residence & source of drinking water for each residence. Definition of ‘village’ not 
provided. Strengths: Addressed data quality with small test-retest study (12 participants reinterviewed one week after initial interview). Limitations: No response rate provided.  
           
Ho et al. (1989) 
 
Hong  35 105 Hospital & residential 
 
Hospital & Interview 
  
Living in rural area 1-20 yrs 1.30 0.40-4.40 NS 
Kong   care residential care  Living in rural area 21-40 yrs 2.10 0.70-6.70 NS 
       Living in rural area > 40 yrs 4.90 1.40-18.20 - 
Study design: Matched case-control study. Controls matched on sex, age +/- 2 years & hospital. Question: No definition of ‘rural living’. Limitations: Small sample size & women over-
represented in sample (69%); proxy respondants used for participants with dementia. A matched design was used, however data analyses appears to be for an unmatched study. 
           
Golbe et al. (1990) US 106 106 Clinic Spouses of cases Telephone 
Interview 
Rural experience 2.00 1.04-4.00 0.05 
Study design: case-control study. Question: ‘Rural Experience’: no definition provided. Limitations: Spouse controls are overmatched on residential history & mismatched on sex. No test-retest 
repeatability or validity testing of questionnaire mentioned, no definition of how ‘rural experience’ was assessed. Generalisability of study results unknown. 
           
Zayed et al. (1990) Canada 42 84 GPs & Neurologists Phone book matched Interview Rural residency 0.31 0.11-0.91 <0.05 
     to same town, age  Rural residency 1-10 years 0.30 0.04-1.79 NS 
     & sex  Rural residency 11-20 years 0.31 0.06-1.47 NS 
       Rural residency 21-30 years 0.47 0.14-1.57 NS 
           Rural residency >30years 0.67 0.13-3.26 NS
Study design:. Matched case-control study Question: No information about definition of rural residency or how assessed Limitations: Small sample size; Response rate of controls not stated 
Strengths High participation rate amongst GPs & Neurologists in study area (91.5%); questionnaire pretested (however only 5 participants) 
           
Koller et al. (1990) US         150 150 Clinic Clinic Interview Rural residence 1.90 - 0.01
Study design: Matched case-control study. Participants randomly selected, controls matched on age & sex. Question: Not provided; years spent living in rural area collected (residential history 
obtained); Rural living defined as residing in a town with a population less than 2,500 people (US Bureau of Census criterion). Strengths: Population of towns in which participants lived verified 
with data US Census Bureau data (no details of degree of agreement). Retest on 20 participants 4-13 months after first interview, reported ‘reliability’ of between 80-100% for all factors studied. 
Limitations: No response rate for cases or controls reported. 
           
Semchuk et al. (1991) Canada 130 260 Case register developed Random Digit Dialing Interview First 15 years of life 0.93 0.60-1.43 NS 
    from GPs & 
Neurologists 
 (semi-
structured) 
First 45 years of life 0.78 0.51-1.21 NS 
Study design: Matched case-control study. Question: Complete residential history obtained for first 45 years of life. Participant self-selected if each residence was city/town or not (ie rural) 
Limitations: no validity or test-retest repeatability of question. Strengths: Cases recruited from all GPs & Neurologists in study area, controls randomly recruited from general population, good 
response rate (cases 88.4%, controls 75.8%) 
           
Wong et al. (1991) US 38 38 Clinic - 19 pairs of 
siblings concordant for 
PD 
General Neurology 
& Medicine Clinics 
(diagnoses included 
headache, back pain, 
arthritis & heart 
disease 
Interview     
      38  Movement Disorders
Clinic – 19 sibling 
pairs with familial 
essential tremor 
 Lived in rural area 4.30 - 0.01 
Study design: matched case-control study. Controls individually matched on sex, & age. Question: Years spent in rural vs urban living. No details of how assessed or definition of rural. 
Limitations: No details of response rate provided. Small sample size. How this complicated study design was analysed & the use of the two different control groups was not fully explained. 
           
Stern et al. (1991) US 149 149 Hospital - Young & Old Friends of cases & Interview Rural living for 1+ years 1.70 0.90-1.70 0.8 
    Onset Patients 
 
hospital controls  Rural living 1-10 years 
 
2.50 1.20-5.30 0.02 
         
   
   
 Rural 10+ years 1.30 0.70-2.40 0.47
  80 80 Hospital - Old Onset 
Patients 
Friends of cases & 
hospital controls 
 Rural living ≥1 year  2.40 1.00-5.40 NS
  69 69 Hospital - Young Onset 
Patients 
Friends of cases & 
hospital controls 
 Rural living ≥1 year 1.20 0.60-2.50 NS
Study design: Matched case-control study (1:1 match). Question: Lifetime residential history obtained with estimates of population density, ‘rural’ identified by self-report. Strengths: Considered 
old onset & young onset patients separately allowing for possibly different risk factors between the groups. Limitations: Controls were a mixture of friend controls & hospital patients (excluding 
other movement disorders); Small sample size after stratification by age of onset. No test-retest repeatability or validity testing of questionnaire mentioned. response rate for cases or controls 
provided. 
           
Butterfield et al. 
(1993) 
US 63 68 Young onset Patients – 
recruited from 
neurologists & patient 
support groups 
Rhematoid Arthritis 
patients – from 
rheumatologists & 
patient support 
groups 
Self-
administered 
Residence in town of 10 000 
or less at diagnosis 
2.35   0.87-6.34 0.09
Study design: case-control study. Controls frequency matched on sex, year of birth & year of diagnosis. Question: Lifetime residential history obtained; rural town defined as population <10,000 
but no details of how assessed. Strengths: Questionnaire was reviewed by a team of experts prior to use. Test-retest repeatability & validity was addressed, however the sample size was small. 
Limitations: People with rheumatoid arthritis may be inappropriate controls as they may come from a different source population to the PD cases & have some overlap in risk factors as the cause 
of RA is unknown, this is difficult to discount.  
           
Wang et al. (1993) 
 
China          
         
93 186 Hospital Hospital Interview Rural areas 0.76 0.49-1.18 NS
 Small cities 0.39 0.18-0.84 <0.02
Study design: Matched case-control study. Controls matched on sex, age +/- 3 years & hospital. Question: Residential histories obtained, & source of drinking water. Definitions of rural area & 
small city not provided. Limitations: No response rate provided.  
           
Vieregge et al. (1994) Germany          66 72 Hospital Hospital Interview Rural residence 1.09 0.56-2.16 NS
Study design: frequency matched case-control study (age- & sex-matched). Question: Complete residential history. Limitations: Small study with cases & controls ‘clinic-based’. 
           
Martyn & Osmond  UK    172 343 General Practices General Practices Interview First home - Isolated house 0.80 0.24-2.76 NS 
(1995)       First home – Village 1.40 0.82-2.49 NS 
       First home - Small town 0.90 0.56-1.40 NS 
Study design: Matched case-control study. Controls individually matched on sex, age (+/-3 years). Question: Details of residence & place of birth. No definition provided of each type of 
residence or how assessed. Strengths: High response rate. Trained interviewer.  
           
Seidler et al. (1996) Germany        
        
380 376 Mulitple neurology
clinics throughout 
Germany 
 
Regional controls – 
random route 
method 
Interview Population density 0.90 0.40-2.10 T 0.85
380 379 Neighbourhood
controls – random 
route method 
 Interview Population density 1.20 0.50-2.90 T 0.22t
Study design: Matched case-control study. Controls individually matched on sex, age (+/-3 years) & region or neighbourhood. Question:  Complete residential history with approximate 
population – analysed as average population density. Limitations: Controls matched on residence, therefore may be inappropriate to consider residential history as risk factor – use of regional 
control may have overcome this issue. Multiple neurologists performed diagnosis, whilst standard criteria were used (UK Brain Bank), may have lead to some misclassification. Strengths: Large 
study with population-based control group; experienced interviewers used for data collection & same interviewer used for case & matched control. Experts used to code exposure & developed a 
job exposure matrix. Cases restricted on age & disease duration to reduce memory difficulties. T = Test for trend 
           
Liou et al. (1997) Taiwan          120 240 Hospital Hospital Interview Rural living 2.04 1.23-3.38 <0.05
       Rural living for 1-19 years 1.23 0.51-2.98 NS 
       Rural living for > 19  years 1.68 0.81-3.47 NS 
Study design: Matched case-control study. Controls matched on sex, age +/- 2 years & hospital. Question: years of residing in rural areas – Definition of rural area not provided. Limitations: No 
response rate provided. Strengths: Performed a ‘reliability check’ with 20 cases and 20 controls 4-10 months later, however little detail provided. 
           
Gorell et al. (1998) US 144 464 Henry Ford Health 
System 
Henry Ford Health 
System 
Interview Lived in rural area 1.19 0.73-1.93 0.48 
Study design: Unmatched case-control (frequency matched); Question: Lifetime residential history obtained, including the number of years lived in a rural environment (a setting with a 
population of a small town or less) Limitations: No validity or test-retest repeatability testing for residential data described. Definition of rural environment is ambiguous. Strengths: Cases & 
controls recruited from a sampling frame shown to represent general population. Response rate provided & detailed description of selection & recruitment procedure. 
           
McCann et al. (1998) Australia 224 310 Hospital, residential care 
& community groups 
Hospitals, residential 
care, community groups 
Self-
administered
Rural residency 1.70 1.17-2.57 0.11 
Study design: case-control frequency matched on age & sex; Question: “Have you ever lived in a non-metropolitan area for twelve or more months?” Limitations: no definition provided of ‘non-
metropolitan’, no validity or test-retest repeatability testing of question. No systematic or random sampling of participants (convenience sample), participants recruited from multiple sources; 
response rate unknown. 
           
De Palma et al. (1998) Italy    100 200 University Hospital
Neurology Clinic 
Outpatient specialist 
Clinics of Same 
Hospital 
Interview Living in rural area 3.62 2.09-6.26 - 
Study design: Case-control study. Question: No information about definition of rural residency Limitations: No response rate reported.  
           
Chan et al. (1998) China      215 313 Hospital Hospital Interview Percentage of life in rural area 1.00 0.100-1.01 0.41 
Study design: Case-control study. Question: Details place of birth & each place of residence for at least one year. Participant asked to identify if rural or urban, but no definition provided.  
Limitations: No response rate provided.  
           
Taylor et al. (1999) US 140 147 Clinic Friends of cases Interview     Rural residence 1.07 0.99-1.15 0.06
Study design: Matched case-control study (1:1 match). Question: Lifetime residential history obtained with estimates of population density, ‘rural’ identified by self-report. Strengths: 
Considered old onset & young onset patients separately allowing for possibly different risk factors between the groups. Limitations: Controls were a mixture of friend controls & hospital 
patients (excluding other movement disorders); Small sample size after stratification by age of onset. No test-retest repeatability or validity testing of questionnaire mentioned. 
           
Werneck & 
Alvarenga (1999) 
Rio de 
Janeiro 
92    110 Hospital Hospital Self-
administered 
Rural life 1.00 0.52-1.95 NS 
Study design: Unclear whether individually matched or frequency matched case-control study. Controls matched on age +/- 2 years & hospital. Question: Place of birth; place of residence; 
former places of residence. Rural residency not defined. Limitations: No response rate provided. Strengths: Attempted to consider data quality, however only retested 5 participants.  
           
Behari et al. (2001) India         377 377 Clinic Clinic Interview Rural residency for ≤ 10 yrs 0.42 0.20-0.89 -
       Rural residency for > 10 yrs 0.94 0.70-1.25 NS 
Study design: Matched case-control study. Controls matched on age +/- 3 years & hospital. Question: Rural residency = resided in a village with population ≤ 2500 people for at least 1 year. 
Limitations: Not all controls were matched on sex; Controls also had neurological conditions. Strengths: very large sample size. Rural residency defined.  
           
Zorzon et al. (2002) 
 
Italy          
      
136 272 Hospital
  
Hospital
 
Interview Rural birth 1.50 0.90-2.30 NS
 Rural living 1.50 1.00-2.40 -
Study design: Matched case-control study. Controls individually matched on sex, age (+/-3 years). Question: Details of residence & place of birth. No information about coding system. 
Limitations: Controls were out-patients of the hospital, but no detail provided as to diagnoses other than neurodegenerative diseases excluded. No response rate reported.  
           
Wirdefeldt et al  Sweden 476 2370 Twin Registry 
 
Twin Registry
 
     
      
Self- Small city 1.11 0.81-1.54 NS
(2005) admnistered Rural area 0.92 0.66-1.28 NS
Study design: Matched case-control study nested within a twin cohort. Controls were sex- & age-matched (within 5 years) twins who were unrelated to the PD cases. Question: No information 
about how the residential classifications were assigned & what they represented. It is likely that they are only indicative of the current residence at the time of data collection. Area of living was 
categorized into living in a large city, living in a small city, & living in rural areas. Limitations: No response rate reported. Sample size is not clearly reported. Unclear what time period the ‘rural 
living’ information refers to. Strengths: Data was collected prior to development of PD, therefore would be unaffected by recall bias. 
           
Individual studies are separated by a line. 
OR = Odds Ratio; 95% CI = 95% Confidence Interval; NS = Not Significant at 0.05 level 
 
 
 
 
 
 
 
 
Table B2: Summary of Case-Control Studies of Groundwater (Well Water) Consumption as a Risk Factor for Parkinson’s Disease  
Authors     Location 
No. 
Cases 
No. 
Controls Case Group Control Group 
Mode of 
Measurement 
Delivery Exposure OR 95% CI P
           
Tanner et al. (1989) China      100 200 Hospital Hospital Interview Well water drinking 0.74 0.41-1.32 NS 
Study design: Matched case-control study. Question: Life histories obtained, including population of each residence & source of drinking water for each residence. Strengths: Addressed data 
quality with small test-retest study (12 participants reinterviewed one week after initial interview). Limitations: No response rate provided.  
           
Golbe et al. (1990) US 106 106 Clinic Spouses of cases Interview     Well water 1.14 0.52-2.53 NS
Study design: case-control study. Question: ‘Rural Experience’: no definition provided. Limitations: Spouse controls are overmatched on residential history & mismatched on sex. No test-retest 
repeatability or validity testing of questionnaire mentioned, no definition of how ‘rural experience’ was assessed. Generalisability of study results unknown. 
           
Zayed et al. (1990) Canada 42 84 GPs & Specialists Telephone book Interview Well water 1-10 years   
         
1.83 0.34-10.69 NS
       Well water 11-20 years 2.40 0.14-40.71 NS 
       Well water 21-30 years 4.13 0.32-3.98 NS 
       Well water >30 years 
 
1.29 0.48-3.54 NS 
 Well water 1.40 0.48-4.02 0.29
Study design:. Matched case-control study Question: No information about definition of well water consumption or how assessed Limitations: Small sample size Strengths High participation rate 
amongst GPs & Neurologists in study area (91.5%); questionnaire pretested (however only 5 participants) 
           
Koller et al. (1990) US          150 150 Clinic Clinic Interview Well water 1.7 - 0.03
Study design: Matched case-control study. Participants randomly selected, controls matched on age & sex. Question: Number of years drinking well water; test-retest assessed in study 
population.  Limitations: No response rate for cases or controls reported. Strengths: Good test-retest repeatability reported for exposure assessment. 
           
Stern et al. (1991) 
 
US 149 149 Hospital young & old  
 
Friends of cases &  Interview 
  
Well water 1-10 years 1 0.5-2.4 0.91 
  onset hospital controls  Well water 10+ years 0.9 0.5-1.7 0.79 
       Well water for > 1 year 0.8 0.4-1.6 0.6 
  80 80 Hospital Old Onset Friends of cases & 
hospital controls 
Interview Well water for > 1 year 1.2 0.6-2.7 NS 
  69 69 Hospital Young Onset Friends of cases & 
hospital controls 
Interview Well water for > 1 year 0.9 0.4-2.1 NS 
Study design: Matched case-control study (1:1 match). Question: Lifetime residential history obtained with water supply identified as well or spring by self-report. Strengths: Considered old 
onset & young onset patients separately allowing for possibly different risk factors between the groups. Limitations: Controls were a mixture of friend controls & hospital patients (excluding 
other movement disorders); Small sample size after stratification by age of onset. No test-retest repeatability or validity testing of questionnaire mentioned. response rate for cases or controls
provided. 
           
Semchuk et al. (1991) Canada 130 260 Case register developed Random Digit  Interview Well water age 0-15 yrs 0.93 0.58-1.50 NS 
    from GPs & Neurologists Dialing  Well water age 0-45 yrs 1.07 0.57-2.02 NS 
Study design: Matched case-control study. Question: “Where did the your drinking water come from?” Question asked for each residence & then participant coded by researcher as exposed or 
unexposed. Limitations: no validity or test-retest repeatability of exposure measurement. Strengths: Cases recruited from all GPs & Neurologists in study area, controls randomly recruited from 
general population, good response rate (cases 88.4%, controls 75.8%). 
           
Wong et al. (1991) US 38 38 Clinic - 19 sibling pairs 
concordant for PD 
Clinic     Interview Well water 2.8 - 0.07
Study design: matched case-control study. Controls individually matched on sex, & age. Question: Years spent in rural vs urban living. No details of how assessed or definition of rural. 
Limitations: No details of response rate provided. Small sample size. How this complicated study design was analysed & the use of the two different control groups was not fully explained. 
           
Butterfield et al. 
(1993) 
US 63 68 Young onset Patients – 
recruited from 
neurologists & patient 
support groups 
Rhematoid Arthritis 
patients – from 
rheumatologists & 
support groups 
Self-
administered 
Use of potable water from 
private bore for 5, 10, 15 & 
20 years 
Ranged fom 
0.51 
To 
1.21 
  NS
Study design: case-control study. Controls frequency matched on sex, year of birth & year of diagnosis. Question: Lifetime residential history obtained; rural town defined as population <10,000 
but no details of how assessed. Strengths: Questionnaire was reviewed by a team of experts prior to use. Test-retest repeatability & validity was addressed, however the sample size was small. 
Limitations: People with rheumatoid arthritis may be inappropriate controls as they may come from a different source population to the PD cases & have some overlap in risk factors as the cause 
of RA is unknown, this is difficult to discount.  
           
Wang et al. (1993) China     93 186 Hospital Hospital Self-
administered 
Well water 0.59 0.36-0.95 <0.05 
Study design: Matched case-control study. Controls matched on sex, age +/- 3 years & hospital. Question: Residential histories obtained, & source of drinking water.  Limitations: No response 
rate provided.  
           
Hertzman et al. (1994) Canada 142 124 GPs & Specialists Electoral roll Interview Well water (men)  
  
0.80 0.35-1.86 NS
       Well water (women) 1.04 0.47-2.33 NS 
  142 121 GPs & Specialists Cardiovascular  Interview Well water (men) 0.81 0.36-1.81 NS
     disease controls from 
GPs & Specialists 
 Well water (women) 1.03 0.39-2.69 NS 
Study design: Case-control study. Two control groups used (cardiovascular disease & electrol roll controls). Question: No information concerning how well-water was measured. Strengths: 
Reported response rate, however relatively low response for electoral roll controls (61%).   
           
Vieregge et al. (1994) Germany          66 72 Hospital Hospital Interview Well water 0.77 0.38-1.57 NS
Study design: frequency matched case-control study (age- & sex-matched). Question: Complete residential history. Limitations: Small study with cases & controls ‘clinic-based’. 
           
Seidler et al. (1996) Germany       
   
380 379 Neurology clinics
throughout Germany 
Neighbourhood – 
Random route 
method 
Interview Well water 0.8 0.6-1.2 NS
  380 376  Regional – Random 
route method 
Interview Well water 0.9 0.6-1.3 NS
Study design: matched case-control study. Controls individually matched on sex, age (+/-3 years) & region or neighbourhood. Question: Complete residential history with details of water supply. 
Limitations: Controls matched on residence, therefore may be inappropriate to consider residential history as risk factor – use of regional control may have overcome this issue. Multiple 
neurologists performed diagnosis, whilst standard criteria were used (UK Brain Bank), may have lead to some misclassification. Strengths: Large study with population-based control group; 
experienced interviewers used for data collection & same interviewer used for case & matched control. Experts used to code exposure & developed a job exposure matrix. Cases restricted on age 
& disease duration to reduce memory difficulties.  
           
De Michele et al. 
(1996) 
Italy        116 232 Hospital Neurological controls
& spouses of cases 
Interview Well water 2.17 1.28-3.69 0.004
Study design: Matched case-control study. Two controls per case (spouse + neurological control with cerebrovascular diseases, neurosis, depression & neuromuscular diseases). Neurological 
contrls matched for sex, age (+/- 2 years & Hospital). Question: No information about question. Limitations: Spouse controls are mismatched on gender. No response rate provided. 
           
Liou et al. (1997) Taiwan      
         
          
120 240 Hospital Hospital Interview Well water for 1-19 years 0.58 0.26-1.32 NS 
       Well water >19 years 
 
0.71 0.40-1.28 NS 
 Well water 1.07 0.19-5.98 NS
 Spring water 1.55 0.90-2.67 NS
Study design: Matched case-control study. Controls matched on sex, age +/- 2 years & hospital. Question: drinking water sources & duration of consumption. Difference between well & spring 
water not defined . Limitations: No response rate provided. Strengths: Performed a ‘reliability check’ with 20 cases & 20 controls 4-10 months later, however little detail provided. 
           
Gorell et al. (1998) 
 
US 144 464 Henry Ford Health  Henry Ford Health  
 
Interview 
 
Before age 20 0.95 0.64-1.45 0.87 
    System System  Well water - ever 0.97 0.65-1.40 0.80 
Study design: Unmatched case-control (frequency matched); Question: Lifetime history of well-water consumption obtained. Limitations: No validity or test-retest repeatability testing for 
domestic exposure data described. Strengths: Cases & controls recruited from a sampling frame shown to represent general population. Response rate provided & detailed description of selection 
& recruitment procedure. 
           
McCann et al. (1998) Australia 224 310 Hospital, residential care 
& community groups 
Hospitals, residential 
care, community 
groups 
Self-
administered 
Well or spring water 0.60 0.38-0.92 <0.01 
Study design: Unmatched case-control; Question: “Have you used well-water, spring-water or bore-water as your main source of drinking water for mre than six months?” Limitations: no 
exposure dose considered; no validity or test-retest repeatability testing of question; no systematic or random sampling of participants (convenience sample); participants recruited from multiple 
sources; response rate unknown. 
           
De Palma et al. (1998) Italy          100 100 Clinic Clinic Interview Well water 2.09 1.27-3.42 -
Study design: Case-control study. Question: Limited details of exposure assessment or definition. Statement that environmental exposures assessed as at least 10 consecutive years of exposure as 
assessed by industrial hygienist, however not specified for well water consumption. Limitations: No response rate reported.  
           
Smargiassi et al. 
(1998) 
Italy     86 86 Hospital Hospital Interview  Well water  2.78 1.23-6.26 - 
Study design: Case-control study. Controls treated for essential arterial hypertension, glaucoma, psoriasis vulgaris & renal diseases. Question:  Occupational history; exposure calssified by an 
industrial hygienist. Exposures only considered if exposed for at least 10 consecutive years prior to onset of PD. Strengths: High participation rate. Trained interviewer & industrial hygienist 
determined exposure status. 
           
Kuopio et al. (1999) Finland 123 246 Population survey Population register Interview Drill water age<20  0.78 0.38-1.58 0.487 
       Drill water ages 20-40 1.07 0.45-2.57 0.88 
       Drill water after age 40 1.48 0.44-4.95 0.525 
Study design: Matched case-control study. Cases identified in a population prevalence survey & controls recruited from population register & matched on age (+-2 years), sex & municipality. 
Question: Main source of drinking water in 3 age groups obtained then graded according to a purification grade (drill well water – well drilled into bedrock); dug well included with other water 
sources in ‘unpurified water’. Strengths: Population-based case & control groups.  
           
Chan et al. (1998) China          215 313 Hospital Hospital Interview Well water 1.04 0.70-1.54 0.85
Study design: Case-control study. Question: “Have you ever used well water for drinking?” & number of years. No definition provided of well water.  Limitations: No response rate provided.  
           
Taylor et al. (1999) US 140 147 Clinic Friends of cases Interview Well water (years of 
drinking) 
0.93   0.88-0.98 0.003
Study design: Matched case-control study (1:1 match). Question: Years of exposure to well water (total days of exposure divided by 365). Strengths: Considered old onset & young onset patients 
separately allowing for possibly different risk factors between the groups. Limitations: Controls were a mixture of friend controls & hospital patients (excluding other movement disorders); Small 
sample size after stratification by age of onset. No test-retest repeatability or validity testing of questionnaire mentioned. 
           
Werneck & 
Alvarenga (1999) 
Rio de 
Janeiro 
92    110 Hospital Hospital Self-
administered 
Well water 1.49 0.74-3.01 NS 
Study design: Unclear whether individually matched or frequency matched case-control study. Controls matched on age +/- 2 years & hospital. Question: “Used to drink well-water in any of the 
places where you lived? For how long”. Limitations: No response rate provided. Strengths: Attempted to consider data quality, however only retested 5 participants.  
           
Behari et al. (2001) India 377 377 Clinic Clinic Interview Well water drinking for 
<=10 years 
0.65   
   
0.19-2.20 0.491
       Well water drinking for >10 
years 
1.94 1.33-2.80 0.08
Study design: Matched case-control study. Controls matched on age +/- 3 years & hospital. Question: Drank well water continuously for at least 1 year. Limitations: Not all controls were 
matched on sex; Controls also had neurological conditions. Strengths: very large sample size. Well water drinking defined.  
           
Zorzon et al. (2002) Italy     136 272 Hospital Hospital Interview Well water use* 1.5 0.9-2.3 ns 
       Well water use 2.0 1.1-3.6 0.03 
Study design: Matched case-control study. Controls individually matched on sex, age (+/-3 years). Question: No information about question. Limitations: Controls were out-patients of the 
hospital, but no detail provided as to diagnoses other than neurodegenerative diseases excluded. No response rate reported. *Adjusted for pack-years smoked ** Mulitple logistic regression 
model including Family history of PD, Family history of essential tremor, Maternal age at birth, Farming as an occupation, General anaesthesia, smoking. 
           
Park et al. (2005) Korea          367 309 Hospital Hospital Interview Well water 1.71* 1.14-2.56 0.02
Study design: Case-control study. Controls were cerebrovascular disease patients from the same hospital. Case & control group mismatched on sex (% male in control group > case group). 
Question: Lifetime occupational history. Coded according to Standard classification system (Korea Standard Industry Code). *Crude OR. Limitations: No response rate reported. Case & control 
groups not well matched on sex ore education level. . 
           
Individual studies are separated by a line. 
OR = Odds Ratio; 95% CI = 95% Confidence Interval; NS = Not Significant at 0.05 level 
 
 
Table B3: Summary of Case-Control Studies of Farming as a Risk Factor for Parkinson’s Disease  
Authors    Location 
No. 
Cases 
No. 
Controls Case Group Control Group 
Mode of 
Measurement 
Delivery Exposure OR 95%CI P
           
Tanner et al. (1989) 
 
China          
        
          
          
          
          
          
         
100 200 Hospital
 
Hospital Interview Wheat growing 0.4 0.20-0.80 0.02
 Corn growing 0.54 0.26-1.12 NS
 Soybean raising 0.67 0.30-1.40 NS
 Fruit growing 1 1.00-1.00 NS
 Rice growing 1.29 0.74-2.25 NS
 Pig raising 0.17 0.09-0.3 0.001
 Chicken raising 0.53 0.30-0.92 0.05
 Other livestock 0.63 0.35-1.14 NS
Study design: Matched case-control study. Question: Life histories obtained. Not defined whether crop & animal raising includes domestic or occupational farming. Strengths: Addressed data 
quality with small test-retest study (12 participants reinterviewed one week after initial interview). Limitations: No response rate provided.  
           
Ho et al. (1989) 
 
Hong  35 105 Hospital & residential 
 
Hospital & residential Interview 1-20 years of farming 0.5 0.10-2.10 NS 
Kong   care facilities care facilities  >20 years of farming 5.2 1.6-17.7 - 
Study design: Matched case-control study. Controls matched on sex, age +/- 2 years & hospital. Question: No definition of ‘farming’. Limitations: Small sample size & women over-represented 
in sample (69%); proxy respondants used for participants with dementia. A matched design was used, however data analyses appears to be for an unmatched study. 
           
Koller et al. (1990) US          150 150 Clinic Clinic Interview Farming 1.3 - 0.19
Study design: Matched case-control study. Participants randomly selected, controls matched on age & sex. Question: Number of years spent farming, no definition of farming provided; test-
retest assessed in study population.  Limitations: No response rate for cases or controls reported. Strengths: Good test-retest repeatability reported for exposure assessment. 
           
Golbe et al. (1990) US 106 106 Clinic Spouses of cases Interview Exposure to farm animals 1.33 0.65-2.80 NS 
Study design: case-control study. Question:. Limitations: Spouse controls are overmatched on residential history & mismatched on sex. No test-retest repeatability or validity testing of 
questionnaire mentioned, no definition of how ‘rural experience’ was assessed. Generalisability of study results unknown. 
           
Hertzman et al. (1990)
 
Canada 57 122 GPs & Specialists 
 
Electoral roll Self- Ever worked in orchard 
 
2.3 - 0.03 
      
         
 administered
 
 Orchard work 3.69 1.34-10.27 0.01
 Planer mill 4.11 0.91-18.50 0.07
Study design: Case-control study. Question: Questions about past occupations since age 25. “Ever worked in an orchard?”; “Ever worked in a planar mill?” Strengths: Attempted to assessed 
data quality by contacting subset of participants 1 month after questionnaire completed; however appears to be somewhat ‘ad hoc’ & results not reported. Good response rate reported. 
Limitations: Small sample size; PD cases chosen by physicians based on whether they thought their patient might respond to a postal questionnaire, rather than by random sampling. 
           
Zayed et al. (1990) 
 
Canada 42 84 GPs & Specialists Telephone book    
         
Interview Farming 0.65 0.25-1.69 0.24
 Farming 1-10 years 0.58 0.16-1.95 NS
          
          
 Farming 11-20 years 1.38 0.37-5.07 NS
 Farming 21-30 years 0.53 0.13-1.98 NS
Study design:. Matched case-control study Question: No information about definition of farming or how assessed Limitations: Small sample size Strengths High participation rate amongst GPs & 
Neurologists in study area (91.5%); questionnaire pretested (however only 5 participants) 
           
Tanner  et al. (1990) US 78 78 Clinic young onset Clinic: spouses of other 
patients with movement 
disorders 
not stated Farming 3.0 1.0-9.8 <0.05 
Study design: Matched case-control study. Question: Lifetime histories of occupations obtained. Farming not defined. 
           
Wong et al. (1991) US 38 38 Clinic - 19 pairs of 
siblings concordant for 
PD 
General Neurology & 
Medicine Clinics 
(diagnosese included 
headache, back pain, 
arthritis & heart 
disease 
Interview     
           38  Movement Disorders
Clinic – 19 sibling 
pairs with familial 
essential tremor 
Farming 2.7 - 0.13
Study design: matched case-control study. Controls individually matched on sex, & age. Question: Years spent farming. No details of how assessed or definition of farming. Limitations: No 
details of response rate provided. Small sample size. How this complicated study design was analysed & the use of the two different control groups was not fully explained. 
           
Wechsler et al. (1991) US 34 22 Clinic & support groups Clinic – Neurological 
Disorders 
Self- 
administered 
Farming   3.1 0.3-35.2 NS
Study design: Case-control study. Cases recruited from Huniversity hospital neurology clinic & PD support groups. Controls recruited solely from the clinic & consisted of patients with other 
neurological disorders. Question: Occupational history. Question not provided. Limitations: cases recruited from two different sources with different methods of recruitment used (no follow up 
phone call for support group cases). Controls were also suffering from neurological conditions.  
           
Semchuk et al. (1992) Canada 130 260 Case register  Random Digit  Interview     
   
Agricultural work 1.94 1.12-3.34 0.017
& (1991)    developed from GPs & 
Neurologists 
Dialing  Agricultural work adjusted 
for herbicides 
1.56 0.85-2.85 NS
       Agricultural work 16-25 yrs 1.65 0.94-2.92 NS 
       Agricultural work 16-35 yrs 2.45 1.09-5.54 0.03 
       Agricultural work 16-45 yrs 3.48 1.17-10.34 0.02 
       Agricultural work 16-55 yrs 1.94 1.12-3.34 0.02 
        
   
 Field crop farming   1.68 0.97-2.91 NS
       Field crop farming adjusted 
for herbicide use 
1.23 0.67-2.28 NS
       Field crop farming 16-25 yrs 1.49 0.84-2.64 NS 
       Field crop farming 16-35 yrs 2.5 1.07-5.87 0.03 
       Field crop farming 16-45 yrs 3.84 1.16-12.70 0.02 
       Field crop farming 16-55 yrs 1.68 0.97-2.91 NS 
         
   
 Grain farming 1.51 0.85-2.66 NS
       Grain farming adjusted for 
herbicide use 
0.97 0.49-1.92 NS
       Grain farming 16-25 yrs 1.39 0.77-2.49 NS 
       Grain farming 16-35 yrs 2.39 0.96-5.93 NS 
       Grain farming 16-45 yrs 4.44 1.15-17.09 0.02 
       Grain farming 16-55 yrs 1.51 0.85-2.66 NS 
          Market gardening 2.68 0.74-9.68 NS
       Farm living age 0-15 0.95 0.61-1.46 NS 
       Farm living age 0-45 0.9 0.58-1.37 NS 
Study design: Matched case-control study. Question: Complete occupational history obtained for first 45 years of life. Researcher coded as exposed to agricultural work or unexposed with 
Canadian Classifcation & Dictionary of Occupations Guide. Limitations: no validity or test-retest repeatability of exposure measurement. Strengths of study: Cases recruited from all GPs & 
Neurologists in study area, controls randomly recruited from general population, good response rate (cases 88.4%, controls 75.8%); Standard used for coding rather than self-selection by 
participants. 
           
Butterfield et al. 
(1993) 
US 63 68 Young onset Patients 
– recruited from 
neurologists & patient 
support groups 
Rhematoid Arthritis 
patients – from 
rheumatologists & 
patient support groups 
Self-
administered 
Ever lived or worked on a 
farm (adjusted OR*) 
0.38   - 0.018
Study design: case-control study. Controls frequency matched on sex, year of birth & year of diagnosis. Question:Definition of farm not provided. Strengths: Questionnaire was reviewed by a 
team of experts prior to use. Test-retest repeatability & validity was addressed, however the sample size was small. Limitations: People with rheumatoid arthritis may be inappropriate controls as 
they may come from a different source population to the PD cases & have some overlap in risk factors as the cause of RA is unknown, this is difficult to discount. *Adjusted for age, diagnosis 
age, race, sex, educational level & family history of PD. 
           
Hertzman et al. (1994) 
 
Canada 142 124 GPs & Specialists 
 
Electoral roll     
       
         
      
      
Interview Farming (men) 1.28 0.54-3.04 NS
 Farming (women) 0.39 0.15-1.01 NS
       Crop farming (men) 0.97 0.31-3.09 NS 
       Hard fruit orchard (men) 0.6 0.28-1.25 NS 
       Hard Fruit orchard (women) 0.32 0.14-0.73 NS 
       Soft fruit orchard (men) 0.6 0.30-1.22 NS 
       Soft fruit orchard (Women) 0.45 0.21-0.98 NS 
 Animal farming (men) 2.69 0.27-27.19 NS
 Animal farming (Women) 1.54 0.33-7.23 NS 
       Mixed farming (Men) 1.58 0.78-3.21 NS 
       Mixed farming (Women) 2.05 0.94-4.5 NS 
  142 121 GPs & Specialists Cardiovascular disease Interview Farming (men) 1.52 0.68-3.40 NS
     controls from GPs &  Farming (women) 0.75 0.27-2.07 NS 
     Specialists  Crop farming (men) 3.19 0.76-13.34 NS 
       Hard fruit orchard (Men) 1.28 0.59-2.81 NS 
       Hard fruit orchard (women) 0.64 0.23-1.82 NS 
       Soft fruit orchard (men) 1.67 0.76-3.65 NS 
       Soft fruit rchard (Women) 1.19 0.44-3.22 NS 
         
      
 Animal farming (men) 0.47 0.11-2.10 NS
 Animal farming (Women) 1.67 0.23-12.3 NS 
       Mixed farming (Men) 1.57 0.79-3.11 NS 
       Mixed farming (Women) 1.49 0.61-3.68 NS 
Study design: Case-control study. Two control groups used (cardiovascular disease & electrol roll controls). Question: Specific questions on occupation targeting farm work, sawmill work, & 
forestry jobs held for a year or more after age 25years. Strengths: Reported response rate, however relatively low response for electoral roll controls (61%).   
           
Seidler et al. (1996) Germany 380 379 Mulitple neurology Neighbourhood –  Interview Farming near home 1 0.7-1.4 NS 
    clinics throughout Random route method 
 
 Living on a farm 0.8 0.6-1.1 NS 
         
        
     
         
 Germany
 
 Farm or agriculture 0.9 0.6-1.4 NS
 Farm animal contact 0.8 0.6-1.1 NS
  380 376  Regional – Random  
 
Interview 
 
Farming near home 1.1 0.8-1.6 NS 
route method  Living on a farm 0.9 0.6-1.2 NS 
       Farm or agriculture 0.7 0.4-1.1 NS 
 Farm animal contact 0.8 0.5-1.0 NS
Study design: matched case-control study. Controls individually matched on sex, age (+/-3 years) & region or neighbourhood. Question: Complete residential history with details of whether it 
was a farm & whether there was farming nearby. Limitations: Controls matched on residence, therefore may be inappropriate to consider residential history as risk factor – use of regional 
control may have overcome this issue. Multiple neurologists performed diagnosis, whilst standard criteria were used (UK Brain Bank), may have lead to some misclassification. Strengths: Large 
study with population-based control group; experienced interviewers used for data collection & same interviewer used for case & matched control. Experts used to code exposure & developed a 
job exposure matrix. Cases restricted on age & disease duration to reduce memory difficulties.  
           
Rocca et al. (1996) Italy          92 124 Population Population Interview Farmer 0.6 0.30-1.30 0.34
Study design: Matched case-control study. Cases & controls identified in population survey.  Controls individually matched on sex, age (+/-1 year) & municipality. Question Principal lifetime 
occupation. No information about coding system Limitations: Possibility of over-matching by selecting controls on geographic area. Strengths: A population-based study; Trained interviewers 
collected the data.  
 
Liou et al. (1997) Taiwan      
         
          
          
120 240 Hospital Hospital Interview Farming for 1-19 years 1.54 0.73-3.23 NS 
       Farming for >19 years 0.85 0.43-1.69 NS 
 Farming 1.81 1.25-2.64 <0.05
 Growing fruit 1.63 0.5-5.33 NS
 Growing rice 1.7 1.13-2.58 <0.05
Study design: Matched case-control study. Controls matched on sex, age +/- 2 years & hospital. Question: years of farming – Definition of farming not provided (eg whether hobby farms were 
included). Limitations: No response rate provided. Strengths: Performed a ‘reliability check’ with 20 cases & 20 controls 4-10 months later, however little detail provided. 
           
Smargiassi et al. Italy         86 86 University Hospital University Hospital Interview Farming 1.25 0.65-2.43 NS
(1998) Neurology Clinic Specialist Clinics 
Study design: Case-control study. Controls treated for essential arterial hypertension, glaucoma, psoriasis vulgaris & renal diseases. Question:  Occupational history; exposure calssified by an 
industrial hygienist. Exposures only considered if exposed for at least 10 consecutive years prior to onset of PD. Strengths: High participation rate. Trained interviewer & industrial hygienist 
determined exposure status. 
           
Chan et al. (1998) China          215 313 Hospital Hospital Interview Farming 0.92 0.59-1.43 0.71
Study design: Case-control study. Question: :Have you ever engaged in farming activities?” & number o fyears in farming. No definition provided of farming & no details of types of farms.  
Limitations: No response rate provided.  
           
Gorell et al. (1998)  US 144 464 Henry Ford Health  Henry Ford Health  Interview Lived or worked on a farm 1.3 0.88-1.93 0.19 
/Kirkey et al. (2001) 
 
   System System  Farming after age 18 2.79 1.03-7.55 0.04 
        Agriculture, fishery, forestry 1.74 0.85-3.60 NS
Study design: Unmatched case-control (frequency matched); Question: Agricultural exposures assessed with questions validated in a previous study Limitations: No validity or test-retest 
repeatability testing on PD study population. Strengths: Cases & controls recruited from a sampling frame shown to represent general population. Response rate provided & detailed description 
of selection & recruitment procedure. Farming occupations coded according to a standard coding system. 
           
Fall et al. (1999) Sweden      113 263 Doctors &
Prescriptions 
Regional population 
register 
Self-
administered 
Agriculture 1.4 0.68-2.9 0.40
Study design: Case-control study. Question: Limited information about the questionnaire – had been used in previous epidemiological studies. Strengths: Population-based case & control groups. 
Good response rate reported. Limitations. Controls were younger than cases; No information about the sex distribution of the two groups.  
           
Kuopio et al. (1999) Finland 123 246 Population survey Population register     
          
Interview Farming 1.45 0.88-2.41 0.15
 Part-time farming 1.56 0.95-2.54 0.08
       Farming as occupation 0.77 0.41-1.43 0.41 
Study design: Matched case-control study. Cases identified in a population prevalence survey & controls recruited from population register & matched on age (+-2 years), sex & municipality. 
Question: Occupation classed with a standard classification system. Agricultural workers included farming, gardening, & forestry. Strengths: Population-based case & control groups.  
           
Tsui et al. (1999) Canada       414 6659 Movement Disorders
Clinic 
Population Records Farm/horticulture 0.68 0.32-1.41 NS
Study design: Case-control study. Cases obtained from database of Movement Disorders Clinic; Controls identified in census data. Controls were much younger than cases & poorly matched on 
sex (46.5% of controls female vs 29.4% of cases). Question: Current occupation as listed on census used for controls & occupation at time of diagnosis used for cases. Limitations: The records 
may have resulted in substantial misclassification error, case & control groups were poorly matched on age & sex.  
           
Behari et al. (2001) 
 
India      
        
377 377 Clinic
 
Clinic Interview Farming <=10 years 0.55 0.13-2.32 NS 
 Farming >10 years 0.72 0.48-1.05 NS
Study design: Matched case-control study. Controls matched on age +/- 3 years & hospital. Question: Total number of years spent farming. Limitations: Not all controls were matched on sex; 
Controls also had neurological conditions. Strengths: very large sample size.  
           
Zorzon et al. (2002) Italy     136 272 Hospital Hospital Interview Farming as occupation* 1.6 0.80-2.50 NS 
       Farming as occupation ** 7.7 1.4-44.1 0.02 
Study design: Matched case-control study. Controls individually matched on sex, age (+/-3 years). Question: Details of occupation. No information about coding system. Limitations: Controls 
were out-patients of the hospital, but no detail provided as to diagnoses other than neurodegenerative diseases excluded. No response rate reported. *Adjusted for pack-years smoked ** Mulitple 
logistic regression model including Family history of PD, Family history of essential tremor, Maternal age at birth, General anaesthesia, Well water use, smoking. 
           
Park et al. (2005) Korea 367 309 Hospital Hospital Interview Agriculture, hunting & 
forestry 
1.88   
          
1.12–3.15 -
 Agriculture production
crops 
 1.96 1.16–3.30
Study design: Case-control study. Controls were cerebrovascular disease patients from the same hospital. Case & control group mismatched on sex (% male in control group > case group). 
Question: Lifetime occupational history. Coded according to Standard classification system (Korea Standard Industry Code). Mulitple logistic regression model included age, sex, smoking & 
education level. Limitations: No response rate reported. Case & control groups not well matched on sex ore education level.  Strengths: Large study utilising a standardised occupational coding 
system. 
           
Park et al. (2005) US   
        
        
33678 2,501,541 Death certificates Death certificates Death Certificate All-farm related occupations 1.14* 1.08-1.19  
       As above (age<65 years) 
 
1.58* 1.08-2.24  
 Farmers 1.16* 1.11-1.22
       Farmers (age <65 years) 2.23* 1.47-3.26  
 Horticultural specialist 1.65* 0.92-2.71 0.07
Study design: Case-control study. Cases & controls from death certificates..Question: Occupation obtained from death certificate & exposure determined with JEM. *Mortality Odds Ratio 
adjusted for age, race, gender, region & SES. Limitations: Reliance on death certificate data for outcome & exposure measurement, which can lead to substantial misclassification error; Using 
mortality as the point at which participants are ‘recruited’ may not be suitable for a study of aetiology if exposure is related to increased mortality in PD rather than increased risk.   
           
Individual studies are separated by a line. 
OR = Odds Ratio; 95% CI = 95% Confidence Interval; NS = Not Significant at 0.05 level 
 
 
 
 
Table B4: Summary of Case-Control Studies of Exposure to Pesticides as a Risk Factor for Parkinson’s Disease  
Authors Location 
No. 
Cases 
No. 
Controls Case Group Control Group 
Mode of 
Measurement 
Delivery Exposure OR 95%CI P 
Mixed           
Ohlson & Hogstedt 
(1981) 
Sweden 106 93 Hospital registers Hospital registers 
(subarachnoid 
hemorrhage patients) 
Self-
administered 
Agricultural chemicals 0.40 0.1-1.4  
Study design: Case-control study. Question: Limited information about the questionnaire – Relatively short self-administered questionnaire (27 questions). Exposure assessed as more than 15 
days of exposure with agricultural chemicals. Limitations: No information about validity or repeatability of exposure assessment.  
           
Ho et al. (1989)  Hong 
Kong 
35 105 Hospitals &  
residential care 
Hospitals &  
residential care 
Interview Use of herbicide & 
pesticides 
3.60 1.00-12.90 - 
Study design: Matched case-control study. Controls matched on sex, age +/- 2 years & hospital. Question: No definition of ‘exposure’. Limitations: Small sample size & women over-
represented in sample (69%); proxy respondants used for participants with dementia. A matched design was used, however data analyses appears to be for an unmatched study. 
           
Hertzman et al. 
(1990)  
Canada 57 122 GPs & Specialists Electoral roll Self- 
administered 
Chemical spraying 2.23  0.03 
Study design: Case-control study. Question: “Ever been involved in chemical spraying?”; question appears vague & unclear, ‘involved in’ & ‘chemical spraying’ not defined. Strengths: 
Attempted to assessed data quality by contacting subset of participants 1 month after questionnaire completed; however appears to be somewhat ‘ad hoc’ & results not reported. Good response 
rate reported. Limitations: Small sample size; PD cases chosen by physicians based on whether they thought their patient might respond to a postal questionnaire, rather than by random 
sampling. 
           
Zayed et al. (1990) Canada 42 84 GPs & Specialists Telephone book Interview Pesticides 1-10 years 0.81 0.24-2.68  
       Pesticides 11-20 years 1.08 0.24-4.66  
       Pesticides 21-30 years 1.08 0.24-4.12  
       Pesticides >30 years 1.92 0.56-6.57  
       Pesticide use 1.23 0.46-3.29 0.35 
Study design:. Matched case-control study Question: No information about definition of pesticide exposure or how assessed Limitations: Small sample size Strengths High participation rate 
amongst GPs & Neurologists in study area (91.5%); questionnaire pretested (however only 5 participants) 
           
Koller et al. (1990) US 150 150 Clinic Clinic Interview Herbicide/pesticide use 1.10 - 0.82 
Study design: Matched case-control study. Participants randomly selected, controls matched on age & sex. Question: Questions used by a previous study that included validation; test-retest 
assessed in study population.  Limitations: No response rate for cases or controls reported. Strengths: Good test-retest repeatability reported for exposure assessment. 
           
Wong et al. (1991) US 38 38 Clinic - 19 pairs of 
siblings concordant for 
PD 
General Neurology & 
Medicine Clinics 
(diagnosese ncluded 
headache, back pain, 
Interview     
arthritis & heart disease
   38  Movement Disorders 
Clinic – 19 sibling pairs 
with familial essential 
tremor 
 Herbicide/pesticide use 1.00 - 1.00 
Study design: matched case-control study. Controls individually matched on sex, & age. Question: Years spent farming. No details of how assessed or definition of farming. Limitations: No 
details of response rate provided. Small sample size. How this complicated study design was analysed & the use of the two different control groups was not fully explained. 
           
Semchuk et al. (1992) Canada 130 260 Case register 
developed from GPs & 
Neurologists 
Random Digit Dialing Interview Pesticide use 2.25 1.27-3.99 0.005 
Study design: Matched case-control study. Question: “Have you ever had any contact with pesticide chemicals?” Question repeated for fungicides, herbicides, & insecticides Limitations: no 
validity or test-retest repeatability of exposure measurement. Strengths: Cases recruited from all GPs & Neurologists in study area, controls randomly recruited from general population, good 
response rate (cases 88.4%, controls 75.8%); Standard used for coding rather than self-selection by participants. Definition provided for each type of pesticide. 
           
Hubble et al. (1993)  US 63 76 Clinic & support 
groups 
Media release & senior 
citizen luncheon & 
friend controls 
Self-
administered 
Pesticide use 3.42 1.27-7.32 0.004 
Study design: Unmatched case-control; Question: Used pesticides for more than 20 days during any 1 year. No details on ‘use’. Limitations: No systematic or random sampling of participants 
(convenience sample); participants recruited from multiple sources; response rate unknown. 
           
Butterfield et al. 
(1993) 
US 63 68 Young onset Patients – 
recruited from 
neurologists & patient 
support groups 
Rhematoid Arthritis 
patients – from 
rheumatologists & 
patient support groups 
Self-
administered 
Ever lived within ¼ mile of 
agricultural spraying 
(adjusted OR*) 
1.99 - 0.099 
Study design: case-control study. Controls frequency matched on sex, year of birth & year of diagnosis. Question: Questions not provided. Strengths: Questionnaire was reviewed by a team of 
experts prior to use. Test-retest repeatability & validity was addressed, however the sample size was small. Limitations: People with rheumatoid arthritis may be inappropriate controls as they 
may come from a different source population to the PD cases & have some overlap in risk factors as the cause of RA is unknown, this is difficult to discount. *Adjusted for age, diagnosis age, 
race, sex, educational level & family history of PD. 
           
Hertzman et al.  Canada 142 124 GPs & Specialists Electoral roll Interview Ocupational pesticide (men) 2.32 1.10-4.88  
(1994)       Occupational pesticide (women) 1.36 0.48-3.85  
  142 121 GPs & Specialists Cardiovascular disease Interview Occupational pesticide (men) 2.03 1.00-4.12  
     controls from GPs & 
Specialists 
 Occupational pesticide (women) 1.11 0.32-3.80  
Study design: Case-control study. Two control groups used (cardiovascular disease & electrol roll controls). Question: Exposure defined as handling the chemical or working in an area that 
had been recently sprayed with the chemical. Detailed questions & cue cards attempted to identify specific pesticides. Strengths: Reported response rate, however relatively low response for 
electoral roll controls (61%). Exposure defined. 
           
Chaturvedi et al.  Canada 87 2070 From large population- From large population- Self- Hobby gardening 1.42 0.86-2.37  
(1995)    based survey based survey administered Hobby pesticide/herbicide use 1.67 0.67-3.63 NS 
       Occupational 
Pesticides/fertilizers 
1.81 0.92-3.36 NS 
       Occupational defoliants, 
fumigants 
1.40 - - 
Study design: Cross-sectional study analysed as a case-control; Question: Limited information provided about the questions. Included occupations, hobbies & were ‘semi-quanittative nature’. 
Limitations: no definition provided of ‘exposed’; no exposure dose considered; no validity or test-retest repeatability testing of question;  
           
Liou et al. (1997)  Taiwan 120 240 Hospital Hospital Interview Herbicides/pesticides 1-19 
years 
1.41 0.52-3.85 - 
       Herbicides/pesticides >19 
years 
6.72 2.62-17.21 - 
       Herbicide/pesticide Use 2.89 2.28-3.66 <0.01 
Study design: Matched case-control study. Controls matched on sex, age +/- 2 years & hospital. Question: Occupational or residential exposure to pesticides/herbicides, however no definition 
of exposures. Limitations: No response rate provided. Strengths: Performed a ‘reliability check’ with 20 cases & 20 controls 4-10 months later, however little detail provided. 
           
McCann et al. (1998) Australia 224 310 Hospital, residential 
care & community 
groups 
Hospitals, residential 
care, community 
groups 
Self-
administered 
Herbicides/pesticides 1.20 0.80-1.50 0.50 
Study design: Unmatched case-control; Question: “Have you ever been exposed to herbicides or pesticides?” Limitations: no definition provided of ‘exposed’; no exposure dose considered; no 
validity or test-retest repeatability testing of question; no systematic or random sampling of participants (convenience sample); participants recruited from multiple sources; response rate 
unknown. 
           
Menegon et al. (1998) Australia 96 95 Hospitals & 
community groups 
Not stated Self-
administered 
Pesticide exposure > once a 
week for 6 months or more 
2.30 1.2-4.4 0.02 
Study design: Unmatched case-control; Question: “Have you ever been exposed to herbicides or pesticides?” Limitations: no definition provided of ‘exposed’; no exposure dose considered; no 
validity or test-retest repeatability testing of question; no systematic or random sampling of participants (convenience sample); participants recruited from multiple sources; response rate 
unknown. 
           
Chan et al. (1998)  China 215 313 Hospital Hospital Interview  Farm pesticides 0.75 0.25-2.22 0.608 
       Pesticide (number of years) 1.05 0.99-1.11 0.09 
Study design: Case-control study. Question: “Have you used pesticides in farming?” & number of years of use. No definition provided.  Limitations: No response rate provided.  
           
De Palma et al. (1998) Italy 100 200 Clinic Clinic Interview Pesticides 2.92 1.38-6.14  
Study design: Case-control study. Question: At least 10 consecutive years of exposure as assessed by industrial hygienist. Strengths: Exposure assessed by an industrial hygienist. Limitations: 
No response rate reported.  
           
Smargiassi et al. 
(1998) 
Italy 86 86 Hospital Hospital Interview Pesticide & herbicide 1.15 0.56-2.36 - 
Study design: Case-control study. Controls treated for essential arterial hypertension, glaucoma, psoriasis vulgaris & renal diseases. Question:  Occupational history; exposure calssified by an 
industrial hygienist. Exposures only considered if exposed for at least 10 consecutive years prior to onset of PD. Strengths: High participation rate. Trained interviewer & industrial hygienist 
determined exposure status. 
           
Fall et al. (1999)  Sweden 113 263 Doctors &  Regional population  Self- Agricultural pesticides 1.90 0.46-7.3 0.45 
    Prescriptions register administered Occupational pesticide 2.80 0.89-8.70 0.081 
Study design: Case-control study. Question: Limited information about the questionnaire – had been used in previous epidemiological studies. Strengths: Population-based case & control 
groups. Good response rate reported. Limitations. Controls were younger than cases; No information about the sex distribution of the two groups.  
           
Kuopio et al. (1999)  Finland 123 246 Population survey Population register Interview Occasional pesticide use 1.23 0.74-2.04 0.431 
       Regular pesticide use 0.65 0.33-1.29 0.221 
       Pesticide use - any 1.02 0.63-1.65 0.935 
Study design: Matched case-control study. Cases identified in a population prevalence survey & controls recruited from population register & matched on age (+-2 years), sex & municipality. 
Question: Regular & occational contact with herbicides & pesticides recorded with number of contact years. Regular & occasional not defined. Strengths: Population-based case & control 
groups.  
           
Werneck & 
Alvarenga (1999)  
Rio de 
Janeiro 
92 110 Hospital Hospital Self-
administered 
Herbicide/insecticide 2.49 0.53-13.14 - 
Study design: Unclear whether individually matched or frequency matched case-control study. Controls matched on age +/- 2 years & hospital. Question: “Ever inhaled or handled herbicides 
& insecticides? For how long?”. Exposure is not well defined, unclear if domestic exposures included. Limitations: No response rate provided. Strengths: Attempted to consider data quality, 
however only retested 5 participants.  
           
Herishanu et al. 
(2001) 
Israel 93 93 Outpatient PD Clinic Outpatient 
dermatiology, 
neurology & internal 
medicine clinics 
Interview Exposure to pesticides 7.73 0.86-69.60 0.07 
Study design: Frequency matched case-control study. Controls matched on sex, age +/- 2 years & hospital. Question: Occupational & household exposure to pesticides, herbicides, fungicides. 
Actual questions not provided. Limitations: No resonse rate provided. Strengths: States that questionnaire has been validated, however no results or details provided. 
           
Zorzon et al. (2002) Italy 136 272 Hospital Hospital Interview Pesticides* 1.60 1.00-2.40  
Study design: Matched case-control study. Controls individually matched on sex, age (+/-3 years). Question: No information about definition of exposure or how measured. Limitations: 
Controls were out-patients of the hospital, but no detail provided as to diagnoses other than neurodegenerative diseases excluded. No response rate reported. *Adjusted for pack-years smoked  
           
Baldi et al. (2002) France 84 252 Hospital Electoral Roll Interview Occupational pesticides* 2.20 1.11-4.34 0.02 
Study design: Matched case-control study. Controls individually matched on sex, age (+/-1 year). Question: Occupational history obtained in calendar & then level of exposure assessed by 
panel of 6 experts to produce JEM in a pilot study. Most of the pesticides applied in this district are fungicides. *Conditional multiple logistic regression adjusted for age, sex, educational 
level & smoking. Limitations: Smoking was assoicatied with increased risk of PD which is in disagreement with the majority of Epidemiological studies. No response rate reported for cases.  
           
Park et al. (2005) US 33678 2,501,541 Death certificates Death certificates Death  Pesticides 1.14* 1.09-1.20  
      Certificate Pesticides (age <65 yrs) 1.59* 1.09-2.26  
       Pest control  1.19* 0.47-2.43 >0.5 
Study design: Case-control study. Cases & controls from death certificates..Question: Occupation obtained from death certificate & exposure determined with JEM. *Mortality Odds Ratio 
adjusted for age, race, gender, region & SES. Limitations: Reliance on death certificate data for outcome & exposure measurement, which can lead to substantial misclassification error; Using 
mortality as the point at which participants are ‘recruited’ may not be suitable for a study of aetiology if exposure is related to increased mortality in PD rather than increased risk.   
           
Herbicide           
Stern et al. (1991) US 149 149 Hospital - Young & 
Old Onset Patients 
Friends of cases & 
hospital controls 
Interview Herbicides 0.90 0.60-1.50 0.73 
  80 80 Hospital - Old Onset 
Patients 
Friends of cases & 
hospital controls 
Interview Herbicides 1.30 0.70-2.40 NS 
  69 69 Hospital - Young 
Onset Patients 
Friends of cases & 
hospital controls 
Interview Herbicides 0.90 0.50-1.70 NS 
Study design: Matched case-control study (1:1 match). Question: Questions not provided. Exposure to insecticides & herbicides measured by self-report, individual questions about use of 
agents in the home, yard or garden, neighbourhood by household members or professionals. Exposure assessed only as ever/never. Strengths: Considered old onset & young onset patients 
separately allowing for possibly different risk factors between the groups. Limitations: Controls were a mixture of friend controls & hospital patients (excluding other movement disorders); 
Small sample size after stratification by age of onset. No response rate for cases or controls provided. Only domestic exposure measured, no exposure dose considered. No test-retest 
repeatability or validity testing of questionnaire mentioned. 
           
Semchuk et al. 
(1992) 
Canada 130 260 Case register 
developed from GPs & 
Neurologists 
Random Digit Dialing Interview Herbicide Use 2.83 1.13-7.06 <0.05 
 
           
Butterfield et al. 
(1993) 
US 63 68 Young onset patients – 
recruited from 
Rhematoid arthritis 
patients – from 
Self-
administered 
Exposure to herbicides 
(crude OR) 
3.46 - 0.011 
    neurologists & patient 
support groups 
rheumatologists & 
patient support groups 
 Herbicide exposure > 10 
times/year (adjusted OR*) 
3.22 - 0.033 
Study design: case-control study. Controls frequency matched on sex, year of birth & year of diagnosis. Question: Herbicides defined as “products that kill plants & weeds”, Fungicides 
defined as “products used to control blight & mildew”, rodenticides as “rat & mole poison” & fumigation was defined as a “tent placed over the home & insecticides applied”. Strengths: 
Questionnaire was reviewed by a team of experts prior to use. Test-retest repeatability & validity was addressed, however the sample size was small. Limitations: People with rheumatoid 
arthritis may be inappropriate controls as they may come from a different source population to the PD cases & have some overlap in risk factors as the cause of RA is unknown, this is difficult 
to discount. *Adjusted for age, diagnosis age, race, sex, educational level & family history of PD. 
           
Hertzman et al.  Canada 142 124 GPs & Specialists Electoral roll Interview Herbicide use (men) 1.19 0.57-2.45 NS 
(1994)       Paraquat use (men) 1.25 0.34-4.63 NS 
       Herbicide use (women) 0.67 0.29-1.56 NS 
  142 121 GPs & Specialists Cardiovascular disease Interview Herbicide use (men) 1.02 0.50-2.07 NS 
     controls from GPs &   Herbicides use (women) 0.55 0.21-1.48 NS 
     Specialists  Paraquat (men) 1.11 0.32-3.87 NS 
 
           
Seidler et al. (1996)  Germany 380 379 Multiple neurology  Neighbourhood –  Interview Herbicide 1-40 years 1.70 1.00-2.70 - 
    clinics throughout Random route method  Herbicide 41-80 years 1.40 0.80-2.50 NS 
    Germany   Herbicide >80 years 2.20 0.90-5.20 - 
  380 376  Regional – Random   Herbicide 1-40 years 1.70 1.00-2.60 - 
     route method  Herbicide 41-80 years 3.00 1.50-6.00 - 
       Herbicide >80 years 2.40 1.00-6.00 - 
Study design: matched case-control study. Controls individually matched on sex, age (+/-3 years) & region or neighbourhood. Question: Complete residential history with details of whether 
whether there was a garden, whether or not pesticides were applied & if so which ones. Types of pesticides used, toxicologic expert categorised as regular exposure or not. Occupational 
exposures assessed with JEM Limitations: Controls matched on residence, therefore may be inappropriate to consider residential history as risk factor – use of regional control may have 
overcome this issue. Multiple neurologists performed diagnosis, whilst standard criteria were used (UK Brain Bank), may have lead to some misclassification. Strengths: Large study with 
population-based control group; experienced interviewers used for data collection & same interviewer used for case & matched control. Experts used to code exposure & developed a job 
exposure matrix. Cases restricted on age & disease duration to reduce memory difficulties.  
           
Liou et al. (1997) Taiwan 120 240 Hospital Hospital Interview Paraquat use 1-19 years 0.96 0.24-3.83 NS 
       Paraquat for >19 years 6.44 2.41-17.20 <0.01 
       Paraquat 1-19 years 0.96 0.24-3.83 - 
       Paraquat use 3.22 2.41-4.31 <0.01 
Study design: Matched case-control study. Controls matched on sex, age +/- 2 years & hospital. Question: Occupational or residential exposure to pesticides/herbicides, however no definition 
of exposures. Limitations: No response rate provided. Strengths: Performed a ‘reliability check’ with 20 cases & 20 controls 4-10 months later, however little detail provided. 
           
Gorell et al. (1998) US 144 464 Henry Ford Health  Henry Ford Health  Interview Home gardening herbicides 1.39 0.84-2.28 0.20 
    System System  Farming herbicides 1.64 0.70-3.82 0.25 
       Occupational herbicide 4.10 1.37-12.24 0.01 
Study design: Unmatched case-control study (frequency matched); Question: pesticide exposures assessed with questions validated in a previous study. Definitions provided for each type of 
pesticide. Limitations: No validity or test-retest repeatability testing on PD study population. Strengths: Cases & controls recruited from a sampling frame shown to represent general 
population. Response rate provided & detailed description of selection & recruitment procedure. 
           
Taylor et al. (1999) US 140 147 Clinic Friends of cases Interview Herbicide (years of) 1.06 0.68-1.65 0.81 
Study design: Matched case-control study (1:1 match). Question: Years of exposure to pesticides or herbicides assessed as years of exposure (total days of exposure divided by 365) & 
frequency of exposure according to categories. ‘Exposure’ not defined. Strengths: Considered old onset & young onset patients separately allowing for possibly different risk factors between 
the groups. Limitations: Controls were a mixture of friend controls & hospital patients (excluding other movement disorders); Small sample size after stratification by age of onset. No test-
           
Kuopio et al. (1999) Finland 123 246 Population survey Population register Interview Regular herbicide use 0.79 0.38-1.66 0.54 
       Occasional herbicide use 1.71 0.90-3.23 0.10 
       Herbicide use - any 1.40 0.79-2.48 0.25 
Study design: Matched case-control study. Cases identified in a population prevalence survey & controls recruited from population register & matched on age (+-2 years), sex & municipality. 
Question: Regular & occational contact with herbicides & pesticides recorded with number of contact years. Regular & occasional not defined. Strengths: Population-based case & control 
groups.  
           
Insecticide           
Golbe et al. (1990) US 106 106 Clinic Spouses of cases Interview Sprayed insecticides 7.00  <0.05 
           
Stern et al. (1991) US 149 149 Hospital young & old 
onset 
Friends of cases & 
hospital controls 
Interview Insecticide any 0.50 0.2-1.1 0.1 
  80 80 Hospital - Old onset Friends of cases & 
hospital controls 
Interview Insecticides 0.80 0.3-2.1  
  69 69 Hospital young onset Friends of cases & 
hospital controls 
Interview Insecticides 0.60 0.2-1.7  
           
Semchuk et al. 
(1992)  
Canada 130 260 Case register 
developed  
Random Digit Dialing Interview Insecticide use 2.05 1.03-4.07 0.042 
    from GPs & 
Neurologists 
  Occupational insecticides 
adjusted for herbicides 
1.48 0.68-3.24  
           
Butterfield et al. 
(1993) 
US 63 68 Young onset Patients 
– recruited from 
Rhematoid Arthritis 
patients – from 
Self-
administered 
Exposure to insecticides 
(crude OR) 
4.04 - 0.002 
    neurologists & patient 
support groups 
rheumatologists & 
patient support groups
 Insecticide exposure > 10 
times/year (adjusted OR*) 
5.75 - 0.001 
       Residency in a fumigated 
house (adjusted OR*) 
5.25 - 0.045 
           
Hertzman et al.  Canada 142 124 GPs & Specialists Electoral roll Interview Insecticide (men) 0.33 0.12-0.90  
(1994)       Insecticides (women) 0.41 0.19-0.88  
       Occupational organochlorine 
(men) 
0.80 0.40-1.63  
       Occupational organochlorine 
(women) 
0.75 0.29-1.96  
       Occupational 
Organophosphate (men) 
0.56 0.26-1.23  
       Occupational 
Organophosphate (women) 
0.79 0.30-2.10  
       Occupational carbamate (men) 0.83 0.39-1.78  
       Occupational carbamate 
(women) 
0.66 0.15-2.91  
       Occupational carbamate (men) 0.83 0.39-1.78  
           
  142 121 GPs & Specialists Cardiovascular  Interview Insecticides (men) 0.62 0.28-1.38  
     disease controls from  Insecticides in (women) 0.65 0.27-1.57  
     GPs & Specialists  Occupational 
Organochlorine (men) 
0.89 0.45-1.76  
       Occupational 
organochlorine (women) 
0.75 0.34-1.64  
       Occupational 
organophosphate (men) 
1.23 0.62-2.45  
       Occupational 
organophosphate (women)
0.63 0.29-1.38  
       Occupational carbamates 
(women) 
0.44 0.13-1.47  
       Occupational carbamates 
(men) 
1.06 0.48-2.37  
Study design: Case-control study. Two control groups used (cardiovascular disease & electrol roll controls). Question: Exposure defined as handling the chemical or working in an area that had 
been recently sprayed with the chemical. Detailed questions & cue cards attempted to identify specific pesticides. Strengths: Reported response rate, however relatively low response for electoral 
roll controls (61%). Exposure defined. 
           
Seidler et al. (1996)  Germany 380 379 Multiple neurology Neighbourhood –  Interview Insecticide 1-40 years 1.40 0.9-2.1  
    clinics throughout Random route method  Insecticide 41-80 yrs 1.50 0.9-2.5  
    Germany   Insecticide >80 years 1.60 0.7-3.4  
       Organochlorine use 1.60 0.4-6.2  
       Alkylated phosphate & 
carbamate use 
1.80 0.93-3.3  
  380 376  Regional – Random  Interview Insecticide 1-40 years 1.80 1.1-2.7  
     route method  Insecticide 41-80 yrs 2.50 1.40-4.50  
       Insecticide >80 years 2.10 0.9-4.8  
       Organochlorine use 5.80 1.10-30.40  
       Alkylated phosphate & 
carbamate use 
2.50 1.30-4.6  
Study design: matched case-control study. Controls individually matched on sex, age (+/-3 years) & region or neighbourhood. Question:Complete residential history with details of whether it 
was a farm & whether there was farming nearby. Limitations: Controls matched on residence, therefore may be inappropriate to consider residential history as risk factor – use of regional 
control may have overcome this issue. Multiple neurologists performed diagnosis, whilst standard criteria were used (UK Brain Bank), may have lead to some misclassification. Strengths: 
Large study with population-based control group; experienced interviewers used for data collection & same interviewer used for case & matched control. Experts used to code exposure & 
developed a job exposure matrix. Cases restricted on age & disease duration to reduce memory difficulties.  
           
Gorell et al. (1998)  US 144 464 Henry Ford Health  Henry Ford Health  Interview Residential insecticide 1.03 0.63-1.70 0.902 
    System System  Home gardening 
insecticides 
0.90 0.58-1.38 0.619 
       Farming insecticides 1.28 0.69-2.40 0.435 
       Occupational insecticide 3.55 1.75-7.18 0.001 
       Occupational insecticide 
<10 years 
2.39 0.89-6.40  
       Occupational insecticide > 
10 yrs 
5.81 1.99-16.97  
           
Taylor et al. (1999)  US 140 147 Clinic Friends of cases Interview Insecticide (years of) 1.02 0.93-1.17 0.48 
Study design: Matched case-control study (1:1 match). Question: Years of exposure to pesticides or herbicides assessed as years of exposure (total days of exposure divided by 365) & 
frequency of exposure according to categories. ‘Exposure’ not defined. Strengths: Considered old onset & young onset patients separately allowing for possibly different risk factors between 
the groups. Limitations: Controls were a mixture of friend controls & hospital patients (excluding other movement disorders); Small sample size after stratification by age of onset. No test-
           
Fall et al. (1999)  Sweden 113 263 Doctors & 
Prescriptions 
Regional population 
register 
Self-
administered
Agricultural insecticide 2.20 0.48-9 0.4 
Study design: Case-control study. Question: Limited information about the questionnaire – had been used in previous epidemiological studies. Strengths: Population-based case & control 
groups. Good response rate reported. Limitations. Controls were younger than cases; No information about the sex distribution of the two groups.  
           
Kuopio et al. (1999) Finland 123 246 Population survey Population register Interview Use of DDT 1.04 0.68-1.6 0.855 
Study design: Matched case-control study. Cases identified in a population prevalence survey & controls recruited from population register & matched on age (+-2 years), sex & municipality. 
Question: Regular & occational contact with herbicides & pesticides recorded with number of contact years. Regular & occasional not defined. Strengths: Population-based case & control 
groups.  
           
Pals et al. (2003) Belgium 423 205 PD support groups Spouses of PD cases Self- Organophosphates 3.73 0.47-29.41  
    + 3 University 
hospitals 
 administered     
Study design: Case-control study. Controls were spouses. Questions:. “Have you been exposed for longer than 6 months, prior to the onset of PD, to insecticides, herbicides, 
organophosphates, metallic based pesticides & more specific to DDT, lindane, pyrethrum, E605, paraquat & dieldrine or aldrin (if yes, specify if possible & indicate the duration of the 
exposure)? Was this contact occupational?” & “What is your present occupation?” Limitations: Spouse controls. As there was a male preponderance in the study sample for PD cases, there 
was a large gender imbalance between the case & control groups (N male cases = 256, N male controls = 70). There was also less than half the number of controls as cases. Therefore, rarer 
exposures may not appear in the control group due to lack of numbers. No response rate.Strengths: test-retest reproducibility assessed with subset of participants with good to excellent 
reprocibility repoted. 
           
Fungicide           
Semchuk et al. (1992) Canada 130 260 Case register 
developed from GPs & 
Neurologists 
Random Digit  
Dialing 
Interview Fungicide use 1.63 0.81-3.29 ns 
           
Butterfield et al. 
(1993) 
US 63 68 Young onset Patients – 
recruited from 
Rhematoid Arthritis 
patients – from 
Self-
administered 
Exposure to fungicides 
(crude OR) 
1.50 - 0.74 
    neurologists & patient 
support groups 
rheumatologists & 
patient support groups 
     
           
Hetzman et al. (1994) Canada 142 124 GPs & Specialists Electoral roll Interview Fungicide use (men) 0.52 0.25-1.08  
       Fungicides (women) 0.44 0.14-1.33  
  142 121 GPs & Specialists Cardiovascular disease  Interview Fungicides  (men) 1.04 0.49-2.24  
     controls from GPs & 
Specialists 
 Fungicides (women) 0.53 0.13-2.18  
 
Gorell et al. (1998)  US 144 464 Henry Ford Health  Henry Ford Health  interview Home gardening fungicides 0.96 0.55-1.66 0.879 
    System System  Farming fungicides 0.96 0.29-3.12 0.944 
       Occupational fungicides 1.60 0.47-5.45 0.453 
 
Individual studies are separated by a line. 
OR = Odds Ratio; 95% CI = 95% Confidence Interval; NS = Not Significant at 0.05 level 
 
 
Table B5: Summary of Case-Control Studies of Exposure to Metals as a Risk Factor for Parkinson’s Disease 
Authors     Location 
No. 
Cases 
No. 
Controls Case Group Control Group 
Mode of 
Measurement 
Delivery Exposure OR 95% CI P
           
Ohlson & Hogstedt 
(1981) 
Sweden          106 93 Hospital Hospital Self Mercury 2.40 0.50-5.00 NS
Study design: Case-control study. Question: Limited information about the questionnaire – Relatively short self-administered questionnaire (27 questions). Exposure assessed as more than 15 
days of exposure to mercury. Limitations: No information about validity or repeatability of exposure assessment.  
           
Tanner et al. (1989) China           100 200 Hospital Hospital Interview Steel 1.27 0.20-7.99 NS
Study design: Matched case-control study. Question: Exposure to ‘steel’ not defined. Strengths: Addressed data quality with small test-retest study (12 participants reinterviewed one week after 
initial interview). Limitations: No response rate provided.  
           
Zayed et al. (1990) Canada 42 84 GPs & Specialists Telephone book Interview Working with Mn, Fe, AL 
11-20 years 
0.76   
   
0.08-8.69 NS
       Working with Mn, Fe, AL 2.28 0.85-2.77 0.07 
       working with Mn, Fe, Al 
>30 years 
13.64 1.52-76.28 -
Study design:. Matched case-control study Question: No information about definition of work with Mn, Fe, Al or how assessed Limitations: Small sample size Strengths High participation rate 
amongst GPs & Neurologists in study area (91.5%); questionnaire pretested (however only 5 participants) 
           
Wang et al. (1993) China          93 186 Hospital Hospital Self Steel Plants 2.57 0.85-7.74 NS
Study design: Matched case-control study. Controls matched on sex, age +/- 3 years & hospital. Question: Exposure to ‘Steel Plants’ not defined. Limitations: No response rate provided.  
           
Hertzman et al. 
(1994) 
Canada 142 124 GPs & Specialists Electoral roll Interview Occupational heavy metals 
(men) 
0.99   
   
         
   
   
0.45-2.18 NS
       Occupational heavy metals 
(women) 
2.12 0.42-10.56 NS
       Contacted manganese (men) 
 
0.66 0.28-1.53 NS 
 Contacted manganese
(women) 
 1.21 0.70-2.09 NS
       Lead exposure (men) 0.96 0.24-3.79 NS 
  142 121 GPs & Specialists Cardiovascular 
disease controls from 
Interview Occupational heavy metals 
(men) 
1.30 0.57-2.95 NS
     GPs & Specialists  Occupational heavy metals 
(women) 
1.32 0.41-4.29 NS
       Contacted manganese (men) 0.83 0.49-1.40 NS 
           Contacted manganese
(women) 
 0.92 0.65-1.31 NS
Study design: Case-control study. Two control groups used (cardiovascular disease & electrol roll controls). Question: Exposure defined as handling the chemical or working in an area that had 
been recently sprayed with the chemical.. Strengths: Reported response rate, however relatively low response for electoral roll controls (61%). Exposure defined. 
           
Seidler et al. (1996) Germany 380 379 Multiple neurology Neighbourhood –  Interview
 
    
    
    
    
           
Occupational zinc 1.10 0.70-1.70 NS
    Clinics throughout Random route method
 
Occupational lead  1.20 0.70-2.00 NS 
 Germany  Occupational mercury 1.30 0.60-2.60 NS 
  380 376 Clinic 
 
Regional – Random  
 
Interview
 
Occupational zinc 1.50 0.90-2.40 NS
route method  Occupational lead  1.90 1.10-1.30 - 
 Occupational mercury 2.00 0.90-4.20 NS
Study design: matched case-control study. Controls individually matched on sex, age (+/-3 years) & region or neighbourhood. Question: JEM & expert assessment in addition to ‘ever/never’ 
response from participants. Limitations: Multiple neurologists performed diagnosis, whilst standard criteria were used (UK Brain Bank), may have lead to some misclassification. Strengths: 
Large study with population-based control group; experienced interviewers used for data collection & same interviewer used for case & matched control. Experts used to code exposure & 
developed a job exposure matrix. Cases restricted on age & disease duration to reduce memory difficulties.  
           
Liou et al. (1997) Taiwan          120 240 Hospital Hospital Interview Heavy metals 1.57 0.002-1416 NS
Study design: Matched case-control study. Controls matched on sex, age +/- 2 years & hospital. Question: Exposure to heavy metals, however no definition of exposure. Limitations: No 
response rate provided. Strengths: Performed a ‘reliability check’ with 20 cases & 20 controls 4-10 months later, however little detail provided. 
           
Ngim et al. (1988) Singapore 54 95 Not stated Hospital Interview Mercury body burden -
blood level 2 
49.60   
   
   
   
         
2.40-1027.10 -
       mercury body burden -
blood level 3 
56.10 3.70-858.40 -
       mercury body burden -
blood level 4 
70.10 3.90-1252.20 -
       mercury body burden -
scalp hair 
 
12.30 2.50-60.90 -
 
De Palma et al. (1998) Italy          100 200 Clinic Clinic Interview Copper sulphate 2.69 1.34-5.41 -
Study design: Case-control study. Question: At least 10 consecutive years of exposure as assessed by industrial hygienist. Strengths: Exposure assessed by an industrial hygienist. Limitations: 
No response rate reported.  
           
Rybicki et al. (1999) 
 
US 144 464 Henry Ford Health  Henry Ford Health  
 
Interview 
 
Occupational iron 1.10 - - 
  
         
          
 System
 
System  Occupational lead  1.40 - - 
 Occupational copper 1.60 - -
 Occupational lead,
copper, or iron 
 1.20 - -
Study design: Unmatched case-control (frequency matched); Question: Lifetime Detailed occupational history obtained & industrial hygienist coded for exposure to specific metals Limitations: 
No validity or test-retest repeatability testing for hygienist coding described. Strengths: Cases & controls recruited from a sampling frame shown to represent general population. Response rate 
provided & detailed description of selection & recruitment procedure. Detailed exposure data collected & hygienist coding. 
           
Fall et al. (1999) Sweden 113 263 Doctors & Prescriptions Population   Self Metal work 0.34 0.12-0.82 0.013
Study design: Case-control study. Question: Limited information about the questionnaire – had been used in previous epidemiological studies. Strengths: Population-based case & control 
groups. Good response rate reported. Limitations. Controls were younger than cases; No information about the sex distribution of the two groups.  
           
Kuopio et al. (1999) Finland          
         
         
123 246 Population survey Population register Interview Mercury-containing
pickling solutions 
Regular use 
1.37 0.53-3.53 0.518
 Mercury-containing
pickling solutions 
Occasional use 
 1.47 0.58-3.70 0.42
 Mercury-containing
Pickling solutions 
 1.58 0.74-3.42 0.24
Study design: Matched case-control study. Cases identified in a population prevalence survey & controls recruited from population register & matched on age (+-2 years), sex & municipality. 
Question: Limited information provided on question. Strengths: Population-based case & control groups.  
           
Pals et al. (2003) Belgium 423 205 PD support groups Spouses of PD cases    Self- Metallurgic activity 3.1 1.04-9.20 
    + 3 University   administered Exposure to metals 1.57 0.90-2.74  
    hospitals   Exposure to zinc 11.6 1.51-90.90  
       Exposure to lead 1.76 0.76-4.05  
Study design: Case-control study. Controls were spouses. Questions:. “Have you been exposed for longer than 6 months, prior to the onset of PD, to lead, mercury, selenium, manganese, 
alumninum, zinc, iron, cadmium, tin, arsenicum, magnesium, thallium & copper? Did this exposure took place in occupational context?” & “What is your present occupation? Give a 
descritption of your professional career? Have you been employed in metallurgy, wood processing industries, textile manufacturing & processing, petrochemical industry, industrial painting, 
agriculture (if yes, for how long)?”Limitations: Spouse controls. As there was a male preponderance in the study sample for PD cases, there was a large gender imbalance between the case & 
control groups (N male cases = 256, N male controls = 70). There was also less than half the number of controls as cases. Therefore, rarer exposures may not appear in the control group due to 
lack of numbers. No response rate.Strengths: test-retest reproducibility assessed with subset of participants with good to excellent reprocibility repoted. 
           
McDonnell et al.  UK 57 206 Death certificates from Death certificates from Occupational Ever worked with metals 1.55* 0.78-3.09 0.22 
(2003)    Rolls-Royce National Rolls-Royce National records     
    Pension Fund Archive Pension Fund Archive      
Study design: Case-control study. Cases & controls from death certificates..Question: Occupation obtained from occupational records & coded by an occupational hygienist. *Mortality Odds 
Ratio adjusted for age at death & location of work. Limitations: Reliance on death certificate data for outcome measurement, which can lead to substantial misclassification error; Using 
mortality as the point at which participants are ‘recruited’ may not be suitable for a study of aetiology if exposure is related to increased mortality in PD rather than increased risk; Small sample 
size. Strengths: Occupational data from personnel records is a major advantage to this study 
           
Park et al. (2005) Korea         367 309 Hospital Hospital Interview Hazardous materials 0.42* 0.22-0.81 <0.001
Study design: Case-control study. Controls were cerebrovascular disease patients from the same hospital. Case & control group mismatched on sex (% male in control group > case group). 
Question: Lifetime occupational history. “Exposure to hazardous material” assessed as having worked in occupations with potential exposure to manganese such as welder, smelter, welding 
rod manufacturer, manganese miner, workers in the iron & steel industries, & dry cell batteries manufacturers.*Adjusted for age, sex, smoking & educaton level. Limitations: No response rate 
reported. Case & control groups not well matched on sex ore education level. . 
           
Park et al. (2005) US  33678 2,501,541 Death certificates Death certificates Death Certificate Arc-welding steel 0.87* 0.80-0.95  
       Arc-welding steel (age<65) 1.77* 1.08-2.75  
Study design: Case-control study. Cases & controls from death certificates..Question: Occupation obtained from death certificate & exposure determined with JEM. *Mortality Odds Ratio 
adjusted for age, race, gender, region & SES. Limitations: Reliance on death certificate data for outcome & exposure measurement, which can lead to substantial misclassification error; Using 
mortality as the point at which participants are ‘recruited’ may not be suitable for a study of aetiology if exposure is related to increased mortality in PD rather than increased risk.   
           
Individual studies are separated by a line. 
OR = Odds Ratio; 95% CI = 95% Confidence Interval; NS = Not Significant at 0.05 level 
 
 
 Table B6: Summary of Case-Control Studies of Solvent Exposure as a Risk Factor for Parkinson’s Disease 
Authors     Location 
No. 
Cases 
No. 
Controls Case Group Control Group 
Mode of 
Measurement 
Delivery Exposure OR 95% CI P
           
Ohlson & Hogstedt 
(1981) 
Sweden        106 93 Hospital Hospital Self-
administered
Solvents 1.1 0.4-2.9
Study design: Case-control study. Question: Limited information about the questionnaire – Relatively short self-administered questionnaire (27 questions). Exposure assessed as more than 6 
months of exposure to solvents. Limitations: No information about validity or repeatability of exposure assessment.  
           
Wang et al. (1993) 
 
China          
       
93 186 Hospital
 
Hospital Interview
 
Printing plants 2.67 0.77-9.20 ns
 Paint plants 3.00 0.20-45.7 ns
Study design: Matched case-control study. Controls matched on sex, age +/- 3 years & hospital. Question: Exposures to printing & paint plants not defined. Limitations: No response rate 
provided.  
           
Chaturvedi et al.  Canada 87 2070 From large population- From large population-
 
Self- Hobby Paints, stains, lacquers
 
1.28 0.52-2.76 NS 
(1995)    based survey based survey administered Hobby paint
Remover/degreaser 
1.88   
          
       
      
   
         
         
          
0.75-4.11 NS
 Hobby painting 1.89 0.84-3.85 NS
 Hobby aerosol spray paints 3.89 1.42-9.18 <0.05 
       Hobby plastic Cement/glues 4.26 1.76-9.26 <0.05 
 Hobby chemical solvents 1.66 0.70-3.47 NS 
       Occupational paints, stains, 
varnishes 
1.35 0.70-2.48 NS
       Occupational glues or adhesives
  
0.68 - - 
 Occupational solvents
 
1.31 0.67-2.43 NS
 Epoxy resins 6.94 2.23-18.28 <0.05
 Plastic resins 8.79 2.43-25.89 <0.05
Study design: Cross-sectional study analysed as a case-control; Question: Limited information provided about the questions. Included occupations, hobbies & were ‘semi-quanittative nature’. 
Limitations: no definition provided of ‘exposed’; no exposure dose considered; no validity or test-retest repeatability testing of question;  
           
Seidler et al. (1996) 
 
Germany 380 379 Multiple neurology  Neighbourhood –  Interview Paint, lacquer, glue – hobby 1.1 0.7-1.8  
      
   
 clinics throughout
Germany 
 Random route method  Paint, lacquer, glue – 
occupational 
1.6 1.1-2.4
       Solvents – hobby 2.6 1.2-5.4  
       Solvents – occupational 1.6 1.1-2.4  
  380 376  Regional – Random  Interview Paint, lacquer, glue – hobby 1.5 0.9-2.6  
     route method  Paint, lacquer, glue – 
occupational 
1.5 1.0-2.3
       Solvents – hobby 3.4 1.5-7.5  
       Solvents – occupational 1.8 1.2-2.7  
Study design: matched case-control study. Controls individually matched on sex, age (+/-3 years) & region or neighbourhood. Question: : JEM & expert assessment in addition to ‘ever/never’ 
response from participants. Limitations: Multiple neurologists performed diagnosis, whilst standard criteria were used (UK Brain Bank), may have lead to some misclassification. Strengths: 
Large study with population-based control group; experienced interviewers used for data collection & same interviewer used for case & matched control. Experts used to code exposure & 
developed a job exposure matrix. Cases restricted on age & disease duration to reduce memory difficulties.  
           
De Palma et al. (1998) Italy        100 200 Clinic Clinic Self-
administered
solvents 1.15 0.65-2.03
Study design: Case-control study. Question: At least 10 consecutive years of exposure as assessed by industrial hygienist. Strengths: Exposure assessed by an industrial hygienist. Limitations: 
No response rate reported.  
           
Smargiassi et al. (1998) Italy          86 86 Hospital Hospital Interview Organic solvents 2.78 1.23-6.26
Study design: Case-control study. Controls treated for essential arterial hypertension, glaucoma, psoriasis vulgaris & renal diseases. Question:  Occupational history; exposure calssified by an 
industrial hygienist. Exposures only considered if exposed for at least 10 consecutive years prior to onset of PD. Strengths: High participation rate. Trained interviewer & industrial hygienist 
determined exposure status. 
           
Pals et al. (2003) Belgium 423 205 PD support groups Spouses of PD cases Self- Toluene 7.8 1.03-58.82  
    + 3 University hospitals  administered     
Study design: Case-control study. Controls were spouses. Questions:. “Have you been exposed for longer than six months, prior to the onset of PD, to chloroform, benzene, toluene, xylene, 
styrene, hexane, white spirit, thinner, varnishes, wood presearvatives, glues, paints, oil products or carbon monoxide?” & “What is your present occupation? Give a descritption of your 
professional career? Have you been employed in metallurgy, wood processing industries, textile manufacturing & processing, petrochemical industry, industrial painting, agriculture (if yes, for 
how long)?” Limitations: Spouse controls. As there was a male preponderance in the study sample for PD cases, there was a large gender imbalance between the case & control groups (N male 
cases = 256, N male controls = 70). There was also less than half the number of controls as cases. Therefore, rarer exposures may not appear in the control group due to lack of numbers. No 
response rate.Strengths: test-retest reproducibility assessed with subset of participants with good to excellent reprocibility repoted. 
           
McDonnell et al.  UK 57 206 Death certificates from Death certificates from Occupational Any exposure to solvents 1.53 0.81-2.87 0.19 
(2003)    Rolls-Royce National Rolls-Royce National records <10 yrs solvent exposure 1.20* 0.53-2.71  
    Pension Fund Archive Pension Fund Archive  10-20 yrs solvent exposure 1.13* 0.40-3.24  
       20-30 yrs solvent exposure 1..29* 0.31-5.34  
       > 30 yrs solvent exposure 3.59* 1.26-10.26  
Study design: Case-control study. Cases & controls from death certificates..Question: Occupation obtained from occupational records & coded by an occupational hygienist. *Mortality Odds 
Ratio adjusted for age at death & location of work. Limitations: Reliance on death certificate data for outcome measurement, which can lead to substantial misclassification error; Using 
mortality as the point at which participants are ‘recruited’ may not be suitable for a study of aetiology if exposure is related to increased mortality in PD rather than increased risk; Small sample 
size. Strengths: Occupational data from personnel records is a major advantage to this study 
           
Park et al. (2005) US  
    
33678 2,501,541
 
Death certificates
 
Death certificates 
 
Death Certificate
 
Level of exposure (0-9) 
 
1.07* 1.00-1.13  
 Painters/sculptors 1.23* 1.00-1.51 0.047
Study design: Case-control study. Cases & controls from death certificates..Question: Occupation obtained from death certificate & exposure determined with JEM. *Mortality Odds Ratio 
adjusted for age, race, gender, region & SES. Limitations: Reliance on death certificate data for outcome & exposure measurement, which can lead to substantial misclassification error; Using 
mortality as the point at which participants are ‘recruited’ may not be suitable for a study of aetiology if exposure is related to increased mortality in PD rather than increased risk.   
           
Individual studies are separated by a line. 
OR = Odds Ratio; 95% CI = 95% Confidence Interval; NS = Not Significant at 0.05 level 
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Table C1:Rural Residency Table C2: Well Water
Study. Authors  Study. Authors 
1 McCann et al. (1998)  1 McCann et al. (1998) 
2 Gorell et al. (1998)  2 Gorell et al. (1998) 
3 Semchuk et al. (1991)  3 Semchuk et al. (1991) 
4 Koller et al. (1990)  4 Koller et al. (1990) 
5 Stern et al. (1991)  5 Stern et al. (1991) 
6 Taylor et al. (1999)  6 Taylor et al. (1999) 
7 Golbe et al. (1990)  7 Hertzman et al. (1994) 
8 Butterfield et al. (1993)  8 Golbe et al. (1990) 
9 Zayed et al. (1990)  9 Zayed et al. (1990) 
10 Wong et al. (1991)  10 Wong et al. (1991) 
11 Seidler et al. (1996)  11 Seidler et al. (1996) 
12 Martyn & Osmond (1995)  12 Kuopio et al. (1999) 
13 Zorzon et al. (2002)  13 De Michele et al. (1996) 
14 De Palma et al. (1998)  14 De Palma et al. (1998) 
15 Vieregge et al. (1994)  15 Smargiassi et al. (1998) 
16 Chan et al. (1998)  16 Vieregge et al. (1994) 
17 Liou et al. (1997)  17 Chan et al. (1998) 
18 Tanner et al. (1989)  18 Liou et al. (1997) 
19 Wang et al. (1993)  19 Tanner et al. (1989) 
20 Ho et al. (1989)  20 Wang et al. (1993) 
21 Behari et al. (2001)  21 Behari et al. (2001) 
22 Werneck & Alvarenga (1999)  22 Werneck and Alvarenga (1999) 
Table C3: Farming Exposures Table C4: Pesticide Exposures
Study. Authors  Study. Authors 
1 Tsui et al. (1999)  1 McCann et al. (1998) 
2 Semchuk et al. (1991/92)  2 Menegon et al. (1998) 
3 Hertzman et al. (1990/94)  3 Chaturvedi et al. (1995) 
4 Zayed et al. (1990)  4 Semchuk et al. (1992) 
5 Chan et al. (1998)  5 Herzman et al. (1994) 
6 Tanner et al. (1989)  6 Zayed et al. (1990) 
7 Kuopio et al. (1999)  7 Gorell et al. (1998) 
8 Seidler et al. (1996)  8 Koller et al. (1990) 
9 Ho et al. (1989)  9 Stern et al. (1991) 
10 Behari et al. (2001)  10 Taylor et al. (1999) 
11 Zorzon et al. (2002)  11 Golbe et al. (1990) 
12 Rocca et al. (1996)  12 Hubble et al. (1993) 
13 Smargiassi et al. (1998)  13 Butterfield et al. (1993) 
14 Fall et al. (1999)  14 Wong et al. (1991) 
15 Liou et al. (1997)  15 Seidler et al. (1996) 
16 Gorell et al. (1998)/Kirkey et al. (2001)  16 Zorzon et al. (2002) 
17 Koller et al. (1990)  17 De Palma et al. (1998) 
18 Golbe et al. (1990)  18 Smargiassi et al. (1998) 
19 Tanner et al. (1990)  19 Kuopio et al. (1999) 
20 Wong et al. (1991)  20 Fall et al. (1999) 
21 Wechsler et al. (1991)  21 Ohlson and Hogsetedt (1981) 
   22 Chan et al. (1998) 
   23 Liou et al. (1997) 
   24 Ho et al. (1989) 
   25 Werneck and Alvarenga (1999) 
   26 Herishanu et al. (2001) 
 
 
 
 
 
 
 
Appendix D 
 
 
 
 
 
Written Questionnaire by Mellick et al. 
 
Instructions: 
 
Please circle the correct answers and complete the survey to the 
best of your ability. 
 
The answers will be treated as strictly confidential.  
 
 
Thank-you for your co-operation and assistance with this valuable 
research. 
 
 
 
Date of completing this form……………………. 
 
1. Do you have Parkinson’s disease?    (Yes/No) 
 
2. Sex        (Male/Female) 
 
3. Were you born in Australia?     (Yes/No) 
 
If not, where were you born?…………………………….……… 
 
When did you come to Australia?…………………………….… 
 
4. What is your ethnic background?…………………………………... 
 
5. What ethnic background was your father?………………………… 
 
6. What ethnic background was your mother?……………………….. 
 
7. Has any member of your family (blood relatives) suffered from any 
of the following conditions? 
 
Parkinson’s disease   (Yes/No) 
 
Alzheimer’s disease   (Yes/No) 
 
Motor neurone disease   (Yes/No) 
 
Any other long term brain disease (Yes/No) 
 
If you have answered “yes” to any of these please specify which relative 
was affected and by what disease. 
 
Name of Relative  Relationship (brother/sister etc) Disease 
 
……………………. …………………………………. …………… 
……………………. …………………………………. …………… 
……………………. …………………………………. …………… 
……………………. …………………………………. …………… 
8. What has been your main occupation?……………………………….. 
 
 
 
9. Have you ever lived or worked on a farm for twelve or more 
months?         (Yes/No) 
 
10. Have you ever lived in a non-metropolitan area for twelve or 
more months?        (Yes/No) 
 
If “yes”, please specify where you lived and for how long……….. 
……………………………………………………………………………
……………………………………………………………………………
……………………………………………………………………………
…….…………………………………………………………………….. 
 
11. Have you ever been exposed to herbicides or pesticides? 
 
1. No 
2. Occasionally 
3. Regularly (weekly exposure for more than six months) 
 
If you have been exposed to herbicides or pesticides, how were 
you exposed? 
1. Hobby gardening 
2. Farming 
3. Industrial or factory 
4. Other (specify) ………………………………. 
 
Which chemicals were you exposed to?………………………. 
 
……………………………………………………………………… 
 
12. Have you used well-water, spring-water or bore-water as your 
main source of drinking water for more than six months? 
          (Yes/No) 
 
13. Have you ever suffered from repeated head injury as 
experienced in contact sports (such as boxing, martial arts, 
football)?         (Yes/No) 
 
14 Have you ever been a cigarette smoker? 
 
1. Never smoked 
2. Ex-smoker:  What age did you start?…………………. 
What age did you stop?..……………...… 
How many cigs/day did you smoke?….... 
3. Current Smoker What age did you start?…………………. 
    How many cigs/day do you smoke?……. 
15. Do you suffer/(have you ever suffered) from any of the 
following? 
 
Condition      Year(s) affected 
Parkinson’s disease    ……………………………. 
Stroke      ……………………………. 
Heart attack      ……………………………. 
High blood pressure    ……………………………. 
Depression that required treatment  ……………………………. 
Head injury that resulted in a loss of consciousness…………………… 
Operation with general anaesthetic  ……………………………. 
Other major illness    ……………………………. 
 
 
Do you have any of the following problems? 
 
16. Do your arms or legs ever shake?    (Yes/No) 
 
17. During the day do your muscles ever feel stiff and aching apart 
from after exercise?       (Yes/No) 
 
18. Do you find it difficult to get out of a chair?   (Yes/No) 
 
19. Do you shuffle when you walk?    (Yes/No) 
 
20. Do you have difficulty turning in bed?   (Yes/No) 
 
21. Has your handwriting become smaller?   (Yes/No) 
 
22. Do you find it difficult to open jars (other than new, previously 
unopened ones) or use a screwdriver or fasten the small buttons 
on your shirt or blouse? (Yes/No) 
 
23. Do you lose your balance when turning?   (Yes/No) 
 
 
Thank you very much for your co-operation. 
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Appendix F 
 
 
 
 
 
New Exposure Measurement Instrument for Case-Control Study 
 
 
 
 
 
 
 
 
 
 
 
Questionnaire for PD Cases 
PARKINSON'S DISEASE QUESTIONNAIRE  
 
Date: ____ ____ 20_____ 
Interviewer: 
_____ ______ 
 Subject Code: 
____ ____ ____ _____ 
Respondent 
1 - Case 
2 - Control 
Sex 
1 - Male 
2 - Female 
Location of interview 
1 - Respondent's home 
2 - Clinic___________________ 
___  ________________________ 
        (other, please specify) 
Others present 
1 – None 
2 - Partner_______________ 
3 - Child ________________ 
4 – Other__________________ 
                (please specify) 
 
Interviewer: Questions marked with a ● are to be asked of all subjects. Whether a question 
marked with ? is asked, depends on how the subject answers a previous question. 
 
 
 
"Thank-you for participating in this research study. The purpose of this questionnaire is to 
assess your exposure to factors that may either increase or decrease the risk of developing a 
chronic disease. 
 
Some of the questions will ask you to think back about places you have lived and different 
work you may have performed. 
 
Many of the questions will seem repetitive, but for consistency between interviews we must 
ask all questions in exactly the same way.  
 
Before we begin, I would like to remind you that your participation in this study is 
voluntary, and that all information collected will be kept completely confidential. If there is 
a question you'd rather not answer, we can skip it and move on to the next one. 
 
If you do not know or cannot remember the answer to a question, please tell me. 
 
If you would like a break from the questions at any time, please tell me. 
 
Do you have any questions before we begin?" 
 
 
 
 Page 1
Section A: Background 
 
"The following questions are to obtain some background information about you. Whilst 
some of the questions may not appear very relevant to the study, they may be used for 
comparison purposes.”  
 
QUESTIONS (Instructions in italics) ANSWERS 
● 1 (a). What is your birth date?  
D:________M:_________Y: 19________ 
● 1 (b). Are you of Aboriginal or Torres Strait 
Islander Origin? 
Neither…………………………………..1 
Aboriginal……………………………….2 
Torres Strait Islander…………...……….3 
Both……………………………………..4 
Unsure…………………………………..5 
● 1 (c). In what country were you born?  Australia……………………….……..036 
U.K. & Ireland………….……………962 
Italy…………………………………..380 
Greece………………………………..300 
Netherlands…………………………..528 
Germany……………………………..280 
New Zealand…………………………554 
Viet Nam……………………………..704 
Poland………………………………...616 
 
Other________________________   _____
If born in Australia, go to 1(e), otherwise go to 1(d).  
? 1(d). What year did you arrive in Australia?  
19______________
● 1(e). In your home, do you usually speak 
English?  
Yes………………………………………1 
No……………………………………….0 
If YES, go to 1(g), In NO go to 1(f). 
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? 1(f). What language do you usually speak at 
home?  
Italian………………………………..0231
Greek………………………………..0411
Cantonese……………………………0811
Mandarin...…………………………..0814
German……………………………...0121
Arabic……………………………….0612
Other_______________________  _____
● 1(g). (In reference to your birth parents). What 
was your mother's ancestry (ethnic background)? 
 
 
 
Code _____  _____
_________________________________ 
_________________________________ 
Don't know……………………………99 
● 1(h). What was your father's ancestry (ethnic 
background)? 
 
Code _____  _____
_________________________________ 
_________________________________ 
Don't know……………………………99 
● 2.  What is your current marital status? Married……….………..…………..……1 
De facto………….…….………………..2 
Separated……………..….……………...3 
Divorced………….…….…….…………4 
Widowed………….….…….……………5 
Never married…….….……….…………6 
● 2(a). How many children have you had? _______  _______
I would now like to ask about your schooling. 
 
● 3. At what age did you leave school? 
Never went to school……………………1 
Under 14 years………………………….2 
14 years…………………………………3 
15 years…………………………………4 
16 years…………………………………5 
17 years…………………………………6 
18 years…………………………………7 
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19 years…………………………………8 
20 years…………………………………9 
21 years and over………………………10 
● 3(a). Did you complete the highest year of 
secondary school available at the time? 
Yes………………………………………1 
No……………………………………….0 
● 3(b). Since leaving school, have you completed a 
trade certificate, degree or any other educational 
qualification? 
Yes………………………………………1 
No……………………………………….0 
● 3(c). Have you enrolled to vote, that is, is your 
name listed on the Commonwealth Electoral 
Roll? 
Yes………………………………………1 
No……………………………………….0 
Validated by viewing electoral role? Yes - listed..…..…………………………1 
Yes - not listed…………………………..2 
Not checked.....………………………….3 
 
 Page 4
Section B: Residential History 
"In this section of the Questionnaire you will be asked for details about every place that you 
have lived for at least one year, since birth until now. Where you have lived in different 
houses in the same town we can call them one place if they were in similar suburbs and 
similar conditions, such as the same type of water supply. Some of the questions may seem 
very repetitive or obvious, however, for consistency and completeness we must ask all the 
questions in the same way." 
 
QUESTIONS (instructions in italics) ANSWERS 
Complete information on timeline for each residence. 
Residence 1 
● 4. Where did you first live when you were born?   
__________________________________
__________________________________
__________________________________
Place LIST A in view of subject and ask them to refer to it to answer 4(a). 
● 4(a). From List A, what type of location was it? Capital city……………………………...1 
Other metropolitan centre………………2 
Large rural centre……………………….3 
Small rural centre ………………………4 
Other rural centre ……………………....5 
Remote centre ………………………….6 
Other remote area ………………………7
● 4(b).Was this home within 1 mile of an 
agricultural area that was sprayed with pesticides 
or herbicides? 
Yes……………………………………...1 
No………………………………………0 
Don't know……………………………..9 
● 4(c). Was this home on a farm? (By farm I mean 
a place that raises crops or live-stock and sells them 
to earn money). 
Yes.……………………………………..1 
No ………..…………………………….0 
Don't know……………………………..9 
If YES, go to 4(d), if NO go to 4(g) 
? 4(d). What crops or herds were raised on it?  
Crops                            Code_____  _____
 
__________________________________
Code_____  _____
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__________________________________
Herds                            Code_____  _____
 
__________________________________ 
Code_____  _____
 
__________________________________
? 4(e). While living there did you also work on the 
farm? 
Yes.……………………………………..1 
No ………..…………………………….0 
Don't know……………………………..9 
If YES, go to 4(f), if NO go to 4(g). 
?? 4(f). What were your main tasks on the farm? 
 
 
                        Code _____  _____
__________________________________
__________________________________
Code _____  _____
 
__________________________________
 
__________________________________
 
Code _____  _____
__________________________________
 
__________________________________
 
● 4(g). Can you recall if it was a public (also known 
as reticulated or town supply) or private drinking 
water supply at this residence? 
Public Supply…………….……………..1 
Private Supply…..………………………2 
Both……………………………………..3 
Don't know…………….………………..9 
If PRIVATE SUPPLY Place LIST B in view of subject and ask them to refer to it to answer 4(h). 
Otherwise go to 4(i) 
? 4(h). From List B, can you recall what type of 
water supply it was?  
Underground (incl bore)……………….1
Rainwater………………………………2
River…………………………………...3
Dam……………………………………4
Lake……………………………………5
Other:___________________________6
Can't remember………………………..9
● 4(i). When did you first move away from that 
home for more than a few months? 19 ___________
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Repeat 5(a) to 5(h) until complete residential history is obtained. Write the relevant number of 
residence below (eg 2, 3, 4). Insert more pages as needed. 
Residence ______ 
● 5. Where did you move to?  
__________________________________
__________________________________
__________________________________
Place LIST A in view of subject and ask them to refer to it to answer 5(a). 
● 5(a). From List A, what type of location was it? Capital city……………………………...1 
Other metropolitan centre………………2 
Large rural centre……………………….3 
Small rural centre ………………………4 
Other rural centre ……………………....5 
Remote centre ………………………….6 
Other remote area ………………………7
● 5(b). Was this home within one mile (1.5 km) of 
an agricultural area that was sprayed with 
pesticides or herbicides? 
Yes……………………………………...1 
No………………………………………0 
Don't know……………………………..9 
● 5(c). Was this home on a farm? (By farm I mean 
a place that raises crops or live-stock and sells them 
to earn money). 
Yes.……………………………………..1 
No ………..…………………………….0 
Don't know……………………………..9 
If YES, go to 5(d), if NO go to 5(g) 
? 5(d). What crops or herds were raised on it?  Crops                            Code_____  _____
 
__________________________________
Code_____  _____
 
__________________________________
Herds                            Code_____  _____
 
__________________________________ 
Code_____  _____
 
__________________________________
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? 5(e). While living there did you also work on the 
farm? 
Yes.……………………………………..1 
No ………..…………………………….0 
Don't know……………………………..9 
If YES, go to 5(f), if NO go to 5(g). 
?? 5(f). What were your main tasks on the farm? 
Code _____  _____
__________________________________
 
__________________________________
Code _____  _____
 
__________________________________
 
__________________________________
 
Code _____  _____
__________________________________
 
__________________________________
 
● 5(g). Can you recall if it was a public (also known 
as reticulated or town supply) or private drinking 
water supply at this residence? 
Public Supply…………….……………..1 
Private Supply…..………………………2 
Don't know…………….………………..9 
If PRIVATE SUPPLY Place LIST B in view of subject and ask them to refer to it to answer 5(h). 
Otherwise go to 5(i) 
? 5(h). From List B, can you recall what type of 
water supply it was?  
Underground (incl bore)……………….1
Rainwater………………………………2
River…………………………………...3
Dam……………………………………4
Lake……………………………………5
Other:___________________________6
Can't remember………………………..9
● 5(i). When did you move away from that home? 
Prompt: How old were you when you moved away 
from that home? 
19 ___________
 
 
 
Questions 5 to 5(i) repeated here until full residential history obtained. 
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Section C: Home Exposures 
“I would now like to ask you some questions about laundry that you may have done for 
people living in your household. In each of the questions I will be referring to washing work 
clothes that were worn whilst working on a farm or with pesticides. By pesticides, I mean 
herbicides or insecticides or fungicides” 
LAUNDRY QUESTIONS 
● 6. Have you ever done the laundry for anyone 
in your home who worked on a farm? Including 
yourself, and farms that you may have lived on. 
Yes……………………………………….1
No………………………………………..0
Don't know……………………………….9
If YES, go to 6(a), if NO go to 6(d). 
? 6(a). Did any of these people, that you did 
laundry for, ever mix or apply pesticides when 
they worked on a farm? (Pesticides are used on 
crops or livestock to kill weeds or insects). 
Yes……………………………………….1
No………………………………………..0
Don't know……………………………….9
? 6(b). Did of these people, that you did laundry 
for, work in crop fields or with livestock on which 
pesticides were used? 
Yes……………………………………….1
No………………………………………..0
Don't know……………………………….9
? 6(c). How many people who worked on farms 
did you do the laundry for, including yourself? 
Don’t know……………………………99
_____ _____
● 6(d). Have you ever done the laundry for 
anyone in your home who mixed, applied or 
manufactured pesticides in any non-farming 
occupations, including yourself? For example, as 
a pest control operator.  
Yes……………………………………….1
No………………………………………..0
Don't know……………………………….9
If YES, go to 6(e), if NO go to 6(g). 
? 6(e). What occupation were they working in 
which involved use of pesticides? 
Code_________
___________________________________
___________________________________ 
? 6(f). How many people did you do laundry for 
that worked with pesticides other than on farms, 
including yourself? 
Don’t know……………………………99
_____ _____
? 6(g). How did you wash these work clothes? 
Was it ever: (read each option) 
 
By hand…………. 
By ringer or by 
washboard………... 
By automatic 
washing machine…. 
By any other method 
Yes 
1 
 
1 
1 
1 
No 
0 
 
0 
 
0 
 
0 
DK 
9 
 
9 
 
9 
 
9 
 (Please specify_____________________) 
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? 6(h). Did you regularly wash these work clothes 
along with the other regular laundry? 
Yes……………………………………….1
No………………………………………..0
Don't know………………………………9
? 6(i). What years did you do the laundry for 
anyone in your home who worked on farms or in 
other jobs using pesticides? 
________ to ________
________ to ________
________ to ________
________ to ________
________ to ________
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“I would now like to ask you about work you may have performed in gardens or lawns at 
the homes you have lived at.” 
 
DOMESTIC GARDEN EXPOSURES 
● 7. During your lifetime, have you ever gardened for 
a hobby? By hobby gardening, I do not mean general 
lawn maintenance such as just mowing the lawn, but 
tending plants in pots or garden beds. 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 7(a), if NO, go to 8. 
? 7(a). Approximately, how many years did you 
work in the garden as a hobby?  (If only worked in the 
garden a few times in entire lifetime all up, write number 
of times TOTAL and move onto 8.)  
 
Don’t know…………………………99
_____ _____
 
OR    _____ _____ times TOTAL 
? 7(b). During those years, on average, how often did 
you work in the garden?  
(If participant doesn’t specify if the answer relates to 
days per week, month or year, ask them “is that ___ 
days per week?” If answered in days per week or month, 
convert to days per year). 
 
Days per week:________________ 
 
Days per month:_______________ 
 
Days per year:_________________ 
If participant provides answer in days per week or month, convert to days per year. 
 
"The following questions are about your use of herbicides in your home lawns and gardens. 
By herbicide I mean a chemical used for killing weeds and other plants." 
 
DOMESTIC GARDEN HERBICIDE EXPOSURES 
● 8. During your lifetime, have you ever personally 
mixed herbicides for home lawn or garden use? (That 
is diluted a concentrated herbicide, or mixed two or 
more different herbicides together). 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, go to 8(a), if NO, go to 8(c). 
? 8(a). How many years did you personally mix 
herbicides for home lawn or garden use? (If only 
mixed herbicides a few times in entire lifetime all up, 
write number of times TOTAL and move onto 8(c).)   
Don’t know…………………………99
_____ _____
 
OR    _____ _____ times TOTAL 
? 8(b). During those years, on average, how often did 
you personally mix herbicides for home lawn or 
garden use? (If participant doesn’t specify if the answer 
relates to days per week, month or year, ask them “is 
that ___ days per week?” If answered in days per week 
or month, convert to days per year). 
 
Was that for 12 months of the year? 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
If participant provides answer in days per week or month, convert to days per year 
 Page 11
● 8(c). During your lifetime, have you ever personally 
applied herbicides on your home lawn or garden? 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If participant has mixed herbicides, but not applied them, go to 8(f). 
If participant has neither mixed nor applied herbicides go to 9. 
If participant has applied herbicides go to 8(d). 
? 8(d). Approximately, how many years did you 
personally apply herbicides to your home lawn or 
garden? (If only mixed herbicides a few times in entire 
lifetime all up, write number of times TOTAL and move 
onto 8(f).)   
Don’t know…………………………99
_____ _____
OR    _____ _____ times TOTAL 
? 8(e). During those years, on average, how often did 
you personally apply herbicides to your home lawn 
or garden? (If participant doesn’t specify if the answer 
relates to days per week, month or year, ask them “is 
that ___ days per week?” If answered in days per week 
or month, convert to days per year).  
If answered in per week or month: Was that for 12 
months of the year? 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
If participant provides answer in days per week or month, convert to days per year. 
? 8(f). Can you recall the names of the weeds, or 
plants the herbicides were used on? 
Can't recall names…………………….0 
Code____________
Weeds___________________________
________________________________ 
Code____________
Plants___________________________
_______________________________ 
? 8(g). Can you recall the name of the herbicides you 
used? 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Can't recall names………………….0 
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"The following questions are about your use of insecticides in your home lawns and gardens, 
but not inside your home. By insecticide I mean a chemical used for killing insect pests." 
DOMESTIC GARDEN INSECTICIDE EXPOSURES 
● 9. During your lifetime, have you ever personally 
mixed insecticides for home lawn or garden use? 
(That is diluted a concentrated insecticide, or mixed 
two or more different insecticides together). 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, go to 9(a), if NO, go to 9(c). 
? 9(a). Approximately, how many years did you 
personally mix insecticides for home lawn or garden 
use? (If only mixed insecticides a few times in entire 
lifetime all up, write number of times TOTAL and move 
onto 9(c).)   
Don’t know…………………………99
_____ _____
OR    _____ _____ times TOTAL 
? 9(b). During those years, on average, how often did 
you personally mix insecticides for home lawn or 
garden use? (If participant doesn’t specify if the answer 
relates to days per week, month or year, ask them “is 
that ___ days per week?” If answered in days per week 
or month, convert to days per year). 
If answered in per week or month: Was that for 12 
months of the year? 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
If subject provides answer in days per week or month, convert to days per year 
● 9(c). During your lifetime, have you ever personally 
applied insecticides on your home lawn or garden? 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If subject has mixed insecticides, but not applied them, go to 9(f). 
If subject has neither mixed nor applied insecticides go to 10. 
If subject has applied insecticides go to 9(d). 
? 9(d). Approximately, how many years did you 
personally apply insecticides to your home lawn or 
garden? (If only applied insecticides a few times in 
entire lifetime all up, write number of times TOTAL and 
move onto 9(f).)   
Don’t know…………………………99
_____ _____
OR    _____ _____ times TOTAL 
? 9(e). During those years, on average, how often did 
you personally apply insecticides to your lawn or 
home garden? (If participant doesn’t specify if the 
answer relates to days per week, month or year, ask 
them “is that ___ days per week?” If answered in days 
per week or month, convert to days per year). 
If answered in per week or month: Was that for 12 
months of the year? 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
? 9(f). Can you recall the names of the pests, or 
plants the insecticides were used on? 
Can't recall names…………………….0 
Code____________
Weeds___________________________
________________________________ 
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Code____________
Plants___________________________
_______________________________ 
? 9(g). Can you recall the name of the insecticides 
you used? 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Can't recall names………………….0 
 
 
"The following questions are about your use of fungicides in your home lawns and gardens, 
but not inside your home. By fungicide I mean a chemical used for killing mould, mildew 
and other fungi." 
 
DOMESTIC GARDEN FUNGICIDE EXPOSURES 
● 10. During your lifetime, have you ever personally 
mixed fungicides for home lawn or garden use? (That 
is diluted a concentrated fungicide, or mixed two or 
more different fungicides together). 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, go to 10(a), if NO, go to 10(c). 
? 10(a). Approximately, how many years did you 
personally mix fungicides for home lawn or garden 
use?  
(If only mixed up fungicides a few times in entire lifetime 
all up, write number of times TOTAL and move onto 
10(c).   
Don’t know…………………………99
_____ _____
 
OR    _____ _____ times TOTAL 
? 10(b). During those years, on average, how often 
did you personally mix fungicides for home lawn or 
garden use? (If participant doesn’t specify if the answer 
relates to days per week, month or year, ask them “is 
that ___ days per week?” If answered in days per week 
or month, convert to days per year). 
If answered in per week or month: Was that for 12 
months of the year? 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
If subject provides answer in days per week or month, convert to days per year 
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● 10(c). During your lifetime, have you ever 
personally applied fungicides on your home lawn or 
garden? 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If subject has mixed fungicides, but not applied them, go to 10(f). 
If subject has neither mixed nor applied fungicides go to 11. 
If subject has applied fungicides go to 10(d). 
? 10(d). Approximately, how many years did you 
personally apply fungicides to your home lawn or 
garden?  (If only applied fungicides a few times in entire 
lifetime all up, write number of times TOTAL and move 
onto 10(f).)   
Don’t know…………………………99
_____ _____
 
OR    _____ _____ times TOTAL 
? 10(e). During those years, on average, how often 
did you personally apply fungicides to your home 
lawn or garden? (If participant doesn’t specify if the 
answer relates to days per week, month or year, ask 
them “is that ___ days per week?” If answered in days 
per week or month, convert to days per year). 
If answered in per week or month: Was that for 12 
months of the year? 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
? 10(f). Can you recall the names of the pests, or 
plants the fungicides were used on? 
Can't recall names…………………….0 
Code____________
Weeds___________________________
________________________________ 
Code____________
Plants___________________________
_______________________________ 
? 10(g). Can you recall the name of the fungicides 
you used? 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Can't recall names………………….0 
 
“The following questions are about your use of insecticides INSIDE homes you have lived in.” 
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DOMESTIC HOUSEHOLD INSECTICIDE EXPOSURES 
● 11. For this question, “personal use” only refers to 
use of insecticides by yourself, not other household 
members or pest control operators. From List C, 
over your lifetime, would you describe your personal 
use of insecticides inside your home as….(read out to 
participant). 
 
Never (never used home insecticide 
products)……….………………..……0 
 
Irregular (< once a week)…………..…1 
Regular (at least once a week).……….2 
Very Regular (at least once a day on 
most days).…………………….……...3 
If YES (ie has used products), go to 11(a),if NEVER go to 11(c). 
? 11(a). Did you use any insecticides other than 
household spray cans for general pests such as 
cockroaches and flies? 
No…………………………………….0 
Yes……………………………………1 
Don't know……………………………9 
If YES, go to 11(b), if NO go to 11(c) 
?? 11(b). What insecticides did you use other than 
household spray cans for general pests? 
Code________
_______________________________
Code_______
_______________________________
● 11(c). Have you ever had pesticides applied inside 
your home by a professional pest control operator? 
No…………………………………….0 
Yes……………………………………1 
If YES, go to 11(d), if NO go to 12. 
? 11(d1). For how many years approximately did you 
have professional pest control performed in your 
home? (If only had pest control performed a few times 
in entire lifetime all up, write number of times TOTAL 
and move onto 12.)   
Don’t know…………………………99
_____ _____
OR    _____ _____ times TOTAL 
? 11(d2). Can you recall over what years you had 
professional pest control performed in your home? 
Don’t know…………………………99
___________ to ___________
? 11(e). How often did you have your home treated 
by a professional pest control operator?  
 
___________Times per month 
___________Times per year 
Once every _______ years 
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“I would now like to ask you about your contact with asbestos in and around homes you 
have lived in.” 
 
DOMESTIC ASBESTOS EXPOSURES 
● 12. Have you ever lived in a home which contained 
asbestos fibre insulation material? That is, the 
asbestos material that is usually in the ceiling cavity. 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, go to 12(a), if NO go to 12(c). 
?  12(a). Can you estimate, approximately, how 
many years did you live in homes containing asbestos 
fibre insulation materials?  
Don’t know…………………………99
_____ _____
?  12(b). Did you ever have direct contact with the 
insulation material? (Eg whilst performing 
renovations, installation of it etc). 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
● 12(c). Have you ever lived in a home constructed of 
asbestos fibre sheeting? (eg walls or roof) 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, go to 12(d), if NO go to 13. 
? 12(d). For how many years did you live in homes 
constructed of asbestos fibre sheeting? 
Don’t know…………………………99
_____ _____
? 12(e). Did you ever have direct contact with the 
asbestos fibre sheets such as in their removal or 
installation? 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………..9 
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"I would now like to ask you about your contact with electric or magnetic fields around 
homes you have lived in.” 
 
DOMESTIC ELECTROMAGNETIC RADIATION EXPOSURES 
● 13. Have you ever lived within 100 yards (100 
metres) of high voltage power lines or an electricity 
supply substation? 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, go to 13(a), if NO go to 13(b). 
? 13(a). Can you estimate approximately how many 
years you lived within 100 yards (100 metres) of high 
voltage power lines or an electricity supply 
substation? 
Don’t know…………………………99
_____ _____
● 13(b). Have you ever used an electric blanket on 
your bed? 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, go to 13(c), if NO go to 13(d). 
? 13(c). Can you estimate approximately how many 
years you have used an electric blanket on your bed? 
Don’t know…………………………99
_____ _____
● 13(d). Have you had any hobbies that involved 
working close to electric machinery, motors or other 
electric or magnetic fields?  
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………..9 
If YES, go to 13(e), if NO go to 13(i). 
? 13(e). What was the hobby? 
Code_____ _____
_______________________________
Code_____ _____
________________________________
Code_____ _____
_______________________________
? 13(f). What was the electric machinery, motor or 
other electric or magnetic field involved in the 
hobby? 
Code_____ _____
_______________________________
Code_____ _____
_______________________________
Code_____ _____
_______________________________
? 13(g). Can you estimate approximately how many 
years you had this hobby? 
Don’t know…………………………99
_____ _____
? 13(h). During those years, on average, how often 
did you work on this hobby? (If participant doesn’t 
specify if the answer relates to days per week, month or 
year, ask them “is that ___ days per week?” If answered 
 
Days per week:________________ 
                  For____________ months 
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in days per week or month, convert to days per year). 
If answered in per week or month: Was that for 12 
months of the year? 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
● 13(i). Have you ever received an electric shock 
from machinery, a power point or an electric fence, 
such that you were physically ‘thrown back’ or 
required medical treatment. 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………..9 
If YES, go to 13(j), if NO go to 14. 
? 13(j). How many times has this happened to you? Don’t know…………………………99
_____ _____
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Section C: Occupational History 
 
"I would now like to ask you some questions about your current occupation and then about 
other occupations you have worked in throughout your life." 
 
QUESTIONS (Instructions in italics) ANSWERS 
Complete information in timeline as information is collected. 
● 14. Do you currently do any work at all in a job, 
business or farm including unpaid voluntary 
work? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 14(a), if NO, go to 15. 
I would now like to ask you about your main job, 
that is the job in which you usually work the most 
hours.  
? 14(a). What is the name of your occupation? 
Code _____  ______
 
___________________________________ 
 
___________________________________ 
 
? 14(b). What are your main tasks or duties in 
this occupation? 
 
 
 
 
Code _____  _____
 
___________________________________
___________________________________
Code _____  _____
 
___________________________________ 
 
___________________________________ 
 
Code _____  _____
___________________________________ 
 
___________________________________ 
 
? 14(c). In this job, do you work……  For an employer for wages or salary……...1 
In your own business with employees……2 
    With no employees……………….……3 
Without pay in a family business…...…….4 
What are your working arrangements? 
   Payment in kind…………..…………….5 
   Unpaid voluntary work………..………..6 
? 14(d). When did you first start working in this 
job? ______________
? 14(e). How many hours a week do you usually 
work in this job? ___________________ hours
? 14(f). How many hours a week do you usually 
work in all your current jobs? ___________________ hours
 
MAIN LIFETIME OCCUPATIONS 
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● 15. What was the occupation you held for the 
longest time? 
Code _____   _____
 
___________________________________ 
● 15(a). What were your main tasks in that 
occupation?                                
                                                     Code _____  _____ 
 
___________________________________ 
 
Code _____  _____
 
___________________________________ 
Code _____  _____
___________________________________
Code _____  _____
___________________________________
Code _____  _____
___________________________________
● 15(b). Can you remember approximately what 
years you started and finished working in that 
occupation? 
_______________  to _______________ 
_______________  to _______________ 
● 15(c). What was the occupation you held for the 
second longest time? 
Code _____   _____
 
___________________________________ 
If participant has held other occupations go to 15(d), if NO other occupation held, go to 15(i).  
? 15(d). What were your main tasks in that 
occupation? 
                                                     Code _____  _____ 
 
___________________________________
Code _____  _____
___________________________________
 
Code _____  _____
___________________________________
Code _____  _____
___________________________________
Code _____  _____
___________________________________
? 15(e). Can you remember approximately what 
years you started and finished working in that 
occupation? 
_______________  to _______________ 
_______________  to _______________ 
? 15(f). What was the occupation you held for the 
third longest time? 
Code _____   _____
 
___________________________________ 
 
If third occupation held, go to 15(g), if NO other occupation, go to 16 
? 15(g). What were your main tasks in that 
occupation? 
                                                     Code _____  _____ 
 
___________________________________
Code _____  _____
___________________________________
 
Code _____  _____
___________________________________
Code _____  _____
___________________________________
Code _____  _____
___________________________________
? 15(h). Can you remember approximately what _______________  to _______________ 
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years you started and finished working in that 
occupation? _______________  to _______________ 
FARM WORK 
● 16. Have you ever worked on a farm? Yes…………………………...……..…….1 
No…………………………………………0 
If YES go to 16(a), if NO, go to 17. 
? 16(a). Have you ever worked on a farm that 
you didn’t also live on? 
Yes…………………………...……..…….1 
No…………………………………………0 
If YES go to 16(b), if NO go to 17. 
?? 16(b). What type of farms have you worked 
on, that you didn’t also live on?  
For each farm, ask “Can you recall what years 
you worked there?” 
  Code:______  ______
1. _________________________________
From ________ to _______ (# years:______)
 
 
 
 
 
  Code:______  ______
5. _________________________________
From ________ to _______ (# years:______)
  Code:______  ______
2. _________________________________
From ________ to _______ (# years:______)
 
 
 
 
 
  Code:______  ______
6. _________________________________
From ________ to _______ (# years:______)
  Code:______  ______
3. _________________________________
From ________ to _______ (# years:______)
 
 
 
 
 
  Code:______  ______
7. _________________________________
From ________ to _______ (# years:______)
  Code:______  ______
4. _________________________________
From ________ to _______ (# years:______)
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"I would now like to ask you some questions about your use of herbicides in your work." 
 
OCCUPATIONAL HERBICIDE EXPOSURES 
● 17. During your lifetime, have you ever personally 
mixed herbicides as part of your work? By mixing, I 
mean diluting a concentrated herbicide, or mixing 
two or more different herbicides together. 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If YES go to 17(a). if NO, go to 17(c). 
? 17(a). Approximately, how many years did you 
personally mix herbicides in your work?   
Don't know………………………….99
_______ _______
? 17(b). During those years, approximately how 
often did you personally mix herbicides? (If 
participant doesn’t specify if the answer relates to days 
per week, month or year, ask them “is that ___ days per 
week?” If answered in days per week or month, convert 
to days per year).  
If answered in per week or month: Was that for 12 
months of the year? 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
● 17(c). During your lifetime, have you ever 
personally applied herbicides as part of your work?  
By applying, I mean applying herbicides to plants, 
crops or weeds. 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If subject has mixed herbicides, but not applied them, go to 17(f). 
If subject has neither mixed nor applied herbicides go to 18. 
If subject has applied herbicides go to 17(d). 
? 17(d). Approximately, how many years did you 
personally apply herbicides as part of your work.  
Don’t know………………………...99
_____ _____
? 17(e). During those years, approximately how often 
did you personally apply herbicides? (If participant 
doesn’t specify if the answer relates to days per week, 
month or year, ask them “is that ___ days per week?” If 
answered in days per week or month, convert to days per 
year).  
If answered in per week or month: Was that for 12 
months of the year? 
Days per week:________________
                  For____________ months
Days per month:_______________
                  For____________ months
Days per year:_________________
? 17(f). Can you estimate approximately when you 
first started and last used herbicides in your work? First started__________
Last used__________
? 17(g). Can you recall the names of the weeds, or 
crops the herbicides were used on? 
Can't recall names…………………….0
Weeds                      Code______ _____
________________________________
Code_____  _____
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________________________________
Code_____ _____
________________________________
Crops                      Code______ _____
________________________________
Code_____  _____
________________________________
Code_____ _____
________________________________
? 17(h). Can you recall the name of the herbicides 
you used? 
Can't recall names……………………0
Code______  ______
________________________________
Code ______ ______
________________________________
Code ______ _____
________________________________
Code______ _____
_______________________________
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"I would now like to ask you some questions about your use of insecticides in your work." 
OCCUPATIONAL INSECTICIDE EXPOSURES 
●18. During your lifetime, have you ever personally 
mixed insecticides as part of your work? By mixing, I 
mean diluting a concentrated insecticide, or mixing 
two or more different insecticides together. 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If YES go to 18(a), if NO, go to 18(c). 
? 18(a). Approximately, how many years did you 
personally mix insecticides in your work?  
Don't know………………………….99
_______  _______
? 18(b). During those years, approximately how 
often did you personally mix insecticides? (If 
participant doesn’t specify if the answer relates to days 
per week, month or year, ask them “is that ___ days per 
week?” If answered in days per week or month, convert 
to days per year). 
If answered in per week or month: Was that for 12 
months of the year? 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
● 18(c). During your lifetime, have you ever 
personally applied insecticides as part of your work?  
By applying, I mean applying insecticides to pests, 
crops or herds. 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If subject has mixed insecticides, but not applied them, go to 18(f). 
If subject has neither mixed nor applied insecticides go to 19. 
If subject has applied herbicides go to 18(d). 
? 18(d). Approximately, how many years did you 
personally apply insecticides as part of your work.  
Don't know………………………….99
_______ _______
? 18(e). During those years, approximately how often 
did you personally apply insecticides? (If participant 
doesn’t specify if the answer relates to days per week, 
month or year, ask them “is that ___ days per week?” If 
answered in days per week or month, convert to days per 
year). 
If answered in per week or month: Was that for 12 
months of the year? 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
? 18(f). Can you estimate approximately when you 
first started and last used insecticides in your work? First started__________
Last used__________
? 18(g). Can you recall the names of the pests, or 
crops or herds the insecticides were used on? 
Can't recall names…………………….0
Pests                        Code______ _____ 
________________________________
Code_____  _____
________________________________
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Code_____ _____
________________________________
Crops/herds             Code______ _____
________________________________
Code_____  _____
________________________________
Code_____ _____
________________________________
? 18(h). Can you recall the name of the insecticides 
you used? 
Can't recall names……………………0
Code______  ______
________________________________
Code ______ ______
________________________________
Code ______ _____
________________________________
Code______ _____
_______________________________
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"I would now like to ask you some questions about your use of fungicides in your work." 
 
OCCUPATIONAL FUNGICIDE EXPOSURES 
● 19. During your lifetime, have you ever personally 
mixed fungicides as part of your work? By mixing, I 
mean diluting a concentrated fungicide, or mixing 
two or more different fungicides together. 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If YES go to 19(a), if NO, go to 19(c). 
? 19(a). Approximately, how many years did you 
personally mix fungicides in your work? 
Don't know………………………….99
_______ _______
? 19(b). During those years, approximately how 
often did you personally mix fungicides? (If 
participant doesn’t specify if the answer relates to days 
per week, month or year, ask them “is that ___ days per 
week?” If answered in days per week or month, convert 
to days per year). 
If answered in per week or month: Was that for 12 
months of the year? 
 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
● 19(c). During your lifetime, have you ever 
personally applied fungicides as part of your work?  
By applying, I mean applying fungicides to mould, 
mildew, other fungi or crops. 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If subject has mixed fungicides, but not applied them, go to 19(f). 
If subject has neither mixed nor applied fungicides go to 20. 
If subject has applied fungicides go to 19(d). 
? 19(d). Approximately, how many years did you 
personally apply fungicides as part of your work.  
Don't know………………………….99
_______ _______
? 19(e). During those years, approximately how often 
did you personally apply fungicides? (If participant 
doesn’t specify if the answer relates to days per week, 
month or year, ask them “is that ___ days per week?” If 
answered in days per week or month, convert to days per 
year). 
If answered in per week or month: Was that for 12 
months of the year? 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
? 19(f). Can you estimate approximately when you 
first started and last used fungicides in your work? First started__________
Last used__________
? 19(g). Can you recall the names of the fungi, or 
crops the fungicides were used on? 
Can't recall names…………………….0
Fungi                      Code______ _____
________________________________
Code_____  _____
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________________________________
Code_____ _____
________________________________
Crops/herds             Code______ _____
________________________________
Code_____  _____
________________________________
Code_____ _____
________________________________
? 19(h). Can you recall the name of the fungicides 
you used? 
Can't recall names……………………0
Code______  ______
________________________________
Code ______ ______
________________________________
Code ______ _____
________________________________
Code______ _____
_______________________________
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"I would now like to ask you about your exposure to metals in your work" 
 
OCCUPATIONAL METAL EXPOSURES 
● 20. During your lifetime, did you come into contact 
with metal fumes or were you involved in processing 
of metals in your work? (Eg welding, smelting) 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If YES go to 20(a), if NO, go to21. 
? 20(a). How did you have contact with metal fumes 
or working with metals? What tasks were you doing? 
Welding……………………………...1 
Moulding of molten metal….……….2 
Grinding……………………………..3 
Electroplating/electroforming……….4 
Other___________________________
_______________________________ 
? 20(b). What types of metal fumes did you have 
contact with? 
Code ______ ______
                           ________________________________ 
Code ______ ______
                           ________________________________ 
Can't remember………….……………0
Code ______ ______
________________________________
Code ______ ______
________________________________
? 20(c). Approximately, how many years did you 
work with metals as part of your work?  
Don't know………………………….99
_______ _______
? 20(d). During those years, approximately how 
often did you work with metals? (If participant doesn’t 
specify if the answer relates to days per week, month or 
year, ask them “is that ___ days per week?” If answered 
in days per week or month, convert to days per year). 
If answered in per week or month: Was that for 12 
months of the year? 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
? 20(e). Can you estimate approximately when you 
first started and last did metal work in your work? First started__________
Last used__________
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"I would now like to ask you about your exposure to solvents in your work." 
 
OCCUPATIONAL SOLVENT EXPOSURES 
● 21. During your lifetime, did you come into contact 
with solvents in your work? (Eg dry cleaning fluids, 
lacquers) 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If YES go to 21(a), if NO, go to 22. 
? 21(a). How did you have contact with solvents? 
What tasks were you doing? 
Dry cleaning.………………………...1 
Other cleaning…………….…..……..2 
Applying paint or lacquer……………3 
Other___________________________ 
? 21(b). What types of solvents did you have contact 
with? 
Code ______ ______
                           ________________________________ 
Code ______ ______
                           ________________________________ 
Can't remember………….……………0
Code ______ ______
________________________________
Code ______ ______
________________________________
? 21(c). Approximately, how many years did you 
work with solvents as part of your work?  
Don’t know…………………………99
_____ _____
? 21(d). During those years, approximately how 
often did you work with solvents? (If participant 
doesn’t specify if the answer relates to days per week, 
month or year, ask them “is that ___ days per week?” If 
answered in days per week or month, convert to days per 
year). 
If answered in per week or month: Was that for 12 
months of the year? 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
? 21(e). Can you estimate approximately when you 
first started and last did solvent work in your work? First started__________
Last used__________
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“I would now like to ask you about your contact with asbestos fibres at work” 
 
OCCUPATIONAL ASBESTOS EXPOSURES 
● 22. During your lifetime, did you come into contact 
with asbestos fibres in your work? (Eg installing 
asbestos roof insulation, asbestos roofing etc) 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………..9 
If YES go to 22(a), if NO, go to 23 
? 22(a). How did you have contact with asbestos? 
What tasks were you doing? 
Don’t know…………………………99
_____ _____
? 22(b). How did you have contact with asbestos 
fibres? What tasks were you doing? 
Handling asbestos insulation…………1 
Handling asbestos sheeting…………..2 
Active removal of asbestos…………..3 
Other:__________________________ 
_______________________________ 
_______________________________ 
? 22(b). Can you recall what types of asbestos you 
had contact with in your work? 
Don’t know….………….……………0 
blue (crocidolite)……………………..1  
brown (amosite)………………………2 
white (chrysotile)……………………..3 
?  22(c). Approximately, how many years did you 
work with asbestos as part of your work?  
Don't know………………………….99
_______ _______
? 22(d). During those years, approximately how 
often did you work with asbestos? (If participant 
doesn’t specify if the answer relates to days per week, 
month or year, ask them “is that ___ days per week?” If 
answered in days per week or month, convert to days per 
year). 
If answered in per week or month: Was that for 12 
months of the year? 
Days per week:________________
                  For____________ months
Days per month:_______________
                  For____________ months
Days per year:_________________
? 22(e). Can you estimate approximately when you 
first started and last worked with asbestos in your 
work? 
First started__________
Last used__________
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I would now like to ask you about your contact with electric or magnetic fields at work. 
OCCUPATIONAL ELECTROMAGNET RADIATION EXPOSURES 
● 23. During your lifetime, have you ever worked 
closely with electrical machinery or electric fields as 
part of a major task in your work? Please refer to 
List D for examples. 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………..9 
If YES go to 23(a), if NO, go to 24 
? 23(a). What type of work did you do, in which you 
were in contact with machinery or electric fields? 
 
Code _____ ____
________________________________
Code _____ ____
________________________________
Code _____ ____
________________________________
? 23(b). What was the machinery or source of 
electric field that you worked with? 
 
 
Code _____ ____
________________________________
Code ____ ____
________________________________
Code ____ ____
_______________________________
? 23(c). Approximately, how many years did you 
work with machinery or close to electric fields as part 
of your work?  
Don’t know…………………………99
_____ _____
? 23(d). During those years, approximately how 
often did you work with the machinery or close to 
electric fields? (If participant doesn’t specify if the 
answer relates to days per week, month or year, ask 
them “is that ___ days per week?” If answered in days 
per week or month, convert to days per year). 
If answered in per week or month: Was that for 12 
months of the year? 
Days per week:________________
                  For____________ months
Days per month:_______________
                  For____________ months
Days per year:_________________
? 23(e). Can you estimate approximately when you 
first started and last worked with machinery in your 
work? 
First started__________
Last used__________
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Section D - Poisoning Incidents 
 
"I'd now like to ask you about any poisoning incidents that may have happened to you." 
 
QUESTIONS (Instructions in italics) ANSWERS 
● 24. Have you ever been sprayed or splashed with a 
pesticide so that it got onto your skin or inside your 
body? 
Yes…………….……………………...1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, ask 24(a), if NO go to 24(d) 
? 24(a). When did this happen? 
Details (if given)_______________________________ 
_____________________________________________
_____________________________________________ 
Don’t know………………………0000
__________
? 24(b). Can you recall the name or type of pesticide 
involved? (Prompt for herbicide or insecticide) 
Herbicide:____________________…..1
Insecticide:___________________…..2 
Other:_______________________..___ 
Can't remember……………………….9 
? 24(c). What areas of your body were sprayed or 
splashed with the pesticide?  
 
Head…………………………………..1 
Arms………………………………….2 
Torso………………………………….3 
Legs…………………………………..4 
Whole body…………………………..5 
Can’t remember………………………9 
● 24(d). Have you ever swallowed a pesticide? Yes…………….……………………...1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, ask 24(e), if NO go to 25. 
? 24(e). Approximately what year did this happen? Don’t know………………………0000
_______`___
? 24(f). Do you recall the name or type of pesticide 
involved? (Prompt for herbicide or insecticide, eg was 
this a herbicide?) 
Herbicide:____________________…..1
Insecticide:___________________…..2 
Other:________________________…3 
Can't remember/don’t know………….9 
? 24(g). Do you know approximately how much you 
swallowed? 
Don't know………………………….99
Code ______
_______________________________
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Section E – Other Chemical Exposures 
 
"I'd now like to ask you about other exposures to chemicals, including pesticides that have 
not already been covered." 
QUESTIONS (Instructions in italics) ANSWERS 
● 25. Can you think of any other ways you have been 
exposed to chemicals during your life? 
Yes…………….……………………...1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, ask 25(a), if NO go to 26. 
? 25(a). What chemicals were you exposed to and 
how were you exposed to them? 
 
For each of the chemicals identified, ask 
“What years were you exposed to _____________?” 
“During those years how often were you exposed to 
it?” 
Code:______  ______
What:___________________________
How:____________________________
________________________________
Years:____________ to ____________
How often?______times per _________
Code:______  ______
What:___________________________
How:____________________________
________________________________
Years:____________ to ____________
How often?______times per _________
 
Code:______  ______
What:___________________________
How:____________________________
________________________________
Years:____________ to ____________
How often?______times per _________
Code:______  ______
What:___________________________
How:____________________________
________________________________
Years:____________ to ____________
How often?______times per _________
Code:______  ______
What:___________________________
How:____________________________
________________________________
Years:____________ to ____________
How often?______times per _________
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Section F - Medical and Family History 
 
"The following questions are about head injuries." 
 
QUESTIONS (Instructions in italics) ANSWERS 
●26. Have you ever had a serious head injury? 
Details (if given)_______________________________ 
_____________________________________________
_____________________________________________ 
_____________________________________________ 
Yes……………………………………1 
No…………………………………….0 
Don’t’ know…………………………..9 
If YES, go to 26(a), if NO, go to 27. 
? 26(a). How many serious head injuries have you 
had? 
Don't know……………………….999
_______ _______
? 26(b). Can you recall approximately what years 
you had these head injuries? 
Don't know………………………….0
_________   __________   _________
_________   __________   _________
_________   __________   _________
? 26(c). Did you lose consciousness with any of these 
head injuries?  
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES go to 26(d), if NO go to 26(e). 
?? 26(d). With how many head injuries did you lose 
consciousness? 
Don't know………………………….99
_______ _______
● 26(e). Did you every play contact sports such as 
boxing or football? 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
? 26(f). Which sport did you play? 
Code____ ____
_______________________________
Code ____ ___
_______________________________
Code____ ____
_______________________________
Code ____ ___
_______________________________
? 26(g). Can you estimate approximately how many 
years you played contact sports for? 
Don't know………………………….99
_______ _______
? 26(h). Can you estimate approximately what years 
you played contact sports? ___________ to ___________
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“I would now like to ask some background information about your family members. I am 
interested only in your blood relatives, including your mother, father, children, full sisters 
and full brothers, and half sisters and half brothers, aunts, uncles, cousins and 
grandparents. Do not include adopted or foster relatives or those related only through 
marriage. Please include all relatives, both living and deceased. 
 
FAMILY HISTORY 
● 27. How many sisters do you have? ____   ____
● 27(a). How many brothers do you have? ____   ____
● 27(b). How many daughters do you have? ____   ____
● 27(c). How many sons do you have? ____   _____
● 27(d). Do you know of any blood relatives of yours 
that have been diagnosed with Parkinson’s disease by 
a physician? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 27(e), if NO go to 27(g) 
? 27(e). How many blood relatives of yours been 
diagnosed with Parkinson's disease? ____  _____
? 27(f). What relationship are they to you? 
 
Write the number of relatives with Parkinson's disease 
for each relationship. Eg if 2 brothers have PD: 
Brother…2………………………3 
Mother………………………………...1 
Father…………………………………2 
Brother………………………………..3 
Sister………………………………….4 
Uncle (mother's side)…………………5 
Aunt (mother's side)…………………..6 
Uncle (father's side)…………………..7 
Aunt (father's side)……………….…..8 
Male cousin (mother's side)……….…9 
Female cousin (mother's side)………10 
Male cousin (father's side)…………..11 
Female cousin (father's side)………..12 
Other:_________________________ 
● 27(g). Do you know of any blood relatives of yours 
that have been diagnosed with Alzheimer’s disease? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 27(h), if NO, go to 27(j). 
? 27(h). How many blood relatives of yours have had 
Alzheimer's disease? ____  _____
 
 
 
 
 
 
Mother………………………………...1 
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? 27(I). What relationship are they to you? 
 
Write the number of relatives with Alzheimer's disease 
for each relationship. Eg if 2 brothers have AD: 
Brother…2………………………3 
Father…………………………………2 
Brother………………………………..3 
Sister………………………………….4 
Uncle (mother's side)…………………5 
Aunt (mother's side)…………………..6 
Uncle (father's side)…………………..7 
Aunt (father's side)……………….…..8 
Male cousin (mother's side)……….…9 
Female cousin (mother's side)………10 
Male cousin (father's side)…………..11 
Female cousin (father's side)………..12 
Other:_________________________ 
● 27(j). Do you know of any blood relatives of yours 
that have been diagnosed with motor neuron disease? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 27(k), if NO, go to 27(m). 
? 27(k). How many blood relatives of yours have had 
motor neuron disease? ____  _____
? 27(l). What relationship are they to you? 
 
Write the number of relatives with MND for each 
relationship. Eg if 2 brothers have MND: 
Brother…2………………………3 
Mother………………………………...1 
Father…………………………………2 
Brother………………………………..3 
Sister………………………………….4 
Uncle (mother's side)…………………5 
Aunt (mother's side)…………………..6 
Uncle (father's side)…………………..7 
Aunt (father's side)……………….…..8 
Male cousin (mother's side)……….…9 
Female cousin (mother's side)………10 
Male cousin (father's side)…………..11 
Female cousin (father's side)………..12 
Other:_________________________ 
● 27(m). Do you know of any blood relatives of yours 
that were diagnosed with Down’s syndrome? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 27(n), if NO, go to 27(p). 
? 27(n). How many blood relatives of yours were ____  _____
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diagnosed Down's Syndrome? 
? 27(o). What relationship are they to you? 
 
Write the number of relatives with Down's syndrome for 
each relationship. Eg if 2 brothers have Down's 
syndrome: 
Brother…2………………………3 
Mother………………………………...1 
Father…………………………………2 
Brother………………………………..3 
Sister………………………………….4 
Uncle (mother's side)…………………5 
Aunt (mother's side)…………………..6 
Uncle (father's side)…………………..7 
Aunt (father's side)……………….…..8 
Male cousin (mother's side)……….…9 
Female cousin (mother's side)………10 
Male cousin (father's side)…………..11 
Female cousin (father's side)………..12 
Other:_________________________ 
● 27(p). Do you know of any other blood relatives of 
yours that have been diagnosed with a disorder that 
causes tremors? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 27(q), if NO, go to 28. 
? 27(q). How many other blood relatives of yours have 
had a disorder that causes tremors? ____  _____
? 27(r). Can you recall the name of the disorder? Code____  _____
________________________________ 
? 27(s). What relationship are they to you? 
 
Write the number of relatives with disorders causing 
tremor for each relationship. Eg if 2 brothers have 
tremors: 
Brother…2………………………3 
Mother………………………………...1 
Father…………………………………2 
Brother………………………………..3 
Sister………………………………….4 
Uncle (mother's side)…………………5 
Aunt (mother's side)…………………..6 
Uncle (father's side)…………………..7 
Aunt (father's side)……………….…..8 
Male cousin (mother's side)……….…9 
Female cousin (mother's side)………10 
Male cousin (father's side)…………..11 
Female cousin (father's side)………..12 
Other:_________________________13 
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Section G -  
 
"The following questions are about your height and weight." 
QUESTIONS (Instructions in italics) ANSWERS 
● 28. Do you consider yourself to be…. Acceptable weight?………………….1 
Underweight?………………………..2 
Overweight?…………………………3 
● 28(a). How tall are you without shoes? Centimetres:_________________ 
Feet__________ Inches________ 
Don't know……………………….9999 
● 28(b). How much do you weigh? Kilograms_________________ 
Stone_________ pounds________ 
Pounds__________________ 
Don't known……………………99999 
 
“Now, I would like to ask you some questions about smoking and your use of tobacco.” 
TOBACCO HISTORY 
● 29. Have you ever smoked cigarettes or tried any 
other forms of tobacco? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 29(b), if NO, go to 29(a) 
? 29(a). So you have never even experimented one 
time with any form of tobacco? 
Yes, have experimented………………1 
No, haven't experimented…………….0 
If YES, go to 29(b). If NO, go to 30. 
? 29(b). How old were you when you first smoked a 
cigarette? 
 
? 29(c). From List E, which best describes your 
experience with smoking? 
Once/few times "just to try"…………..1 
Only occasionally…………………….2 
As often as 1-2/ week regularly for 6 
months or more……………...………..3 
Daily, or nearly every day, regularly for 
a month or more………………...…….4 
If smoked REGULARLY go to 29(d),  if only few times or occasionally, go to, go to 30.  
?? 29(d). How old were you when you first started 
smoking regularly? ________
?? 29(e). Are you a current smoker? Yes……………………………………1 
No…………………………………….0 
If YES, go to 29(j), if NO, go to 29(f) 
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?? 29(f). At what age did you stop smoking? _________ 
?? 29(g). Approximately, what years did you 
smoke for? Taking into account and excluding 
any non-smoking years during that time. 
 
From _________ to __________ 
From _________ to __________ 
From _________ to __________ 
Total years __________
?? 29(h). Approximately, how many cigarettes 
per day did you usually smoke? _________
?? 29(i). Which smoke did you find hardest to 
give up? The first one in the morning, a smoke 
while watching tv, or some other smoke? 
First in morning……………………..1 
Other smoke…………………………2 
Go to 29(p). 
?? 29(j). Have you had any non-smoking years 
since you first started smoking? If yes, how 
many years did you quit smoking for? 
Yes……………______  _____ years 
No…………………………….0 years 
?? 29(k). Which smoke would you most hate to 
give up? The first one in the morning, a smoke 
while watching tv, or some other cigarette? 
First in morning……………………..1 
Other smoke…………………………2 
?? 29(l). How many cigarettes per day do you 
usually smoke? 
 
?? 29(m). Have you always smoked about this 
amount of cigarettes? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 29(p), if NO go to 29(l) 
?? 29(n). How many cigarettes did you usually 
smoke per day before cutting down/increasing? 
 
?? 29(o). Approximately, what year did you 
cut down/increase to your current number of 
cigarettes per day? 
 
_____________
Go to 29(p). 
? 29(p). Have you regularly used any other forms of 
tobacco, such as cigars or pipes? 
Yes……………………………………1 
No……………………………………..0
If YES go to 29(q), if NO go to 30. 
?? 29(q). What other forms of tobacco did 
you smoke? 
Code:_____ _____
(a)______________________________
Code:_____ _____
(b)______________________________
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?? 29(r). On average, how often did you 
smoke (a)________? ________ per day
________ per week
________ per year
?? 29(s). Approximately, how many years did 
you smoke (a)____ for? ________
?? 29(t). On average, how often did you 
smoke (b)________? ________ per day
________ per week
________ per year
?? 29(u). Approximately, how many years 
did you smoke (b)____ for? 
 
Go to 30. 
? 30. Have you ever lived with someone who smoked Yes……………………………………1 
No……………………………………..0
? 30(a). Approximately, how many years did you live 
with someone who smoked? _________
? 30(b). Did they regularly smoke near you? For 
example, in the same room? 
Yes……………………………………1 
No……………………………………..0
If YES, go to 30(c), if NO, go to 30(d). 
?? 30(c). Can you recall, approximately how much 
they smoked when you were near them? Was it… 
More than once a day……………….1 
About once a day……………………2 
Less than once a day…………………3 
? 30(d). Have you ever worked in a workplace in 
which there was a lot of tobacco smoke, such as in a 
bar, club or casino? 
Yes……………………………………1 
No……………………………………..0
If YES, go to 30(e), if NO, go to 31 
? 30(e). Approximately, how many years did you 
work in workplaces with a lot of tobacco smoke? ___________
? 30(f). On average, how many hours per week did 
you work in these workplaces? 
 
_________ hours per week
Or _______ hours per ________
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Coffee and Tea Consumption 
“I would now like to ask you some questions about your consumption of caffeine-containing 
drinks, such as regular coffee and tea. When answering these questions please do not 
include your consumption of decaffeinated coffee or tea.” 
 
TEA AND COFFEE DRINKING HISTORY 
● 31. Have you ever drunk coffee regularly? (ie more 
than once a week). 
Yes………………………………….1 
No…………………………………..0 
If YES, go to 31(a), if NO, go to 31(j). 
? 31(a). How old were you when you started 
drinking coffee? ___________
? 31(b). Are you still a coffee drinker? Yes…………………………………..1 
No……………………………………0 
If YES, go to 31(f), if NO, go to 31(c).  
?? 31(c). What year did you stop drinking 
coffee? (or how old were you when you 
stopped) _______________
?? 31(d). Approximately, how many years 
would you have drunk coffee for? Taking into 
account any years you did not drink coffee for 
during that time. ______ ______
?? 31(e). How many cups of coffee did you 
usually drink per day? If less than one a day, 
how many per week? 
      _____________ per day
OR _____________ per week
Go to 31(k). 
?? 31 (f). Did you have any years since you 
first starting drinking coffee that you stopped 
drinking it for a time? If yes, how many years 
did you stop drinking coffee for before starting 
again? 
Yes……………______  _____ years 
No…………………………….0 years 
??  31(g). How many cups per day do you 
usually drink? _________
??  31(h). Have you always drunk about this 
much coffee? 
Yes…………………………………..1 
No……………………………………0 
If YES, go to 31(k), if NO, go to 31(i) 
?? 31(i). How many cups per day or week did 
you usually drink before you cut 
down/increased? 
_________ per day
_________ per week
?? 31(j). Approximately, what year did you 
cut down/ increase the amount of coffee you 
usually drank? ___________
● 31(k). Have you ever drunk tea regularly? (more 
than once a week). 
Yes………………………………….1 
No…………………………………..0 
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If YES, go to 31(l), if NO, go to 32. 
? 31(l). How old were you when you started drinking 
tea? 
 
                              _______________ 
? 31(m). Are you still a tea drinker? Yes……………………………….…..1 
No……………………………………0 
If YES, go to 31(q), if NO, go to 31(n).  
?? 31(n). What year did you stop drinking 
tea? 
 
?? 31(o). Approximately, how many years 
would you have drunk tea for? 
 
?? 31(p). How many cups of tea did you 
usually drink per day? If less than one a day, 
how many per week? 
      _____________ per day 
OR _____________ per week 
Go to 32. 
?? 31 (q). Did you have any years since you 
first starting drinking tea that you stopped 
drinking it for a time?  
If yes, how many years did you stop drinking 
tea for before starting again?  
Yes……………______  _____ years 
No…………………………….0 years 
?? 31(r). How many cups per day do you 
usually drink? 
 
?? 31(s). Have you always drunk about this 
much tea? 
Yes…………………………………..1 
No……………………………………0 
If no, go to 31(t), if yes, go to 32. 
?? 31(t). How many cups did you usually 
drink per day before you cut down or 
increased? Of if less than one a day, how many 
per week? 
      _____________ per day 
OR _____________ per week 
?? 31(u). Approximately, what year did you 
cut down/increase the amount of tea you 
usually drank? 
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Alcohol Consumption 
“I would now like to ask you some questions about your consumption of alcohol-containing 
drinks, such as beer, wine or spirits.” 
 
ALCOHOL DRINKING HISTORY 
● 32. Have you ever drunk alcoholic beverages  
regularly? (ie at least once a week). 
Yes………………………………….1 
No…………………………………..0 
If YES, go to 32(a), if NO, go to 33. 
? 32(a). How old were you when you started 
drinking alcohol beverages? ___________
? 32(b). Do you still drink alcoholic beverages? Yes…………………………………..1 
No……………………………………0 
If YES, go to 32(f), if NO, go to 32(c).  
?? 32(c). What year did you stop drinking 
alcoholic beverages? (or how old were you 
when you stopped) _______________
?? 32(d). Approximately, how many years 
would you have drunk alcoholic beverages for? 
Taking into account any years you stopped 
drinking alcoholic beverages for during that 
time. ______ ______
?? 32(e). How many alcoholic beverages did 
you usually drink per day or week?  
      _____________ per day
OR _____________ per week
Go to 32(k). 
?? 32 (f). Did you have any years since you 
first starting drinking alcohol that you stopped 
drinking it for a time?  
If yes, how many years did you stop drinking 
alcohol for before starting again?  
Yes……………______  _____ years 
No…………………………….0 years 
??  32(g). How many drinks per day or week 
do you usually drink? 
      _____________ per day
OR _____________ per week
??  32(h). Have you always drunk about this 
many alcoholic beverages? 
Yes…………………………………..1 
No……………………………………0 
If YES, go to 32(k), if NO, go to 32(i) 
?? 32(i). How many alcoholic beverages did 
you usually drink per day or week before you 
cut down or increased?  
_________ per day
OR ____________ per week
?? 32(j). Approximately, what year did you 
cut down/ increase the amount of alcohol you 
usually drank? ___________
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Section H: Parkinson's Diagnosis 
The following questions are only for cases. 
"I would now like to ask you some questions about your diagnosis with Parkinson's 
disease." 
 
● 33. What year were you diagnosed with 
Parkinson’s disease? (Prompt: How old were you 
when you were diagnosed with Parkinson’s 
disease?) 
Year_____________ 
OR Age____________ 
● 33(a). Who made the diagnosis of Parkinson's 
disease? 
(If a name is provided, ask “Are they are GP?”) 
GP……………………………………….1 
Neurologist..…………………………….2 
 
Other:_______________________ ……3 
● 33(b). What was your first symptom or 
symptoms? 
(Write more details in space below, if necessary) 
Code:_____  _____
_________________________________
Code:_____ _____
_________________________________
● 33(c). What year did you notice your first 
symptom? 
 
__________ 
● 33(d). What would you say is or are your main 
symptom or symptoms at the present time? 
Code:_____  _____
_________________________________ 
Code: _____  _____
_________________________________ 
Less sense of smell than you used to have? 
Yes…...1                    No…….0                    Unsure…….9 
Stiffness in muscles?______________________________ 
Yes…...1                    No…….0                    Unsure…….9 
Lazy muscles that don’t move very well?_______________ 
Yes…...1                    No…….0                    Unsure…….9 
Less expression in your facial features? 
Yes…...1                    No…….0                    Unsure…….9 
● 33(e). Have you experienced 
any of the following 
Parkinson's symptoms? (Read 
each symptom to participant) 
Problems with balance? 
Yes…...1                    No…….0                    Unsure…….9 
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Changes in your walk? 
Yes…...1                    No…….0                    Unsure…….9 
Depression? 
Yes…...1                    No…….0                    Unsure…….9 
Lethargy? 
Yes…...1                    No…….0                    Unsure…….9 
Tremor?  (if yes, where?)____________________________ 
Yes…...1                    No…….0                    Unsure…….9 
Difficulty Swallowing? 
Yes…...1                    No…….0                    Unsure…….9 
Less volume in your voice? 
Yes…...1                    No…….0                    Unsure…….9 
Any other symptoms I haven’t mentioned? 
Code:_____  _____
_________________________________________________
Code:_____  _____
_________________________________________________
Code:______  ______
_________________________________________________
● 33(f). Are you currently taking any medication 
for Parkinson’s Disease? 
Yes………………………………………1 
If yes, “Which Parkinson’s medications?” 
______________________  Code_______ 
______________________  Code_______
______________________  Code_______ 
No……………………………………….0 
● 33(g). Have you had any surgery, such as 
pallidotomy, for your Parkinson’s disease? 
Yes………………………………………1 
No……………………………………….0 
 
 Page 46
● 33(h). Do you have any suspicions about what 
caused you to develop Parkinson's disease? 
No suspicions ……………………….…..1 
Inherited ………………………………...2 
Head trauma……………………………..3  
Infectious illness………………………...4 
Exposure to pesticides…………………..5 
Exposure to metals.……………………..6 
Exposure to toxic substances……………7   
Lifestyle related…………………………8 
 
Other:___________________________  9 
 
 
 
 
END: 
"We have now finished the questionnaire. Thank-you for your time and assistance, your 
participation in this study is very much appreciated." 
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LIST A 
 
City/town Areas 
 
1  Capital City 
 
2. Other city with a population greater than 100 000 
 
3. Urban centre with a population between 25 000 - 99 999 
 
4. Urban centre with a population between 10 000 - 24 999 
 
5. Urban centre with a population less than 10 000 
 
Remote areas 
6. Remote centre with an urban population of greater than 5000 
 
7.  Other remote area with an urban population less than 5000 
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LIST B 
 
Underground (including bore water) 
Rainwater 
River (including creek, stream etc) 
Dam 
Lake 
Other (please specify) 
 Page 49 of 53
LIST C 
 
Never: Never used home insecticide products. 
 
Irregular: Used insecticide products less than once a week. 
 
Regular: Usually used insecticide products at least once a 
week. 
 
Very Regular: Used insecticide products at least once a day 
on most days. 
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LIST D 
 
 
Electrician 
Electrical engineer 
Telephone equipment repair or installation 
Operator of mechanical equipment such as: 
• Sewing machine 
• Lathe 
• Other machinery 
Repairer of machinery 
Radio operator 
Switchboard/telephone operator 
Computer work 
Work involving electricity line (such as repair) 
Work at a power plant or electricity substation 
 
Please note, this is not a complete list of occupations 
involving electric and magnetic fields. 
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LIST E 
 
I have only smoked once or a few times "just to try". 
 
I have only smoked occasionally. 
 
I have smoked as often as once or twice a week regularly 
for 6 months or more. 
 
I have smoked daily, or nearly every day, regularly for a 
month or more. 
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Questionnaire for Controls 
 
PARKINSON'S DISEASE QUESTIONNAIRE  
 
Date: ____ ____ 20_____ 
Interviewer: 
_____ ______ 
 Subject Code: 
____ ____ ____ _____ 
Respondent 
1 - Case 
2 - Control 
Sex 
1 - Male 
2 - Female 
Location of interview 
1 - Respondent's home 
2 - Clinic___________________ 
___  ________________________ 
        (other, please specify) 
Others present 
1 – None 
2 - Partner_______________ 
3 - Child ________________ 
4 – Other__________________ 
                (please specify) 
 
Interviewer: Questions marked with a ● are to be asked of all subjects. Whether a question 
marked with ? is asked, depends on how the subject answers a previous question. 
 
 
 
"Thank-you for participating in this research study. The purpose of this questionnaire is to 
assess your exposure to factors that may either increase or decrease the risk of developing a 
chronic disease. 
 
Some of the questions will ask you to think back about places you have lived and different 
work you may have performed. 
 
Many of the questions will seem repetitive, but for consistency between interviews we must 
ask all questions in exactly the same way.  
 
Before we begin, I would like to remind you that your participation in this study is 
voluntary, and that all information collected will be kept completely confidential. If there is 
a question you'd rather not answer, we can skip it and move on to the next one. 
 
If you do not know or cannot remember the answer to a question, please tell me. 
 
If you would like a break from the questions at any time, please tell me. 
 
Do you have any questions before we begin?" 
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Section A: Background 
 
"The following questions are to obtain some background information about you.” (Whilst 
some of the questions may not appear very relevant to the study, they may be used for 
comparison purposes.) 
 
QUESTIONS (Instructions in italics) ANSWERS 
● 1 (a). What is your birth date?  
D:________M:_________Y: 19________ 
● 1 (b). Are you of Aboriginal or Torres Strait 
Islander Origin? 
Neither…………………………………..1 
Aboriginal……………………………….2 
Torres Strait Islander…………...……….3 
Both……………………………………..4 
Unsure…………………………………..5 
● 1 (c). In what country were you born?  Australia……………………….……..036 
U.K. & Ireland………….……………962 
Italy…………………………………..380 
Greece………………………………..300 
Netherlands…………………………..528 
Germany……………………………..280 
New Zealand…………………………554 
Viet Nam……………………………..704 
Poland………………………………...616 
 
Other________________________   _____
If born in Australia, go to 1(e), otherwise go to 1(d).  
? 1(d). What year did you arrive in Australia?  
19______________
● 1(e). In your home, do you usually speak 
English?  
Yes………………………………………1 
No……………………………………….0 
If YES, go to 1(g), In NO go to 1(f). 
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? 1(f). What language do you usually speak at 
home?  
Italian………………………………..0231
Greek………………………………..0411
Cantonese……………………………0811
Mandarin...…………………………..0814
German……………………………...0121
Arabic……………………………….0612
Other_______________________  _____
● 1(g). (In reference to your birth parents). What 
was your mother's ancestry (ethnic background)? 
 
 
 
Code _____  _____
_________________________________ 
_________________________________ 
Don't know……………………………99 
● 1(h). What was your father's ancestry (ethnic 
background)? 
 
Code _____  _____
_________________________________ 
_________________________________ 
Don't know……………………………99 
● 2.  What is your current marital status? Married……….………..…………..……1 
De facto………….…….………………..2 
Separated……………..….……………...3 
Divorced………….…….…….…………4 
Widowed………….….…….……………5 
Never married…….….……….…………6 
● 2(a). How many children have you had? _______  _______
I would now like to ask about your schooling. 
 
● 3. At what age did you leave school? 
Never went to school……………………1 
Under 14 years………………………….2 
14 years…………………………………3 
15 years…………………………………4 
16 years…………………………………5 
17 years…………………………………6 
18 years…………………………………7 
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19 years…………………………………8 
20 years…………………………………9 
21 years and over………………………10 
● 3(a). Did you complete the highest year of 
secondary school available at the time? 
Yes………………………………………1 
No……………………………………….0 
● 3(b). Since leaving school, have you completed a 
trade certificate, degree or any other educational 
qualification? 
Yes………………………………………1 
No……………………………………….0 
● 3(c). Have you enrolled to vote, that is, is your 
name listed on the Commonwealth Electoral 
Roll? 
Yes………………………………………1 
No……………………………………….0 
Validated by viewing electoral role? Yes - listed..…..…………………………1 
Yes - not listed…………………………..2 
Not checked.....………………………….3 
 
 Page 4
Section B: Residential History 
"In this section of the Questionnaire you will be asked for details about every place that you 
have lived for at least one year, since birth until now. Where you have lived in different 
houses in the same town we can call them one place if they were in similar suburbs and 
similar conditions, such as the same type of water supply. Some of the questions may seem 
very repetitive or obvious, however, for consistency and completeness we must ask all the 
questions in the same way." 
 
QUESTIONS (instructions in italics) ANSWERS 
Complete information on timeline for each residence. 
Residence 1 
● 4. Where did you first live when you were born?   
__________________________________
__________________________________
__________________________________
Place LIST A in view of subject and ask them to refer to it to answer 4(a). 
● 4(a). From List A, what type of location was it? Capital city……………………………...1 
Other metropolitan centre………………2 
Large rural centre……………………….3 
Small rural centre ………………………4 
Other rural centre ……………………....5 
Remote centre ………………………….6 
Other remote area ………………………7
● 4(b).Was this home within 1 mile of an 
agricultural area that was sprayed with pesticides 
or herbicides? 
Yes……………………………………...1 
No………………………………………0 
Don't know……………………………..9 
● 4(c). Was this home on a farm? (By farm I mean 
a place that raises crops or live-stock and sells them 
to earn money). 
Yes.……………………………………..1 
No ………..…………………………….0 
Don't know……………………………..9 
If YES, go to 4(d), if NO go to 4(g) 
? 4(d). What crops or herds were raised on it?  
Crops                            Code_____  _____
 
__________________________________
Code_____  _____
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__________________________________
Herds                            Code_____  _____
 
__________________________________ 
Code_____  _____
 
__________________________________
? 4(e). While living there did you also work on the 
farm? 
Yes.……………………………………..1 
No ………..…………………………….0 
Don't know……………………………..9 
If YES, go to 4(f), if NO go to 4(g). 
?? 4(f). What were your main tasks on the farm? 
 
 
                        Code _____  _____
__________________________________
__________________________________
Code _____  _____
 
__________________________________
 
__________________________________
 
Code _____  _____
__________________________________
 
__________________________________
 
● 4(g). Can you recall if it was a public (also known 
as reticulated or town supply) or private drinking 
water supply at this residence? 
Public Supply…………….……………..1 
Private Supply…..………………………2 
Both……………………………………..3 
Don't know…………….………………..9 
If PRIVATE SUPPLY Place LIST B in view of subject and ask them to refer to it to answer 4(h). 
Otherwise go to 4(i) 
? 4(h). From List B, can you recall what type of 
water supply it was?  
Underground (incl bore)……………….1
Rainwater………………………………2
River…………………………………...3
Dam……………………………………4
Lake……………………………………5
Other:___________________________6
Can't remember………………………..9
● 4(i). When did you first move away from that 
home for more than a few months? 19 ___________
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Repeat 5(a) to 5(h) until complete residential history is obtained. Write the relevant number of 
residence below (eg 2, 3, 4). Insert more pages as needed. 
Residence ______ 
● 5. Where did you move to?  
__________________________________
__________________________________
__________________________________
Place LIST A in view of subject and ask them to refer to it to answer 5(a). 
● 5(a). From List A, what type of location was it? Capital city……………………………...1 
Other metropolitan centre………………2 
Large rural centre……………………….3 
Small rural centre ………………………4 
Other rural centre ……………………....5 
Remote centre ………………………….6 
Other remote area ………………………7
● 5(b). Was this home within one mile (1.5 km) of 
an agricultural area that was sprayed with 
pesticides or herbicides? 
Yes……………………………………...1 
No………………………………………0 
Don't know……………………………..9 
● 5(c). Was this home on a farm? (By farm I mean 
a place that raises crops or live-stock and sells them 
to earn money). 
Yes.……………………………………..1 
No ………..…………………………….0 
Don't know……………………………..9 
If YES, go to 5(d), if NO go to 5(g) 
? 5(d). What crops or herds were raised on it?  Crops                            Code_____  _____
 
__________________________________
Code_____  _____
 
__________________________________
Herds                            Code_____  _____
 
__________________________________ 
Code_____  _____
 
__________________________________
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? 5(e). While living there did you also work on the 
farm? 
Yes.……………………………………..1 
No ………..…………………………….0 
Don't know……………………………..9 
If YES, go to 5(f), if NO go to 5(g). 
?? 5(f). What were your main tasks on the farm? 
Code _____  _____
__________________________________
 
__________________________________
Code _____  _____
 
__________________________________
 
__________________________________
 
Code _____  _____
__________________________________
 
__________________________________
 
● 5(g). Can you recall if it was a public (also known 
as reticulated or town supply) or private drinking 
water supply at this residence? 
Public Supply…………….……………..1 
Private Supply…..………………………2 
Don't know…………….………………..9 
If PRIVATE SUPPLY Place LIST B in view of subject and ask them to refer to it to answer 5(h). 
Otherwise go to 5(i) 
? 5(h). From List B, can you recall what type of 
water supply it was?  
Underground (incl bore)……………….1
Rainwater………………………………2
River…………………………………...3
Dam……………………………………4
Lake……………………………………5
Other:___________________________6
Can't remember………………………..9
● 5(i). When did you move away from that home? 
Prompt: How old were you when you moved away 
from that home? 
19 ___________
 
 
 
Questions 5 to 5(i) repeated here until full residential history obtained. 
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Section C: Home Exposures 
“I would now like to ask you some questions about laundry that you may have done for 
people living in your household. In each of the questions I will be referring to washing work 
clothes that were worn whilst working on a farm or with pesticides. By pesticides, I mean 
herbicides or insecticides or fungicides” 
LAUNDRY QUESTIONS 
● 6. Have you ever done the laundry for anyone 
in your home who worked on a farm? Including 
yourself, and farms that you may have lived on. 
Yes……………………………………….1
No………………………………………..0
Don't know……………………………….9
If YES, go to 6(a), if NO go to 6(d). 
? 6(a). Did any of these people, that you did 
laundry for, ever mix or apply pesticides when 
they worked on a farm? (Pesticides are used on 
crops or livestock to kill weeds or insects). 
Yes……………………………………….1
No………………………………………..0
Don't know……………………………….9
? 6(b). Did of these people, that you did laundry 
for, work in crop fields or with livestock on which 
pesticides were used? 
Yes……………………………………….1
No………………………………………..0
Don't know……………………………….9
? 6(c). How many people who worked on farms 
did you do the laundry for, including yourself? 
Don’t know……………………………99
_____ _____
● 6(d). Have you ever done the laundry for 
anyone in your home who mixed, applied or 
manufactured pesticides in any non-farming 
occupations, including yourself? For example, as 
a pest control operator.  
Yes……………………………………….1
No………………………………………..0
Don't know……………………………….9
If YES, go to 6(e), if NO go to 6(g). 
? 6(e). What occupation were they working in 
which involved use of pesticides? 
Code_________
___________________________________
___________________________________ 
? 6(f). How many people did you do laundry for 
that worked with pesticides other than on farms, 
including yourself? 
Don’t know……………………………99
_____ _____
? 6(g). How did you wash these work clothes? 
Was it ever: (read each option) 
 
By hand…………. 
By ringer or by 
washboard………... 
By automatic 
washing machine…. 
By any other method 
Yes 
1 
 
1 
1 
1 
No 
0 
 
0 
 
0 
 
0 
DK 
9 
 
9 
 
9 
 
9 
 (Please specify_____________________) 
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? 6(h). Did you regularly wash these work clothes 
along with the other regular laundry? 
Yes……………………………………….1
No………………………………………..0
Don't know………………………………9
? 6(i). What years did you do the laundry for 
anyone in your home who worked on farms or in 
other jobs using pesticides? 
________ to ________
________ to ________
________ to ________
________ to ________
________ to ________
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“I would now like to ask you about work you may have performed in gardens or lawns at 
the homes you have lived at.” 
 
DOMESTIC GARDEN EXPOSURES 
● 7. During your lifetime, have you ever gardened for 
a hobby? By hobby gardening, I do not mean general 
lawn maintenance such as just mowing the lawn, but 
tending plants in pots or garden beds. 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 7(a), if NO, go to 8. 
? 7(a). Approximately, how many years did you 
work in the garden as a hobby?  (If only worked in the 
garden a few times in entire lifetime all up, write number 
of times TOTAL and move onto 8.)  
 
Don’t know…………………………99
_____ _____
 
OR    _____ _____ times TOTAL 
? 7(b). During those years, on average, how often did 
you work in the garden?  
(If participant doesn’t specify if the answer relates to 
days per week, month or year, ask them “is that ___ 
days per week?” If answered in days per week or month, 
convert to days per year). 
 
Days per week:________________ 
 
Days per month:_______________ 
 
Days per year:_________________ 
If participant provides answer in days per week or month, convert to days per year. 
 
"The following questions are about your use of herbicides in your home lawns and gardens. 
By herbicide I mean a chemical used for killing weeds and other plants." 
 
DOMESTIC GARDEN HERBICIDE EXPOSURES 
● 8. During your lifetime, have you ever personally 
mixed herbicides for home lawn or garden use? (That 
is diluted a concentrated herbicide, or mixed two or 
more different herbicides together). 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, go to 8(a), if NO, go to 8(c). 
? 8(a). How many years did you personally mix 
herbicides for home lawn or garden use? (If only 
mixed herbicides a few times in entire lifetime all up, 
write number of times TOTAL and move onto 8(c).)   
Don’t know…………………………99
_____ _____
 
OR    _____ _____ times TOTAL 
? 8(b). During those years, on average, how often did 
you personally mix herbicides for home lawn or 
garden use? (If participant doesn’t specify if the answer 
relates to days per week, month or year, ask them “is 
that ___ days per week?” If answered in days per week 
or month, convert to days per year). 
 
 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
If participant provides answer in days per week or month, convert to days per year 
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● 8(c). During your lifetime, have you ever personally 
applied herbicides on your home lawn or garden? 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If participant has mixed herbicides, but not applied them, go to 8(f). 
If participant has neither mixed nor applied herbicides go to 9. 
If participant has applied herbicides go to 8(d). 
? 8(d). Approximately, how many years did you 
personally apply herbicides to your home lawn or 
garden? (If only mixed herbicides a few times in entire 
lifetime all up, write number of times TOTAL and move 
onto 8(f).)   
Don’t know…………………………99
_____ _____
OR    _____ _____ times TOTAL 
? 8(e). During those years, on average, how often did 
you personally apply herbicides to your home lawn 
or garden? (If participant doesn’t specify if the answer 
relates to days per week, month or year, ask them “is 
that ___ days per week?” If answered in days per week 
or month, convert to days per year).  
 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
If participant provides answer in days per week or month, convert to days per year. 
? 8(f). Can you recall the names of the weeds, or 
plants the herbicides were used on? 
Can't recall names…………………….0 
Code____________
Weeds___________________________
________________________________ 
Code____________
Plants___________________________
_______________________________ 
? 8(g). Can you recall the name of the herbicides you 
used? 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Can't recall names………………….0 
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"The following questions are about your use of insecticides in your home lawns and gardens, 
but not inside your home. By insecticide I mean a chemical used for killing insect pests." 
DOMESTIC GARDEN INSECTICIDE EXPOSURES 
● 9. During your lifetime, have you ever personally 
mixed insecticides for home lawn or garden use? 
(That is diluted a concentrated insecticide, or mixed 
two or more different insecticides together). 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, go to 9(a), if NO, go to 9(c). 
? 9(a). Approximately, how many years did you 
personally mix insecticides for home lawn or garden 
use? (If only mixed insecticides a few times in entire 
lifetime all up, write number of times TOTAL and move 
onto 9(c).)   
Don’t know…………………………99
_____ _____
OR    _____ _____ times TOTAL 
? 9(b). During those years, on average, how often did 
you personally mix insecticides for home lawn or 
garden use? (If participant doesn’t specify if the answer 
relates to days per week, month or year, ask them “is 
that ___ days per week?” If answered in days per week 
or month, convert to days per year). 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
If subject provides answer in days per week or month, convert to days per year 
● 9(c). During your lifetime, have you ever personally 
applied insecticides on your home lawn or garden? 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If subject has mixed insecticides, but not applied them, go to 9(f). 
If subject has neither mixed nor applied insecticides go to 10. 
If subject has applied insecticides go to 9(d). 
? 9(d). Approximately, how many years did you 
personally apply insecticides to your home lawn or 
garden? (If only applied insecticides a few times in 
entire lifetime all up, write number of times TOTAL and 
move onto 9(f).)   
Don’t know…………………………99
_____ _____
OR    _____ _____ times TOTAL 
? 9(e). During those years, on average, how often did 
you personally apply insecticides to your lawn or 
home garden? (If participant doesn’t specify if the 
answer relates to days per week, month or year, ask 
them “is that ___ days per week?” If answered in days 
per week or month, convert to days per year). 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
? 9(f). Can you recall the names of the pests, or 
plants the insecticides were used on? 
Can't recall names…………………….0 
Code____________
Weeds___________________________
________________________________ 
Code____________
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Plants___________________________
_______________________________ 
? 9(g). Can you recall the name of the insecticides 
you used? 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Can't recall names………………….0 
 
 
"The following questions are about your use of fungicides in your home lawns and gardens, 
but not inside your home. By fungicide I mean a chemical used for killing mould, mildew 
and other fungi." 
 
DOMESTIC GARDEN FUNGICIDE EXPOSURES 
● 10. During your lifetime, have you ever personally 
mixed fungicides for home lawn or garden use? (That 
is diluted a concentrated fungicide, or mixed two or 
more different fungicides together). 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, go to 10(a), if NO, go to 10(c). 
? 10(a). Approximately, how many years did you 
personally mix fungicides for home lawn or garden 
use?  
(If only mixed up fungicides a few times in entire lifetime 
all up, write number of times TOTAL and move onto 
10(c).   
Don’t know…………………………99
_____ _____
 
OR    _____ _____ times TOTAL 
? 10(b). During those years, on average, how often 
did you personally mix fungicides for home lawn or 
garden use? (If participant doesn’t specify if the answer 
relates to days per week, month or year, ask them “is 
that ___ days per week?” If answered in days per week 
or month, convert to days per year). 
 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
If subject provides answer in days per week or month, convert to days per year 
● 10(c). During your lifetime, have you ever 
personally applied fungicides on your home lawn or 
Yes……………………………………1 
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garden? No…………………………………….0 
Don’t know…………………………...9 
If subject has mixed fungicides, but not applied them, go to 10(f). 
If subject has neither mixed nor applied fungicides go to 11. 
If subject has applied fungicides go to 10(d). 
? 10(d). Approximately, how many years did you 
personally apply fungicides to your home lawn or 
garden?  (If only applied fungicides a few times in entire 
lifetime all up, write number of times TOTAL and move 
onto 10(f).)   
Don’t know…………………………99
_____ _____
 
OR    _____ _____ times TOTAL 
? 10(e). During those years, on average, how often 
did you personally apply fungicides to your home 
lawn or garden? (If participant doesn’t specify if the 
answer relates to days per week, month or year, ask 
them “is that ___ days per week?” If answered in days 
per week or month, convert to days per year). 
 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
? 10(f). Can you recall the names of the pests, or 
plants the fungicides were used on? 
Can't recall names…………………….0 
Code____________
Weeds___________________________
________________________________ 
Code____________
Plants___________________________
_______________________________ 
? 10(g). Can you recall the name of the fungicides 
you used? 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Code ___________
________________________________ 
Can't recall names………………….0 
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“The following questions are about your use of insecticides INSIDE homes you have lived in.” 
DOMESTIC HOUSEHOLD INSECTICIDE EXPOSURES 
● 11. For this question, I will only be referring to use 
of insecticides by yourself, not other household 
members or pest control operators. From List C, 
which one best describes your use of insecticides 
inside your home, over your lifetime? 
 
Never (never used home insecticide 
products)……….………………..……0 
 
Irregular (< once a week)…………..…1 
Regular (at least once a week).……….2 
Very Regular (at least once a day on 
most days).…………………….……...3 
If YES (ie has used products), go to 11(a),if NEVER go to 11(c). 
? 11(a). Did you use any insecticides other than 
household spray cans for general pests such as 
cockroaches and flies? 
No…………………………………….0 
Yes……………………………………1 
Don't know……………………………9 
If YES, go to 11(b), if NO go to 11(c) 
?? 11(b). What insecticides did you use other than 
household spray cans for general pests? 
Code________
_______________________________
Code_______
_______________________________
● 11(c). Have you ever had pesticides applied inside 
your home by a professional pest control operator? 
No…………………………………….0 
Yes……………………………………1 
If YES, go to 11(d), if NO go to 12. 
? 11(d1). For how many years approximately did you 
have professional pest control performed in your 
home? (If only had pest control performed a few times 
in entire lifetime all up, write number of times TOTAL 
and move onto 12.)   
Don’t know…………………………99
_____ _____
OR    _____ _____ times TOTAL 
? 11(d2). Can you recall over what years you had 
professional pest control performed in your home? 
Don’t know…………………………99
___________ to ___________
? 11(e). How often did you have your home treated 
by a professional pest control operator?  
 
___________Times per month 
___________Times per year 
Once every _______ years 
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“I would now like to ask you about your contact with asbestos in and around homes you 
have lived in.” 
 
DOMESTIC ASBESTOS EXPOSURES 
● 12. Have you ever lived in a home which contained 
asbestos fibre insulation material? That is, the 
asbestos material that is usually in the ceiling cavity. 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, go to 12(a), if NO go to 12(c). 
?  12(a). Can you estimate, approximately, how 
many years did you live in homes containing asbestos 
fibre insulation materials?  
Don’t know…………………………99
_____ _____
?  12(b). Did you ever have direct contact with the 
insulation material? (Eg whilst performing 
renovations, installation of it etc). 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
● 12(c). Have you ever lived in a home constructed of 
asbestos fibre sheeting? (eg walls or roof) 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, go to 12(d), if NO go to 13. 
? 12(d). For how many years did you live in homes 
constructed of asbestos fibre sheeting? 
Don’t know…………………………99
_____ _____
? 12(e). Did you ever have direct contact with the 
asbestos fibre sheets such as in their removal or 
installation? 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………..9 
 
 Page 17
"I would now like to ask you about your contact with electric or magnetic fields around 
homes you have lived in.” 
 
DOMESTIC ELECTROMAGNETIC RADIATION EXPOSURES 
● 13. Have you ever lived within 100 metres of high 
voltage power lines or an electricity supply 
substation? 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, go to 13(a), if NO go to 13(b). 
? 13(a). Can you estimate approximately how many 
years you lived within 100 metres of high voltage 
power lines or an electricity supply substation? 
Don’t know…………………………99
_____ _____
● 13(b). Have you ever used an electric blanket on 
your bed? 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, go to 13(c), if NO go to 13(d). 
? 13(c). Can you estimate approximately how many 
years you have used an electric blanket on your bed? 
Don’t know…………………………99
_____ _____
● 13(d). Have you had any hobbies that involved 
working close to electric machinery, motors or other 
electric or magnetic fields?  
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………..9 
If YES, go to 13(e), if NO go to 13(i). 
? 13(e). What was the hobby? 
Code_____ _____
_______________________________
Code_____ _____
________________________________
Code_____ _____
_______________________________
? 13(f). What was the electric machinery, motor or 
other electric or magnetic field involved in the 
hobby? 
Code_____ _____
_______________________________
Code_____ _____
_______________________________
Code_____ _____
_______________________________
? 13(g). Can you estimate approximately how many 
years you had this hobby? 
Don’t know…………………………99
_____ _____
? 13(h). During those years, on average, how often 
did you work on this hobby? (If participant doesn’t 
specify if the answer relates to days per week, month or 
year, ask them “is that ___ days per week?” If answered 
in days per week or month, convert to days per year). 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
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                   For____________ months 
Days per year:_________________ 
● 13(i). Have you ever received an electric shock 
from machinery, a power point or an electric fence, 
such that you were physically ‘thrown back’ or 
required medical treatment. 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………..9 
If YES, go to 13(j), if NO go to 14. 
? 13(j). How many times has this happened to you? Don’t know…………………………99
_____ _____
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Section C: Occupational History 
 
"I would now like to ask you some questions about your current occupation and then about 
other occupations you have worked in throughout your life." 
 
QUESTIONS (Instructions in italics) ANSWERS 
Complete information in timeline as information is collected. 
● 14. Do you currently do any work at all in a job, 
business or farm including unpaid voluntary 
work? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 14(a), if NO, go to 15. 
I would now like to ask you about your main job, 
that is the job in which you usually work the most 
hours.  
? 14(a). What is the name of your occupation? 
Code _____  ______
 
___________________________________ 
 
___________________________________ 
 
? 14(b). What are your main tasks or duties in 
this occupation? 
 
 
 
 
Code _____  _____
 
___________________________________
___________________________________
Code _____  _____
 
___________________________________ 
 
___________________________________ 
 
Code _____  _____
___________________________________ 
 
___________________________________ 
 
? 14(c). In this job, do you work……  For an employer for wages or salary……...1 
In your own business with employees……2 
    With no employees……………….……3 
Without pay in a family business…...…….4 
What are your working arrangements? 
   Payment in kind…………..…………….5 
   Unpaid voluntary work………..………..6 
? 14(d). When did you first start working in this 
job? ______________
? 14(e). How many hours a week do you usually 
work in this job? ___________________ hours
? 14(f). How many hours a week do you usually 
work in all your current jobs? ___________________ hours
 
MAIN LIFETIME OCCUPATIONS 
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● 15. What was the occupation you held for the 
longest time? 
Code _____   _____
 
___________________________________ 
● 15(a). What were your main tasks in that 
occupation?                                
                                                     Code _____  _____ 
 
___________________________________ 
 
Code _____  _____
 
___________________________________ 
Code _____  _____
___________________________________
Code _____  _____
___________________________________
Code _____  _____
___________________________________
● 15(b). Can you remember approximately what 
years you started and finished working in that 
occupation? 
_______________  to _______________ 
_______________  to _______________ 
● 15(c). What was the occupation you held for the 
second longest time? 
Code _____   _____
 
___________________________________ 
If participant has held other occupations go to 15(d), if NO other occupation held, go to 15(i).  
? 15(d). What were your main tasks in that 
occupation? 
                                                     Code _____  _____ 
 
___________________________________
Code _____  _____
___________________________________
 
Code _____  _____
___________________________________
Code _____  _____
___________________________________
Code _____  _____
___________________________________
? 15(e). Can you remember approximately what 
years you started and finished working in that 
occupation? 
_______________  to _______________ 
_______________  to _______________ 
? 15(f). What was the occupation you held for the 
third longest time? 
Code _____   _____
 
___________________________________ 
 
If third occupation held, go to 15(g), if NO other occupation, go to 16 
? 15(g). What were your main tasks in that 
occupation? 
                                                     Code _____  _____ 
 
___________________________________
Code _____  _____
___________________________________
 
Code _____  _____
___________________________________
Code _____  _____
___________________________________
Code _____  _____
___________________________________
? 15(h). Can you remember approximately what _______________  to _______________ 
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years you started and finished working in that 
occupation? _______________  to _______________ 
FARM WORK 
● 16. Have you ever worked on a farm? Yes…………………………...……..…….1 
No…………………………………………0 
If YES go to 16(a), if NO, go to 17. 
? 16(a). Have you ever worked on a farm that 
you didn’t also live on? 
Yes…………………………...……..…….1 
No…………………………………………0 
If YES go to 16(b), if NO go to 17. 
?? 16(b). What type of farms have you worked 
on, that you didn’t also live on?  
For each farm, ask “Can you recall what years 
you worked there?” 
  Code:______  ______
1. _________________________________
From ________ to _______ (# years:______)
 
 
 
 
 
  Code:______  ______
5. _________________________________
From ________ to _______ (# years:______)
  Code:______  ______
2. _________________________________
From ________ to _______ (# years:______)
 
 
 
 
 
  Code:______  ______
6. _________________________________
From ________ to _______ (# years:______)
  Code:______  ______
3. _________________________________
From ________ to _______ (# years:______)
 
 
 
 
 
  Code:______  ______
7. _________________________________
From ________ to _______ (# years:______)
  Code:______  ______
4. _________________________________
From ________ to _______ (# years:______)
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"I would now like to ask you some questions about your use of herbicides in your work." 
 
OCCUPATIONAL HERBICIDE EXPOSURES 
● 17. During your lifetime, have you ever personally 
mixed herbicides as part of your work? By mixing, I 
mean diluting a concentrated herbicide, or mixing 
two or more different herbicides together. 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If YES go to 17(a). if NO, go to 17(c). 
? 17(a). Approximately, how many years did you 
personally mix herbicides in your work?   
Don't know………………………….99
_______ _______
? 17(b). During those years, approximately how 
often did you personally mix herbicides? (If 
participant doesn’t specify if the answer relates to days 
per week, month or year, ask them “is that ___ days per 
week?” If answered in days per week or month, convert 
to days per year).  
If answered in per week or month: Was that for 12 
months of the year? 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
● 17(c). During your lifetime, have you ever 
personally applied herbicides as part of your work?  
By applying, I mean applying herbicides to plants, 
crops or weeds. 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If subject has mixed herbicides, but not applied them, go to 17(f). 
If subject has neither mixed nor applied herbicides go to 18. 
If subject has applied herbicides go to 17(d). 
? 17(d). Approximately, how many years did you 
personally apply herbicides as part of your work.  
Don’t know………………………...99
_____ _____
? 17(e). During those years, approximately how often 
did you personally apply herbicides? (If participant 
doesn’t specify if the answer relates to days per week, 
month or year, ask them “is that ___ days per week?” If 
answered in days per week or month, convert to days per 
year).  
If answered in per week or month: Was that for 12 
months of the year? 
Days per week:________________
                  For____________ months
Days per month:_______________
                  For____________ months
Days per year:_________________
? 17(f). Can you estimate approximately when you 
first started and last used herbicides in your work? First started__________
Last used__________
? 17(g). Can you recall the names of the weeds, or 
crops the herbicides were used on? 
Can't recall names…………………….0
Weeds                      Code______ _____
________________________________
Code_____  _____
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________________________________
Code_____ _____
________________________________
Crops                      Code______ _____
________________________________
Code_____  _____
________________________________
Code_____ _____
________________________________
? 17(h). Can you recall the name of the herbicides 
you used? 
Can't recall names……………………0
Code______  ______
________________________________
Code ______ ______
________________________________
Code ______ _____
________________________________
Code______ _____
_______________________________
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"I would now like to ask you some questions about your use of insecticides in your work." 
OCCUPATIONAL INSECTICIDE EXPOSURES 
●18. During your lifetime, have you ever personally 
mixed insecticides as part of your work? By mixing, I 
mean diluting a concentrated insecticide, or mixing 
two or more different insecticides together. 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If YES go to 18(a), if NO, go to 18(c). 
? 18(a). Approximately, how many years did you 
personally mix insecticides in your work?  
Don't know………………………….99
_______  _______
? 18(b). During those years, approximately how 
often did you personally mix insecticides? (If 
participant doesn’t specify if the answer relates to days 
per week, month or year, ask them “is that ___ days per 
week?” If answered in days per week or month, convert 
to days per year). 
If answered in per week or month: Was that for 12 
months of the year? 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
● 18(c). During your lifetime, have you ever 
personally applied insecticides as part of your work?  
By applying, I mean applying insecticides to pests, 
crops or herds. 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If subject has mixed insecticides, but not applied them, go to 18(f). 
If subject has neither mixed nor applied insecticides go to 19. 
If subject has applied herbicides go to 18(d). 
? 18(d). Approximately, how many years did you 
personally apply insecticides as part of your work.  
Don't know………………………….99
_______ _______
? 18(e). During those years, approximately how often 
did you personally apply insecticides? (If participant 
doesn’t specify if the answer relates to days per week, 
month or year, ask them “is that ___ days per week?” If 
answered in days per week or month, convert to days per 
year). 
If answered in per week or month: Was that for 12 
months of the year? 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
? 18(f). Can you estimate approximately when you 
first started and last used insecticides in your work? First started__________
Last used__________
? 18(g). Can you recall the names of the pests, or 
crops or herds the insecticides were used on? 
Can't recall names…………………….0
Pests                        Code______ _____ 
________________________________
Code_____  _____
________________________________
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Code_____ _____
________________________________
Crops/herds             Code______ _____
________________________________
Code_____  _____
________________________________
Code_____ _____
________________________________
? 18(h). Can you recall the name of the insecticides 
you used? 
Can't recall names……………………0
Code______  ______
________________________________
Code ______ ______
________________________________
Code ______ _____
________________________________
Code______ _____
_______________________________
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"I would now like to ask you some questions about your use of fungicides in your work." 
 
OCCUPATIONAL FUNGICIDE EXPOSURES 
● 19. During your lifetime, have you ever personally 
mixed fungicides as part of your work? By mixing, I 
mean diluting a concentrated fungicide, or mixing 
two or more different fungicides together. 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If YES go to 19(a), if NO, go to 19(c). 
? 19(a). Approximately, how many years did you 
personally mix fungicides in your work? 
Don't know………………………….99
_______ _______
? 19(b). During those years, approximately how 
often did you personally mix fungicides? (If 
participant doesn’t specify if the answer relates to days 
per week, month or year, ask them “is that ___ days per 
week?” If answered in days per week or month, convert 
to days per year). 
If answered in per week or month: Was that for 12 
months of the year? 
 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
● 19(c). During your lifetime, have you ever 
personally applied fungicides as part of your work?  
By applying, I mean applying fungicides to mould, 
mildew, other fungi or crops. 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If subject has mixed fungicides, but not applied them, go to 19(f). 
If subject has neither mixed nor applied fungicides go to 20. 
If subject has applied fungicides go to 19(d). 
? 19(d). Approximately, how many years did you 
personally apply fungicides as part of your work.  
Don't know………………………….99
_______ _______
? 19(e). During those years, approximately how often 
did you personally apply fungicides? (If participant 
doesn’t specify if the answer relates to days per week, 
month or year, ask them “is that ___ days per week?” If 
answered in days per week or month, convert to days per 
year). 
If answered in per week or month: Was that for 12 
months of the year? 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
? 19(f). Can you estimate approximately when you 
first started and last used fungicides in your work? First started__________
Last used__________
? 19(g). Can you recall the names of the fungi, or 
crops the fungicides were used on? 
Can't recall names…………………….0
Fungi                      Code______ _____
________________________________
Code_____  _____
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________________________________
Code_____ _____
________________________________
Crops/herds             Code______ _____
________________________________
Code_____  _____
________________________________
Code_____ _____
________________________________
? 19(h). Can you recall the name of the fungicides 
you used? 
Can't recall names……………………0
Code______  ______
________________________________
Code ______ ______
________________________________
Code ______ _____
________________________________
Code______ _____
_______________________________
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"I would now like to ask you about your exposure to metals in your work" 
 
OCCUPATIONAL METAL EXPOSURES 
● 20. During your lifetime, did you come into contact 
with metal fumes or were you involved in processing 
of metals in your work? (Eg welding, smelting) 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If YES go to 20(a), if NO, go to21. 
? 20(a). How did you have contact with metal fumes 
or working with metals? What tasks were you doing? 
Welding……………………………...1 
Moulding of molten metal….……….2 
Grinding……………………………..3 
Electroplating/electroforming……….4 
Other___________________________
_______________________________ 
? 20(b). What types of metal fumes did you have 
contact with? 
Code ______ ______
                           ________________________________ 
Code ______ ______
                           ________________________________ 
Can't remember………….……………0
Code ______ ______
________________________________
Code ______ ______
________________________________
? 20(c). Approximately, how many years did you 
work with metals as part of your work?  
Don't know………………………….99
_______ _______
? 20(d). During those years, approximately how 
often did you work with metals? (If participant doesn’t 
specify if the answer relates to days per week, month or 
year, ask them “is that ___ days per week?” If answered 
in days per week or month, convert to days per year). 
 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
? 20(e). Can you estimate approximately when you 
first started and last did metal work in your work? First started__________
Last used__________
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"I would now like to ask you about your exposure to solvents in your work." 
 
OCCUPATIONAL SOLVENT EXPOSURES 
● 21. During your lifetime, did you come into contact 
with solvents in your work? (Eg dry cleaning fluids, 
lacquers, thinners, glues) 
Yes……………………………………1 
No…………………………………….0 
Don't know……………………………9 
If YES go to 21(a), if NO, go to 22. 
? 21(a). How did you have contact with solvents? 
What tasks were you doing? 
Dry cleaning.………………………...1 
Other cleaning…………….…..……..2 
Applying paint or lacquer……………3 
Other___________________________ 
? 21(b). What types of solvents did you have contact 
with? 
Code ______ ______
                           ________________________________ 
Code ______ ______
                           ________________________________ 
Can't remember………….……………0
Code ______ ______
________________________________
Code ______ ______
________________________________
? 21(c). Approximately, how many years did you 
work with solvents as part of your work?  
Don’t know…………………………99
_____ _____
? 21(d). During those years, approximately how 
often did you work with solvents? (If participant 
doesn’t specify if the answer relates to days per week, 
month or year, ask them “is that ___ days per week?” If 
answered in days per week or month, convert to days per 
year). 
 
 
Days per week:________________ 
                  For____________ months 
Days per month:_______________ 
                  For____________ months 
Days per year:_________________ 
? 21(e). Can you estimate approximately when you 
first started and last did solvent work in your work? First started__________
Last used__________
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“I would now like to ask you about your contact with asbestos fibres at work” 
 
OCCUPATIONAL ASBESTOS EXPOSURES 
● 22. During your lifetime, did you come into contact 
with asbestos fibres in your work? (Eg installing 
asbestos roof insulation, asbestos roofing etc) 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………..9 
If YES go to 22(a), if NO, go to 23 
? 22(a). How did you have contact with asbestos? 
What tasks were you doing? 
Don’t know…………………………99
_____ _____
? 22(b). How did you have contact with asbestos 
fibres? What tasks were you doing? 
Handling asbestos insulation…………1 
Handling asbestos sheeting…………..2 
Active removal of asbestos…………..3 
Other:__________________________ 
_______________________________ 
_______________________________ 
? 22(b). Can you recall what types of asbestos you 
had contact with in your work? 
Don’t know….………….……………0 
blue (crocidolite)……………………..1  
brown (amosite)………………………2 
white (chrysotile)……………………..3 
?  22(c). Approximately, how many years did you 
work with asbestos as part of your work?  
Don't know………………………….99
_______ _______
? 22(d). During those years, approximately how 
often did you work with asbestos? (If participant 
doesn’t specify if the answer relates to days per week, 
month or year, ask them “is that ___ days per week?” If 
answered in days per week or month, convert to days per 
year). 
 
Days per week:________________
                  For____________ months
Days per month:_______________
                  For____________ months
Days per year:_________________
? 22(e). Can you estimate approximately when you 
first started and last worked with asbestos in your 
work? 
First started__________
Last used__________
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I would now like to ask you about your contact with electric or magnetic fields at work. 
OCCUPATIONAL ELECTROMAGNET RADIATION EXPOSURES 
● 23. During your lifetime, have you ever worked 
closely with electrical machinery or electric fields as 
part of a major task in your work? Please refer to 
List D for examples. 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………..9 
If YES go to 23(a), if NO, go to 24 
? 23(a). What type of work did you do, in which you 
were in contact with machinery or electric fields? 
 
Code _____ ____
________________________________
Code _____ ____
________________________________
Code _____ ____
________________________________
? 23(b). What was the machinery or source of 
electric field that you worked with? 
 
 
Code _____ ____
________________________________
Code ____ ____
________________________________
Code ____ ____
_______________________________
? 23(c). Approximately, how many years did you 
work with machinery or close to electric fields as part 
of your work?  
Don’t know…………………………99
_____ _____
? 23(d). During those years, approximately how 
often did you work with the machinery or close to 
electric fields? (If participant doesn’t specify if the 
answer relates to days per week, month or year, ask 
them “is that ___ days per week?” If answered in days 
per week or month, convert to days per year). 
 
Days per week:________________
                  For____________ months
Days per month:_______________
                  For____________ months
Days per year:_________________
? 23(e). Can you estimate approximately when you 
first started and last worked with machinery in your 
work? 
First started__________
Last used__________
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Section D - Poisoning Incidents 
 
"I'd now like to ask you about any poisoning incidents that may have happened to you." 
 
QUESTIONS (Instructions in italics) ANSWERS 
● 24. Have you ever been sprayed or splashed with a 
pesticide so that it got onto your skin or inside your 
body? 
Yes…………….……………………...1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, ask 24(a), if NO go to 24(d) 
? 24(a). When did this happen? 
Details (if given)_______________________________ 
_____________________________________________
_____________________________________________ 
Don’t know………………………0000
__________
? 24(b). Can you recall the name or type of pesticide 
involved? (Prompt for herbicide or insecticide) 
Herbicide:____________________…..1
Insecticide:___________________…..2 
Other:_______________________..___ 
Can't remember……………………….9 
? 24(c). What areas of your body were sprayed or 
splashed with the pesticide?  
 
Head…………………………………..1 
Arms………………………………….2 
Torso………………………………….3 
Legs…………………………………..4 
Whole body…………………………..5 
Can’t remember………………………9 
● 24(d). Have you ever swallowed a pesticide? Yes…………….……………………...1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, ask 24(e), if NO go to 25. 
? 24(e). Approximately what year did this happen? Don’t know………………………0000
_______`___
? 24(f). Do you recall the name or type of pesticide 
involved? (Prompt for herbicide or insecticide, eg was 
this a herbicide?) 
Herbicide:____________________…..1
Insecticide:___________________…..2 
Other:________________________…3 
Can't remember/don’t know………….9 
? 24(g). Do you know approximately how much you 
swallowed? 
Don't know………………………….99
Code ______
_______________________________
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Section E – Other Chemical Exposures 
 
"I'd now like to ask you about other exposures to chemicals, including pesticides that have 
not already been covered." 
QUESTIONS (Instructions in italics) ANSWERS 
● 25. Can you think of any other ways you have been 
exposed to chemicals during your life? 
Yes…………….……………………...1 
No…………………………………….0 
Don’t know…………………………...9 
If YES, ask 25(a), if NO go to 26. 
? 25(a). What chemicals were you exposed to and 
how were you exposed to them? 
 
For each of the chemicals identified, ask 
“What years were you exposed to _____________?” 
“During those years how often were you exposed to 
it?” 
Code:______  ______
What:___________________________
How:____________________________
________________________________
Years:____________ to ____________
How often?______times per _________
Code:______  ______
What:___________________________
How:____________________________
________________________________
Years:____________ to ____________
How often?______times per _________
 
Code:______  ______
What:___________________________
How:____________________________
________________________________
Years:____________ to ____________
How often?______times per _________
Code:______  ______
What:___________________________
How:____________________________
________________________________
Years:____________ to ____________
How often?______times per _________
Code:______  ______
What:___________________________
How:____________________________
________________________________
Years:____________ to ____________
How often?______times per _________
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Section F - Medical and Family History 
 
"The following questions are about head injuries." 
 
QUESTIONS (Instructions in italics) ANSWERS 
●26. Have you ever had a serious head injury? 
Details (if given)_______________________________ 
_____________________________________________
_____________________________________________ 
_____________________________________________ 
Yes……………………………………1 
No…………………………………….0 
Don’t’ know…………………………..9 
If YES, go to 26(a), if NO, go to 27. 
? 26(a). How many serious head injuries have you 
had? 
Don't know……………………….999
_______ _______
? 26(b). Can you recall approximately what years 
you had these head injuries? 
Don't know………………………….0
_________   __________   _________
_________   __________   _________
_________   __________   _________
? 26(c). Did you lose consciousness with any of these 
head injuries?  
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
If YES go to 26(d), if NO go to 26(e). 
?? 26(d). With how many head injuries did you lose 
consciousness? 
Don't know………………………….99
_______ _______
● 26(e). Did you every play contact sports such as 
boxing or football? 
Yes……………………………………1 
No…………………………………….0 
Don’t know…………………………...9 
? 26(f). Which sport did you play? 
Code____ ____
_______________________________
Code ____ ___
_______________________________
Code____ ____
_______________________________
Code ____ ___
_______________________________
? 26(g). Can you estimate approximately how many 
years you played contact sports for? 
Don't know………………………….99
_______ _______
? 26(h). Can you estimate approximately what years 
you played contact sports? ___________ to ___________
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“I would now like to ask some background information about your family members. I am 
interested only in your blood relatives, including first and second degree relatives. Do not 
include adopted or foster relatives or those related only through marriage. And please 
include all relatives, both living and deceased in your answers. 
 
FAMILY HISTORY 
● 27. How many sisters do you have? ____   ____
● 27(a). How many brothers do you have? ____   ____
● 27(b). How many daughters do you have? ____   ____
● 27(c). How many sons do you have? ____   _____
● 27(d). Do you know of any blood relatives of yours 
that have been diagnosed with Parkinson’s disease by 
a physician? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 27(e), if NO go to 27(g) 
? 27(e). How many blood relatives of yours been 
diagnosed with Parkinson's disease? ____  _____
? 27(f). What relationship are they to you? 
 
Write the number of relatives with Parkinson's disease 
for each relationship. Eg if 2 brothers have PD: 
Brother…2………………………3 
Mother………………………………...1 
Father…………………………………2 
Brother………………………………..3 
Sister………………………………….4 
Uncle (mother's side)…………………5 
Aunt (mother's side)…………………..6 
Uncle (father's side)…………………..7 
Aunt (father's side)……………….…..8 
Male cousin (mother's side)……….…9 
Female cousin (mother's side)………10 
Male cousin (father's side)…………..11 
Female cousin (father's side)………..12 
Other:_________________________ 
● 27(g). Do you know of any blood relatives of yours 
that have been diagnosed with Alzheimer’s disease? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 27(h), if NO, go to 27(j). 
? 27(h). How many blood relatives of yours have had 
Alzheimer's disease? ____  _____
 
 
 
 
? 27(I). What relationship are they to you? 
 
 
Mother………………………………...1 
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Write the number of relatives with Alzheimer's disease 
for each relationship. Eg if 2 brothers have AD: 
Brother…2………………………3 
Father…………………………………2 
Brother………………………………..3 
Sister………………………………….4 
Uncle (mother's side)…………………5 
Aunt (mother's side)…………………..6 
Uncle (father's side)…………………..7 
Aunt (father's side)……………….…..8 
Male cousin (mother's side)……….…9 
Female cousin (mother's side)………10 
Male cousin (father's side)…………..11 
Female cousin (father's side)………..12 
Other:_________________________ 
● 27(j). Do you know of any blood relatives of yours 
that have been diagnosed with motor neuron disease? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 27(k), if NO, go to 27(m). 
? 27(k). How many blood relatives of yours have had 
motor neuron disease? ____  _____
? 27(l). What relationship are they to you? 
 
Write the number of relatives with MND for each 
relationship. Eg if 2 brothers have MND: 
Brother…2………………………3 
Mother………………………………...1 
Father…………………………………2 
Brother………………………………..3 
Sister………………………………….4 
Uncle (mother's side)…………………5 
Aunt (mother's side)…………………..6 
Uncle (father's side)…………………..7 
Aunt (father's side)……………….…..8 
Male cousin (mother's side)……….…9 
Female cousin (mother's side)………10 
Male cousin (father's side)…………..11 
Female cousin (father's side)………..12 
Other:_________________________ 
● 27(m). Do you know of any blood relatives of yours 
that were diagnosed with Down’s syndrome? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 27(n), if NO, go to 27(p). 
? 27(n). How many blood relatives of yours were ____  _____
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diagnosed Down's Syndrome? 
? 27(o). What relationship are they to you? 
 
Write the number of relatives with Down's syndrome for 
each relationship. Eg if 2 brothers have Down's 
syndrome: 
Brother…2………………………3 
Mother………………………………...1 
Father…………………………………2 
Brother………………………………..3 
Sister………………………………….4 
Uncle (mother's side)…………………5 
Aunt (mother's side)…………………..6 
Uncle (father's side)…………………..7 
Aunt (father's side)……………….…..8 
Male cousin (mother's side)……….…9 
Female cousin (mother's side)………10 
Male cousin (father's side)…………..11 
Female cousin (father's side)………..12 
Other:_________________________ 
● 27(p). Do you know of any other blood relatives of 
yours that have been diagnosed with a disorder that 
causes tremors? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 27(q), if NO, go to 28. 
? 27(q). How many other blood relatives of yours have 
had a disorder that causes tremors? ____  _____
? 27(r). Can you recall the name of the disorder? Code____  _____
________________________________ 
? 27(s). What relationship are they to you? 
 
Write the number of relatives with disorders causing 
tremor for each relationship. Eg if 2 brothers have 
tremors: 
Brother…2………………………3 
Mother………………………………...1 
Father…………………………………2 
Brother………………………………..3 
Sister………………………………….4 
Uncle (mother's side)…………………5 
Aunt (mother's side)…………………..6 
Uncle (father's side)…………………..7 
Aunt (father's side)……………….…..8 
Male cousin (mother's side)……….…9 
Female cousin (mother's side)………10 
Male cousin (father's side)…………..11 
Female cousin (father's side)………..12 
Other:_________________________13 
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Section G -  
"The following questions are about general health and well-being and some specific 
symptoms." 
QUESTIONS (Instructions in italics) ANSWERS 
● 28. Do you consider yourself to be…. Acceptable weight?………………….1 
Underweight?………………………..2 
Overweight?…………………………3 
● 28(a). How tall are you without shoes? Centimetres:_________________ 
Feet__________ Inches________ 
Don't know……………………….9999 
● 28(b). How much do you weigh? Kilograms_________________ 
Stone_________ pounds________ 
Pounds__________________ 
Don't known……………………99999 
● 28(c). Do you have trouble arising from a standard 
chair (eg kitchen chair, rather than a deep soft chair) 
Yes……………………………………1 
No…………………………………….0 
● 28(d). Is your handwriting smaller than it once 
was? 
Yes……………………………………1 
No…………………………………….0 
● 28(e). Is your balance, when walking, poor? Yes……………………………………1 
No…………………………………….0 
● 28(f). Do your feet suddenly seem to freeze in 
doorways? 
Yes……………………………………1 
No…………………………………….0 
● 28(g). Do you find it difficult to start walking from 
a standstill or have difficulty in stopping suddenly 
when you want to? 
Yes……………………………………1 
No…………………………………….0 
● 28(h). Does your face seem less expressive than it 
used to? 
Yes……………………………………1 
No…………………………………….0 
● 28(i). Do your arms and legs shake? Yes……………………………………1 
No…………………………………….0 
● 28(j). Do you have trouble buttoning buttons? Yes……………………………………1 
No…………………………………….0 
● 28(k). Do you shuffle your feet and take tiny steps 
when you walk? 
Yes……………………………………1 
No…………………………………….0 
● 28(l). Do you have less sense of smell than you once 
did? 
Yes……………………………………1 
No…………………………………….0 
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● 28(m). Do you have any existing medical 
conditions? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 28(n), if NO, go to 29. 
? 28(n). What is the name of the condition? Code:________________
________________________________
________________________________ 
? 28(o). How long have you had this condition?  
_______________________________ 
________________________________ 
 
 
 
 
 
 
 
“Now, I would like to ask you some questions about smoking and your use of tobacco.” 
TOBACCO HISTORY 
● 29. Have you ever smoked cigarettes or tried any 
other forms of tobacco? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 29(b), if NO, go to 29(a) 
? 29(a). So you have never even experimented one 
time with any form of tobacco? 
Yes, have experimented………………1 
No, haven't experimented…………….0 
If YES, go to 29(b). If NO, go to 30. 
? 29(b). How old were you when you first smoked a 
cigarette? 
 
? 29(c). From List E, which best describes your 
experience with smoking? 
Once/few times "just to try"…………..1 
Only occasionally…………………….2 
As often as 1-2/ week regularly for 6 
months or more……………...………..3 
Daily, or nearly every day, regularly for 
a month or more………………...…….4 
If smoked REGULARLY go to 29(d),  if only few times or occasionally, go to, go to 30.  
?? 29(d). How old were you when you first started 
smoking regularly? ________
?? 29(e). Are you a current smoker? Yes……………………………………1 
No…………………………………….0 
If YES, go to 29(j), if NO, go to 29(f) 
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?? 29(f). At what age did you stop smoking? _________ 
?? 29(g). Approximately, what years did you 
smoke for? Taking into account and excluding 
any non-smoking years during that time. 
 
From _________ to __________ 
From _________ to __________ 
From _________ to __________ 
Total years __________
?? 29(h). Approximately, how many cigarettes 
per day did you usually smoke? _________
?? 29(i). Which smoke did you find hardest to 
give up? The first one in the morning, a smoke 
while watching tv, or some other smoke? 
First in morning……………………..1 
Other smoke…………………………2 
Go to 29(p). 
?? 29(j). Have you had any non-smoking years 
since you first started smoking? If yes, how 
many years did you quit smoking for? 
Yes……………______  _____ years 
No…………………………….0 years 
?? 29(k). Which smoke would you most hate to 
give up? The first one in the morning, a smoke 
while watching tv, or some other cigarette? 
First in morning……………………..1 
Other smoke…………………………2 
?? 29(l). How many cigarettes per day do you 
usually smoke? 
 
?? 29(m). Have you always smoked about this 
amount of cigarettes? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 29(p), if NO go to 29(l) 
?? 29(n). How many cigarettes did you usually 
smoke per day before cutting down/increasing? 
 
?? 29(o). Approximately, what year did you 
cut down/increase to your current number of 
cigarettes per day? 
 
_____________
Go to 29(p). 
? 29(p). Have you regularly used any other forms of 
tobacco, such as cigars or pipes? 
Yes……………………………………1 
No……………………………………..0
If YES go to 29(q), if NO go to 30. 
?? 29(q). What other forms of tobacco did 
you smoke? 
Code:_____ _____
(a)______________________________
Code:_____ _____
(b)______________________________
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?? 29(r). On average, how often did you 
smoke (a)________? ________ per day
________ per week
________ per year
?? 29(s). Approximately, how many years did 
you smoke (a)____ for? ________
?? 29(t). On average, how often did you 
smoke (b)________? ________ per day
________ per week
________ per year
?? 29(u). Approximately, how many years 
did you smoke (b)____ for? 
 
Go to 30. 
? 30. Have you ever lived with someone who smoked Yes……………………………………1 
No……………………………………..0
? 30(a). Approximately, how many years did you live 
with someone who smoked? _________
? 30(b). Did they regularly smoke near you? For 
example, in the same room? 
Yes……………………………………1 
No……………………………………..0
If YES, go to 30(c), if NO, go to 30(d). 
?? 30(c). Can you recall, approximately how much 
they smoked when you were near them? Was it… 
More than once a day……………….1 
About once a day……………………2 
Less than once a day…………………3 
? 30(d). Have you ever worked in a workplace in 
which there was a lot of tobacco smoke, such as in a 
bar, club or casino? 
Yes……………………………………1 
No……………………………………..0
If YES, go to 30(e), if NO, go to 31 
? 30(e). Approximately, how many years did you 
work in workplaces with a lot of tobacco smoke? ___________
? 30(f). On average, how many hours per week did 
you work in these workplaces? 
 
_________ hours per week
Or _______ hours per ________
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Coffee and Tea Consumption 
“I would now like to ask you some questions about your consumption of caffeine-containing 
drinks, such as regular coffee and tea. When answering these questions please do not 
include your consumption of decaffeinated coffee or tea, if you drink decaff.” 
 
TEA AND COFFEE DRINKING HISTORY 
● 31. Have you ever drunk coffee regularly? (ie more 
than once a week). 
Yes………………………………….1 
No…………………………………..0 
If YES, go to 31(a), if NO, go to 31(j). 
? 31(a). How old were you when you started 
drinking coffee? ___________
? 31(b). Are you still a coffee drinker? Yes…………………………………..1 
No……………………………………0 
If YES, go to 31(f), if NO, go to 31(c).  
?? 31(c). What year did you stop drinking 
coffee? (or how old were you when you 
stopped) _______________
?? 31(d). Approximately, how many years 
would you have drunk coffee for? Taking into 
account any years you did not drink coffee for 
during that time. ______ ______
?? 31(e). How many cups of coffee did you 
usually drink per day? If less than one a day, 
how many per week? 
      _____________ per day
OR _____________ per week
Go to 31(k). 
?? 31 (f). Did you have any years since you 
first starting drinking coffee that you stopped 
drinking it for a time? If yes, how many years 
did you stop drinking coffee for before starting 
again? 
Yes……………______  _____ years 
No…………………………….0 years 
??  31(g). How many cups per day do you 
usually drink? _________
??  31(h). Have you always drunk about this 
much coffee? 
Yes…………………………………..1 
No……………………………………0 
If YES, go to 31(k), if NO, go to 31(i) 
?? 31(i). How many cups per day or week did 
you usually drink before you cut 
down/increased? 
_________ per day
_________ per week
?? 31(j). Approximately, what year did you 
cut down/ increase the amount of coffee you 
usually drank? ___________
● 31(k). Have you ever drunk tea regularly? (more 
than once a week). 
Yes………………………………….1 
No…………………………………..0 
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If YES, go to 31(l), if NO, go to 32. 
? 31(l). How old were you when you started drinking 
tea? 
 
                              _______________ 
? 31(m). Are you still a tea drinker? Yes……………………………….…..1 
No……………………………………0 
If YES, go to 31(q), if NO, go to 31(n).  
?? 31(n). What year did you stop drinking 
tea? 
 
?? 31(o). Approximately, how many years 
would you have drunk tea for? 
 
?? 31(p). How many cups of tea did you 
usually drink per day? If less than one a day, 
how many per week? 
      _____________ per day 
OR _____________ per week 
Go to 32. 
?? 31 (q). Did you have any years since you 
first starting drinking tea that you stopped 
drinking it for a time?  
If yes, how many years did you stop drinking 
tea for before starting again?  
Yes……………______  _____ years 
No…………………………….0 years 
?? 31(r). How many cups per day do you 
usually drink? 
 
?? 31(s). Have you always drunk about this 
much tea? 
Yes…………………………………..1 
No……………………………………0 
If no, go to 31(t), if yes, go to 32. 
?? 31(t). How many cups did you usually 
drink per day before you cut down or 
increased? Of if less than one a day, how many 
per week? 
      _____________ per day 
OR _____________ per week 
?? 31(u). Approximately, what year did you 
cut down/increase the amount of tea you 
usually drank? 
 
EX
-T
EA
 
C
U
R
E
E
N
T
 T
E
A
 
C
H
A
N
G
E 
 
 Page 44
Alcohol Consumption 
“I would now like to ask you some questions about your consumption of alcohol-containing 
drinks, such as beer, wine or spirits.” 
 
ALCOHOL DRINKING HISTORY 
● 32. Have you ever drunk alcoholic beverages  
regularly? (ie at least once a week). 
Yes………………………………….1 
No…………………………………..0 
If YES, go to 32(a), if NO, go to 33. 
? 32(a). How old were you when you started 
drinking alcohol beverages? ___________
? 32(b). Do you still drink alcoholic beverages? Yes…………………………………..1 
No……………………………………0 
If YES, go to 32(f), if NO, go to 32(c).  
?? 32(c). What year did you stop drinking 
alcoholic beverages? (or how old were you 
when you stopped) _______________
?? 32(d). Approximately, how many years 
would you have drunk alcoholic beverages for? 
Taking into account any years you stopped 
drinking alcoholic beverages for during that 
time. ______ ______
?? 32(e). How many alcoholic beverages did 
you usually drink per day or week?  
      _____________ per day
OR _____________ per week
Go to 32(k). 
?? 32 (f). Did you have any years since you 
first starting drinking alcohol that you stopped 
drinking it for a time?  
If yes, how many years did you stop drinking 
alcohol for before starting again?  
Yes……………______  _____ years 
No…………………………….0 years 
??  32(g). How many drinks per day or week 
do you usually drink? 
      _____________ per day
OR _____________ per week
??  32(h). Have you always drunk about this 
many alcoholic beverages? 
Yes…………………………………..1 
No……………………………………0 
If YES, go to 32(k), if NO, go to 32(i) 
?? 32(i). How many alcoholic beverages did 
you usually drink per day or week before you 
cut down or increased?  
_________ per day
OR ____________ per week
?? 32(j). Approximately, what year did you 
cut down/ increase the amount of alcohol you 
usually drank? ___________
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 Section H: Parkinson's Disease 
The following questions are only for controls. 
"I would now like to ask you some general questions about your knowledge about 
Parkinson's disease." 
● 34. Do you personally know anyone with 
Parkinson’s disease? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 34(a), if NO, go to 34(b). 
? 34(a). What is your relationship with them? 
 
Friend.………………………………..1 
In-law___________________……….2 
Business acquaintance…………….…3 
Other:_______________________ …4 
● 34(b). Prior to participating in this research 
study, did you know anything about Parkinson’s 
disease? 
Yes……………………………………1 
No…………………………………….0 
If YES, go to 34(c), if NO, go to 34(d). 
? 34(c). How had you heard of Parkinson’s 
disease?_____________________________________
____________________________________________
____________________________________________ 
________________________________
________________________________
________________________________
________________________________ 
● 34(d). Would you be prepared to go through this 
interview again in a few months time to allow us to 
check for consistency of responses? 
(Explain the purpose of the reliability study if 
necessary) 
Yes……………………………………1 
No…………………………………….0 
● 34(e). Would you be prepared to also fill in a 
short questionnaire that you can complete at home 
and post back to us, again in a few months time? 
Yes……………………………………1 
No…………………………………….0 
● 34(f). Would you be prepared to donate a 10mL 
sample of your blood for genetic analysis for 
susceptibility to environmental exposures? 
Yes……………………………………1 
No…………………………………….0 
If YES, collect specimen or organise it for a later date and go to END, if NO, go to 34(g). 
? 34(g). Would you be prepared to give us a swab 
from the inside cheek of your mouth for the 
purpose of genetic analysis? 
Yes……………………………………1 
No…………………………………….0 
 
 
END: 
"We have now finished the questionnaire. Thank-you for your time and assistance, your 
participation in this study is very much appreciated." 
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LIST A 
 
City/town Areas 
 
1  Capital City 
 
2. Other city with a population greater than 100 000 
 
3. Urban centre with a population between 25 000 - 99 999 
 
4. Urban centre with a population between 10 000 - 24 999 
 
5. Urban centre with a population less than 10 000 
 
Remote areas 
6. Remote centre with an urban population of greater than 5000 
 
7.  Other remote area with an urban population less than 5000 
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LIST B 
 
Underground (including bore water) 
Rainwater 
River (including creek, stream etc) 
Dam 
Lake 
Other (please specify) 
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LIST C 
 
Never: Never used home insecticide products. 
 
Irregular: Used insecticide products less than once a week. 
 
Regular: Usually used insecticide products at least once a 
week. 
 
Very Regular: Used insecticide products at least once a day 
on most days. 
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LIST D 
 
 
Electrician 
Electrical engineer 
Telephone equipment repair or installation 
Operator of mechanical equipment such as: 
• Sewing machine 
• Lathe 
• Other machinery 
Repairer of machinery 
Radio operator 
Switchboard/telephone operator 
Computer work 
Work involving electricity line (such as repair) 
Work at a power plant or electricity substation 
 
Please note, this is not a complete list of occupations 
involving electric and magnetic fields. 
 Page 50 of 52
LIST E 
 
I have only smoked once or a few times "just to try". 
 
I have only smoked occasionally. 
 
I have smoked as often as once or twice a week regularly 
for 6 months or more. 
 
I have smoked daily, or nearly every day, regularly for a 
month or more. 
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Appendix G 
 
 
 
 
 
Candidate Performing Interview with Participant 
 
 
 
 
Photograph of data collection performed by Coral Gartner with participant* 
 
 
 
 
 
________________________________________________________________________ 
*Permission granted by participant for use of image 
 
 
 
 
 
 
 
 
 
 
 
Appendix H 
 
 
 
 
 
Telephone Questionnaire for Non-Participants  
  
 
 
 
TELEPHONE QUESTIONNAIRE FOR THOSE NOT WANTING TO DO FACE-TO-
FACE INTERVIEW 
 
ID CODE:_____________________     SEX:   M   /  F 
 
“What is your current age?”________________ 
 
"Have you ever been diagnosed with Parkinson's disease?"  ٱ   YES  ٱ NO 
 
 
"During your lifetime, have you ever gardened for a hobby? By hobby 
gardening, I do not mean general lawn maintenance, but tending plants in pots 
or garden beds"  ?   YES  ? NO 
Any comments: 
 
 
"During your lifetime, have you ever personally applied herbicides, insecticides 
or fungicides on your home lawn or garden?"  
(Herbicides are pesticides used to kill plants, insecticides kill insects and fungicides 
kill moulds)   ? YES  ? NO 
 
Any comments (including names of products or time frames): 
 
 
"What was the occupation you held for the longest time?"  
 
record all details offered:_________________________________________________ 
 
_____________________________________________________________________ 
 
"What were your main tasks in that occupation?" 
 
record all details offered:_________________________________________________ 
 
_____________________________________________________________________ 
 
"Can you remember approximately what years you started and finished working 
in that occupation?" 
record all details offered:_________________________________________________ 
 
_____________________________________________________________________ 
 
"Have you ever lived on a farm, by a farm I mean a place that grows and sells 
crops or animals for profit"   ?  YES  ? NO 
 
IF YES, "Can you remember approximately how many years you lived on 
a farm?" 
__________________YEARS 
 
 
"Have you ever worked on a farm?"   ?   YES  ? NO 
 
IF YES, "Can you remember approximately how many years you worked on a 
farm?"  
__________________YEARS 
 
"During your lifetime, have you ever personally applied herbicides as part of 
your work? "   ?  YES  ? NO 
Any comments: 
 
 
"During your lifetime, have you ever personally applied insecticides as part of 
your work? "    ? YES  ? NO 
Any comments: 
 
 
"During your lifetime, have you ever personally applied fungicides as part of 
your work? "   ?  YES  ? NO 
Any comments: 
 
 
"During your lifetime, did you come into contact with metal fumes or were you 
involved in processing of metals in your work? (Eg welding, smelting)" 
      ? YES  ? NO 
Any comments: 
 
 
"Approximately, how many years did you work with metals as part of your 
work? "   ? YES  ? NO 
Any comments: 
 
 
"During your lifetime, did you come into contact with solvents in your work? 
(Eg dry cleaning fluids, lacquers)"  ?   YES  ? NO 
Any comments: 
 
 
IF YES, "Approximately, how many years did you work with solvents as 
part of your work?"  
       _____________YEARS 
 
"Have you ever smoked cigarettes or tried any other forms of tobacco?"  
     ?   YES  ? NO 
Any comments: 
 
 
If YES, How old were you when you first started smoking regularly?  
"Are you a current smoker?" ?   YES  ? NO 
Any comments: 
If not a current smoker, but have smoked previously "At what age did you stop 
smoking?" 
 
 
For current and ex-smokers, "How many cigarettes per day did you/do you usually 
smoke?"  
 
 
"Have you ever had a serious head injury?" ?   YES  ? NO 
Any comments: 
 
"Did you lose consciousness"   ? YES  ? NO 
Any comments: 
 
 
Screening questions for CONTROLS ONLY: 
 
"Do you have difficulty arising from a normal kitchen chair?" ?   YES    ? NO 
Any comments: 
 
 
"Is your handwriting smaller than it once was?"  ?   YES  ? NO 
Any comments: 
 
 
 “Is your balance poor?"   ?   YES  ? NO 
Any comments: 
 
 
"Do your feet freeze when you are walking through a doorway?" (ie when 
walking through a doorway do your feet sometimes stop as if you can’t keep walking) 
?   YES  ? NO 
Any comments: 
 
 
 
"Do you have difficulty in starting walking from a standstill or stopping when 
you want to?"   ?   YES  ? NO 
Any comments: 
 
 
"Is your face less expressive than it used to be?" ?   YES  ? NO 
Any comments: 
 
 
"Do your arms or legs shake?"   ?   YES  ? NO 
Any comments: 
 
 
"Do you have difficulty buttoning buttons?" ?   YES  ? NO 
Any comments: 
 
 
"Do you shuffle your feet or take tiny steps when you walk?" ?   YES      ? NO 
Any comments: 
 
 
"Do you less sense of smell than you used to?"  ?   YES  ? NO 
Any comments: 
 
 
Any other Comments about symptoms: 
 
 
 
“Do you personally know anyone with Parkinson's disease?" ?   YES   ? NO 
Any comments: 
 
 
 
“What is your relationship with that person?" 
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QUT
UNIVERSITY HUMAN RESEARCH ETHICS COMMITTEE
Ms CoralGartner
Schoolof PublicHealth
OUT KelvinGrove
27 February,2002
DearMs Gartner
I write further to your applicationfor expeditedethical clearance for your research project,
"EnvironmentalRisk Factorsfor Parkinson'sDisease"(OUT Ref No 2510H). The decisionto award
your projectexpeditedethicalclearancewas reviewedat the 26 February2002 meetingof the
UniversityHumanResearchEthicsCommittee's(UHREC).
The Committeeresolvedto ratifythe ExpeditedEthicalReviewPanel'sdecisionsin relationto your
project.
If you were awardedconditional clearanceby the ExpeditedEthical Review Panel the UHREC
has ratifiedboth the clearanceand the conditions attachedto this clearance(ie they must still
be addressedbeforethis projectmaybe commenced).
Pleasedonothesitatetocontactmeifyouhaveanyfurtherqueriesin relationtothismatter.
YoursSincerely,
1:;;;n
Secretary,UniversityHumanResearchEthicsCommittee
OUT Secretariat
GPO Box2434
Brisbane04001
Telephone: (07)38642902
Facsimile: (07)38641818
Email: gx.allen@qut.edu.au
http://www.qut.edu.au/draa/or/ethics/human/index.html
Cc: DrMichaelDunne,Schoolof PublicHealth
QueenslandUniversityofTechnolo
GARDENS POINT CAMPUS 2 GEORGE STREET GPO BOX 2434BRISBANE QLD 4001PHONE (07)38642111FAX (07)38641510
Campuses:GardensPoint (City), Kelvin Grove,Carseldine World Wide Web: http://www.qut.edu.aulABN:83791724622
QUT International: Victoria ParkRoad Kelvin GroveQLD 4059AustraliaPhone+61738643142Fax +61738643529
QUT
UNIVERSITY HUMAN RESEARCH ETHICS COMMITTEE
Ms CoralGartner
Schoolof PublicHealth
aUT KelvinGrove
April17, 2002
DearMs Gartner
At its 16 April 2002 meeting,the UniversityHuman Research Ethics Committeeconsideredthe additional
information/ revisionsyouprovidedin relationtoyourproject"EnvironmentalRisk Factorsfor Parkinson'sDisease"
(RefNo aUT 251OH).
The Committeeis satisfiedthatthe informationprovidedaddressesitsconcerns,andhasconfirmedthefullethical
clearancestatusofthisproject.
Pleasedo nothesitatetocontactmeifyouhaveanyfurtherqueriesin relationtothismatter.
finCerelY
GaryAlien
Secretary,UniversityHumanResearchEthicsCommittee
aUT Secretariat
Telephone:(07)38642902
Facsimile:(07)38641818
Email:gx.allen@qut.edu.au
http://www.qut.edu.au/draa/or/ethics/human/index.html
Cc: DrMichaelDunne,Schoolof PublicHealth
QueenslandUniversityofTechnolo
GARDENS POINT CAMPUS 2 GEORGE STREET GPO BOX 2434BRISBANE OLD 4001PHONE 07 38642111FAX 07 38641510
Campuses:GardensPoint(City),KelvinGrove,CalseldineWorldWide Web: http://www.qut.edu.au/ABN:83791724622
OUT International:VictoriaParkRoadKelvinGroveQLD 4059AustraliaPhone+61738643142Fax+61738643529
GaryAlien, 10:06AM 7/03/2002+1000,Conditionalethicalclearance- 2510H
Date:Thu,07Mar200210:06:52+1000
From:GaryAlien<gx.allen@qut.edu.au>
Subject:Conditionalethicalclearance-251OH
X-Sender:allengj@pop.qut.edu.au
To:c.gartner@qut.edu.au
Cc:m.dunne@qut.edu.au
X-Mailer:QUALCOMMWindowsEudoraVersion4.3.2
DearCoral
Iwritefurthertotheadditionalinformationprovidedinrelationtoyourproject,"Environmental
RiskFactorsforParkinson'sDisease"(QUTRefNo2510H).
ThisistoconfirmthatyourresponsehasaddressedthecommentsI concernsofthe
ExpeditedEthicalReviewPanel.
Thisdecisionissubjectoratificationatthe16April2002meetingoftheUniversityHuman
ResearchEthicsCommittee.
However,youareauthorisedto inmediatelycommencethisprojectonthisbasis.
Pleasedonothesitatetocontactme if you haveanyfurtherqueries in relationto this matter.
Regards
GaryAlien
Secretary,UHREC
x2902
PrintedforCoralGartner<c.gartner@qut.edu.au> 1
GaryAlien,01:42PM 3/04/2002+1000,Minorchange-251OH
Date:Wed, 03 Apr 200213:42:24 +1000
From: Gary Alien<gx.allen@qut.edu.au>
Subject: Minorchange -2510H
X-Sender: allengj@pop.qut.edu.au
To: c.gartner@qut.edu.au
Cc: m.dunne@qut.edu.au
X-Mailer:QUALCOMM Windows Eudora Version 4.3.2
Dear Coral
Iwritefurtherto the requests submittedfor a minorchange to the project,"Environmental
Risk Factors for Parkinson's Disease" (QUT Ref No 251OH).
This is to confirm thatthe Chairperson of UniversityHuman Research Ethics Committe~has
considered this requeston behalfof the Committee.
TheChairpersonhasapprovedtherequestedchangestothedatacollectionproceduresto
includethecollectionofa sampleof bloodforgenetictesting(noresultsof significanceto
individuals).
This decision is:
* onthestrictunderstandingthattheresearchteamtakeextracarewiththestorage,
controlofaccess anduseofthegeneticinformation(egthroughtheuseof codinganda
separatekey);and
*
subject to ratificationat the 21 May2002 meetingof the Committee.
However, you are authorisedto inmediatelyconmence the revised project on this
basis. I will onlycontactyou againin relationto this matterif the Committeehas any
additionalconments or requests in relationto this change.
Please do nothesitateto contactme if you haveanyfurtherqueries in relationto this matter.
Regards
GaryAlien
Secretary,UHREC
x2902
PrintedforCoralGartner<c.gartner@qut.edu.au> 1
GaryAlien,08:23AM23/04/2002+1000,Minorchange.2510H
Date:Tue,23Apr200208:23:58+1000
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Subject:Minorchange-2510H
X-Sender:allengj@pop.qut.edu.au
To:c.gartner@qut.edu.au
Cc:m.dunne@qut.edu.au
X-l'v1ailer:QUALCOMMWindowsEudoraVersion4.3.2
DearCoral
Iwritefurthertotherequestsubmittedfora minorchangetotheproject,"Environmental
RiskFactorsforParkinson'sDisease"(QUTRefNo251OH).
ThisistoconfirmthatheChairpersonofUniversityHumanResearchEthicsCommitteehas
consideredthisrequestonbehalfoftheCommittee.
TheChairpersonhasapprovedtherequestedchangestothedatacollectionproceduresto
includetheaccess todata(asdescribed)fromtheparticipantmedicalrecords(with
consent)..
This decision is subject to ratificationat the211'v1ay2002 meetingof the Committee.
However,you are authorisedto immediatelycommencethe revised project on this
basis. I will onlycontactyou againin relationto this matterif the Committeehas any
additionalcommentsor requests in relationto this change.
Pleasedonothesitatetocontactmeifyouhaveanyfurtherqueriesinrelationtothismatter.
Regards
GaryAlien
Secretary,UHREC
x2902
PrintedforCoralGartner<c.gartner@qut.edu.au> 1
AustralianElectoralCommission AEC
Our Reference: 2001/00547 (J02l0179) West Block Offices
Parkes ACT 2600
Contact Officer: Usa Gray PO Box E201
Kingston ACT 2604
Telephone: (02) 6271 4618
Telephone (02) 6271 4411
Facsimile (02) 6271 4556
www.aec.gov.au
ABN 21 133285851
Ms CoralGartner
Schoolof PublicHealth
Facultyof Health
QueenslandUniversityofTechnology
VictoriaParkRoad
KELVIN GROVE QLD 4059
DearMs Gartner
ELECTOR EXTRACT BY AGE RANGE
PleasefindenclosedoneCD-ROM containingElectorExtractsbyAge Range.
As peryourrequestthisCD-ROM containselectoralinformationfortheage-cohorts20-21,
22-23, 24-25, 26-27, 28-29, 30-31, 32-33, 34-35,36-37,38-39, 40-41, 42-43, 44-45,
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70-71,72-73,74-75,76-77,78-79,80-81,82-83,"84-85,86-87,88-89,90-91,92-93and
94-95for the FederalDivisionsof Blair, Bowman,Brisbane,Dickson,Fadden, Fairfax,
Fisher, Forde, Griffith,Hinkler,Lilley,Longman,Mcpherson,Moncrieff,Moreton,Oxley,
Petrie,Rankin,RyanandWideBay.
I haveenclosedTechnicalSpecifications,a RecordLayoutanda tableof the nominated
FederalDivisionsand their FederalDivisionnumberto assist you with interpretingthe
data. Also enclosedis Invoice2255to thevalueof $291.50for thecostsassociatedwith
producingthisextract.
PleasecontacttheClientServicesUniton (02)62714618shouldyouhaveanyqueries
regardingtheproduct.
Yourssincerely
LiS9u:ir
A/gAssistantManager
ClientServicesUnit
29April2002
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Information Package 
 
 
 
Title of Study:  Risk Factors for Parkinson's Disease 
 
 
 
Objective of Study: To find out if certain exposures in the workplace 
or home environment increase the chance of 
developing Parkinson's Disease in susceptible 
people. 
 
 
QUT Involvement: This project is being conducted as part of my PhD 
studies at Queensland University of Technology. 
 
 
Contact Details of Researchers: 
 
 
Ms Coral Gartner 
(Doctor of Philosophy Student) 
Ph: (07) 3864 5768 
Email: c.gartner@qut.edu.au 
 
Supervisor   Dr Michael Dunne 
Ph (07) 3864 3928 
Email: m.dunne@qut.edu.au 
 
Dr George Mellick 
Ph (07) 3240 2903 
Email: GMellick@medicine.pa.uq.edu.au 
 
 
 
Postal/physical address:  C/- School of Public Health 
O Block  
Queensland University of Technology 
Victoria Park Road, Kelvin Grove Q 4059 
 
    Fax: (07) 3864 3369 
 
 Page 1 Risk Factors for Parkinson's Disease 
 
  
Description of the Study Project 
 
What is the purpose of the project?  
The project aims to investigate if exposure to various potential risk 
factors may increase the chance of developing Parkinson's Disease in 
susceptible individuals. The purpose is to help the understanding of 
what causes Parkinson's Disease. 
 
How will the project be conducted? 
Information will be gathered about exposures to various potential risk 
factors in people with Parkinson's Disease (cases) and people without 
Parkinson's Disease (controls). Analysis of your blood for genes that 
may increase your susceptibility to developing Parkinson’s disease may 
also be included, with your consent. A comparison of this information 
between cases and controls will allow us to identify which exposures 
may be risk factors for Parkinson's Disease, ie which exposures may 
increase the chance of developing Parkinson's Disease. 
 
What will my involvement require? 
You will be given a face to face interview with a standard set of 
questions. You will be asked questions about whether family members 
have Parkinson's disease or other similar conditions, where you have 
lived throughout your life, occupations you have held throughout your 
life, and various questions about possible exposures you may have 
experienced in your life. You will only be expected to answer the 
questions to the best of your ability. You are also welcome to have a 
family member (eg your partner) with you in the interview to help you 
answer the questions. The interview will take approximately 1 hour of 
your time. 
 
You may also be invited to be reinterviewed at a later date to allow us to 
measure how reliable the interviews are. 
 
Genetic analysis will involve collection of approximately 10 mL of blood 
from a vein in your forearm in exactly the same way as blood is collected 
for routine pathology tests.  
 
What will the outcome of the project be? 
The project will help us to understand the possible causes of 
Parkinson's Disease better. A better understanding of the disease may 
eventually lead to prevention measures for the disease. Whilst the study 
will not directly benefit you, it may provide a benefit to others in the 
future. It is anticipated that the results of the project will be published in 
a suitable academic journal to allow the knowledge obtained from the 
study to be shared. Results of the study will also be supplied to all 
participants in the study and to Parkinson's Queensland Inc.  
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Is my participation and information provided in the study 
confidential? 
Yes, all information collected in the study will be treated as confidential. 
Your anonymity and confidentiality will be safeguarded in any publication 
or dissemination of the results of this research, through the use of 
aggregate (grouped) data, rather than information about you as an 
individual. Your name or identifying information will not be released in 
any of the published or disseminated results of the study.  
 
What if I agree to participate and then change my mind? 
You can choose to leave the study at any time, for any reason. If you 
decide not to continue your involvement with the study, simply notify the 
researchers of your wishes. 
 
What risks involved with participation in the study? 
The following have been identified has potential risks to you as a 
participant in the study and how the researchers will manage the 
potential risk. 
 
1. The interview could be fatiguing for some people. 
If you find the interview tiring, you will be able to stop for a break at any 
time or discontinue the interview if you wish. 
 
2. You will be asked to disclose personal information about your health 
and medical treatment. 
Only the research team will have access to the information you provide.  
Your anonymity and confidentiality will be safeguarded in any publication 
or dissemination of the results of this research, through the use of 
aggregate (grouped) data, rather than information about you as an 
individual. Your name or identifying information will not be released in 
any of the published or disseminated results of the study. All information 
that is collected from you will be treated as confidential between yourself 
and the research team.  
 
3. There could be some discomfort, bruising, swelling or bleeding at the 
site of the puncture if blood is collected from you. 
 
What if I want more information or have questions about the study? 
Please contact Coral Gartner (see page 2 for contact details), if you 
require further information or have any questions.  
 
What if I have concerns or a complaint about the study? 
If you have concerns about the project or your participation in it, please discuss 
these with the researchers. If you have any concerns or complaints about the 
ethical conduct of the project you should contact the Secretary of the University 
Human Research Ethics Committee on 3864 2902. 
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Consent Form 
 
Risk Factors for Parkinson's Disease 
 
Researchers:  Ms Coral Gartner  Ph: (07) 3864 5768 
Dr Michael Dunne Ph: (07) 3864 3928 
 Dr George Mellick Ph: (07) 3240 2903 
     
Postal address:  C/- School of Public Health 
Queensland University of Technology 
Victoria Park Road, Kelvin Grove Q 4059 
Fax: (07) 3864 3369 
 
Statement of consent 
 
By signing below, you are indicating that you have: 
• read and understood the information package about this project; 
• had any questions answered to your satisfaction; 
• understood that if you have any additional questions you can contact the researcher; 
• understood that you are free to withdraw at any time, without comment or penalty; 
• understood that you can contact the Secretary of the University Human Research Ethics 
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Abstract  
There is substantial disagreement among published epidemiological studies regarding environmental risk 
factors for Parkinson’s disease (PD). Differences in the quality of measurement of environmental exposures 
may contribute to this variation. The current study examined the test–retest repeatability of self-report data on 
risk factors for PD obtained from a series of 32 PD cases recruited from neurology clinics and 29 healthy sex-
, age-and residential suburb-matched controls. Exposure data were collected in face-to-face interviews using a 
structured questionnaire derived from previous epidemiological studies. High repeatability was demonstrated 
for ‘lifestyle’ exposures, such as smoking and coffee/tea consumption (kappas 0.70–1.00). Environmental 
exposures that involved some action by the person, such as pesticide application and use of solvents and 
metals, also showed high repeatability (kappas>0.78). Lower repeatability was seen for rural residency and 
bore water consumption (kappa 0.39–0.74). In general, we found that case and control participants provided 
similar rates of incongruent and missing responses for categorical and continuous occupational, domestic, 
lifestyle and medical exposures.  
Keywords: Parkinson’s disease; Data quality; Test–retest repeatability; Environmental exposures; 
Questionnaires; Exposure assessment  
 
1. Introduction  
Since, the discovery of a Parkinsonian syndrome induced by the chemical MPTP1, the search for 
environmental risk factors for Parkinson’s disease (PD) has returned mixed results. Epidemiological studies 
have, to varying extents, implicated exposures such as pesticides, solvents, neurotoxic metals, well-water 
consumption, and rural residency2,3. Of these exposures, pesticides have most frequently returned a positive 
association, though not consistently. The most consistent finding in PD research remains the inverse 
relationship between the disease and tobacco smoking4.  
Exposure assessment relying on recall may be particularly problematic in patients with PD, due to the 
specific characteristics of this population. Firstly, prevalence of PD increases with age, increasing from 0.6% 
in persons aged 65–69 to 2.6% in those aged 70–80 years5. Declining data quality with increasing age has 
been observed in self-report data from research involving general populations6. Secondly, the onset of PD is a 
slow and insidious process commencing some time prior to development of noticeable motor symptoms7,26,27. 
Therefore, exact timing of exposures in relation to PD onset may be difficult to establish, or recall as to 
whether an exposure occurred prior to, or after the commencement of the disease process. Thirdly, cognitive 
dysfunction is a recognised feature of PD. Unfortunately, the majority of exposures assessed by researchers in 
this field are not verifiable against reliable external measures, such as accurate records of pesticide use. Most 
of the epidemiological research to date has relied on self-report. Given the potential for poor data quality to 
influence the results of epidemiological research, it is surprising that few studies have investigated the quality 
of environmental exposure data.  
Only two published test–retest repeatability studies of risk factor questionnaires for Parkinson’s disease 
could be identified8,9. Both of these surveys obtained information on demographics, medical history, places of 
residence, and occupations. Butterfield et al.’s8 study recruited only 11 participants of unknown case status. 
Seven of the participants completed the repeat questionnaire, which was mailed only 2 weeks after the first 
questionnaire was completed. Another limitation of this study was the use of an abridged questionnaire in the 
repeatability study, rather than the full questionnaire that was to be used in the case-control study. Whilst the 
authors’ report high kappa statistics for many variables, they do not mention which variables these relate to 
and fail to report the numbers of exposed individuals in their sample for these variables. A sample size of 
only seven is unlikely to be sufficient to establish repeatability for many exposures that have low rates in the 
general community.  
The study by Reider and Hubble9 involved 22 participants (11 pairs of twins discordant for PD), though 
only 20 participants completed the self-administered retest. This study also had many limitations. The authors 
report an ‘overall’ kappa statistic of 0.88 for their 23 item risk factor questionnaire, however, this figure 
appears to be overestimated as lower kappas (0.75) are reported for some individual items. Whilst the authors 
report 100% agreement in responses for ‘pesticide exposure’, they omit to report the number exposed in the 
sample and sufficient details as to how this variable was measured. Whilst some previous case-control studies 
have mentioned the inclusion of a retest to assess repeatability of the measures2,3,10–13, most only involved a 
small number of participants or did not report results.  
The purpose of this study was to examine the repeatability of a range of measurements of environmental 
and lifestyle exposures that are commonly used in PD research.  
 
2. Methods  
2.1. The participants  
Forty eligible potential participants with PD were identified from a previous genetic study14. These 
participants were a purposive sample recruited from a private neurology clinic and a public hospital-based 
neurology clinic, in Brisbane. Their prior research participation involved donation of 10 mL of blood by 
venipuncture for genetic analysis and completion of a brief self-administered questionnaire approximately 1–
2 years prior to recruitment into the current study. All patients resided in the greater Brisbane area and had 
been previously examined by a neurologist (PS), who confirmed the diagnosis of PD. These selected 
participants were similar to the entire case series, who were recruited for a case-control study, in terms of 
gender, marital status, age at interview and age at diagnosis (p>0.05).  
Letters of invitation to participate in the current study were posted to all of these identified individuals. 
Two letters were returned stamped ‘Not known at this address’. One declined to participate due to illness and 
two refused to participate without stating a reason. This left a sample of 35 recruited PD cases.  
Thirty-five healthy controls matched to the cases on the parameters of age (±2 years), sex and residential 
suburb were selected from the Australian Commonwealth Electoral Roll by simple random sampling. 
Enrolment is compulsory for Australian citizens who are 18 years or over. Suitable controls were not found 
for two of the cases. A further seven controls were recruited by the same procedure due to follow-up 
interviews not being possible for some of the original controls. Informed written consent was obtained from 
all participants prior to participation in the study, as approved by the Human Research Ethics Committees of 
Queensland University of Technology, University of Queensland and the Princess Alexandra Hospital. 
Repeat face-to-face interviews were conducted with 32 of the cases and 29 of the controls, a median of 65 
days later (range 40–251 days).  
 
2.2. The questionnaire  
Exposure data were collected in face-to-face interviews with a new questionnaire derived from questions 
used in previous epidemiological studies15,16. The length of the interview took between 45 min and 1½ h, with 
the majority lasting for 1 h. The same questionnaire was used in the initial and repeat interviews. Details 
relating to residential history, such as type of drinking water, were obtained for each residence on a residence-
by-residence basis. At the broadest level of response, ‘Ever/Never’ variables were constructed as a composite 
of questions for multiple residence and farm data. For example, from questions about drinking water supply, 
living on a farm, type of livestock or crop raised on the property, and proximity of residence to an agricultural 
area that had been sprayed with pesticides, a composite variable was coded NEVER if the respondent 
answered ‘no’ for the question for all residences/farms and EVER if the respondent answered ‘yes’ for any 
residence/farm. Where a question was not applicable due to a previous NO response, the question was coded 
as ‘no’. Information about years of exposure and frequency of exposure was collected for specific activities 
such as mixing and applying herbicides, insecticides and fungicides, using solvents, working with metals, 
smoking and consumption of tea, coffee and alcohol. Where possible, we obtained the names of the specific 
chemicals used.  
In addition to the exposures of interest to PD aetiology, a number of ‘dummy’ exposures relating to 
asbestos and electromagnetic radiation were included to check for consistent over-reporting of exposure by 
case participants, which may be indicative of recall bias. These ‘dummy’ exposures are unlikely to be 
relevant to PD aetiology, but are generally viewed as ‘toxic’ by the public.  
 
2.3. Statistical methods  
For all variables the proportion in exact agreement was calculated. For categorical variables, Cohen’s 
kappa coefficient (a measure of agreement beyond chance) was calculated17. Weighted kappas were 
calculated for ordinal data using Cicchetti–Allison weights18. For continuous variables, intraclass correlation 
coefficients (ICC)19, the mean of the differences between responses on the initial and repeat interviews and 
the ‘limits of agreement’ were calculated20. Qualitative interpretation of kappa and ICC values were taken as 
‘high repeatability’ for values in the range 0.75–1.00, ‘fair to moderate repeatability’ for 0.40–0.74 and ‘low 
repeatability’ for <0.4021. Repeatability statistics and risk estimates were calculated in Microsoft Excel 2000, 
and SAS version 8/Enterprise Guide version 1. 
 
3. Results  
In general, the distributions of demographic variables were similar for cases and controls. Similar 
proportions of cases and controls completed further education in the form of a trade certificate or university 
degree, although fewer cases had completed secondary school (Table 1). Whilst more cases were born in 
Australia than were controls, the majority of cases and controls were Caucasian. Sixty-nine percent of cases 
and 69% of controls had both parents with British (English, Scottish and/or Irish) ancestry, whilst 78% of 
cases and 86% of controls had at least one parent of British ancestry.  
 
Table 1 Characteristics of study participants  
 Cases n = 32 Controls n = 29 
Age, mean (SD)  64.8 (7.7) 66.1  (7.6)  
Sex, n (%)    
Males  19 (59) 17  (59)  
Females  13 (41) 12  (41)  
Education, n (%)    
Did not complete high school 21 (66) 16  (55)  
Completed high school 11 (34) 13  (45)  
Completed trade certificate/degree 22 (69) 17  (59)  
Country of birth, n (%)    
Australia  28 (78) 20  (69)  
Other  4 (22) 9  (31)  
Days between first and second 
interview, median (range)  60 (41–251) 67  (40–142) 
 
The proportion of ‘yes’ (+) and ‘no’ (-) responses recorded at both interviews, number of missing 
responses, percentage agreement and kappa values for dichotomous categorical exposures according to case-
control status are presented in Table 2. 
 Table 2 Response at initial and repeat interview, percent agreement and kappa values for categorical exposures 
according to case status  
Prevalence at first and 
repeat interview 
Exposure 
Case 
status ++ +- -- -+ 
Missing
(%) 
Percent 
agreement 
Kappa (95% 
confidence interval) 
Occupational exposures  
Case 10 0 21 1 0 (0) 0.97 0.93 (0.79–1.00) Worked with metalsa Control 9 1 18 1 0 (0) 0.93 0.85 (0.64–1.00) 
Case 12 0 19 1 0 (0) 0.97 0.93 (0.81–1.00) Used solventsa Control 10 0 18 1 0 (0) 0.97 0.93 (0.78–1.00) 
Case 4 0 28 0 0 (0) 1.00 1.00 (1.00–1.00) Applied herbicides Control 0 1 28 0 0 (0) 0.97 – 
Case 6 0 23 2 1 (3) 0.94 0.82 (0.58–1.00) Applied insecticidesa Control 1 0 28 0 0 (0) 1.00 1.00 (1.00–1.00) 
Case 2 0 30 0 0 (0) 1.00 1.00 (1.00–1.00) Applied fungicides Control 0 0 28 0 1 (3) 1.00 – 
Case 8 1 20 2 1 (3) 0.90 0.77 (0.53–1.00) Skin was sprayed with 
pesticidea Control 10 0 18 1 0 (0) 0.97 0.93 (0.78–1.00) 
Case 8 2 22 0 0 (0) 0.94 0.84 (0.64–1.00) Worked on a farm Control 6 0 20 2 1 (3) 0.90 0.81 (0.56–1.00) 
Case 3 1 28 0 0 (0) 0.97 0.84 (0.54–1.00) Worked on a non-residential 
farm Control 1 2 23 2 1 (3) 0.86 0.25 (0.27–0.78) 
Case 6 2 23 1 0 (0) 0.91 0.74 (0.46–1.00) Worked with asbestos Control 5 0 24 0 0 (0) 1.00 1.00 (1.00–1.00) 
Case 13 0 17 1 1 (3) 0.97 0.93 (0.81–1.00) Worked with EMRa Control 16 2 10 1 0 (0) 0.90 0.78 (0.55–1.00) 
Domestic exposures         
Case 3 0 28 0 1 (3) 1.00 1.00 (1.00–1.00) Did laundry for farm worker Control 1 2 25 1 0 (0) 0.90 0.35 (0.22–0.92) 
Case 15 3 13 1 0 (0) 0.88 0.75 (0.52–0.98) Hobby gardenera Control 19 1 9 0 0 (0) 0.97 0.92 (0.77 –1.00) 
Case 19 2 10 1 0 (0) 0.91 0.80 (0.58–1.00) Used pesticides in home 
gardena Control 26 1 2 0 0 (0) 0.97 0.78 (0.37–1.00) 
Case 27 1 2 0 2 (6) 0.97 0.78 (0.37–1.00) Home treated by pest control 
operator Control 28 0 0 1 0 (0) 0.97 – 
Case 11 5 12 4 0 (0) 0.72 0.44 (0.13–0.75) Lived in a centre of 10,000–
100,000 pop Control 11 2 9 7 0 (0) 0.69 0.39 (0.08–0.71) 
Case 13 1 13 5 0 (0) 0.81 0.63 (0.37–0.89) Lived in a remote centre or 
area Control 13 4 8 4 0 (0) 0.72 0.43 (0.10–0.76) 
Case 14 5 10 3 0 (0) 0.75 0.49 (0.19–0.79) Lived within a mile of a pest-
icide sprayed agricultural area Control 13 1 11 4 0 (0) 0.83 0.66 (0.39–0.92) 
Case 7 1 22 2 0 (0) 0.91 0.76 (0.50–1.00) Lived on a farma Control 8 1 20 0 0 (0) 0.97 0.92 (0.76–1.00) 
Case 7 1 23 1 0 (0) 0.94 0.83 (0.61–1.00) Worked on a home farma Control 6 0 23 0 0 (0) 1.00 1.00 (1.00–1.00) 
Case 7 3 22 0 0 (0) 0.91 0.74 (0.47–1.00) Drank bore water Control 5 3 19 2 0 (0) 0.83 0.55 (0.20–0.90) 
Caseb 10 5 5 0 12 (38) 0.75 0.50 (0.17–0.83) Lived in house containing 
asbestos Control 19 2 6 1 1 (3) 0.89 0.73 (0.44–1.00) 
Case 23 1 4 1 3 (9) 0.93 0.76 (0.44–1.00) Used an electric blanketa Control 22 2 5 0 0 (0) 0.93 0.79 (0.52–1.00) 
Case 7 1 22 1 1 (3) 0.94 0.83 (0.61–1.00) Received an electric shock Control 5 1 22 0 1 (3) 0.96 0.66 (0.36–0.96) 
Case 5 2 22 1 2 (6) 0.90 0.71 (0.39–1.00) Lived close to high voltage 
power lines Control 2 0 25 1 1 (3) 0.96 0.78 (0.37–1.00) 
Lifestyle exposures         
Case 23 0 8 1 0 (0) 0.97 0.92 (0.77–1.00) Drank coffee regularly Control 21 1 5 2 0 (0) 0.90 0.70 (0.39–1.00) 
Case 26 1 5 0 0 (0) 0.97 0.89 (0.68–1.00) Drank tea regularly Control 24 1 3 1 0 (0) 0.93 0.71 (0.33–1.00) 
Case 20 0 11 1 0 (0) 0.97 0.93 (0.80–1.00) Drank alcohol regularlya Control 20 0 9 0 0 (0) 1.00 1.00 (1.00–1.00) 
Case 10 2 19 1 0 (0) 0.91 0.80 (0.58–1.00) Ever smoked regularly a,c Control 17 0 12 0 0 (0) 1.00 1.00 (1.00–1.00) 
Case 20 1 8 2 1 (3) 0.90 0.77 (0.53–1.00) Lived with a smoker 
Control 21 1 3 2 2 (6) 0.89 0.60 (0.19–1.00) 
Case 4 0 24 4 0 (0) 0.88 0.60 (0.26–0.94) Worked in a smoky 
workplace Control 5 3 19 1 1 (3) 0.86 0.62 (0.29–0.95) 
Medical exposures         
Case 6 2 23 1 0 (0) 0.91 0.74 (0.46–1.00) Received a serious head 
injury Control 9 1 17 2 0 (0) 0.91 0.78 (0.54–1.00) 
Case 5 2 24 0 1 (3) 0.94 0.79 (0.53–1.00) Knocked unconsciousa Control 4 1 22 0 2 (7) 0.96 0.87 (0.61–1.00) 
Case 10 0 21 0 1 (3) 1.00 1.00 (1.00–1.00) Played contact sportsa Control 10 0 16 2 0 (0) 0.93 0.85 (0.65–1.00) 
++, ‘yes’ response at first and repeat interviews; +-, ‘yes’ response at first and ‘no’ at repeat interview; --, ‘no’ response at first 
and repeat interviews; -+, ‘no’ response at first and ‘yes’ at repeat interview; EMR, electromagnetic radiation. 
a Exposure recalled with high repeatability (kappa = 0.74) by both cases and controls. 
b More than 10% of responses missing for this exposure. 
c Weighted kappa case 0.90; control 0.93 (never smoked; only smoked once or a few times; only smoked occasionally; smoked 
as often as 1–2/week for >6 months; smoked daily or nearly every day for a >month). 
 
Results for those exposures examined as continuous measures are presented in Table 3. A summary of the 
exposures according to repeatability is presented in Table 4. Occupational exposures were generally recalled 
with higher repeatability than domestic exposures by both cases and controls, though slightly more ‘missing’ 
responses were recorded for occupational exposures, which was mainly due to the inability of many 
participants to recall specific chemicals to which they were exposed in the occupational environment. The 
proportion exposed for the majority of occupational exposures was less than 15%, with only the variables 
‘Worked with Metals’, ‘Used Solvents’ and ‘Worked with Electromagnetic Radiation’ having 30% or higher 
exposure rates. The variable ‘Skin was Sprayed with Pesticide’ also recorded a proportion exposed of 25–
31%, however, this variable also included pesticide spills in the domestic environment. Occupational 
exposure to metal fumes and dusts, solvents and electromagnetic radiation was recalled with high 
repeatability by both cases and controls (kappa 0.78–1.00). Exposure to specific metals and solvents were 
more difficult to measure and resulted in more missing responses. Occupational exposure to herbicides, 
insecticides and fungicides was recalled with very high repeatability by cases when assessed as ever/never 
(kappa 0.82–1.00), or as a continuous measure (years and frequency; ICC 0.92–1.00). However, insufficient 
numbers of controls exposed to occupational pesticides made repeatability indeterminable, for that group.  
Whether or not a participant had gardened for a hobby and number of years spent hobby gardening was 
recalled with high repeatability by cases and controls, as was whether participants had used pesticides in their 
home garden. Differentiation between types of pesticides (herbicides, insecticides and fungicides) used in the 
home garden proved more difficult with only moderate to high repeatability (kappa 0.63–0.92).  
In general, lifestyle exposures were recalled with high repeatability when assessed both as ‘ever/never’ 
(kappa statistic =0.75) and as a continuous measure (ICC=0.75). This was particularly true for behaviours that 
required active participation by the person and were often habitual in nature, such as cigarette smoking or 
coffee drinking. Lower repeatability was seen for very light smoking (only 1–2 cigarettes per week), which 
may have lacked the ‘habitual’ nature that accompanies heavier smoking. Our measures of passive smoking at 
home (living with a smoker) and work (working in a ‘smoky workplace, such as a bar, club or casino’) were 
reproduced with moderate to high repeatability (kappa 0.60–0.77; ICC 0.79–0.88).  
As with the lifestyle exposures, environmental exposures involving active participation by the person, such as 
occupationally applying pesticides and those of a habitual nature, such as hobby gardening were recalled with 
the highest repeatability. In contrast, ‘background’ exposures, such as living within a mile of an agricultural 
area treated with pesticides or type of household drinking water supply, were recalled with only moderate to 
fair repeatability.  
Case and control participants provided similar rates of incongruent and missing responses for categorical 
and continuous occupational, domestic, lifestyle and medical exposures.  
A summary of exposure variables for which both cases and controls recalled with high, moderate and low 
repeatability is presented in Table 4. Similarly, exposure variables for which cases and controls demonstrated 
recall which fell into two different repeatability categories (e.g. high and moderate) are shown in Table 5.  
 Table 3 Comparison of participant responses for continuous exposures at initial and repeat interviews, intraclass 
correlation coefficients and mean of differences  
Exposure Case status 
Perfect 
agreement 
n (%) 
Lower in 
repeat 
interview 
Higher in 
repeat 
interview 
Missing 
n(%) 
ICC (95% 
confidence 
interval) 
Mean of 
differences (limits 
of agreement) 
Occupational exposures  
Cases 25 (81) 1 5 1 (3) 0.85 (0.71–0.93) 1.32(-12.76–15.20) Years worked with 
metalsa Controls 22 (85) 2 2 3 (10) 0.95 (0.90–0.98) -0.50(-7.43–6.43) 
Cases 25 (81) 1 5 1 (3) 0.92 (0.84–0.96) 1.10(-9.83–12.02) Years worked with 
solvents  Controls 22 (81) 0 5 2 (6) 0.68 (0.41–0.84) 3.15(-15.02–21.32) 
Cases 31 (97) 1 0 0 (0) 1.00 (1.00–1.00) 0.03(-0.32–0.39) Years applied 
herbicides at work Controls 28 (97) 1 0 0 (0) 0.00 (-0.37–0.37) 0.07(-0.67–0.81) 
Cases 24 (83) 2 3 3 (9) 0.93 (0.92–0.98) -0.31(-5.50–4.88) Years applied 
insecticides at worka Controls 28 (97) 1 0 0 (0) 0.92 (0.84–0.96) 0.03(-0.34–0.41) 
Cases 30 (94) 1 1 0 (0) 0.96 (0.92–0.98) -0.13(-1.94–1.69) Years applied  
fungicides at work Controls 29 (100) 0 0 0 (0) –  0.00(0.00–0.00) 
Cases 25 (86) 2 2 3 (9) 0.90 (0.80–0.95) -0.03(-3.03–2.97) Years worked  
with asbestos  Controls 25 (86) 1 3 0 (0) 0.42 (0.06–0.68) 1.27(-12.25–14.78) 
Cases 19 (61) 7 5 1 (3) 0.85 (0.70–0.92) -1.52(-16.72–13.69)Years worked  
with EMR  Controls 18 (62) 7 4 0 (0) 0.61 (0.31–0.80) 0.55(-22.42–23.52) 
Domestic exposures            
Cases 20 (67) 7 3 2 (6) 0.80 (0.62–0.90) 1.03(-24.43–50.92) Years hobby  
gardening  Controls 14 (48) 10 5 0 (0) 0.86 (0.73–0.93) 4.24(-14.83–23.21) 
Casesb 16 (59) 8 3 5 (16) 0.89 (0.76–0.95) 2.30(-12.24–16.83) Years applied  
herbicides at home Controlsb 9 (53) 6 2 12 (41) 0.79 (0.50–0.92) 3.24(-12.55–19.02) 
Caseb 14 (54) 5 7 6 (19) 0.86 (0.71–0.94) -1.27(-13.20–10.66)Years applied 
insecticides at home Controlsb 13 (65) 4 3 9 (31) 0.72 (0.41–0.88) 3.05(-16.16–22.26) 
Caseb 24 (86) 1 3 4 (13) 0.90 (0.80–0.95) -0.93(-7.92–6.06) Years applied 
fungicides at home Controlsb 21 (88) 0 3 5 (17) 0.51 (0.13–0.76) -2.50(-18.10–13.10)
Caseb 17 (74) 4 2 9 (28) 0.57 (0.21–0.80) -1.09(-10.58–8.41) Years living in a 
large rural centre Controlsb 15 (71) 3 3 8 (28) 0.93 (0.83–0.97) 0.10(-4.19–4.38) 
Caseb 14 (61) 5 4 9 (28) 0.78 (0.54–0.90) 0.48(-12.90–13.85) Years living in a 
small rural centre Controlsb 15 (71) 3 3 8 (28) 0.45 (0.02–0.74) -0.24(-14.08–13.60)
Caseb 19 (83) 3 1 9 (28) 0.93 (0.83–0.97) 0.43(-9.85–10.72) Years living in a 
remote area  Controlsb 13 (62) 2 6 8 (28) 0.21 (-0.24–0.59) 2.71(-11.23–16.66) 
Years living  Cases 25 (83) 2 3 2 (6) 0.93 (0.86–0.97) 0.66(-10.81–12.12) 
on a farma Controls 22 (81) 2 3 2 (6) 0.99 (0.98–1.00) 0.18(-1.71–2.07) 
Caseb 20 (83) 4 0 8 (25) 0.98 (0.95–0.99) -1.31(-9.17–6.55) Years drank bore 
water  Controlsb 16 (67) 3 5 5 (17) 0.66 (0.36–0.84) -0.93(-10.31–8.45) 
Caseb 26 (96) 1 0 5 (16) 0.84 (0.68–0.93) -0.37(-4.22–3.48) Years lived near high 
voltage powerlines Controls 26 (93) 1 1 1 (3) 0.32 (-0.06–0.62) 1.11(-19.36–21.57) 
Caseb 11 (39) 11 6 4 (13) 0.64 (0.36–0.82) -8.46(-31.08–14.15)Years using an 
electric blanket  Controls 12 (43) 9 7 1 (3) 0.94 (0.87–0.97) -8.71(-32.17–14.74)
Cases 27 (90) 1 2 2 (6) 0.99 (0.98–1.00) 0.07(-0.83–0.97) Number of electric 
shocks received Controls 24 (92) 2 0 3 (10) 0.21 -0.19–0.55) -0.54(-5.28–4.20) 
           
Lifestyle exposures            
Cases 12 (40) 10 8 2 (6) 0.91 (0.81–0.96) -1.70(-19.40–16.00)Years drank coffeea Controls 8 (30) 7 12 2 (6) 0.88 (0.75–0.94) 1.89(-18.52–22.30) 
Cases 16 (53) 6 8 2 (6) 0.87 (0.74–0.93) 1.41(-21.14–23.95) Years drank teaa Controls 12 (44) 8 7 2 (6) 0.84 (0.68–0.93) 0.67(-22.00–23.33) 
Cases 16 (53) 8 6 2 (6) 0.91 (0.82–0.96) -1.50(-17.91–14.91)Years drank alcohola Controls 19 (70) 6 2 2 (6) 0.99 (0.98–1.00) 0.48(-6.09–7.05) 
Cases 21 (72) 4 4 3 (9) 0.98 (0.97–0.99) 0.23(-5.08–5.54) Pack-yearsa  
Controls 20 (69) 4 5 0 (0) 0.99 (0.98–1.00) 0.31(-4.93–5.56) 
Cases 14 (45) 9 8 1 (3) 0.88 (0.77–0.94) -0.94(-18.63–16.75)Years lived with a 
smokera  Controls 12 (44) 11 4 2 (6) 0.84 (0.68–0.93) -7.79(-32.36–16.78)
Cases 25 (78) 1 6 0 (0) 0.79 (0.62–0.90) 0.83(-8.19–9.84) Years worked in 
smoky workplacesa Controls 20 (71) 4 4 1 (3) 0.79 (0.60–0.90) -1.12(-13.31–11.07)
Medical exposures           
Cases 25 (83) 3 2 2 (6) 0.65 (0.38–0.82) -0.17(-2.21–1.87) Number of  
head injuries  Controls 25 (89) 1 2 1 (3) 0.92 (0.84–0.97) 0.04(-0.63–0.70) 
Cases 25 (81) 5 1 1 (3) 0.99 (0.98–0.99) -0.06(-1.85–1.72) Years played  
contact sportsa Controls 20 (77) 4 2 3 (10) 0.99 (0.98–1.00) -0.15(-1.62–1.31) 
a Exposure recalled with high repeatability (kappa>0.74) by both cases and controls.  
b More than 10% of responses missing for this exposure.  
 
Duration of exposure to residential passive smoke was reported with high repeatability by our sample (ICC 
0.84), though Pron et al.26 report only fair repeatability for this variable (ICC 0.45). Of the environmental 
exposures examined in previous case-control studies of PD, rural residency and well-water consumption have 
yielded the most inconsistent results consistency between studies. Interestingly, we have found these 
variables to have only fair to moderate repeatability in our sample. Likewise, exposures such as smoking, 
coffee abstinence, pesticide exposure, solvent exposure, metal exposure and head injury, which have 
displayed more consistency between studies, demonstrated high repeatability. 
 
Table 4 Summary of variables with non-differential recall between cases and controls  
High recall (kappa/ICC>0.74) 
Pesticides  Applied insecticides at work  Skin was sprayed with pesticide  
 Years applied insecticides at work  Hobby gardener  
 Days per year applied insecticides  Years hobby gardening  
 Applied fungicides at work  Used pesticides at home  
 Years applied fungicides at work  Years applied herbicides at home  
Agriculture  Lived on a farm  Worked on home farm  
 Years living on a farm  Lived on a sugarcane farm  
Metals  Worked with metals  Years worked with metals  
Solvents  Used solvents  Used thinners  
Dummy exposures  Worked with asbestos sheets  Days per week working with EMR  
 Worked with EMR  Used an electric blanket  
Lifestyle  Drank alcohol  Years drank alcohol  
 Ever smoked regularly  Pack years  
 Years drank coffee  Years lived with a smoker  
 Years drank tea  Years worked in smoky workplace  
Medical  Received a serious head injury  Played contact sports  
 Knocked unconscious  Years played contact sports  
Fair to moderate recall (kappa/ICC 0.40–0.74) 
Agriculture  Lived within mile of agricultural area which was sprayed with pesticides 
Years within mile of agricultural 
area which was sprayed with 
pesticides 
Metals  Welding  Soldering  
Residential  Private drinking water supply  Lived in popn centre of 10–100 k  
 Bore water  Lived in a remote centre or area  
Dummy exposures  Switchboard  Electric welder  
Lifestyle  Worked in a smoky workplace   
Low recall (kappa/ICC<0.40)   
Metals  Grinding metal  Aluminium  
 Steel  Copper  
Lifestyle  Lived with smoker who regularly 
smoked in the same room 
Number of cigars per year  
EMR, electromagnetic radiation.  
 
Table 5 Summary of variables with differential recall between cases and controls  
Pesticides  Applied herbicides at work  Years applied insecticides at homea 
 Years applied herbicides at worka  Years applied fungicides at homea  
 Did laundry for a farm workera   
Metals  Worked in vicinity of metal worka  Leada  
Solvents  Worked in vicinity of solventsa  Years worked with solventsa  
Dummy exposures  Years worked with asbestosa  Total days working with asbestosb  
 Years worked with EMRa  Years using an electric blanketb  
 Years living near high voltage linesa Number of electric shocks receiveda  
Residential  Years living in a large rural centreb  Years living in a remote areaa  
 Years living in a small rural centrea  Years drinking bore watera  
Medical  Number of serious head injuriesb   
Lifestyle  Hours/week in a smoky workplaceb   
EMR, electromagnetic radiation.  
a Cases with higher recall than controls.  
b Controls with higher recall than cases. 
 
4. Discussion  
Few published studies of test–retest repeatability for pesticide and other environmental exposures are 
available. Even fewer are available in the context of Parkinson’s disease.  
We obtained high repeatability for various occupational pesticide exposures, including mixing and 
applying herbicides, insecticides and fungicides in our PD cases when measured as ever/never (kappas 0.94–
1.00) and for duration and frequency of use (ICCs 0.73–1.00). These results were higher than those obtained 
by Duell et al.22 in a case-control study of female breast cancer patients and healthy controls for the exposure 
‘Ever applied pesticides to crops’ (kappas 0.75 and 0.63). Likewise, Blair et al.23 only obtained moderate 
kappa statistics in the order of 0.50–0.60 for use of specific pesticides and lower repeatability for specific 
application practices (kappa 0.11–51). Only moderate repeatability was reported for duration and frequency 
of mixing or applying pesticides (weighted kappa: years 0.56, days/year 0.45). We may have obtained higher 
repeatability than Blair et al.23 on these exposures due to a lower number of exposed individuals in our 
sample.  
Our results for repeatability of exposure to agriculture were comparable to those obtained by Duell et al.22. 
Our sample yielded similar kappas (case 0.76, control 0.92) for ‘ever lived on a farm’ as obtained in the 
previous study (case 0.78, control 0.87). However, whilst our results for ‘ever worked on a non-residential 
farm’ and ‘ever laundered clothes for a farm worker’ in control participants (kappas 0.25 and 0.35) were also 
similar to Duell et al. control results (kappas 0.26 and 0.43), our PD cases reported these exposures with 
much higher repeatability (kappas 0.84 and 1.00) than the breast cancer patients (0.15 and 0.53). However, 
this difference may have been due to the lower occurrence of laundering farm worker clothing in our 
community-based study compared to Duell et al. study population which only included participants with a 
history of working or living on a farm.  
Repeatability of the lifestyle exposures, smoking, and coffee and tea consumption compared favourably 
with previous studies23–26. We obtained higher repeatability for a number of variables, including ‘years 
smoked’, ‘lifetime cigarettes smoked’, ‘current coffee-drinker (yes/no)’, and ‘current number of cups of 
coffee drunk per day’ than obtained in a study of bladder cancer cases and controls with benign urological 
conditions27. Our repeatability results for caffeine consumption (regular coffee/tea drinking) and alcohol 
consumption were similar to those obtained in a sample of patients with depressive disorders and healthy 
controls24 and higher than found in a general hospital sample25. The repeatability of our measures of passive 
smoking were similar to those reported by Pron et al.26 for residential environments (kappa 0.66). However, 
slightly higher repeatability was obtained in our sample for occupational passive smoke (kappa 0.62 vs 0.46).  
In general, case participants did not demonstrate lower or higher repeatability or a higher rate of missing 
responses, compared to control participants. Also, among those individual exposures with differential recall 
between cases and controls, no clear pattern was evident, suggesting that differences in recall repeatability 
between cases and controls were random in nature rather than due to systematic differences between cases 
and controls. Such non-differential exposure misclassification is more likely to result in dilution of the 
observed relationship rather than produce spurious associations. This also suggests that any PD-specific 
memory deficits present in the case group were not sufficient to impact substantially on exposure data 
repeatability compared to age-matched controls.  
 
5. Conclusions  
Reliable and valid measurement of environmental exposures is a challenge for epidemiological studies of 
PD aetiology. Our results demonstrate that many exposures of interest to PD aetiology can be measured with 
moderate to high repeatability using the interviewer-delivered questionnaire. Whilst some environmental 
exposures, such as pesticide, solvent and metal exposure demonstrated high repeatability, other exposures 
such as rural residency, and living near areas sprayed with agricultural pesticides showed lower repeatability. 
As such, the repeatability of exposure measurement should be considered in assessment of environmental 
exposures in studies of PD aetiology.  
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Abstract  
The prevalence of idiopathic Parkinson’s disease (IPD) in Australia is unclear. We estimated the 
prevalence of IPD, and other forms of parkinsonism, through the study of typical caseloads in general 
practice. A random sample of general practitioners (GPs) throughout Queensland (401 responses from 528 
validated practice addresses) was asked to estimate the numbers of patients with IPD and parkinsonism seen 
in the preceding year. The estimated prevalence of diagnosed IPD in Queensland was 146 per 100 000 (95% 
CI = 136–155). A further 51 per 100 000 in the population were suspected by doctors to have IPD without 
formal diagnosis, whereas another 51 per 100 000 people may have non-idiopathic parkinsonism. Idiopathic 
Parkinson’s disease was more common in rural than metropolitan areas. Although most GPs were confident 
in making diagnoses of IPD, the majority had little or no confidence in their ability to treat the disease, 
especially in its later stages. Support from neurologists was perceived by GPs to be very good in cities, but 
poor in remote areas.  
 
Keywords: General practice survey; Parkinson’s disease; Prevalence  
 
 
 
 
1. Introduction  
Little is known about the prevalence of idiopathic Parkinson’s disease (IPD) in Australia or the frequency 
with which people with IPD are seen in general practice. Three previous Australian epidemiological studies 
have reported prevalence estimates ranging from 66 to 415 per 100 000.1–3 These studies sampled small 
geographical regions and were unable to comment on the distribution of IPD on a state-or nation-wide basis. 
The Australian Institute of Health and Welfare based their estimate of the prevalence of Parkinson’s disease 
in Australia (200 per 100 000)4 on two published European studies5,6 and the population age and sex 
distributions of Australians.  
The primary aim of the present study was to describe the extent to which IPD and parkinsonian symptoms 
encountered in a representative cross-section of general practices throughout Queensland and, thereby, to 
estimate prevalence. A secondary aim of the present study was to assess the confidence of general 
practitioners (GPs) in their ability to diagnose and effectively treat IPD in the early and later stages of the 
illness. We also asked GPs about the adequacy of support available to them from specialist neurologists and 
about their contact with community based Parkinson’s disease support agencies.  
2. Methods  
2.1. Sample  
We drew a one-in-four stratified random sample of GPs listed on a Queensland Medical Education Centre 
database. Each of seven regional strata in the Rural, Remote and Metropolitan Areas (RRaMA) classification 
for Queensland was included (Capital City, Other Metropolitan Area, Large Rural Centre, Small Rural 
Centre, Other Rural Area, Remote Centre and Other Remote Area).7 Of the initial 728 GPs selected, 106 (one 
in seven) were chosen for a pilot study, with the remainder (639) being approached for the primary survey. 
Investigation by telephone of survey non-respondents revealed that only 528 of the 639 addresses could be 
validated as the current practice address of the selected registered GP. The final response rate, after follow-up 
letter and telephone contact, was 76% (401/528 of those for whom current, valid addresses in Queensland 
could be obtained).  
 
2.2. Procedure  
The postal questionnaire mailed to the GPs consisted of 10 questions, with the majority in multiple choice 
format. With regard to their primary practice location, the participating GPs were asked to estimate the 
approximate number of patients seen during the preceding 12 months: (i) with a confirmed diagnosis of IPD; 
(ii) with non-idiopathic parkinsonism; and (iii) whom they strongly suspected had IPD, but had not yet been 
diagnosed.  
General practitioners were also asked to indicate how confident they were in the diagnosis and treatment of 
IPD, the degree of access they had to neurologists and their familiarity with relevant community support 
agencies. Basic demographic information regarding the GP was also requested. Postcodes were used to 
allocate respondents to the appropriate RRaMA classification category.  
 
2.3. Subsidiary telephone survey of people with Parkinson’s disease  
A brief telephone survey of a convenient sample of people living with Parkinson’s disease who had contact 
with a state-wide support agency (Parkinson’s Queensland Incorporated; PQi) was conducted to obtain an 
estimate of the average number of GPs people with Parkinson’s disease consult over a 12-month period. We 
contacted individuals listed on the PQi database until 100 interviews were completed (response rate 90%). 
These data were used to adjust for the effects of double counting.  
 
2.4. Prevalence estimation  
Prevalence was estimated within each of three types of geographic areas: (i) metropolitan (RRaMA zones 1 
and 2); (ii) Rural (RRaMA zones 3, 4 and 5); and (iii) Remote (RRaMA zones 6 and 7). This was achieved 
using a simple algorithm with three steps, as follows:  
Step 1: Npatients = Rp/Rgp · TOTALgp  
Step 2: PrevIPD = Npatients/TOTALpop · 105  
Step 3: PrevIPD(adj) = PrevIPD/Meanconsults  
where Npatients is the estimated total number of patients with IPD in the area; Rp is the sum of patient 
numbers estimated by sampled GPs in the area, Rgp is the number of GPs in the sample for that area, 
TOTALgp is the total number of GPs in the area; TOTALpop is the estimated population size of the area8 and 
Meanconsults is the average number of different GPs visited by people with Parkinson’s disease in 1 year, 
estimated from a subsidiary telephone survey, to adjust for double counting. The 95% confidence intervals 
(CI) for the prevalence estimates were calculated according to the method of Haenszel et al.9  
 
 
 
3. Results  
3.1. Sample characteristics  
Of the 401 GP respondents, 377 (94%) stated that they were currently in general practice. The remainder 
were removed from subsequent analysis. Of the 377 GPs included in the study, 135 (35.8%) were female and 
the age of the GPs ranged from <30 to >70 years (modal group = 40–49 years). Female GPs were 
significantly more likely than male GPs to be in the younger age bands (v2
 
= 52.6, df= 10, p < 0.01). Time at 
the current, primary practice location ranged from 4 months to 46 years (mean ±SD = 11.4 ± 8.4 years). The 
geographic distribution of GPs was as follows: metropolitan 59%; rural 33%; and remote 8%.  
3.2. Estimated cases of parkinsonism and IPD  
Estimates of the prevalence of IPD, non-idiopathic parkinsonism and suspected cases are summarized in 
Table 1. Approximately three-quarters of all GPs had at least one patient with IPD. However, caseloads were 
quite low on average, with 81.9% of responding GPs (304/371) estimating that they had fewer than five IPD 
patients in the preceding year and more than 90% estimating that they saw fewer than five patients with other 
types of parkinsonism in the preceding year.  
Table 1 Number of cases of idiopathic Parkinson’s disease, non-idiopathic parkinsonism and suspected 
cases of idiopathic Parkinson’s disease reported by general practitioners 
IPD Non-IPD Suspected IPD No. patients 
reported n % n % n % 
No response  6  1.6  13  3.5  13  3.5 
None  87  23.8  197  53.7  159  43.3  
1  65  17.8  87  23.7  126  34.3  
2  74  20.2  45  12.3  40  10.9  
3  34  9.3 6  1.6  19  5.2  
4  34  9.3  8  2.2  5  1.4  
5–7  50  13.7  8  2.2  5  1.4  
8–10  14  3.8  1  0.3  0  0.0  
11–15  1  0.3 1  0.3  0  0.0  
16–20  1  0.3  1  0.3  0  0.0  
Total  366  100  367 100 367 100 
IPD = idiopathic Parkinson’s disease.  
 
Prevalence estimates for each category of parkinsonism in each geographic area are given in Table 2. Of all 
parkinsonism encountered by GPs, approximately 60% appeared to occur among patients who have a formal 
diagnosis. It also appears likely that IPD is more common in rural and remote regions than in metropolitan 
locations.  
 
3.3. General practitioner confidence in the diagnosis and management of IPD  
Three questions focused on the level of confidence of GPs in their ability to diagnose and treat early and 
late-stage IPD (Table 3). The majority of GPs were quite confident in their ability to diagnose IPD (67.9% 
were either moderately or very confident). However, more than half said they were only ‘a little’ or ‘not at 
all’ confident in their ability to treat the early (60.2%) and late (68.4%) stages of the disease.  
There was no significant relationship between the age of the GP and confidence in treating the late stages 
of this disease (v 2 = 8.062, df = 6, p = 0.234). However, younger GPs (< 30 years) were less confident than 
older GPs (40+ years) in their ability to diagnose IPD (v 2 = 13.721, df = 6, p = 0.033) and to treat the 
condition in the early stages (v 2 = 20.189, df = 6, p = 0.003). Gender and geographic location were not 
associated with decreased confidence in the ability to diagnose and treat early IPD.  
3.4. Perceived adequacy of support from neurologists  
Of the GPs who answered the question, the majority (256/362; 70.7%) reported ‘regular, easy access’ or 
‘quite good access’ to this specialist service (Table 4). However, perceived adequacy was very strongly 
influenced by geographic location (v 
2 
= 87.0, df = 6, p < 0.0001). As would be expected, those GPs working 
in metropolitan areas reported better access to neurologist support than those from rural and remote centres.  
 
Table 2: Prevalence of parkinsonism per 100 000 of population in rural, remote and metropolitan areas 
RRaMA  IPD Non–IPD Suspected IPD Population 65+years  
Metropolitan 
Rural  
Remote 
Queensland  
130 (119–142) 
164 (147–182) 
208 (160–270) 
145 (136–155) 
41 (35–48) 
64 (54–76) 
82 (53–121) 
51 (45–57) 
47 (41–55) 
54 (45–65) 
72 (45–110) 
51 (45–57) 
12.1% 
12.3% 
7.9% 
12.0% 
Data show the prevalence estimates for each category of parkinsonism in each geographic area, with 95% 
confidence intervals given in parentheses. RRaMA = Rural, Remote and Metropolitan Areas, IPD = idiopathic 
Parkinson’s disease.  
 
Table 3 Confidence of general practitioners in their ability to diagnose and treat Parkinson’s disease 
 Treatment 
 Diagnosis Early stages Late stages 
Response n % n % n % 
Very confident 17 4.5 18 4.8 15 4.1 
Moderately confident 239 63.4 129 34.2 102 27.6 
A little confident 94 24.9 158 41.9 147 39.7 
Not at all confident 20 5.3 65 17.2 106 28.1 
Missing response 7 1.9 7 1.9 7 1.9 
Total 377 100 377 100 377 100 
 
Table 4 General practitioners’ perceived access to specialist neurology services in diﬀerent geographical settings 
 Geographic classification  
 Metropolitan (RRaMA 1-2) Rural (RRaMA 3–5) Remote (RRaMA 6-7) Total 
 n % n % n % n % 
Regular, easy access  89 42 21 17.5 6 20 116 32 
Quite good access  92 43.4 42 35 6 20 140 38.7 
Limited access  26 12.2 40 33.3 5 16.7 71 19.6 
Very limited access  5 2.4 17 14.2 13 43.3 35 9.7 
Total  212 100 120 100 30 100 362 100 
RRaMA = Rural, Remote and Metropolitan Areas. 
 
3.5. Awareness of the main Parkinson’s disease support agency  
More than half of all GPs (223/373; 59%) said they were aware of PQi, which is the major community 
support agency for people with Parkinson’s disease in the state. Of these GPs, 94/222 (42.3%) had 
recommended PQi to their patients. The geographic location of the primary practice was not significantly 
associated with awareness of this agency.  
4. Discussion  
The present study represents the first state-wide GP survey to measure prevalence of parkinsonism and IPD 
in Australia and is one of few studies to have estimated the prevalence of this disease in Australia generally. 
The inclusion of the entire state of Queensland allowed investigation of the distribution of IPD in 
metropolitan, rural and remote regions of the state. By including a large area for the study, the results of the 
present study may be more representative than studies confined to small geographic locations, such as 
previous attempts to ascertain the prevalence of IPD in Australia.1–3 In addition, the present study is novel in 
that it reports the perceptions of GPs with regard to the diagnosis and treatment of parkinsonism in Australia 
in different practice settings. The only other published study of IPD prevalence in Queensland was conducted 
by McCann et al.2 Methodological differences can explain the difference in the estimated prevalence reported 
by McCann et al.2 of 415 per 100 000 and our more conservative figure of 145 (95% CI 136–155) per 100 
000. First, the study of McCann et al.2 was restricted to the rural town of Nambour on Queensland’s Sunshine 
Coast. Second, their prevalence estimate was based on only five participants with IPD, resulting in a very 
wide 95% CI of 53–775 per 100 000. The prevalence estimate calculated in the present study is also lower 
than the crude estimate of 360 per 100 000 derived from a door-to-door survey of residents aged between 55 
and 90 years in the Randwick area of Sydney (NSW, Australia).3  
The prevalence estimate of 145 per 100 000 compares favourably with the average prevalence of IPD 
estimated in collaborative population-based European studies (180 per 100 000)10 and other studies of 
prevalence in the western world.11 Unfortunately, our methodology does not enable us to comment on the 
influence of age or sex on the prevalence of IPD in Queensland. It is generally accepted from international 
studies that population-corrected prevalence increases steadily with increasing age with little, if any, gender 
difference in prevalence.10  
The present study identified a significantly higher prevalence of IPD and non-idiopathic parkinsonism in 
rural/remote regions compared with metropolitan Brisbane (Queensland, Australia). Three other prevalence 
studies have examined differences in prevalence between urban and rural areas. Our data support the 
population-based studies of Tandberg et al.12 (Norway) and Kuopio et al.13 (Finland), which suggest that IPD 
is more common in rural areas. Numerous case-control studies also lend support for the notion that rural 
residency increases the risk for IPD.2,14–19 Other epidemiological studies suggest that this association may be 
causal and due to the increased likelihood of agricultural exposures in rural areas.20–22 However, contradictory 
studies are not uncommon23,24 and the exact nature of the causal exposures in rural environments remains 
unclear. Queensland has a diverse mix of agriculture, mining and various manufacturing industries, mainly 
located in non-metropolitan regions of the state, which provide potential exposure to a range of putative 
agents, such as pesticides, solvents and metals.  
Although prevalence estimates in the present study are not age adjusted, examination of the age structures 
of the three main geographical categories (Metropolitan, Rural and Remote) suggests that the higher 
prevalence of parkinsonism in rural and remote areas is not a result of regional differences in the population’s 
age structure. In fact, the percentage of the population over 65 years of age in remote areas is lower than in 
metropolitan areas (Table 2), suggesting that age-adjusted prevalence in non-metropolitan areas may be 
higher than our uncorrected estimates.  
Epidemiological surveys of relatively rare diseases are difficult when population density is low. Door-to-
door surveys using screening tools and physician assessment with simple random samples produce the most 
accurate estimates of the prevalence of neurological disease in localized areas.11 However, such surveys tend 
to be prohibitively expensive, making it extremely difficult to examine geographical differences with 
sufficient power. This is particularly true in a large country, such as Australia.  
Surveys of patient numbers in general medical practice offer a reasonable alternative for accurately 
estimating the prevalence of IPD in Australia and exploring prevalence trends. Such surveys may be superior 
to studies of neurologists’ caseloads or pharmaceutical prescriptions for the following two reasons. First, 
there is good public access to GPs in all but the most remote locations of Australia. Second, the majority of 
people with moderate or severe IPD have regular contact with GPs, irrespective of whether they are currently 
receiving pharmaceutical treatment.  
The present study has several important limitations. First, cases are only counted if they seek medical 
attention. For this reason, people with mild symptoms may go unrecognized, leading to underestimation of 
the actual prevalence of IPD in Queensland. Previous door-to-door surveys of prevalence provide some 
insight into this potential underestimation. For example, of the IPD cases identified in the Rotterdam study, 
12% were newly diagnosed and some Spanish studies have reported significantly higher levels of new 
diagnoses (27–68%) depending on the screening tool used and the type of health services available in the 
surveyed region.25  
In the only Australian door-to-door survey of the prevalence of IPD, Chan et al.
3 
found that eight of 19 
cases (42%) were new diagnoses, which suggests a significant risk of underestimation if we rely solely on 
GPs’ estimates of diagnosed cases in their practice. We addressed this problem indirectly by asking GPs to 
identify the number of patients they suspected of ‘undiagnosed’ IPD, yielding an estimated figure of 51 per 
100 000 (Table 2). Interestingly, including all of this undiagnosed component into the prevalence estimate 
would inflate the figure to 196 per 100 000 (a 35% increase), which is very close to the estimate of 200 per 
100 000 calculated by Mathers et al.4 on the basis of European studies.  
A second limitation to our method is the reliance on GPs to provide accurate estimates of their caseloads 
and on their diagnostic abilities to recognise parkinsonism and distinguish between IPD and non-idiopathic 
parkinsonism. Even in the hands of expert movement disorders neurologists, these clinical distinctions may 
prove challenging.26,27. We provided no standard definition of IPD to the survey participants. We included 
non-idiopathic parkinsonism and suspected IPD in the survey to minimize potential error in the classification 
of individuals with parkinsonian syndromes. Nonetheless, given that only 67.9% of GPs surveyed were either 
‘very confident’ or ‘moderately confident’ in their ability to diagnose IPD (Table 3), some misclassification 
of patients with parkinsonian symptoms would be expected. There are also other potential limitations related 
to the use of self-reported questionnaires, including the possibility for respondents to misinterpret the 
questions.  
Although the majority of GPs surveyed reported ‘quite good’ or ‘regular easy’ access to neurologists, it is 
clear that limitations exist in rural and remote regions of the state. General practitioners play an important role 
in managing IPD. Many people with IPD do not consult a neurologist and rely solely on GPs for the 
management of their condition. Textbooks on medicine and neurology often imply that Parkinson’s disease is 
easily diagnosed and managed. However, the diagnosis is often difficult owing to the absence of confirmatory 
laboratory tests. Often, treatment strategies can be complex and very much individualized to patients’ needs, 
particularly in the later stages of the illness. Our analysis reveals that there are substantial differences between 
GPs in their ability to diagnose and treat Parkinson’s disease, with young clinicians reporting less confidence 
in their abilities.  
Approximately 90% of GPs identified a need for postgraduate training in the diagnosis and management of 
IPD and other neurological conditions. With the ageing of our society, the prevalence of IPD is expected to 
increase in the coming decades. Therefore, it is essential that GPs be adequately trained to deal with these 
problems. Interdisciplinary and collaborative approaches involving GPs, neurologists, allied health 
professionals, basic scientists and community support organizations will help to address these needs.  
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